<SEC-DOCUMENT>0001193125-16-734735.txt : 20161011
<SEC-HEADER>0001193125-16-734735.hdr.sgml : 20161011
<ACCEPTANCE-DATETIME>20161011070658
ACCESSION NUMBER:		0001193125-16-734735
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		8
CONFORMED PERIOD OF REPORT:	20161201
FILED AS OF DATE:		20161011
DATE AS OF CHANGE:		20161011
EFFECTIVENESS DATE:		20161011

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MYRIAD GENETICS INC
		CENTRAL INDEX KEY:			0000899923
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				870494517
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26642
		FILM NUMBER:		161929343

	BUSINESS ADDRESS:	
		STREET 1:		320 WAKARA WAY
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84108
		BUSINESS PHONE:		801-584-3600

	MAIL ADDRESS:	
		STREET 1:		320 WAKARA WAY
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84108
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d257749ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML><HEAD>
<TITLE>DEF 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C.&nbsp;20549 </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
</B></P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section 14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(Amendment No.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ) </B></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed by a Party other than the
Registrant&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preliminary Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B><FONT STYLE="white-space:nowrap">Confidential,&nbsp;for&nbsp;Use&nbsp;of&nbsp;the&nbsp;Commission&nbsp;Only&nbsp;(as&nbsp;permitted&nbsp;by&nbsp;Rule&nbsp;14a-6(e)(2))</FONT></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Additional Materials</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Soliciting Material Under Rule 14a-12</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B>Myriad Genetics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">No fee required.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title of each class of securities to which transaction applies:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aggregate number of securities to which transaction applies:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing
fee is calculated and state how it was determined):</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Proposed maximum aggregate value of transaction:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">5)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total fee paid:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee paid previously with preliminary materials.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously.&nbsp;Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amount previously paid:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Form, Schedule or Registration Statement No:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filing party:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date Filed:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MYRIAD GENETICS, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">October 11, 2016 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Stockholders, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You are cordially invited to attend the 2016 Annual Meeting of Stockholders of Myriad Genetics, Inc. (the &#147;Annual Meeting&#148;) to be
held at 9:00 a.m. MST on Thursday, December 1, 2016, at our offices at 320 Wakara Way, Salt Lake City, Utah.&nbsp;Details regarding the meeting, the business to be conducted, and information about Myriad Genetics, Inc. that you should consider when
you vote your shares are described in this proxy statement.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the Annual Meeting, two persons will be elected to our Board of
Directors.&nbsp;We also will seek stockholder approval to amend our 2010 Employee, Director and Consultant Equity Incentive Plan and ask stockholders to ratify the selection of Ernst &amp; Young LLP as our independent registered public accounting
firm for the fiscal year ending June 30, 2017.&nbsp;In addition, we will seek stockholder approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in this proxy statement.&nbsp;The Board of Directors
recommends the approval of all of these proposals.&nbsp;Other business will be transacted that may be properly addressed during the Annual Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Securities and Exchange Commission rules that allow companies to furnish proxy materials to stockholders over the Internet, we have
elected to deliver our proxy materials to the majority of our stockholders in this manner.&nbsp;We believe this process will facilitate the accelerated delivery of proxy materials, save costs and reduce the environmental impact of our Annual
Meeting.&nbsp;On or about October 11, 2016, we began sending our stockholders a Notice of Internet Availability of Proxy Materials containing instructions on how to access the proxy statement for our 2016 Annual Meeting of Stockholders and our 2016
annual report to stockholders.&nbsp;The Notice also provides instructions on how to vote online or by telephone and how to receive a paper copy of the proxy materials by mail. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hope you will be able to attend the Annual Meeting.&nbsp;Whether you plan to attend the meeting or not, it is important that you cast your
vote.&nbsp;You may vote over the Internet as well as by telephone.&nbsp;In addition, if you requested printed proxy materials, you may vote by completing, signing, dating and returning your proxy card by mail.&nbsp;You are urged to vote promptly in
accordance with the instructions provided in the Notice of Internet Availability of Proxy Materials or on your proxy card.&nbsp;We encourage you to vote by proxy so that your shares will be represented and voted at the meeting, whether or not you
attend. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Sincerely, </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt; margin-left:54%; text-indent:-2%">


<IMG SRC="g257749g09i36.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Mark C. Capone </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">President and Chief Executive Officer </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Your vote is important.&nbsp;Please vote as soon as possible by using the Internet or by telephone or, if you received a paper copy of the proxy card by
mail, by completing, signing, dating, and returning the enclosed proxy card.&nbsp;Instructions for your voting options are described on the Notice of Internet Availability of Proxy Materials or proxy card. </B></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MYRIAD GENETICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>320 Wakara Way </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Salt Lake
City, Utah 84108 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF 2016 ANNUAL MEETING OF STOCKHOLDERS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TIME:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9:00 a.m. MST</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DATE:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Thursday, December 1, 2016</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PLACE:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">The offices of Myriad Genetics, Inc., 320 Wakara Way, Salt Lake City, Utah 84108</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PURPOSES: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top">To elect two Class II directors to the Board of Directors to serve three-year terms expiring in 2019; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top">To approve a proposed amendment to our 2010 Employee, Director and Consultant Equity Incentive Plan; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top">To ratify the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2017; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top">To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in this proxy statement; and</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top">To transact such other business that is properly presented at the Annual Meeting and any adjournments or postponements thereof. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WHO MAY VOTE: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may vote if you were an owner of record of
Myriad Genetics, Inc. common stock at the close of business on October 5, 2016. A list of stockholders of record will be available at the Annual Meeting and, during the 10 days prior to the meeting, at the office of the Secretary at the above
address. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All stockholders are cordially invited to attend the Annual Meeting.&nbsp;Whether you plan to attend the meeting or not, please vote by
following the instructions on the Notice of Internet Availability of Proxy Materials that you have previously received, which we refer to as the Notice, or in the section of this proxy statement entitled &#147;Important Information About the Annual
Meeting and Voting &#150; How Do I Vote?&#148; or, if you requested printed proxy materials, your proxy card. You may change or revoke your proxy at any time before it is voted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On or about October 11, 2016, we began sending the Notice of Internet Availability of Proxy Materials to all stockholders entitled to vote at the annual
meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">BY ORDER OF THE BOARD OF DIRECTORS </P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt; margin-left:54%; text-indent:-2%">


<IMG SRC="g257749g42x55.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Richard M. Marsh </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Secretary </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October 11, 2016
</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE STOCKHOLDER MEETING TO
BE HELD ON DECEMBER 1, 2016 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>This proxy statement and our annual report to stockholders for the fiscal year ended June 30, 2016 are
available for viewing, printing, and downloading at </B><B><I>www.proxyvote.com</I></B><B>.&nbsp;To view these materials, please have available your 12-digit control number(s) that appears on your Notice or proxy card.&nbsp;On this website, you can
also elect to receive future distributions of our proxy statements and annual reports to stockholders by electronic delivery. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Additionally, you may find a copy of our Annual Report on Form 10-K, as amended, which includes our financial statements for the fiscal
year ended June 30, 2016, on the website of the Securities and Exchange Commission at </B><B><I>www.sec.gov</I></B><B>, or in the &#147;Financial Reporting/SEC Filings&#148; section of the &#147;Investors&#148; section of our website at
</B><B><I>www.myriad.com.</I></B><B> You&nbsp;also may obtain a printed copy of our Annual Report on Form 10-K, as amended, including our financial statements from us, free of charge, by sending a written request to: Secretary, Myriad Genetics,
Inc., 320 Wakara Way, Salt Lake City, Utah 84108.&nbsp;Exhibits will be provided upon written request and payment of an appropriate processing fee. </B></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MYRIAD GENETICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>320 WAKARA WAY </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SALT LAKE
CITY, UTAH&nbsp;84108 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(801) 584-3600 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROXY
STATEMENT FOR THE MYRIAD GENETICS, INC. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2016 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON DECEMBER 1, 2016 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This proxy statement, along with the accompanying Notice of 2016 Annual Meeting of Stockholders, contains information about the 2016 Annual
Meeting of Stockholders of Myriad Genetics, Inc., including any adjournments or postponements of the annual meeting, which we refer to as the Annual Meeting.&nbsp;In this proxy statement, we refer to Myriad Genetics, Inc. as &#147;Myriad,&#148;
&#147;the Company,&#148; &#147;we&#148; and &#147;us.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This proxy statement relates to the solicitation of proxies by our Board of
Directors for use at the Annual Meeting.&nbsp;On or about October 11, 2016, we began sending the Notice of Internet Availability of Proxy Materials, which we refer to throughout this proxy statement as the Notice, to all stockholders entitled to
vote at the Annual Meeting. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IMPORTANT INFORMATION ABOUT THE ANNUAL MEETING AND VOTING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Why is the Company Soliciting My Proxy? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors of Myriad Genetics, Inc. is soliciting your proxy to vote at the Annual Meeting to be held at our offices, 320 Wakara
Way, Salt Lake City, Utah, on Thursday, December 1, 2016, at 9:00 a.m. MST and any adjournments of the Annual Meeting.&nbsp;The proxy statement, along with the accompanying Notice of 2016 Annual Meeting of Stockholders, summarizes the purposes of
the Annual Meeting and the information you need to know to vote at the meeting.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have sent you the Notice and made this proxy statement,
the Notice of 2016 Annual Meeting of Stockholders, and our annual report to stockholders for the fiscal year ended June 30, 2016 available to you on the Internet because you owned shares of Myriad Genetics, Inc. common stock on the record
date.&nbsp;We also have delivered printed versions of these materials to certain stockholders by mail.&nbsp;The Company commenced distribution of the Notice and the proxy materials to stockholders on or about October 11, 2016. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Why Did I Receive a Notice in the Mail Regarding the Internet Availability of Proxy Materials Instead of a Full Set of Proxy Materials? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As permitted by the rules of the U.S. Securities and Exchange Commission, or the SEC, we may furnish our proxy materials to our stockholders by
providing access to such documents on the Internet, rather than mailing printed copies of these materials to each stockholder.&nbsp;Most stockholders will not receive printed copies of the proxy materials unless they request them.&nbsp;We believe
that this process should expedite stockholders&#146; receipt of proxy materials, lower the costs of the Annual Meeting and help to conserve natural resources.&nbsp;If you received a Notice by mail or electronically, you will not receive a printed or
email copy of the proxy materials, unless you request one by following the instructions included in the Notice.&nbsp;Instead, the Notice will provide instructions on how you may access and review all of the proxy materials and submit your proxy on
the Internet or by telephone.&nbsp;If you requested a paper copy of the proxy materials, you may authorize the voting of your shares by following the instructions on the enclosed proxy card, in addition to the other methods of voting described in
this proxy statement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who Can Vote? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Only stockholders who owned Myriad Genetics, Inc. common stock at the close of business on October 5, 2016 are entitled to vote at the Annual
Meeting.&nbsp;On this record date, there were 68,777,570 shares of our common stock outstanding and entitled to vote.&nbsp;Common stock is our only class of voting stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You do not need to attend the Annual Meeting to vote your shares.&nbsp;Shares represented by valid proxies, received in time for the Annual
Meeting and not revoked prior to the meeting, will be voted at the meeting.&nbsp;For instructions on how to change or revoke your proxy, see &#147;May I Change or Revoke My Proxy?&#148; below.</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How Many Votes Do I Have? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each share of
Myriad Genetics, Inc. common stock that you owned at the close of business on the record date, October 5, 2016, entitles you to one vote. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How Do I
Vote? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whether you plan to attend the Annual Meeting or not, we urge you to vote by proxy. All shares represented by valid proxies that
we receive through this solicitation, and that are not revoked, will be voted in accordance with your instructions on the proxy card or as instructed via Internet or telephone. You may specify whether your shares should be voted for or withheld for
each nominee for director, and whether your shares should be voted for, against or abstain with respect to each of the other proposals.&nbsp;If you properly submit a proxy without giving specific voting instructions, your shares will be voted in
accordance with the board&#146;s recommendations as noted below.&nbsp;Voting by proxy will not affect your right to attend the Annual Meeting. If your shares are registered directly in your name through our stock transfer agent, American Stock
Transfer and Trust Company, or you have stock certificates registered in your name, you may vote: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B>By Internet or by telephone.</B>&nbsp;Follow the instructions included in the Notice or, if you received printed materials, in the proxy card, to vote by Internet or telephone. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B>By mail.</B>&nbsp;If you received your proxy materials by mail, you can vote by completing, signing, dating and returning the proxy card as instructed on the card. If you sign the proxy card but do not specify how
you want your shares voted, they will be voted in accordance with the board&#146;s recommendations as noted below. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B>In person at the meeting.</B> If you attend the Annual Meeting, you may deliver a completed proxy card in person or you may vote by completing a ballot that will be available at the Annual Meeting. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Telephone and Internet voting facilities for stockholders of record will be available 24-hours-a-day and will close at 11:59 p.m. EST on
November 30, 2016. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If your shares are held in &#147;street name&#148; (held in the name of a bank, broker or other holder of record), you
will receive instructions from the holder of record. You must follow the instructions of the holder of record in order for your shares to be voted. Telephone and Internet voting also will be offered to stockholders owning shares through certain
banks and brokers. If your shares are not registered in your own name and you plan to vote your shares in person at the Annual Meeting, you should contact your broker or agent to obtain a legal proxy or broker&#146;s proxy card and bring it to the
meeting in order to vote. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How Does the Board of Directors Recommend That I Vote on the Proposals? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors recommends that you vote as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">&#147;<B>FOR&#148;</B> the election of the two Class II directors for director; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">&#147;<B>FOR</B>&#148; the amendment to our 2010 Employee, Director and Consultant Equity Incentive Plan; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">&#147;<B>FOR</B>&#148; the ratification of the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for our fiscal year ending June 30, 2017; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">&#147;<B>FOR&#148;</B> the compensation of our named executive officers, as disclosed in this proxy statement. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any other matter is presented, your proxy provides that your shares will be voted by the proxy holder listed in the proxy in accordance
with his or her best judgment.&nbsp;At the time this proxy statement was first made available, we knew of no matters that needed to be acted on at the Annual Meeting, other than those described in this proxy statement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>May I Change or Revoke My Proxy? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you
give us your proxy, you may change or revoke it at any time before the Annual Meeting.&nbsp;You may change or revoke your proxy in any of the following ways: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">By re-voting by Internet or by telephone as instructed above; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">If you received printed proxy materials, by signing a new proxy card with a date later than your previously delivered proxy and submitting it as instructed above; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">By notifying our Secretary in writing before the Annual Meeting that you have revoked your proxy; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">By attending the Annual Meeting and voting in person.&nbsp;Attending the Annual Meeting in person will not in and of itself revoke a previously submitted proxy unless you specifically request it. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Your most current vote, whether by telephone, Internet or proxy card, is the one that will be counted. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What if I Receive More Than One Notice or Proxy Card? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may receive more than one Notice or proxy card if you hold shares of our common stock in more than one account, which may be in registered
form or held in street name.&nbsp;Please vote in the manner described under &#147;How Do I Vote?&#148; for each account to ensure that all of your shares are voted. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Will My Shares Be Voted if I Do Not Vote? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If your shares are registered in your name, they will not be voted if you do not vote as described above under &#147;How Do I
Vote?&#148;&nbsp;If your shares are held in street name and you do not provide voting instructions to the bank, broker or other holder of record of your shares as described above, the holder of record has the authority to vote your unvoted shares
only on Proposal 3 if it does not receive instructions from you.&nbsp;Therefore, we encourage you to provide voting instructions.&nbsp;This ensures that your shares will be voted at the Annual Meeting and in the manner you desire.&nbsp;When your
broker cannot vote your shares on a particular matter because it has not received instructions from you and does not have discretionary voting authority or because your broker chooses not to vote on a matter for which it does have discretionary
voting authority, it is referred to as a &#147;broker non-vote.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Your bank, broker or other nominee does not have the ability to
vote your uninstructed shares in the election of directors. Therefore, if you hold your shares in a street name it is critical that you cast your vote if you want your vote to be counted for the election of directors (Proposal 1 of this proxy
statement).&nbsp;In the past, if you held your shares in a street name and you did not indicate how you wanted your shares voted in the election of directors, your bank, broker or other nominee was allowed to vote your shares on your behalf as it
deemed appropriate. In addition, your bank, broker or other nominee is prohibited from voting your uninstructed shares on any matters related to the equity incentive plan and executive compensation. Thus, if you hold your shares in a street name and
do not instruct your bank, broker or other nominee how to vote in the election of directors, on matters related to the equity incentive plan, or executive compensation, no votes will be cast on these proposals on your behalf. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What Vote is Required to Approve Each Proposal and How are Votes Counted?</B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Proposal 1:&nbsp;Elect Directors </B></P></TD>
<TD>The nominees for director who receive the most votes (also known as a &#147;plurality&#148; of the votes) will be elected.&nbsp;Abstentions are not counted for purposes of electing directors.&nbsp;You may vote either FOR all of the nominees,
WITHHOLD your vote from all of the nominees or WITHHOLD your vote from any one or more of the nominees.&nbsp;Votes that are withheld will not be included in the vote tally for the election of directors.&nbsp;Brokerage firms do not have the authority
to vote customers&#146; unvoted shares held by the firms in a street name on this proposal; therefore, any shares not voted by a customer will be treated as a broker non-vote.&nbsp;Such broker non-votes will have no effect on the results of this
vote.</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Proposal 2:&nbsp;Approve the Amendment of the Myriad Genetics, Inc. 2010 Employee, Director and
Consultant Equity Incentive Plan&nbsp;&nbsp;&nbsp;&nbsp; </B></P></TD>
<TD>The affirmative vote of a majority of the shares voted affirmatively or negatively for this proposal is required to approve the amendment of the Myriad Genetics, Inc. 2010 Employee, Director and Consultant Equity Incentive Plan.&nbsp;Abstentions
will have no effect on the results of this vote.&nbsp;Brokerage firms do not have authority to vote customers&#146; unvoted shares held by the firms in street name on this proposal; therefore, any shares not voted by a customer will be treated as a
broker non-vote.&nbsp;Such broker non-votes will have no effect on the results of this vote. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Proposal 3:&nbsp;Ratify the Selection of our Registered Independent Public Accounting Firm </B></P></TD>
<TD>The affirmative vote of a majority of the shares voted affirmatively or negatively for this proposal is required to ratify the selection of Ernst &amp; Young LLP as our independent registered public accounting firm.&nbsp;Abstentions will have no
effect on the results of this vote.&nbsp;Brokerage firms have authority to vote customers&#146; unvoted shares held by the firms in a street name on this proposal. If a broker does not exercise this authority, such broker non-votes will have no
effect on the results of this vote. We are not required to obtain the approval of our stockholders to select our independent registered public accounting firm. However, if our stockholders do not ratify the selection of Ernst &amp; Young LLP as our
independent registered public accounting firm for the fiscal year ending June 30, 2017, our Audit Committee of our Board of Directors will reconsider its selection. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Proposal 4:&nbsp;Approve, on an Advisory Basis,&nbsp;&nbsp;&nbsp;&nbsp; the Compensation of Our Named
Executive Officers </B></P></TD>
<TD>The affirmative vote of a majority of the shares voted affirmatively or negatively for this proposal is required to approve, on an advisory basis, the compensation of our named executive officers, as disclosed in this proxy statement.
Abstentions will have no effect on the result of this vote.&nbsp;Brokerage firms do not have authority to vote customers&#146; unvoted shares held by such firms in street name on this proposal. As a result, any shares not voted by a customer will be
treated as a broker non-vote. Such broker non-votes will have no effect on the results of this vote. Although the advisory vote is non-binding, the Compensation Committee and the Board of Directors will review the voting results and take them into
consideration when making future decisions regarding the compensation of our named executive officers. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Is Voting Confidential? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will keep all the proxies, ballots and voting tabulations private.&nbsp;We only let our Inspector of Elections and our transfer agent,
American Stock Transfer and Trust, examine these documents.&nbsp;Management, other than the Inspector of Elections Richard Marsh, General Counsel and Secretary, will not know how you voted on a specific proposal unless it is necessary to meet legal
requirements.&nbsp;We will, however, forward to management any written comments you make on the proxy card or elsewhere. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Where Can I Find the Voting
Results of the Annual Meeting? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preliminary voting results will be announced at the Annual Meeting, and we will publish
preliminary, or final results if available, in a Current Report on Form 8-K within four business days of the Annual Meeting.&nbsp;If final results are unavailable at the time the Form 8-K is filed, we will file an amended report on Form 8-K to
disclose the final voting results within four business days after the final results are known.</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What Are the Costs of Soliciting these Proxies? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will pay all of the costs of soliciting these proxies.&nbsp;Our directors and employees may solicit proxies in person or by telephone, fax
or email.&nbsp;We will pay these employees and directors no additional compensation for these services.&nbsp;We will ask banks, brokers and other institutions, nominees and fiduciaries to forward these proxy materials to their principals and to
obtain authority to deliver proxies.&nbsp;We will then reimburse them for their expenses. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What Constitutes a Quorum for the Annual Meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The presence, in person or by proxy, of the holders of a majority of the outstanding shares of our common stock is necessary to constitute a
quorum at the Annual Meeting.&nbsp;Votes of stockholders of record who are present at the meeting in person or by proxy, abstentions, and broker non-votes are counted for purposes of determining whether a quorum exists. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Attending the Annual Meeting </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Annual
Meeting will be held at 9:00 a.m. MST on Thursday, December 1, 2016 at the offices of Myriad Genetics, Inc., 320 Wakara Way, Salt Lake City, Utah 84108.&nbsp;When you arrive at our offices, our personnel will direct you to the appropriate meeting
room.&nbsp;You need not attend the Annual Meeting to vote. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Householding of Annual Disclosure Documents </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SEC rules concerning the delivery of annual disclosure documents allow us or your broker to send a single Notice or, if applicable, a single
set of our proxy materials to any household at which two or more of our stockholders reside, if we or your broker believe that the stockholders are members of the same family. This practice, referred to as &#147;householding,&#148; benefits both you
and us. It reduces the volume of duplicate information received at your household and helps to reduce our expenses. The rule applies to our Notices, annual reports, proxy statements and information statements. Once you receive notice from your
broker or from us that communications to your address will be &#147;householded,&#148; the practice will continue until you are otherwise notified or until you revoke your consent to the practice.&nbsp;Stockholders who participate in householding
will continue to have access to and utilize separate proxy voting instructions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If your household received a single Notice or, if
applicable, set of proxy materials this year, but you would prefer to receive your own copy, please contact Broadridge by calling their toll free number 1-800-542-1061.&nbsp;If you do not wish to participate in &#147;householding&#148; and would
like to receive your own Notice or, if applicable, a set of proxy materials in future years, follow the instructions described below. Conversely, if you share an </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
address with another Myriad Genetics, Inc. stockholder and together both of you would like to receive only a single Notice or, if applicable, set of proxy materials, follow these instructions:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">If your Myriad Genetics, Inc. shares are registered in your own name, please contact Broadridge and inform them of your request by calling them at 1-800-542-1061 or writing them at Broadridge Householding Department, 51
Mercedes Way, Edgewood, NY 11717. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">If a broker or other nominee holds your Myriad Genetics, Inc. shares, please contact the broker or other nominee directly and inform them of your request. Be sure to include your name, the name of your brokerage firm
and your account number. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Electronic Delivery of Company Stockholder Communications </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Most stockholders can elect to receive notices of the availability of future proxy materials by email instead of receiving a paper copy in the
mail.&nbsp;You can choose this option and save the cost of producing and mailing these documents by following the instructions provided on your Notice or proxy card or following the instructions provided when you vote over the Internet at
<I>www.proxyvote.com</I>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth certain information with respect to the beneficial ownership of our common stock as of September 1, 2016 for
(a) each stockholder that we know to be the beneficial owner of more than 5% of our common stock, (b) each of our executive officers named in the Summary Compensation Table of this proxy statement (the &#147;Named Executive Officers&#148; or
&#147;NEOs&#148;), (c) each of our directors and director nominees, and (d) all of our current directors and executive officers as a group. Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment
power with respect to the securities.&nbsp;We deem shares of common stock that may be acquired by an individual or group within 60 days of September 1, 2016 pursuant to the exercise of options and the vesting of restricted stock unit awards to be
outstanding for the purpose of computing the percentage ownership of an individual or group, but are not deemed to be outstanding for the purpose of computing the percentage ownership of any other person shown in the table.&nbsp;Except as indicated
in footnotes, we believe that the stockholders named in this table have sole voting and investment power with respect to all shares of common stock shown to be beneficially owned by them based on information provided to us by these
stockholders.&nbsp;Percentage of ownership is based on 68,546,330 shares of common stock outstanding on September 1, 2016. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>
<TD WIDTH="77%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Shares&nbsp;Beneficially&nbsp;Owned</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:68.85pt; font-size:8pt; font-family:Times New Roman">Name and Address**</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">&nbsp;&nbsp;Number&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">&nbsp;&nbsp;Percent&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>5% or More Stockholders</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Baillie Gifford &amp; Co. (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,316,328</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Calton Square &#150; 1 Greenside Row</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Edinburgh, Scotland&nbsp;EH13AN</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Capital Research Global Investors (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,873,032</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">333 South Hope Street</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Los Angeles, CA&nbsp;90071</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Scopia Capital Management (3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,459,139</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">152 W. 57<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Street #33</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">New York, NY&nbsp;10019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">SMALLCAP World Fund, Inc. (4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,766,566</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">333 South Hope Street</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Los Angeles, CA 90071</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">The Vanguard Group (5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,853,649</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">100 Vanguard Blvd</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Malvern, PA&nbsp;19355</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">BlackRock, Inc. (6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,814,288</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">55 East 52<SUP STYLE="font-size:85%; vertical-align:top">nd</SUP> Street</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">New York, NY&nbsp;10055</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Iridian Asset Management LLC (7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,891,072</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">276 Post Road West</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Westport, CT 06880</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Named Executive Officers</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Mark C. Capone (8)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,222,739</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">R. Bryan Riggsbee (9)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,498</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Jerry S. Lanchbury, Ph.D. (10)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">748,658</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Richard M. Marsh (11)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">933,343</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Bernard F. Tobin (12)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,372</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Directors and Director Nominees</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">John T. Henderson, M.D. (13)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">224,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Walter Gilbert, Ph.D. (14)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Lawrence C. Best (15)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">160,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Heiner Dreismann, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Dennis H. Langer, M.D., J.D. (16)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">160,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">S. Louise Phanstiel (17)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">156,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">All current executive officers and directors as a group (16 persons) (18)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,560,199</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Represents beneficial ownership of less than 1% of our outstanding shares of common stock. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">**</TD>
<TD ALIGN="left" VALIGN="top">Unless otherwise indicated, the address for each beneficial owner is c/o Myriad Genetics, Inc., 320 Wakara Way, Salt Lake City, Utah 84108. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">This information is based on a Schedule 13G/A filed with the SEC on February 8, 2016 with respect to Myriad Genetics common stock. Baillie Gifford and Co beneficially owns 11,316,328 shares and has sole dispositive
power for these shares and has sole voting power for 9,632,681 shares. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">This information is based on a Schedule 13G/A filed with the SEC on February 16, 2016 with respect to Myriad Genetics common stock.&nbsp;Capital Research Global Investors beneficially owns and has sole voting power and
sole dispositive power with respect to all such shares. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">This information is based on a Schedule 13G/A filed with the SEC on February 16, 2016 with respect to Myriad Genetics common stock.&nbsp;Scopia Capital Management LP beneficially owns these shares and shares voting and
dispositive power with respect to all such shares with Matthew Sirovich and Jeremy Mindich, who are control persons of Scopia Capital Management LP., and with Scopia Management, Inc. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">This information is based on a Schedule 13G/A filed with the SEC on February 16, 2016 with respect to Myriad Genetics common stock. SMALLCAP World Fund, Inc. is advised by Capital Research Management LP., and with
Scopia Management, Inc. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top">This information is based on a Schedule 13G/A filed with the SEC on February 10, 2016 with respect to Myriad Genetics common stock. The Vanguard Group beneficially owns 4,853,649 shares and has sole dispositive power
for 4,700,649 of these shares and sole voting power for 152,900 of these shares. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top">This information is based on a Schedule 13G filed with the SEC on January 28, 2016 with respect to Myriad Genetics common stock.&nbsp;BlackRock, Inc. beneficially owns these shares and has sole dispositive power for
4,814,288 of these shares and sole voting power for 4,656,810 of these shares. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top">This information is based on a Schedule 13G/A filed with the SEC on January 26, 2016 with respect to Myriad Genetics common stock.&nbsp;Iridian Asset Management LLC beneficially owns 3,891,072 shares and shares voting
and dispositive power with respect to all such shares with David L. Cohen and Harold J. Levy, who indirectly control Iridian Asset Management LLC and have the power to vote and dispose of the shares. Messrs. Cohen and Levy disclaim beneficial
ownership of shares. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top">Includes 1,151,285 shares of common stock subject to currently exercisable options and options exercisable and restricted stock unit awards which vest within 60 days of September 1, 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top">Includes 19,425 shares of common stock subject to restricted stock unit awards which vest within 60 days of September 1, 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top">Includes 721,987 shares of common stock subject to currently exercisable options and options exercisable and restricted stock unit awards which vest within 60 days of September 1, 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top">Includes 902,745 shares of common stock subject to currently exercisable options and options exercisable and restricted stock unit awards which vest within 60 days of September 1, 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top">Includes 12,402 shares of common stock subject to restricted stock unit awards which vest within 60 days of September 1, 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top">Includes shares held directly by Dr. Henderson and his wife, as well as 210,000 shares of common stock subject to currently exercisable options as of September 1, 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(14)</TD>
<TD ALIGN="left" VALIGN="top">Includes 90,000 shares of common stock subject to currently exercisable options as of September 1, 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(15)</TD>
<TD ALIGN="left" VALIGN="top">Includes 150,000 shares of common stock subject to currently exercisable options as of September 1, 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(16)</TD>
<TD ALIGN="left" VALIGN="top">Includes 150,000 shares of common stock subject to currently exercisable options as of September 1, 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(17)</TD>
<TD ALIGN="left" VALIGN="top">Includes 150,000 shares of common stock subject to currently exercisable options as of September 1, 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(18)</TD>
<TD ALIGN="left" VALIGN="top">See Notes 8-17 above.&nbsp;Also includes 683,983 shares of common stock subject to currently exercisable options and options exercisable and restricted stock unit awards which vest within 60 days of September 1, 2016
held by other current executive officers. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MANAGEMENT AND CORPORATE GOVERNANCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Board of Directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Restated
Certificate of Incorporation, as amended, and Restated By-Laws provide that our business is to be managed by or under the direction of our Board of Directors.&nbsp;Our Board of Directors is divided into three classes for purposes of
election.&nbsp;One class is elected at each annual meeting of stockholders to serve for a three-year term.&nbsp;The Board of Directors currently consists of seven members, classified into three classes as follows: John T. Henderson, M.D. and S.
Louise Phanstiel constitute a class with a term ending at the 2018 Annual Meeting (the &#147;Class I Directors&#148;); Mark C. Capone and Heiner Dreismann, Ph.D. constitute a class with a term ending at the 2016 Annual Meeting (the &#147;Class II
Directors&#148;); and Walter Gilbert, Ph.D., Dennis H. Langer, M.D., J.D., and Lawrence C. Best constitute a class with a term ending at the 2017 Annual Meeting (the &#147;Class III Directors&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September 15, 2016, our Board of Directors accepted the recommendation of the Nominating and Governance Committee and voted to nominate
Mark C. Capone and Heiner Dreismann, Ph.D. for election at the Annual Meeting for a term of three years until the 2019 Annual Meeting of stockholders, and until their respective successors have been elected and qualified, or until their earlier
death, resignation, retirement or removal.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Set forth below are the names of the persons nominated as directors and directors whose terms
do not expire this year, their ages as of September 1, 2016, their offices in the Company, if any, their principal occupations or employment for at least the past five years, the length of their tenure as directors and the names of other public
companies in which such persons currently hold directorships or have held directorships in the past five years.&nbsp;Additionally, information about the specific experience, qualifications, attributes or skills that led to the Board&#146;s
conclusion at the time of the filing of this proxy statement that each person listed below should serve as a director is set forth below for each individual director.</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="60%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:24.50pt; font-size:8pt; font-family:Times New Roman"><B>NAME</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AGE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:99.60pt; font-size:8pt; font-family:Times New Roman"><B>POSITION WITH MYRIAD</B></P></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">John T. Henderson, M.D. (2)(3)(4)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">72</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chairman of the Board of Directors</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Walter Gilbert, Ph.D. (2)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">84</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Vice Chairman of the Board of Directors</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Mark C. Capone</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">54</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">President, Chief Executive Officer, Director</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Lawrence C. Best (1)(4)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">67</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Heiner Dreismann, Ph.D. (2)(4)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">63</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dennis H. Langer, M.D., J.D. (1)(3)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">64</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">S. Louise Phanstiel (1)(3)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">58</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Member of the Audit Committee. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Member of the Compensation Committee.</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Member of the Nominating and Governance Committee. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">Member of the Strategic Committee </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a brief summary of the background and
business experience of each of our directors.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>John T. Henderson, M.D.</B>, Chairman of the Board of Directors, has been a director of
Myriad since May 2004 and Chairman of the Board since April 2005.&nbsp;Since December 2000, Dr. Henderson has served as a consultant to the pharmaceutical industry as President of Futurepharm LLC.&nbsp;Dr. Henderson currently serves on the Board of
Directors of Cytokinetics, Inc. and during the past five years has served on the Board of Directors of Myrexis, Inc.&nbsp;Until his retirement in December 2000, he was with Pfizer for over 25 years, most recently as a Vice President in the Pfizer
Pharmaceuticals Group.&nbsp;Dr. Henderson previously held vice presidential level positions with Pfizer in Research and Development in Europe and later in Japan.&nbsp;He also was Vice President, Medical for the Europe, U.S. and International
Pharmaceuticals groups at Pfizer.&nbsp;He earned his bachelor&#146;s and medical degrees from the University of Edinburgh and is a Fellow of the Royal College of Physicians (Ed.). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors has determined that Dr. Henderson should serve on the Board for the
following reasons:&nbsp;His medical background provides the Board with expertise in developing predictive, personalized and prognostic testing services.&nbsp;Dr. Henderson provides the Board with business and management expertise from his senior
positions at Pfizer for over 25 years, including expertise in research and development, which is critical to our development of molecular diagnostic testing services.&nbsp;He brings to the Board international experience as the Company implements
strategies for international expansion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Walter Gilbert, Ph.D.</B>, Vice Chairman of the Board of Directors, joined Myriad as a
founding scientist and director in March 1992. Dr. Gilbert won the Nobel Prize in Chemistry in 1980 for his contributions to the development of DNA sequencing technology.&nbsp;He was a founder of Biogen, Inc. (now Biogen Idec Inc.) and its Chairman
of the Board and Chief Executive Officer from 1981 to 1985.&nbsp;Dr. Gilbert has held professorships at Harvard University in the departments of Physics, Biophysics, Biology, Biochemistry and Molecular Biology, and Molecular and Cellular
Biology.&nbsp;He is a Carl M. Loeb University Professor Emeritus at Harvard University.&nbsp;Dr. Gilbert founded and served on the Board of Directors of both Memory Pharmaceuticals Corp. and Paratek Pharmaceuticals, Inc. He also currently serves on
the board of Amylyx Pharmaceuticals and is a General Partner of BioVentures Investors, an investment fund. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors has
determined that Dr. Gilbert should serve on the Board for the following reasons:&nbsp;He provides the Board with a unique and extensive scientific background and expertise important to us in developing and commercializing molecular diagnostic
products, and understanding technological developments in the industry.&nbsp;Dr. Gilbert provides the Board with business, managerial and financial expertise based on having founded, managed, and directed several companies in the healthcare
industry. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Mark C. Capone</B>, was appointed as the President and Chief Executive Officer, or CEO, of Myriad Genetics, Inc., and a
member of the Board of Directors, effective July 1, 2015.&nbsp;Previously, he served as the President of Myriad Genetic Laboratories, Inc., a wholly owned subsidiary of Myriad.&nbsp;Mr. Capone joined the Company in October 2002, initially as Vice
President of Sales until being named Chief Operating Officer in February 2006, a position he held until his promotion to President of Myriad Genetic Laboratories, Inc. in March 2010. Prior to joining Myriad, he served 17 years with Eli Lilly and
Company, where he held positions as Product Development Manager, Manufacturing Plant Manager, and Area Sales Director.&nbsp;Mr. Capone received his B.S. degree in Chemical Engineering from Penn State University, graduating with highest distinction,
his M.S. degree in Chemical Engineering from the Massachusetts Institute of Technology, and his M.S. in Management from the Massachusetts Institute of Technology. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors has determined that Mr. Capone should serve on the Board for the following reasons:&nbsp;He provides the Board with
business and management expertise at a molecular diagnostic company from his 14 years of service as President, Chief Operating Officer and Vice President of Sales at Myriad Genetic Laboratories.&nbsp;Mr. Capone brings to the Board additional
experience in operations management, product development, finance, sales, and other operational areas from his experience at Eli Lilly and Company.&nbsp;He also provides us with important expertise in investor relations based on his past
interactions with our investor base.&nbsp;Additionally, Mr. Capone&#146;s scientific, engineering and business management background and education provide important insights for the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Lawrence C. Best</B>, a director of Myriad since September 2009, is the Chairman and Founder of OXO Capital LLC, an investment firm focused
on life sciences and therapeutic medical device companies, since 2007.&nbsp;He joined Boston Scientific Corporation in 1992 and served for 15 years as the Executive Vice President-Finance &amp; Administration and Chief Financial Officer.&nbsp;Prior
to joining Boston Scientific, Mr. Best was a partner in the accounting firm of Ernst &amp; Young, where he specialized in serving multinational companies in the high technology and life sciences fields.&nbsp;He served a two-year fellowship at the
SEC from 1979 to 1981 and a one-year term as a White House-appointed Presidential Exchange Executive in Washington, D.C.&nbsp;He is a founding director of the President&#146;s Council at Massachusetts General Hospital.&nbsp;Within the past five
years Mr. Best also </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
has served on the Board of Directors of Haemonetics Corp, Biogen, Inc. and as Executive Chairman of Valtech Cardio Ltd., a privately held medical device company based in Tel Aviv, Israel.&nbsp;He
received a B.B.A. degree from Kent State University. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors has determined that Mr. Best should serve on the Board for
the following reasons:&nbsp;He provides the Board with broad financial accounting and reporting expertise in the technology and life sciences fields.&nbsp;Mr. Best provides extensive financial, business, management and investment expertise from his
15 years of service as the Chief Financial Officer at Boston Scientific.&nbsp;He also provides the Board with substantial experience in the event of potential mergers, acquisitions and licensing opportunities.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Heiner Dreismann, Ph.D.</B>, a director of Myriad since June 2010, had a successful career at the Roche Group from 1985 to 2006 where he
held several senior positions, including President and CEO of Roche Molecular Systems, Head of Global Business Development for Roche Diagnostics and member of Roche&#146;s Global Diagnostic Executive Committee.&nbsp;From 2006 to 2009, Dr. Dreismann
served as the CEO of Vectrant Technologies, Inc., and until 2013 was the Interim CEO for GeneNews Limited.&nbsp;He currently serves on the Board of Directors of Ignyta, Inc.&nbsp;During the past five years, Dr. Dreismann served on the Board of
Directors of Shrink Nanotechnologies, Med BioGene, Inc., Genenews Limited, and Interpace Diagnostics.&nbsp;He earned a M.S. degree in biology and his Ph.D. in microbiology/molecular biology (summa cum laude) from Westfaelische Wilhelms University
(The University of M&uuml;nster) in Germany.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors has determined that Dr. Dreismann should serve on the Board for the
following reasons:&nbsp;He provides the Board with important business and managerial expertise from his more than 20 years at Roche, including specific expertise in developing and commercially launching diagnostic products.&nbsp;Furthermore, Dr.
Dreismann has extensive experience in international markets, specifically in Europe, which is important as we seek to expand internationally.&nbsp;His scientific background and expertise also enable him to provide the Board with technical advice on
product research and development.&nbsp;Dr. Dreismann has a diversified background in managing and serving as a director of several companies in the healthcare industry. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dennis H. Langer, M.D., J.D., </B>has been a director of Myriad since May 2004.&nbsp;From January 2013 to July 2014 he served as Chairman and Chief
Executive Officer of AdvanDx, Inc.&nbsp;From August 2005 to May 2010, Dr.&nbsp;Langer served as Managing Partner of Phoenix IP Ventures, LLC.&nbsp;From January 2004 to July 2005, he was President, North America for Dr. Reddy&#146;s Laboratories,
Inc.&nbsp;From September 1994 until January 2004, Dr. Langer held several high-level positions at GlaxoSmithKline, and its predecessor, SmithKline Beecham, including most recently as a Senior Vice President of Research and Development.&nbsp;He has a
broad base of experience in innovative R&amp;D companies such as Eli Lilly, Abbott and Searle. He is also a clinical professor at the Department of Psychiatry, Georgetown University School of Medicine.&nbsp;Dr. Langer received a J.D. (cum laude)
from Harvard Law School, an M.D. from Georgetown University School of Medicine, and a B.A. in Biology from Columbia University.&nbsp;He currently serves on the Board of Directors of Dicerna Pharmaceuticals, Inc.&nbsp;During the past five years, Dr.
Langer served on the Boards of Delcath Systems, Inc., Myrexis, Inc., and Auxilium Pharmaceuticals, Inc. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors has
determined that Dr. Langer should serve on the Board for the following reasons:&nbsp;His medical background provides the Board with expertise on developing predictive, personalized, and prognostic testing products.&nbsp;Dr. Langer provides the Board
with business and management expertise from senior positions at several major pharmaceutical companies, including expertise in research and development, which is critical to our development of molecular diagnostic testing services.&nbsp;He brings
international experience as we implement strategies for global expansion.&nbsp;Dr. Langer has a diversified background in managing and serving as a director of several companies in the healthcare industry.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B><B>S. Louise Phanstiel</B>, a director of Myriad since September 2009, held several important positions at WellPoint, Inc. from 1996 to
2007, including as President, Specialty Products (2003 to 2007), Senior Vice President, Chief of Staff and Corporate Planning in the Office of the Chairman (2000 to 2003), and Senior Vice President, Chief Accounting Officer, Controller, and Chief
Financial Officer for all WellPoint, Inc. subsidiaries, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
including Blue Cross of California (1996 to 2000).&nbsp;Previously, Ms. Phanstiel was a partner at the international services firm of Coopers &amp; Lybrand where she served clients in life and
property/casualty insurance, high technology, and higher education.&nbsp;She currently serves on the Board of Directors of Verastem, Inc. and the Stony Brook Foundation.&nbsp;Ms. Phanstiel received a B.A. degree in Accounting from Golden Gate
University and is a Certified Public Accountant.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors has determined that Ms. Phanstiel should serve on the Board for
the following reasons:&nbsp;She provides the Board with important expertise on the medical insurance industry based on her extensive experience in several senior positions at WellPoint and Blue Cross of California.&nbsp;This expertise is critical as
we rely on third-party reimbursement for our molecular diagnostic services.&nbsp;Ms. Phanstiel also provides the Board with financial accounting and reporting expertise from her work at Coopers &amp; Lybrand and as a Certified Public
Accountant.&nbsp;In addition, she provides the Board with financial and investment expertise, as well as management expertise, resulting from managing and serving as a director of publicly-traded companies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Independence </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of
Directors has reviewed the materiality of any relationship that each of our directors has with Myriad, either directly or indirectly.&nbsp;Based on this review, the Board has determined that the following members of the Board are &#147;independent
directors&#148; as defined by The NASDAQ Stock Market LLC:&nbsp;Mr. Best, Dr. Dreismann, Dr. Gilbert, Dr. Henderson, Dr. Langer, and Ms. Phanstiel. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Leadership Structure of the Board </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Board does not have a policy regarding the separation of the roles of Chairman of the Board and Chief Executive Officer because the Board believes that it is in our best interests to make that determination based on the position and direction of the
Company and the membership of the Board.&nbsp;However, at this time, and since our inception, the Board has determined that having an independent director serve as Chairman of the Board is in the best interests of our stockholders.&nbsp;Thus, the
roles of Chairman of the Board and Chief Executive Officer are separated.&nbsp;This structure ensures a greater role for the independent directors in the oversight of the Company and their active participation in setting agendas and establishing
Board policies, priorities and procedures.&nbsp;This structure also allows the Chief Executive Officer to focus on the management of our day-to-day operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board&#146;s Role in the Oversight of Risk Management </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board has an active role, directly and through its committees, in the oversight of our risk management efforts.&nbsp;The Board carries out
this oversight role through several levels of review.&nbsp;It regularly reviews and discusses with members of management information regarding the management of risks inherent in the operations of our businesses and the implementation of our
strategic plan, including our risk mitigation efforts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of the Board&#146;s committees also oversees the management of risks that are
under each committee&#146;s areas of responsibility.&nbsp;For example, the Audit Committee oversees management of accounting, auditing, external reporting, internal controls and cash investment risks.&nbsp;The Nominating and Governance Committee
oversees our compliance policies, Code of Conduct, conflicts of interest, director independence and corporate governance policies.&nbsp;The Compensation Committee oversees risks arising from compensation practices and policies.&nbsp;While each
committee has specific responsibilities for oversight of risk, the Board is regularly informed by each committee about such risks.&nbsp;In this manner the Board is able to coordinate its risk oversight. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board&#146;s Consideration of Diversity </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board and Nominating and Governance Committee do not have a formal policy with respect to the consideration of diversity in identifying
nominees for director positions.&nbsp;However, the Board and Nominating and Governance Committee strive to nominate individuals with a variety of diverse backgrounds, skills, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
qualifications, attributes and experience such that the Board, as a group, will possess the appropriate expertise, talent and skills to fulfill its responsibilities to manage the Company in the
long-term interests of the stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board&#146;s Disclosure of Third Party Director and Nominee Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No member of the Board of Directors has any agreement or arrangement with any person or entity other than the Company relating to compensation
or other payment in connection with the Director&#146;s service as a Director of the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Committees of the Board of Directors and Meetings
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I><I>Meeting Attendance.</I>&nbsp;During the fiscal year ended June 30, 2016, or fiscal 2016, there were seven meetings of the
Board of Directors, and the various committees of the Board met a total of 15 times.&nbsp;No director attended fewer than 75 percent of the total number of meetings and of committees of the Board on which he or she served during fiscal
2016.&nbsp;The Board has adopted a policy under which each member is encouraged, but not required to attend each Annual Meeting of Stockholders.&nbsp;At the time of our 2015 Annual Meeting, we had seven board members, and six of the seven Board
members attended the meeting in person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I><I>Audit Committee.</I>&nbsp;Our Audit Committee met five times during fiscal
2016.&nbsp;This committee currently has three members: Ms. Phanstiel (chair), Mr. Best, and Dr. Langer.&nbsp;The Audit Committee&#146;s roles and responsibilities are set forth in its written charter and include the authority to retain and terminate
the services of our independent registered public accounting firm.&nbsp;In addition, the Audit Committee reviews annual financial statements; considers matters relating to accounting policy and internal controls; reviews the scope of annual audits;
and monitors our processes for complying with laws, regulations and our Code of Conduct.&nbsp;Our Board of Directors has determined that all members of the Audit Committee satisfy the current independence standards promulgated by the SEC and by The
NASDAQ Stock Market LLC, as such standards apply specifically to members of audit committees.&nbsp;The Board has determined that Ms. Phanstiel is an &#147;audit committee financial expert,&#148; as the SEC has defined that term in Item 407 of
Regulation S-K under the Securities Act of 1933, as amended, or the Securities Act.&nbsp;A copy of the Audit Committee&#146;s written charter is publicly available on the Investor Information &#150; Understanding Myriad/Corporate Governance section
of our website at <I>www.myriad.com</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Please also see the report of the Audit Committee set forth elsewhere in this proxy statement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I><I>Compensation Committee.</I>&nbsp;Our Compensation Committee met six times during fiscal 2016.&nbsp;This committee currently has
three members: Dr. Dreismann (chair), Dr. Gilbert, and Dr. Henderson.&nbsp;The Compensation Committee&#146;s role and responsibilities are set forth in its written charter and include reviewing, approving and making recommendations regarding our
compensation policies, practices and procedures to ensure that legal and fiduciary responsibilities of the Board of Directors are carried out and that such policies, practices and procedures contribute to our success.&nbsp;The Compensation Committee
also is responsible for evaluating and determining the compensation of our President and Chief Executive Officer, and conducts its decision making process with respect to that issue without the President and Chief Executive Officer present. The
Board has determined that all members of the Compensation Committee qualify as independent under the definition promulgated by The NASDAQ Stock Market LLC.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee is charged with establishing a compensation policy for our executives and directors that is designed to attract and
retain qualified executive talent, to motivate them to achieve corporate objectives, and reward them for superior performance. Our Compensation Committee is also responsible for establishing and administering our executive compensation policies and
equity compensation plans. The Compensation Committee meets at least two times per year and more often as necessary to review and make decisions with regard to executive compensation matters. As part of its review of these matters, the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Compensation Committee may delegate any of the powers given to it to a subcommittee.&nbsp;A copy of the Compensation Committee&#146;s written charter is publicly available on the Investor
Information &#150; Understanding Myriad/Corporate Governance section of our website at <I>www.myriad.com</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further discussion of the
process and procedures for considering and determining executive compensation, including the role that our executive officers play in determining compensation for other executive officers is included below in the section entitled &#147;Executive
Compensation &#150; Compensation Discussion and Analysis.&#148;&nbsp;The Compensation Committee has the authority to directly retain the services of independent consultants and other experts to assist in fulfilling its duties.&nbsp;In fiscal 2016,
the Compensation Committee retained Mercer (US), Inc. (&#147;Mercer&#148;) to update our peer group of companies and provide competitive market data on the salaries and short-term and long-term incentive compensation of executive officers at
comparable companies within our industry.&nbsp;Mercer also was engaged to provide the Compensation Committee an analysis of, and recommendations for, annual salary compensation, short-term incentive compensation, and long-term incentive compensation
for the President and CEO and other executive officers.&nbsp;Mercer performs services solely on behalf of the Compensation Committee and has no relationship with Myriad or its management except as may relate to performing such services.&nbsp;The
Compensation Committee has assessed the independence of Mercer pursuant to SEC rules and the corporate governance rules of The NASDAQ Stock Market LLC and concluded that no conflict of interest exists that would prevent Mercer from independently
representing the Compensation Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Please also see the report of the Compensation Committee set forth elsewhere in this proxy
statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I><I>Nominating and Governance Committee.</I><I>&nbsp;</I>Our Nominating and Governance Committee met two times during
fiscal 2016.&nbsp;This committee currently has three members: Dr. Langer (chair), Dr. Henderson, and Ms. Phanstiel.&nbsp;This committee&#146;s role and responsibilities are set forth in the Nominating and Governance Committee&#146;s written charter
and include evaluating and making recommendations to the full Board as to the size and composition of the Board and its committees, identifying and evaluating potential candidates and recommending the director nominees for election, developing and
recommending corporate governance guidelines applicable to us, and reviewing and approving potential or actual conflicts of interest between our executive officers or members of the Board.&nbsp;The committee also oversees the annual Board
performance evaluations, which may be submitted anonymously at the discretion of the director concerned, as well as our policy on plurality voting for director elections, which is described in &#147;Proposal 1 &#150; Election of Directors&#148; of
this proxy statement.&nbsp;The Board of Directors has determined that all members of the Nominating and Governance Committee qualify as independent under the definition promulgated by The NASDAQ Stock Market LLC.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a stockholder wishes to nominate a candidate for director who is not included in our proxy statement, the stockholder must follow the
procedures described in our Restated By-Laws and in &#147;Stockholder Proposals and Nominations for Director&#148; at the end of this proxy statement.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, under our current corporate governance policies, the Nominating and Governance Committee may consider candidates recommended by
stockholders as well as from other sources such as other directors or officers, third-party search firms or other appropriate sources.&nbsp;For all potential candidates, the Nominating and Governance Committee may consider all factors it deems
relevant, such as a candidate&#146;s personal integrity and sound judgment; business and professional skills and experience; independence, knowledge of the industry in which we operate, possible conflicts of interest, the extent to which the
candidate would fill a present need on the Board; and concern for the long-term interests of the stockholders.&nbsp;In general, persons recommended by stockholders will be considered on the same basis as candidates from other sources.&nbsp;If a
stockholder wishes to propose a candidate for consideration by the Nominating and Governance Committee under our corporate governance policies, for each annual meeting, the Committee will consider only one recommended nominee from any stockholder or
group of affiliated stockholders, and such recommending stockholder or group must have held at least 5 percent of common stock for at least one year.&nbsp;All stockholder recommendations for proposed director
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
nominees must be made in writing to the Nominating and Governance Committee, care of Myriad&#146;s Secretary at 320 Wakara Way, Salt Lake City, Utah 84108, and must be received no later than 120
days prior to the first anniversary of the date of the proxy statement for the previous year&#146;s Annual Meeting.&nbsp;The recommendation must be accompanied by the following information concerning the recommending stockholder: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The name, address and telephone number of the recommending stockholder; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The number of shares of our common stock owned by the recommending stockholder and the time period for which such shares have been held; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">If the recommending stockholder is not a stockholder of record, a statement from the record holder verifying the holdings of the recommending stockholder and a statement from the recommending stockholder of the length
of time such shares have been held (alternatively, the recommending stockholder may furnish a current Schedule 13D, Schedule 13G, Form 3, Form 4 or Form 5 filed with the SEC, together with a statement of the length of time that the shares have been
held); and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">A statement from the recommending stockholder as to the good faith intention to continue to hold such shares through the date of the next annual meeting. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The recommendation must also be accompanied by the following information concerning the proposed nominee: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The information required by Items 401, 403 and 404 of Regulation S-K under the Securities Act; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">A description of all relationships between the proposed nominee and the recommending stockholder, including any agreements or understandings regarding the nomination; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">A description of all relationships between the proposed nominee and any of our competitors, customers, suppliers, labor unions or other persons with special interests regarding the Company; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The contact information for the proposed nominee. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The recommending stockholder must also
furnish a statement supporting a view that the proposed nominee possesses the minimum qualifications as set forth below for director nominees and describing the contributions that the proposed nominee would be expected to make to the Board and to
the governance of Myriad and must state whether, in the stockholder&#146;s view, the proposed nominee, if elected, would represent all stockholders and not serve for the purpose of advancing or favoring any particular stockholder or other
constituency of Myriad.&nbsp;The recommendation must also be accompanied by the written consent of the proposed nominee (i) to be considered by the Nominating and Governance Committee and interviewed if the Nominating and Governance Committee
chooses to do so in its discretion, and (ii) if nominated and elected, to serve as a director.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For all potential candidates, the
Nominating and Governance Committee may consider all factors it deems relevant, including the following threshold criteria: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Candidates should possess the highest personal and professional standards of integrity and ethical values; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Candidates must be committed to promoting and enhancing the long-term value of Myriad for its stockholders; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Candidates must be able to represent fairly and equally all stockholders without favoring or advancing any particular stockholder or other constituency of Myriad; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Candidates must have demonstrated achievements in one or more fields of business, professional, governmental, community, scientific or educational endeavor, and possess mature and objective business judgment and
expertise; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Candidates are expected to have sound judgment, derived from management or policy making experience that demonstrates an ability to function effectively in an oversight role; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Candidates must have a general appreciation regarding major issues facing public companies of a size and operational scope similar to Myriad, including governance concerns, regulatory obligations, strategic business
planning, competition and basic concepts of accounting and finance; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Candidates must have, and be prepared to devote, adequate time to the Board of Directors and its committees. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the Nominating and Governance Committee will take into account the extent to which the candidate would fill a present need on the
Board, including the extent to which a candidate meets the independence and experience standards promulgated by the SEC and by The NASDAQ Stock Market LLC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A copy of the Nominating and Governance Committee&#146;s written charter is publicly available on the Investor Information &#150;
Understanding Myriad/Corporate Governance section of our website at <I>www.myriad.com</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The descriptions of our corporate governance
policies contained in this proxy statement are qualified in their entirety and subject to the terms of such policies as modified by the Board of Directors from time to time.&nbsp;The following corporate governance documents are publicly available on
the Investor Information &#150; Understanding Myriad/Corporate Governance section of our website at <I>www.myriad.com</I>: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Policy on Annual Shareholder Meeting Attendance by Directors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Policy on Security Holder Communications with Directors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Policy on Security Holder Recommendation of Candidates for Election as Directors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Procedures for Security Holders Submitting Nominating Recommendations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Policy Regarding Qualifications of Directors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Policy For Handling Complaints Regarding Accounting and Auditing Matters and Code of Conduct Matters; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Policy on Plurality Vote for Director Elections; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Policy on Limiting Service on Public Company Boards; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Policy on New Director Orientation; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Policy on Continuing Education for the Board; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Policy on Related Person Transactions; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Director and Executive Officer Stock Ownership Guidelines; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Equity Award Holding Requirements for Named Executive Officers; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Corporate Governance Principles; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Corporate Code of Conduct and Ethics; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Policy on Cash Incentive Repayment; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Nominating and Governance Committee Charter; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Audit Committee Charter; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Compensation Committee Charter; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Strategic Committee Charter. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I><I>Strategic Committee.</I><I>&nbsp;</I>Our Strategic
Committee met two times during fiscal 2016.&nbsp;This committee currently has three members: Dr. Henderson (chair), Mr. Best and Dr. Dreismann.&nbsp;The committee&#146;s roles and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
responsibilities are set forth in the Strategic Committee&#146;s written charter and include advising and consulting with senior management on a broad range of strategic initiatives and making
recommendations to the Board regarding such opportunities.&nbsp;A copy of the Strategic Committee&#146;s written charter is publicly available on the Investor Information &#150; Understanding Myriad/Corporate Governance section of our website at
<I>www.myriad.com</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I><I>Compensation Committee Interlocks and Insider Participation</I>.&nbsp;Our Compensation Committee
currently has three members: Dr. Dreismann (Chair), Dr. Gilbert, and Dr. Henderson.&nbsp;No member of our Compensation Committee has at any time been an employee of the Company.&nbsp;None of our executive officers is a member of the Compensation
Committee, nor do any of our executive officers serve as a member of the Board of Directors or Compensation Committee of any entity that has one or more executive officers serving as a member of our Board of directors or Compensation Committee. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stockholder Communications to the Board </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally, stockholders who have questions or concerns should contact our Investor Relations department at (801) 584-1143. However, any
stockholder who wishes to address questions regarding our business directly with the Board of Directors, or any individual director, should send his or her questions in writing to the Chairman of the Board or a designated member of the Board at 320
Wakara Way, Salt Lake City, Utah 84108. Communications will be distributed to the Board, to the Nominating and Governance Committee, or to any individual director or directors as appropriate, depending on the facts and circumstances outlined in the
communications.&nbsp;Items that are unrelated to the duties and responsibilities of the Board may be excluded, such as: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Junk mail and mass mailings; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Resumes and other forms of job inquiry; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Surveys; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Solicitations or advertisements. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, any material that is unduly hostile,
threatening, or illegal in nature may be excluded, provided that any communication that is excluded will be made available to any outside director upon request. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Officers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table
sets forth the name, age (as of September 1, 2016) and position of each of our current&nbsp;executive officers: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="60%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:19.10pt; font-size:8pt; font-family:Times New Roman">Name</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Age</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:26.15pt; font-size:8pt; font-family:Times New Roman">Position</P></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Mark C. Capone</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">54</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">President and Chief Executive Officer and Director</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Virginia Drosos</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">53</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">President, Assurex Health, Inc.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Alexander Ford</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">49</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">President, Myriad Genetic Laboratories, Inc.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Gary A. King</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">60</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Executive Vice President, International Operations</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jerry S. Lanchbury, Ph.D.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">57</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Scientific Officer</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Richard M. Marsh, Esq.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">58</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Executive Vice President, General Counsel and Secretary</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Ralph L. McDade, Ph.D.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">61</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">President, Myriad RBM, Inc.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">R. Bryan Riggsbee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">45</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Financial Officer and Treasurer</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Bernard F. Tobin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">59</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">President, Crescendo Bioscience, Inc.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Richard J. Wenstrup, M.D.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">64</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Medical Officer</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B><B>Mark C. Capone</B>.&nbsp;Please see biography above under &#147;Management and Corporate Governance
&#150; The Board of Directors.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Virginia Drosos</B> became President of Assurex Health, Inc., a wholly owned subsidiary of
Myriad, on August 31, 2016, following the acquisition of Assurex Health by Myriad.&nbsp;Prior to the acquisition by Myriad, she served as President of Assurex Health from August 2013 to June 2014, and as President and CEO of Assurex Health from July
2014 to August 2016.&nbsp;Before joining Assurex Health, Mrs. Drosos worked at The Procter &amp; Gamble Company (P&amp;G) from June 1987 to September 2012 where she held the position of Group President for Global Beauty Care, a $6 billion global
business unit with over 6,000 employees in 120 countries.&nbsp;Mrs. Drosos holds a Bachelor of Business Administration from The Terry School, University of Georgia, and a Master of Business Administration from The Wharton School, University of
Pennsylvania. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Alexander Ford</B> was appointed as the President of Myriad Genetic Laboratories, Inc. (&#147;MGL&#148;), a wholly owned
subsidiary of Myriad, effective July 1, 2015.&nbsp;Mr. Ford joined Myriad in June 2010.&nbsp;Before being named to his current position, he served as the Chief Commercial Officer of MGL. Prior to joining Myriad, Mr. Ford held leadership positions at
Novartis, Sanofi-Aventis, Nektar Therapeutics and Pfizer in the areas of Marketing Research, Product Marketing, Managed Care, Sales and Business Development. He has more than 25 years of experience in the pharmaceutical and biotechnology industries.
Mr. Ford received his B.A. degree in Communications from the University of North Carolina, Wilmington and his M.A. degree from New York University.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B><B>Gary A. King</B>, Executive Vice President, International Operations, joined us in July 2010. Mr. King has been employed in the life
sciences industry for more than 25 years.&nbsp;From June 2008 to June 2010, he was the Chief Executive Officer of AverDx Incorporated, an international biotechnology company that develops novel biomarker diagnostics for critical diseases.&nbsp;From
June 2002 to February 2008, he served as Vice President, International Operations at Biosite Incorporated, a developer of diagnostic products and antibody development technologies where he spent six years building and leading all of the
company&#146;s commercial activities outside the United States. Mr. King received his B.A. degree in Zoology from Pomona College and a M.B.A. degree from Stanford University. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B><B>Jerry S. Lanchbury, Ph.D.,</B> Chief Scientific Officer, joined the Company in September 2002 as Senior Vice President of
Research.&nbsp;In July 2005 he was appointed Executive Vice President of Research, a position he held until he was named to his current position in February 2010.&nbsp;Dr. Lanchbury came to us from GKT School of Medicine, King&#146;s College where
he had served as Reader in Molecular Immunogenetics and Head of Molecular Immunogenetics Unit since 1997.&nbsp;Dr. Lanchbury earned his Ph.D. from the University of Newcastle upon Tyne and 1<SUP STYLE="font-size:85%; vertical-align:top">st</SUP>
Class Honours, B.Sc. &#147;Biology of Man &amp; his Environment&#148; degree from the University of Aston. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B><B>Richard M. Marsh,
Esq., </B>Executive Vice President, General Counsel and Secretary, joined Myriad in November 2002.&nbsp;He previously served as Director of Intellectual Property (2001-2002), Acting General Counsel and Secretary (2000-2001), and Director of
Commercial Legal Affairs (1998-2000) for Iomega Corporation.&nbsp;Mr. Marsh served as a partner with the law firm of Parsons, Behle &amp; Latimer in Salt Lake City from 1989 to 1998.&nbsp;He received an LL.M. degree in Taxation from Georgetown
University Law Center, a J.D. degree, magna cum laude, from Thomas M. Cooley Law School, and a B.S. degree in accounting from Brigham Young University, and was formerly a Certified Public Accountant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Ralph L. McDade, Ph.D.</B>, President of Myriad RBM, Inc., has served in his current role since January 2014.&nbsp;Previously, he served as
Chief Operating Officer of Myriad RBM, which Myriad acquired in May 2011. Dr. McDade was formerly Strategic Development Officer for Myriad RBM and was in that position since the company&#146;s inception in 2002. Prior to joining Myriad RBM, he was
Chief Scientific Officer for Luminex Corporation from 1996 to 2002, where he was closely involved with the development of xMAP technology.&nbsp;Dr. McDade received his Ph.D. in Microbiology from the University of Texas Southwestern Medical School in
1980. Following postdoctoral training at The University of Connecticut Medical Center in Farmington, he held faculty positions at the Rockefeller University in New York and at Louisiana State University School of Medicine in New Orleans. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>R. Bryan Riggsbee</B>, Chief Financial Officer and Treasurer, joined us in October
2014.&nbsp;He previously served 10 years with Laboratory Corporation of America (LabCorp) where his most recent position was as Senior Vice President of Corporate Finance with responsibility for the financial planning and analysis and treasury
functions.&nbsp;Prior to LabCorp, Mr. Riggsbee served in various finance roles with General Electric and began his career in the audit division of KPMG.&nbsp;He received a B.A. in Accounting from North Carolina State University, a B.A. in political
science from the University of North Carolina at Chapel Hill and an M.B.A. from Northwestern University.&nbsp;Mr. Riggsbee is a Certified Public Accountant licensed in the State of North Carolina. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Bernard F. Tobin</B>, President of Crescendo Bioscience, Inc., has served in that role since January 2015.&nbsp;He previously held several
senior positions at Amgen over the course of 8 years, including Executive Director of National Accounts, General Manager of both the Netherlands and Brazil, and Global Head of Commercial Excellence.&nbsp;In addition, he led the global integration of
business development acquisition in more than 100 countries.&nbsp;Prior to that, Mr. Tobin held a variety of leadership roles in the commercial organization at Eli Lilly and Co. over the course of 16 years.&nbsp;He received his B.S. degree in public
service and administration from Iowa State University and his M.B.A from the Fuqua School of Business, Duke University.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Richard J.
Wenstrup, M.D.</B>, Chief Medical Officer, joined Myriad in 2006 as Chief Medical Officer for Myriad Genetic Laboratories, Inc. where he led the Clinical Affairs and Corporate Medical Services Departments.&nbsp;Prior to joining Myriad, he was
internationally recognized for his academic research in heritable disorders of connective tissue and the skeleton and served as a tenured professor of Pediatrics (Human Genetics) at Cincinnati Children&#146;s Hospital and professor of Biomedical
Engineering at the University of Cincinnati. Dr. Wenstrup has published more than 100 peer-reviewed papers on human and mouse genetics.&nbsp;He served as past President of the Medical Advisory Board of the Ehlers-Danlos National Foundation and at
the Osteogenesis Imperfecta Foundation (OIF) and as Chair of the Scientific Advisory Board of the OIF.&nbsp;He currently is a member of the Scientific Advisory Board of the Marfan Foundation. Dr. Wenstrup received his medical degree from the
University of Cincinnati College of Medicine and completed a pediatrics residency at the University of Minnesota Hospital and a fellowship in medical genetics at the University of Washington. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">We have employment agreements with all of our executive officers.&nbsp;The employment agreements for each of our named executive officers are
described elsewhere in the proxy statement under the caption &#147;Executive Compensation &#150; Narrative Disclosure to Summary Compensation Table and 2016 Fiscal Year Grants of Plan-Based Awards Table.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Discussion and Analysis </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><U>Executive
Summary </U></I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Overview </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a leading molecular diagnostic company, with the goal of providing physicians and their patients with critical information to guide
healthcare management.&nbsp;Our goal is to manage our business to maximize the value we provide through our services, making the Company more successful and valuable, and hence maximizing our long-term stockholder value.&nbsp;Our compensation
programs are designed to support these goals, with the primary objectives of attracting and retaining executive talent, motivating our executive officers through pay-for-performance metrics to enhance our growth and profitability, and increasing
long-term stockholder value. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The four principal components of our compensation program for executive officers are: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Annual salary; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Short-term incentive compensation in the form of an annual cash incentive bonus; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Long-term incentive compensation in the form of a three-year cash incentive bonus; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Long-term incentive compensation in the form of restricted stock units or RSUs, subject to time-based vesting, with a performance-based factor applicable to our NEOs.</TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that these compensation components provide the appropriate balance of short-term and long-term compensation and incentives to our
executives to drive our performance, success and long-term growth.&nbsp;As indicated in the charts below, our pay mix largely follows that of our peers, with the majority of our compensation in the form of long-term incentive compensation. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g257749g44q86.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Peer Pay Mix data is a composite of our peer group data and published survey data. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our compensation program seeks to align compensation with Company performance, and hence reward our executive officers for their contribution
to our growth, profitability and increased stockholder value through the recognition of individual leadership, initiatives, achievements and other contributions. Each year our Compensation Committee approves Management Business Objectives
(&#147;MBOs&#148;) for each executive officer that consist of (i) pre-established financial performance targets for the Company such as revenue and adjusted operating income (&#147;Company Financial MBOs&#148;), and (ii) individual objectives
tailored to each executive </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(&#147;Individual MBOs&#148;).&nbsp;The Compensation Committee reviews the achievement of these MBOs in determining compensation to be paid to our executive officers.&nbsp;The Compensation
Committee believes that the MBOs are based on an appropriate mix of financial performance targets and individual objectives that provide appropriate pay-for-performance metrics to incentivize executive officers to increase our profitability, success
and long-term stockholder value.</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Fiscal Year 2016 Performance </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Myriad returned to growth in fiscal year 2016 with revenues up four percent year-over-year to $754 million.&nbsp;We also demonstrated financial
leverage with pro forma adjusted earnings per share growing 12 percent year-over-year to $1.63.&nbsp;During fiscal year 2016, we believe we accomplished many of our strategic objectives that we believe positioned the Company for long-term
growth.&nbsp;We made substantial progress on our three strategic imperatives to: i) transition and expand our hereditary cancer testing business, ii) diversify our product portfolio, and iii) increase our international contribution.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We continued generating strong cash flows from operations and in fiscal year 2016 we generated $166 million in operating cash flow.&nbsp;We
ended the year with $239 million in cash, cash equivalents, and marketable investment securities and plan to continue to exercise a balanced approach to capital deployment, including investing for future growth, paying down debt associated with
recent acquisitions, business development activities and share repurchases.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An explanation of the adjustments to our GAAP financial
measures used in this proxy and a reconciliation of the adjusted financial measures to the comparable GAAP financial measures are included in Appendix A to this proxy statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Focusing on our share repurchases, during fiscal year 2016, we repurchased over 4.5 million shares of our common stock.&nbsp;Since fiscal year
2010, we have purchased over 46 million shares of our common stock under our stock repurchase program for $1.208 billion at a weighted average price of $26.24 per share.</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g257749g00t28.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Focusing on our longer-term growth, over the past five years, we have accomplished a 9 percent
compound annual growth rate (&#147;CAGR&#148;) for revenues. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g257749g78s94.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Over the past three years, we experienced a 4 percent annual stockholder return in our stock price versus a
12 percent return for the NASDAQ composite index.&nbsp;Over the past five years, we experienced a 6 percent annual stockholder return on our stock price versus a 12 percent return for the NASDAQ composite index.</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g257749g48d64.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to our financial results during fiscal year 2016, we also achieved the following
progress on our three strategic imperatives: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Transition and Expansion of the Hereditary Cancer Testing Market </U></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">While fiscal year 2016 hereditary cancer testing revenue of $632 was relatively flat relative to fiscal year 2015 hereditary cancer testing revenue, we continued to retain a significant majority of the market share
despite ongoing competitive pressures. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Completed the conversion of all of our targeted accounts to our new myRisk Hereditary Cancer test. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Signed long term contracts with payers representing 65 percent of revenue for our hereditary cancer business. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">More than doubled the size of our variant classification database since fiscal year 2013 and introduced new algorithmic methodologies to more quickly classify new variants. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Made significant progress in market expansion with the goal of doubling the size of the oncology market. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Diversification of the Portfolio </U></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Grew Prolaris volumes by 94 percent year-over-year while obtaining Medicare coverage for low and very low risk patients and expanding private coverage by 29 million additional lives. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Grew Vectra DA volumes by 11 percent year-over-year and added our first five private payer contracts representing 3 million additional lives. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Validated myChoice HRD in the first prospective Phase 3 study with our partner TESARO; myChoice HRD proved to be highly statistically significant at predicting progression free survival benefit from niraparib.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Completed two major acquisitions, Sividon Diagnostics and Assurex Health, which added two new high-growth diagnostic tests to our product portfolio. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Completed all of the necessary studies for myPath Melanoma and myPlan Lung Cancer to support our reimbursement dossier submissions to Medicare and private payers in fiscal year 2017. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Completed our first validation study for myPlan Renal Cancer and initiated our prospective clinical study for myPath Bipolar. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Increase International Contribution </U></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">46 percent increase in international product revenues (excluding the acquisition of our German clinic); and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Grew international revenue from 4 percent to 6 percent of total revenues in the fourth quarter with a goal of international revenues reaching 10 percent of total sales by fiscal year 2020. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Performance Pay for Fiscal Year 2016 </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To reflect our pay for performance philosophy, based on the Company&#146;s performance for fiscal year 2016, our Compensation Committee: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reduced the fiscal year 2016 annual cash incentive bonus award to our NEOs, respectively, by 7 to 10 percent from target based on their MBO scores to reflect the degree to which annual targets were not achieved;
</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">awarded no compensation under our fiscal year 2014-2016 three-year, long term cash incentive plan because target thresholds were not achieved; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reduced the number of RSUs awarded to NEOs pursuant to our fiscal year 2016 RSU grants by 4.6%&nbsp;to reflect the degree to which the revenue performance goal was not achieved. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, in September 2015, the Compensation Committee determined to reduce the number of RSUs awarded to our executive officers in
fiscal year 2016 as long term equity incentive compensation by 25 percent to better align total compensation with our goal to award compensation between the 50<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> to 75<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP> percentile of our compensation benchmarks.</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Say-on-Pay Results </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At our last annual meeting of stockholders in December 2015, we held a stockholder advisory vote on the compensation of our NEOs.&nbsp;This is
generally referred to as a &#147;Say-on-Pay&#148; vote.&nbsp;ISS and Glass Lewis recommended against approval of our Say-on-Pay vote.&nbsp;Our stockholders approved the compensation of our NEOs with 56.2 percent of stockholder votes cast in favor of
our Say-on-Pay resolution for fiscal year 2015.&nbsp;Given this low approval rate, we reached out to our stockholders to identify and understand concerns and feedback they may have about our executive compensation with the goal of improving on our
approval percentage rate.&nbsp;Additionally, we reviewed the comments made by ISS and Glass Lewis with respect to our executive compensation.&nbsp;Our stockholders made various comments and recommendations with respect to our executive compensation
program including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Continued support for switching from granting stock options to restricted stock units and the stated goal to&nbsp;target compensation at the 50<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> to 75<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP> percentile of our compensation benchmarks; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Support for CEO and CFO compensation to be within the 50<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> to 75<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentile of our compensation benchmarks;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Concern over the level of Board compensation; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Recommendation to align the performance metrics of our three-year long term cash incentive plan to our disclosed strategic goals; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Reduce dependence of long-term metrics on revenue. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Changes To Our Pay Practices and
Philosophy </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In response to the concerns expressed by our stockholders, we are making the following changes, or continuing prior
responsive practices, to our executive compensation program: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Employees, executive officers and directors will continue to be awarded restricted stock units in lieu of stock options for equity incentive compensation to continue to reduce the dilutive impact of equity awards on our
shareholders; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The number of restricted stock units awarded in fiscal year 2016 were reduced by approximately 25 percent from the prior fiscal year levels to better align equity and total compensation with market benchmarks and to
further reduce the dilutive impact of long term equity compensation to stockholders; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The fiscal 2016 reduction in the number of restricted stock units awarded will reduce our dilution rate to 1.1 percent, a 28 percent reduction from the prior fiscal year and a 70 percent reduction from fiscal 2014;
</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g257749g91v69.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Compensation for executive officers is, on average, within the 50<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and 75<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentiles of our compensation
data; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The performance target metrics for our 3 year cash incentive plan for fiscal years 2017- 2019 have been changed by replacing the EBITDA performance metric with two new performance metrics: adjusted operating margin and
non-hereditary cancer revenue which aligns with our plan to diversify strategic goals; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Equity awards to our non-employee directors in the form of RSU grants has been changed from annually awarding a set number of RSUs to the number of RSUs granted being subject to an award cap of $250,000 per year (based
on the closing trading price of our stock on date of grant). </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Pay Practices </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Previously, we adopted other practices that reflect the high standards our Compensation Committee seeks to attain for our compensation
philosophy and pay practices, such as: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The period required for full vesting of restricted stock units shall be greater than four years; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">All restricted stock units awarded to our NEOs are granted subject to a predetermined, objective, formula-based, financial performance metric; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">NEOs are required to hold for at least one year any shares issued upon the vesting of restricted stock units; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Stock ownership guidelines for our directors (three times annual cash retainer) and executive officers subject to Section 16 reporting (for President and CEO, three times annual base salary, and for other executive
officers, two times annual base salary); </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Annual cash bonus an executive officer may receive is capped at a percent of his or her target bonus percentage amount; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Prohibiting any tax gross-up payments by the Company with respect to compensation paid to any employees or directors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Prohibiting&nbsp;hedging the economic risk of holding our stock, including trading in our stock on a short-term basis, short sales of our stock and similar transactions, for which waivers are not granted;
</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Prohibiting the pledge or use of our stock to secure a margin or other loan, for which waivers are not granted; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Prohibiting the Company&#146;s repurchase of underwater stock options under our 2010 Employee, Director and Consultant Equity Incentive Plan, as amended, (the &#147;2010 Plan&#148;); </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Prohibiting the repricing of stock options and other awards under our 2010 Plan without stockholder approval; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Prohibiting the grant of in-the-money stock options under our 2010 Plan;</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Adopting a cash incentive repayment policy (&#147;Claw Back Policy&#148;) that requires an executive officer to repay to us the amount of any annual cash incentive that an executive officer receives to the extent that:
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the amount of such payment was based on the achievement of certain financial results that were subsequently the subject of a restatement that occurred within 12 months of such payment; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the executive officer had engaged in theft, dishonesty or intentional falsification of&nbsp;documents or records that resulted in the obligation to restate our financial results; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a lower annual cash incentive would have been paid to the executive officer based upon the restated financial results. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Employing each executive officer on an &#147;at will&#148; basis without any guarantee as to employment term, salary, or bonus. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the annual review of our executive compensation program and compensation pay components, we will continue our general
approach of establishing Company Financial MBOs and Individual MBOs for our executive officers. These MBOs assist the Compensation Committee in evaluating the performance of our executive officers and to then reward them through short- and long-term
incentive compensation for the value they deliver to our stockholders as demonstrated by the enhanced growth and profitability of the Company.</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><U>Fiscal Year 2016 Named Executive Officer Compensation </U></I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Elements of our Compensation Program </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The compensation program for our executive officers consists principally of a base salary, an annual cash incentive bonus, long-term
compensation in the form of a three-year cash incentive bonus award and equity incentive compensation in the form of restricted stock units.&nbsp;We believe that these elements of our compensation strike an appropriate balance to incentivize and
reward our executive officers for ongoing, short- and long-term performance.&nbsp;An annual base salary provides the foundation of our compensation program and ensures that the executive officer is being paid ongoing compensation, which allows us to
attract and retain high-quality talent.&nbsp;The annual cash incentive bonus forms an important part of our compensation strategy by providing an incentive to reward short-term performance as measured by Company performance and accomplishment of
MBOs.&nbsp;The long-term cash incentive bonus awards and equity incentive compensation also form an important part of our compensation strategy.&nbsp;These incentive bonus awards and equity grants reward our executive officers for the long-term
performance of Myriad, and help to ensure that our executive officers have a stake in our long-term success by providing an incentive to improve our overall growth and value.&nbsp;For example, under our long-term cash incentive awards, performance
metrics are measured by achieving three-year financial performance targets reflecting annual double-digit growth of revenue, diversifying revenues and improving operating margins.&nbsp;This aligns the executive officers&#146; interests with
stockholders&#146; long-term interests.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee, in collaboration with management, attempts to develop an overall
compensation program that incentivizes the executive officers to achieve their objectives without encouraging them to take excessive risks to the business.&nbsp;We believe that this is accomplished through the balance of the various elements of our
compensation program, including the establishment of annual MBOs for each of the executive officers to appropriately guide their performance objectives, establishment of preset annual and three-year growth financial performance targets, and preset
limits on cash incentive compensation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Formulating and Setting Executive Compensation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee is responsible for formulating, evaluating and approving the compensation, including the award of equity
compensation, for our executive officers, including our President and CEO.&nbsp;The Compensation Committee also assists the full board in establishing appropriate incentive compensation and equity-based plans generally for all employees and is
responsible for administering these plans.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For fiscal year 2016, the Compensation Committee retained Mercer (US) Inc. (&#147;Mercer&#148;)
for the purpose of updating our peer group of companies and to provide competitive market data on the salary, short-term incentive compensation and long-term incentive compensation of executive officers at comparable companies within our
industry.&nbsp;The Compensation Committee uses this competitive market data on compensation in determining annual salary compensation, short-term (annual) incentive compensation and long-term incentive compensation (both cash and equity incentive
compensation) for the President and CEO and other executive officers of the Company (the &#147;2016 Mercer Executive Compensation Review&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a basis for the source market data for the 2016 Mercer Executive Compensation Review, Mercer utilized compensation data from the following
group of 15 peer companies, which is our peer group from last fiscal year with the replacement of Merit Medical Systems, Inc. with Insys Therapeutics, Inc.&nbsp;We believe the selected peer group of companies reflects our industry and aligns with
the ISS selected peer group.&nbsp;Presently, 9 of the 15 companies in our peer group are companies which were selected by ISS as part of ISS&#146;s compensation pay review from last year. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="28%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Acorda Therapeutics, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Alexion Pharmaceuticals, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Alkermes plc</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Biomarin Pharmaceutical, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Cepheid</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Hologic, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">IDEXX Laboratories, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Illumina, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Insys Therapeutics, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Medivation, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Quidel Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Regeneron Pharmaceuticals, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">ResMed, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">United Therapeutics Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Vertex Pharmaceuticals, Inc.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, Mercer gathered competitive market data from published survey data in the biotech industry for
similarly sized entities as reflected in the 2015 Mercer US Global Premium Executive Remuneration Suite and the 2016 Radford Global Life Sciences Survey.&nbsp;To determine competitive market compensation, where possible, composite survey data were
equally blended with the proxy data from our peer group set forth above.&nbsp;Compensation data for the peer group were collected from available proxy-disclosed data.&nbsp;This information was gathered and analyzed for the 25th, 50th and 75th
percentiles for annual salary, short-term incentive pay elements and long-term incentive pay elements.&nbsp;Where possible, our executive officers were matched to appropriate proxy and survey positions based on job content and level of
responsibility.&nbsp;Proxy-based and survey-based salaries were aged to 2016 at an annual rate of 3 percent, the average 2015/2016 salary increase for executives in the U.S.&nbsp;Restricted stock units were valued at fair market value (our closing
stock price) on the date of grant.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that the compensation information obtained from the 2016 Mercer Executive Compensation
Review provides us appropriate compensation data and benchmarks, because it is derived from companies that are in our industry, share similar corporate structures, and have similar factors such as number of employees, market value, revenues, net
income, product pipeline and gross margins.&nbsp;Through Mercer, we have selected those companies that we believe represent the various factors of our business as outlined above.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Utilizing the composite peer group data provided us in the 2016 Mercer Executive Compensation Review, the Compensation Committee analyzed,
among other criteria, the average salary, short-term incentive bonus compensation and long-term incentive bonus compensation (both cash and equity compensation) for each of our executive officers at the
25<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, 50<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and 75<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentile ranges.&nbsp;For long-term incentive equity compensation,
the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Compensation Committee analyzed, among other criteria, the average equity compensation for each of our executive officers at the 25<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, 50<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP> and 75<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentile range from the Mercer composite compensation data.&nbsp;The Compensation Committee also analyzed our equity burn rate, issued
equity overhang, total equity overhang and stockholder value transfer.&nbsp;The Compensation Committee also took into account the Company&#146;s stock repurchase program, which creates shareholder value but has a negative impact on equity
overhang.&nbsp;Finally, the Compensation Committee considered the number of restricted stock units awarded to executive officers as a group, as compared to all restricted stock units awarded.&nbsp;In so doing, the Compensation Committee noted that
it anticipates that this ratio will continue to be weighted toward the executive officer group as we transition away from our historical practice of granting equity incentive compensation to all employees.&nbsp;For example, new employees below the
director level are now compensated under our profit sharing plan, rather through equity compensation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee has
approved a pay-for-performance philosophy for the compensation of our executive officers that is intended, in general, to provide base salary, bonus and total compensation within the 50<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> to 75<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP> percentile of comparable companies in our industry.&nbsp;However, we may award compensation above the 75<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentile when deemed appropriate to
further promote and achieve the primary objectives of our compensation programs.&nbsp;The comparable group of companies on which we rely to corroborate our determinations are those represented by the peer groups utilized in the Mercer Executive
Compensation Review and those that participated in the industry survey reports used by Mercer.&nbsp;Within the scope of this pay-for-performance philosophy, we have determined the various components of each executive&#146;s compensation package
based on various factors, including: the executive&#146;s particular background, training and relevant work experience; the executive&#146;s role and responsibilities and the compensation paid to similar persons in comparable companies represented
in the compensation data that we utilized; the demand for individuals with the executive&#146;s specific talents and expertise and our ability to attract and retain comparable talent; Company Financial MBOs and Individual MBOs; the other
expectations of the executive for the position; and the comparison to other executives within our Company having similar skills and experience levels and responsibilities.</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Base Salary </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each year we
evaluate base salaries as part of our management performance program, and establish each executive&#146;s base salary for the ensuing year.&nbsp;In establishing base salaries, we assess the executive officer&#146;s performance in each of the areas
in which MBOs were established, the financial performance of the Company in the areas of responsibility of the executive officer, the overall financial performance of the Company, the experience of the executive, the executive&#146;s role and
responsibilities and particular background, and other significant accomplishments and contributions of the executive officer.&nbsp;An executive&#146;s base salary is also evaluated together with other components of the executive&#146;s
compensation.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on our financial performance for fiscal year 2016, including our evaluation of the
corporate developments, accomplishments and events that occurred during fiscal year 2016, and an assessment of each executive officer&#146;s performance of MBOs for fiscal 2016, we increased the base salaries for our NEOs for fiscal year 2017 as set
forth below.&nbsp;For fiscal year 2017, the base salary of our President and CEO and CFO and Treasurer are now at the 50th percentile of base salaries for our peer group as provided in the 2016 Mercer Executive Compensation Report. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="67%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:64.40pt; font-size:8pt; font-family:Times New Roman"><B>Name and Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fiscal&nbsp;2016</B><br><B>Base&nbsp;Salary&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fiscal&nbsp;2017</B><br><B>Base&nbsp;Salary&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%<BR>Increase</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark C. Capone</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President and Chief Executive Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">800,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">852,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R. Bryan Riggsbee</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Financial Officer and Treasurer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">432,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jerry S. Lanchbury, Ph.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Scientific Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">479,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">493,782</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard M. Marsh</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Executive Vice President, General Counsel and Secretary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">479,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">493,782</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bernard F. Tobin</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President, Crescendo Bioscience, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">412,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">424,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that the salary increases for our President and CEO and CFO and Treasurer were appropriate based on
the performance and accomplishments for each of these individuals and to meet the minimum compensation guidelines at the 50<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentile.&nbsp;We believe that our salaries are appropriately set to
attract and retain key talent necessary to support the continued growth of the Company.&nbsp;Except as noted above, the salary increases for our NEOs for fiscal year 2017 are consistent with the 3 percent salary increase authorized by our Board for
all Company employees for fiscal year 2017.</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Annual Cash Incentive Bonus </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The annual cash incentive bonus amount is determined as part of our management performance program.&nbsp;As a part of this review, we assess
the executive officer&#146;s performance in each of the areas in which MBOs were established, our financial performance in the areas of responsibility of the executive officer, our overall financial performance and other significant accomplishments
and contributions of the executive officer.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For fiscal year 2016, for purposes of determining the annual cash incentive bonuses paid to
our NEOs and executive officers, other than our President and CEO, the Compensation Committee used a formulaic approach, based on a target incentive bonus as a percentage of base salary determined in early fiscal 2016, Company performance, and the
achievement of MBOs.&nbsp;The target incentive bonus as a percentage of base salary for each executive officer ranged from 45 to 60 percent, depending on the responsibilities and experience of the executive officer, and was based on the target
incentive bonus percentage from our peer group for each of the individual executive officers.&nbsp;The annual cash incentive bonus amount for each executive officer was then determined based on the following formula: annual base salary of the
executive officer times (a) the executive officer&#146;s applicable target incentive bonus percentage, and times (b) the executive officer&#146;s performance goals score (based on degree of accomplishment of Company Financial MBOs and Individual
MBOs as determined by the Compensation Committee).&nbsp;The annual cash bonus amount is capped, and, as a percentage, can never exceed 130 percent of the executive officer&#146;s applicable target incentive bonus percentage. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For fiscal year 2016, our pre-established financial performance targets were based on our revenues and adjusted operating income.&nbsp;We
achieved $753.8 million in revenues and adjusted operating income of $179.5 million.&nbsp;Based on these financial results, compared to the pre-established targets, the Compensation Committee determined that the Company Financial MBOs applicable to
each executive officer had been achieved at the 90 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
percent level.&nbsp;Each executive officer was then scored on his or her Individual MBOs, as discussed below for our NEOs under &#147;<I>Named Executive Officer Performance for Fiscal
2016&#148;</I>.&nbsp;The composite MBO performance scores for the executive officer group ranged from 73 to 93 percent, with one executive officer achieving 100%.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For our President and CEO, the Compensation Committee approved pre-determined, objective, formula-based financial performance metrics, along
with the achievement of Individual MBOs which cannot increase but may only reduce the executive officer&#146;s cash incentive bonus.&nbsp;The annual cash incentive bonus for our President and CEO was granted under our 2013 Executive Incentive Plan
(the &#147;Section 162(m) Incentive Plan&#148;), which is a plan that permits qualifying executive compensation to be deducted for federal income tax purposes under Section 162(m).&nbsp;Based on the responsibilities and experience of our President
and CEO, and based on the target incentive bonus percentages from our peer group, the Compensation Committee set the target incentive bonus as a percentage of base salary at 100% for our President and CEO.&nbsp;Accordingly, our President and
CEO&#146;s cash incentive bonus for fiscal year 2016 was determined based on the following formula: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Base Salary &times; Target Incentive
Bonus Percentage (100% ) &times; Total Performance Factor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Total Performance Factor was based on fiscal year 2016 Company revenues
and adjusted operating income and is calculated as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(the Revenue Performance Factor &times; 0.50) + (the Adjusted Operating Income
Performance Factor &times; 0.50).</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Revenue Performance Factor equals the quotient of fiscal year 2016 total revenues divided by the
designated total revenue target for fiscal year 2016.&nbsp;The Adjusted Operating Income Performance Factor equals the quotient of fiscal year 2016 adjusted operating income divided by the designated adjusted operating income target for fiscal year
2016.&nbsp;However, as set forth in the Section 162(m) Incentive Plan in no event may the Total Performance Factor exceed 130% and so there is a separate cap on the total amount that can be paid.&nbsp;The Compensation Committee has the discretion to
reduce the amount payable based on the accomplishment of the Individual MBOs or for any other reason in the discretion of the Compensation Committee but it may not increase the amount of the award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on our financial results for fiscal year 2016, the Compensation Committee determined that Mr.&nbsp;Capone had achieved a Total
Performance Factor of 90.9%.&nbsp;Accordingly, the Compensation Committee determined the annual cash incentive bonus for Mr. Capone for fiscal year 2016 in the amount of $727,200.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because we only partially achieved the revenue and adjusted operating income performance goals we set, and based on the accomplishment of
Individual MBOs for the executive officer group, the annual cash incentive bonus for fiscal year 2016 was reduced by 7 to 27 percent from target levels for the executive officer group. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee determined the annual cash incentive bonuses for our NEOs for fiscal year 2016 as set forth in the chart below.</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="66%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:64.40pt; font-size:8pt; font-family:Times New Roman"><B>Name and Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target&nbsp;Incentive<BR>Bonus&nbsp;(as&nbsp;a&nbsp;%&nbsp;of<BR>Fiscal 2016 Base<BR>Salary)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>MBO<BR>Performance<BR>Goals Score<BR>(as a %)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fiscal&nbsp;2016<BR>Bonus</B><br><B>Payment</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark C. Capone</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President and Chief Executive Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">727,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R. Bryan Riggsbee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Financial Officer and Treasurer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">180,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jerry S. Lanchbury, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Scientific Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">215,730</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard M. Marsh, Esq.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Executive Vice President, General Counsel and Secretary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">218,127</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bernard F. Tobin</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President, Crescendo Bioscience, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">191,580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that this cash incentive bonus compensation is appropriate based on the performance of
the executive officer group for fiscal year 2016.&nbsp;The Compensation Committee believed the financial performance targets set for our annual cash incentive bonuses for our NEOs to be challenging, without any guarantee that the performance targets
could be accomplished.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For fiscal year 2017, the Compensation Committee has decided to utilize the same formulaic approach for determining
the annual cash incentive bonus for executive officers as used for fiscal year 2016.&nbsp;The Compensation Committee established the following target incentive bonus percentages for our NEOs which will be used in determining annual cash incentive
bonus amounts for fiscal year 2017 performance.&nbsp;These are unchanged from the targets established for fiscal year 2016, except for Mr. Riggsbee whose target incentive bonus percentage was increased to 60 percent based on his responsibilities as
our CFO and Treasurer. Additionally, Mr. Capone&#146;s fiscal year 2017 annual cash incentive bonus was granted under our 2013 Executive Incentive Plan based on the predetermined financial performance metrics set by our Compensation Committee. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="75%"></TD>
<TD VALIGN="bottom" WIDTH="22%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:59.65pt; font-size:8pt; font-family:Times New Roman"><B>Executive Officer</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target&nbsp;Incentive&nbsp;Bonus<BR>(% of base salary for<BR>Fiscal Year 2017)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark C. Capone</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President and Chief Executive Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R. Bryan Riggsbee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Financial Officer and Treasurer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jerry S. Lanchbury, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Scientific Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard M. Marsh, Esq.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Executive Vice President, General Counsel and&nbsp;Secretary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bernard F. Tobin</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President, Crescendo Bioscience, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Long-Term Incentive Awards </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To incentivize and reward long-term performance by our executives, we currently provide two forms of long-term incentive compensation: a
three-year cash incentive bonus and the award of restricted stock units.&nbsp;These cash and equity-based incentive awards help ensure that our executive officers have a stake in our long-term success by providing an incentive to improve the overall
growth and value of Myriad.&nbsp;We believe that this fosters an executive culture that aligns our officers&#146; interests with the long-term interests of our stockholders.&nbsp;The Compensation Committee determines the terms of all equity
incentive awards for our NEOs, including our President and CEO.&nbsp;Beginning in fiscal year 2015, we granted our employees, executive officers and Board restricted stock units rather than stock options in order to reduce the dilutive effect of our
equity compensation program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U></U><U>Three-Year Cash Incentive Bonus</U>.&nbsp;In September 2013, the Compensation Committee
established a long-term cash incentive bonus for our executive officers based on predetermined, objective financial formula-based performance targets to be accomplished at the end of the third ensuing fiscal year or fiscal year 2016.&nbsp;The
Compensation Committee believed that these financial performance targets, based on annual double-digit growth, if accomplished, would represent strong financial growth for the Company over the three year period.&nbsp;The financial metrics
established for these payouts were based on the Company&#146;s total revenues (50 percent weight), earnings per share (25 percent weight) and EBITDA (25 percent weight). The three-year incentive bonus award amount was based on a target bonus amount
as a percentage of fiscal year 2016 base salary of 20 percent for our President and CEO and President of MGL and 15 percent for our other executive officers.&nbsp;(For our three-year cash incentive bonuses awarded after fiscal year 2014, the bonus
amount is based on </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
base salary in the year the award is established and not at the effective salary at the end of the third year.)&nbsp;Based on the Company&#146;s financial performance, none of the target
thresholds under the plan were&nbsp;achieved.&nbsp;Accordingly, there was no payout under the fiscal year 2014-2016 three-year, long term, cash incentive plan.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For fiscal year 2016, the Compensation Committee determined to continue our long-term cash incentive bonus program for our executive officers
and established in September 2015 predetermined, objective financial formula-based performance targets of revenue (50 percent weight) and EBITDA (50 percent weight) which must be accomplished at the end of fiscal year 2018.&nbsp;For any amount to be
paid, the minimum predetermined financial metric thresholds must be surpassed; otherwise, no bonus amount will be paid.&nbsp;Under this program, the incentive bonus award amount is based on a target bonus amount as a percentage of fiscal year 2016
base salary of 20 percent for our President and CEO and 15 percent for our other executive officers.&nbsp;For all executive officers, the target bonus percentage and bonus amount is capped.&nbsp;We believe that the three-year cash incentive bonus
adds an additional long-term incentive metric to motivate our executives to achieve financial metrics and operational goals, which will benefit long-term shareholder value.&nbsp;As these financial performance targets are based on double-digit
revenue growth for the Company, the Compensation Committee believed the financial performance targets to be challenging, without any guarantee that the performance targets could be accomplished, in light of growing operational, reimbursement and
competitive factors which may adversely affect the Company&#146;s financial performance.&nbsp;Thus, the performance targets were set at a level that, if obtained, the Company would have accomplished continued strong financial performance.&nbsp;The
three-year cash incentive bonus awards made to our NEOs for fiscal year 2016, and the maximum amount payable under these awards, are reported in the table for 2016 Fiscal Year Grants of Plan Based Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In September 2016, for our fiscal year 2017, the Compensation Committee established the 2019 three-year cash incentive plan.&nbsp;In response
to comments from our shareholders relative to over-dependence on revenue for financial metrics, the Compensation Committee replaced the EBITDA metric to now include target performance goals based on profitability (weighted 25 %) and diversification
(weighted 25%).&nbsp;We believe these new performance goals will further support the Company&#146;s strategic initiatives to improve operating returns and diversify revenues which will enhance our long term shareholder growth and value. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the three-year cash incentive awards established for our executive officers that were outstanding as of the
date of this Proxy Statement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="69%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:47.55pt; font-size:8pt; font-family:Times New Roman">Date of Award</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><FONT STYLE="white-space:nowrap">Three-Year&nbsp;Performance</FONT><br>Period</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September 2014</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">FY&nbsp;2015&nbsp;-&nbsp;2017</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September 2015</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">FY 2016&nbsp;-&nbsp;2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September 2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">FY 2017&nbsp;-&nbsp;2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U></U><U>Initial Equity Awards</U>. Beginning in fiscal 2015, executives who join us, who are granted equity,
are granted restricted stock unit awards.&nbsp;The amount of the initial restricted stock unit award and vesting schedule are determined based on the executive&#146;s position and analysis of the competitive practices of the companies similar in
size as represented in the compensation data that we review with the goal of creating a total compensation package for new employees that is competitive with other similar companies and that will enable us to attract high quality management
personnel.&nbsp;In general, one-fourth of each initial equity award will vest on an annual basis over four-plus years.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U></U><U>Annual
Equity Incentive Awards</U>.&nbsp;In response to continued comments from our stockholders, we will continue to issue long-term equity incentive compensation grants in restricted stock units with one-fourth of the units granted vesting on an annual
basis.&nbsp;Additionally, for our NEOs, the restricted stock units awarded are subject to achievement of a predetermined, formula-based, one-year revenue target that must be achieved in order for the award to commence vesting.&nbsp;Thus, for our
NEOs, the actual number of restricted stock units earned will be determined based on the percentage achievement of the predetermined revenue target with no award being earned if a minimum revenue threshold is not achieved; thereafter, and only if
the minimum threshold has </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
been achieved, vesting of the award is based on the NEO&#146;s continued employment with us.&nbsp;In determining the amount of equity compensation to be awarded, the Compensation Committee will
consider various factors, including our financial and operating performance for the applicable period; the executive officer&#146;s contribution to our performance; the anticipated contribution of the executive officer to our future performance; the
accomplishments of the executive officer as measured by achievement of MBOs; a review of compensation for comparable positions in our peer group from our benchmarking studies; and the total compensation of the executive officer and the anticipated
retentive effect of the grant of additional equity compensation.&nbsp;We also take into consideration the total number of our outstanding shares of our common stock, the relative dilution to stockholders, as well as our gross equity burn rate,
issued equity overhang and total equity overhang.&nbsp;The size of the option grant or restricted stock unit award generally increases as the rank and responsibilities of the executive officer increases.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Restricted stock unit awards are made once a year at our Compensation Committee meeting held in connection with the Board of Director meetings
generally in September.&nbsp;The Board customarily determines the dates of its meetings for the ensuing year at a meeting of the Board in the preceding year.&nbsp;Thus, the dates on which equity compensation is granted are set well in advance. The
Compensation Committee does not time the grant of equity compensation with respect to the release of material nonpublic information, whether or not that information may favorably or unfavorably impact the price of our common stock.&nbsp;Restricted
stock unit awards for the executive officers, including our President and CEO, are approved by the Compensation Committee.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to
reflect our pay for performance philosophy, and in response to shareholders concerns regarding the dilutive impact of equity incentive compensation, we reduced the level of RSUs awarded in fiscal year 2016 by approximately 25%.&nbsp;Based on the
2016 Mercer Executive Compensation Review, which calculated market annual guidelines at the 50th and 75th percentile, the long-term incentive value of the annual restricted stock unit awards made on September 15, 2015, based on fiscal year 2015
performance, to our then President and CEO was below the 50th percentile, and was above the 50th percentile for our CFO and Treasurer.&nbsp;These awards were later reduced by 4.6 percent based on the level of achievement of fiscal 2016 revenues, the
financial performance metric for fiscal 2016 associated with the grant of these restricted stock units.&nbsp;The long-term incentive value of the annual restricted stock unit awards made to our NEOs in fiscal year 2016 is reported in the table for
2016 Fiscal Year Grants of Plan Based Awards and was determined at their grant date fair value calculated in accordance with ASC Topic 718 based on achieving 100% of the award.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We felt the RSU award levels were appropriate based on the comparative long-term peer group compensation data from the 2016 Mercer Executive
Compensation Review, given the Company&#146;s performance relative to its peers, the individual accomplishments of our NEOs during fiscal year 2015, including our President and CEO, relative to their MBOs and to continue to place an increased
weighting of compensation on long term equity compensation.&nbsp;We also believe these equity awards, now directed to the 50<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentile for our President and CEO and CFO and Treasurer, were
appropriate based on the Company&#146;s financial performance.&nbsp;Thus, these equity awards appropriately reward our executives for their consistent past performance, and incentivize our executives to work hard to continue to deliver similar
performance and to remain employed at the Company.</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Compensation Objectives </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The primary objectives of our Compensation Committee in establishing and maintaining our executive compensation programs are to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Attract and retain the best possible executive talent; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Motivate our executive officers to enhance our growth and profitability;</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Increase long-term stockholder value; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Reward the executive officers for their contribution to our growth, profitability and increased stockholder value through the recognition of individual leadership, initiatives, achievements and other
contributions.</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The specific directives of the Compensation Committee are to provide appropriate short and
long-term compensation and incentives, in the form of cash and equity, that motivate and reward the accomplishment of individual and corporate objectives and that align executive officer compensation with the creation of stockholder value.&nbsp;To
achieve these objectives, the Compensation Committee has adopted and implemented a compensation plan that bases our executive officers&#146; compensation on a variety of factors set forth in MBOs. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Establishment and Use of Management Business Objectives </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee has implemented an annual management performance program for the purpose of establishing annual performance
objectives for our executive officers to align their performance with the overall goals and objectives for the Company.&nbsp;This process commences in the fourth quarter of each fiscal year as each executive officer meets with our President and CEO
to establish annual MBOs for the ensuing fiscal year.&nbsp;After review and discussion, the President and CEO finalizes the executive officer&#146;s MBOs for the ensuing fiscal year.&nbsp;Similarly, our President and CEO meets with the Compensation
Committee at the end of each fiscal year to establish his MBOs for the ensuing fiscal year which, after review and discussion, are finalized by the Compensation Committee.&nbsp;During the fiscal year, additional MBOs may be established and assigned
to an executive officer, including our President and CEO. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the end of the ensuing fiscal year, each executive officer&#146;s
performance for the fiscal year is reviewed, including an assessment by management and the Compensation Committee of the achievement of each executive officer&#146;s respective MBOs.&nbsp;At this time, the President and CEO calculates and recommends
to the Compensation Committee an annual cash incentive bonus amount and salary adjustment for the executive officers, other than himself.&nbsp;The Compensation Committee, after further review and discussion with our President and CEO, then
determines the annual cash incentive bonus for the concluding fiscal year and base salary amount for the ensuing fiscal year for the executive officers, other than the President and CEO.&nbsp;In the case of our President and CEO, the Compensation
Committee reviews and discusses the accomplishment of his MBOs for the fiscal year.&nbsp;The Compensation Committee then makes its review and determinations for the President and CEO&#146;s salary and annual cash incentive compensation without any
recommendations from our President and CEO, who is not present in any portions of the meetings of the Compensation Committee where his compensation is calculated, discussed and approved.&nbsp;Additionally, the Compensation Committee reviews the
achievement of each executive officer&#146;s MBOs as it determines the awarding of equity incentive compensation.&nbsp;The annual cash incentive bonus amount, salary adjustments, and long-term incentive compensation for our President and
CEO&nbsp;are reported to the independent members of the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The MBOs for each executive officer for each fiscal year
consist of (i) pre-established financial performance targets for the Company, which for fiscal year 2016 were based on total revenues and adjusted operating income, and (ii) individual objectives tailored to each executive.&nbsp;Each executive
officer receives the same Company Financial MBOs as part of their respective MBOs.&nbsp;The Company Financial MBOs represents 50 percent of the total weighting of each executive officer&#146;s MBOs.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From time to time, for those designated, an executive officer&#146;s incentive compensation may be awarded and administered under our 2013
Executive Incentive Plan, whereby 100 percent of short-term incentive cash compensation (annual cash incentive bonus) and grants of restricted stock units are based on pre-established, objective financial performance targets and are subject to a
cap.&nbsp;It is intended that incentive compensation paid under the 2013 Executive Incentive Plan will be deductible for tax purposes under Section 162(m) of the Internal Revenue Code; however, the Compensation Committee may award compensation which
does not qualify under Section 162(m) in order to accomplish the compensation goals of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The MBOs for our NEOs for fiscal year
2016 were as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Mark C. Capone, President and CEO</B> &#150; manage the Company to achieve designated financial targets for total
revenues and adjusted operating income for fiscal year 2016; achieve designated financial targets for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
transition of hereditary cancer market to myRisk testing with designated percentages of hereditary cancer revenues from long-term payer contracts; achieve financial targets for increased revenue
from non-hereditary cancer testing products; and achieve financial target for revenues from international operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>R. Bryan
Riggsbee, Chief Financial Officer and Treasurer</B> &#150; manage the Company to achieve designated financial targets for total revenues and adjusted operating income for fiscal year 2016; increase level of income generation from international
operations; continue development work on financial function in support of operations; develop internal audit function on enterprise risk; and improved investor relations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Jerry S. Lanchbury, Ph.D., Chief Scientific Officer</B> &#150; manage the Company to achieve designated financial targets for total
revenues and adjusted operating income for fiscal year 2016; achieve one approved investigational device exception (&#147;IDE&#148;)&nbsp;submission and one premarket approval (&#147;PMA&#148;) submission from our product pipeline; initiate early
access launch for a tumor product in the U.S.; provide proof of concept for at least two long &#150; term product opportunities; and complete technical transfer for Clinical Laboratory Improvement Amendments of 1988 (&#147;CLIA&#148;) homologous
recombination deficiency (&#147;HRD&#148;) process to Myriad Genetic Laboratories. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Richard M. Marsh, Executive Vice President, General
Counsel and Secretary</B> &#150; manage the Company to achieve designated financial targets for total revenues and adjusted operating income for fiscal year 2016; continue to develop and implement Company&#146;s intellectual property strategy;
implement and oversee compliance plans for affiliated group, including international activities; and completion of global tax minimization plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Bernard F. Tobin, President Crescendo Bioscience, Inc. &#150; </B>manage the Company to achieve designated financial targets for total
revenues and adjusted operating net income for fiscal 2016; manage Crescendo to achieve financial targets for total revenues and operating loss in fiscal year 2016; complete studies to support guideline adoption and reimbursement for Vectra DA; and
achieve targeted cost savings for fiscal year 2016. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Named Executive Officer Performance for Fiscal 2016 </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">President and CEO:&nbsp;Based on our financial results for fiscal year 2016, the Compensation Committee determined that Mr. Capone had achieved
90.9% of the financial performance targets set for him under the Company Financial MBOs for fiscal 2016.&nbsp;The Compensation Committee also determined that Mr. Capone had accomplished his Individual MBOs based on the transition of all of the
Company&#146;s targeted accounts to myRisk testing with 65% of hereditary cancer revenues from long-term payer contracts; the increase in revenue from non-hereditary cancer testing products; and the increase in revenues for international
operations.&nbsp;Additionally, the Compensation Committee noted that under Mr. Capone&#146;s supervision, the Company&#146;s achieved the additional MBOs set forth below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other Named Executive Officers.&nbsp;The Compensation Committee determined that the other NEOs had substantially accomplished the Company
Financial MBOs and their respective Individual MBOs based on: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Achievement of total annual revenues of $753.8 million for fiscal year 2016; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Achievement of operating income of $166.8 million for fiscal year 2016; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Achievement of net income of $125.3 million for fiscal year 2016; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Achievement of $1.63&nbsp;adjusted EPS for fiscal year 2016; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Doubling the size of our variant classification database and introducing new algorithmic methodologies to more quickly classify new variants; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Growth of Prolaris volumes by 94 percent year-over-year while obtaining Medicare coverage for low and very low risk patients and expanding private coverage by 29 million additional lives; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Growth of Vectra DA volumes by 11 percent year-over-year and added our first five private payer contracts representing 3 million additional lives; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Validation of myChoice HRD in the first prospective Phase 3 study with our partner TESARO which proved to be highly statistically significant at predicting progression free survival benefit from niraparib;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Completion of two major acquisitions, Sividon Diagnostics and Assurex Health, which added two new high-growth diagnostic tests to our product portfolio; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Completion of all of the necessary studies for myPath Melanoma and myPlan Lung Cancer to support our reimbursement dossier submissions to Medicare and private payers in fiscal year 2017; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Completion of our first validation study for myPlan Renal Cancer and initiated our prospective clinical study for myPath Bipolar; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Increase of 46 percent in international product revenues (excluding the acquisition of our German clinic); and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Growth of international revenue to 6 percent of total revenues in the fourth quarter with a goal of international revenues reaching 10 percent of total sales by fiscal year 2020. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Role of Management in Our Compensation Program </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our management, including our President and CEO, supports the Compensation Committee, attends portions of its meetings upon request, and
performs various administrative functions at its request.&nbsp;Our President and CEO provides input to the Compensation Committee on the effectiveness of our compensation program and makes specific recommendations as to the base salary amounts,
annual cash incentive bonus amounts, long-term cash incentive bonus awards and equity incentive awards for the executive officers, other than for himself.&nbsp;At the end of each fiscal year, our President and CEO evaluates the annual performance of
each of our executive officers, including an assessment of the accomplishment of each executive officer&#146;s MBOs, and submits his calculations and recommendations to the Compensation Committee which then determines an annual cash incentive bonus
amount for the concluding fiscal year, the base salary amount for the ensuing fiscal year and long term equity incentive compensation for each of the executive officers.&nbsp;Except for our President and CEO, no executive officer is present when the
Compensation Committee discusses and determines the salary and bonus amounts and equity compensation to be awarded to the executive officers.&nbsp;Our President and CEO is excused from all meetings, and is not present, where matters pertaining to
his compensation are determined and approved by the Compensation Committee.</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Other Compensation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We maintain broad-based benefits that are provided to all employees, including health and dental insurance, life and disability insurance, a
401(k) plan, and a discretionary December holiday bonus. Additionally, we may provide other benefits to new executive officers such as a relocation package or other related compensation as determined on a case-by-case basis.&nbsp;We may also provide
certain compensation benefits in connection with the retirement of our executive officers based on their accomplishments and tenure of employment with us. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Termination and Change-of-Control-Based Compensation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We recognize that, as is the case with many publicly-held corporations, the possibility of a change in control of the Company exists and that
such possibility, and the uncertainty and questions which it may raise among key personnel, may result in the departure or distraction of key personnel to the detriment of us and our stockholders.&nbsp;Therefore, we have entered into a retention
agreement with each of our executive officers to reinforce and encourage the continued employment and dedication of our executive officers without distraction </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
from the possibility of a change in control of the Company and related events and circumstances.&nbsp;We believe that the terms of our retention agreement are consistent with those historically
maintained by others in our industry and therefore are important for attracting and retaining key employees who are critical to our long-term success.&nbsp;The potential benefits provided under the retention agreement are in addition to the current
compensation arrangements we have with our executive officers.&nbsp;In September 2015 in response to shareholder concerns, we entered into amendment to these retention agreement with our executive officers in order to eliminate the tax gross-up set
forth therein that allowed for payments to be made by the Company to the executive officers to offset any excise taxes incurred by the executive officer in the event that any change of control payments are subject to excise tax under Section 4999 of
the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the payments each of our NEOs is entitled to receive upon a change-in-control see &#147;Executive Compensation &#150;
Potential Payments Upon Termination or Change-in-Control&#148; later in this proxy statement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Relationship of Elements of Compensation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As noted above, our compensation structure is primarily comprised of a base salary, an annual cash incentive bonus, long-term incentive
compensation in the form of a three-year cash incentive bonus award and equity incentive awards.&nbsp;In setting executive compensation, the Compensation Committee considers the aggregate compensation payable to an executive officer and the form of
the compensation. The Compensation Committee seeks to achieve an appropriate balance between immediate cash rewards and long-term financial incentives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We utilize long term equity incentive compensation in the form of restricted stock units as a substantial component of compensation (prior to
fiscal year 2015 we utilized stock options).&nbsp;The Compensation Committee views the award of restricted stock units as a primary long-term retention benefit by tying the earning of these awards to a vesting schedule that will be over a period
greater than four years for full vesting of restricted stock units.&nbsp;If an employee leaves the Company before the completion of the vesting period, then that employee will not be entitled to any benefit from the non-vested portion of the
award.&nbsp;However, in connection with an executive officer&#146;s separation of employment, we may accelerate a portion of non-vested equity grants as may be negotiated in the executive officer&#146;s separation or resignation
agreement.&nbsp;Additionally, for our NEOs, the restricted stock unit award also has a performance metric that, if not met, would require the NEO to forfeit a portion up to the entire restricted stock unit award regardless of the additional
requirement of vesting.&nbsp;We believe that this vesting feature makes it more attractive to remain as our employee and this arrangement does not require substantial cash payments by the Company.&nbsp;Similarly, our three-year cash incentive bonus
awards promote long-term performance by establishing significant growth performance targets that must be met over a three-year period.&nbsp;This long-term cash incentive bonus also promotes retention of our executives as no payment is made under our
three-year cash incentive bonus awards if the executive officer is not employed on the last day of the three-year performance period.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Compensation Committee reviews from time to time the mix of the compensation elements for executive officers against comparable companies in our industry as represented in the compensation data we utilize. The size and mix of each element in a
compensation package is based on the impact of the position on the Company, market practice and overall corporate and individual performance relative to stated corporate goals. The level of incentive compensation typically increases in relation to
an executive officer&#146;s responsibilities and ability to meet individual and corporate goals. The Compensation Committee believes that making a significant portion of an executive officer&#146;s compensation contingent on corporate performance
more closely aligns the executive officer&#146;s interests with those of our stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Conclusion </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our compensation policies are designed and are continually being developed to retain and motivate our executive officers and to ultimately
reward them for outstanding individual and corporate performance. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Summary Compensation Table</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows the total compensation paid or accrued during the fiscal years indicated to (1) our President and Chief Executive
Officer, (2) our Chief Financial Officer, and (3) our three next most highly compensated executive officers who earned more than $100,000 during the fiscal year ended June 30, 2016 and were serving as executive officers as of June 30, 2016.</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="36%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Name and Principal</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:68.40pt; font-size:8pt; font-family:Times New Roman"><B>Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fiscal<BR>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Salary<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock<BR>Awards</B><br><B>($) (1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Awards</B><br><B>($) (2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Non-</B><br><B>Equity<BR>Incentive</B><br><B>Plan<BR>Compensation<BR>($) (3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other<BR>Compensation<BR>($) (4)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark C. Capone</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">800,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">512</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,361,875</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">727,200</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">11,048</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">4,900,635</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President and Chief</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Executive Officer*</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2015</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">600,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">333,614</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">4,193,200</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">57,060</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10,248</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">5,194,122</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2014</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">567,157</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">819</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,381,840</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">552,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10,248</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">4,512,064</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jerry S. Lanchbury, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">479,400</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">216,242</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,986,563</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">11,297</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2,693,502</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Scientific Officer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2015</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">470,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">174,514</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2,477,800</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">33,523</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10,110</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,165,947</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2014</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">450,824</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">282,819</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,844,640</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10,662</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2,588,945</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard M. Marsh, Esq.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">479,400</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">218,639</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,925,438</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10,830</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2,634,306</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Executive VP, General</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Counsel &amp; Secretary</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2015</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">470,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">174,514</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2,401,560</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">33,523</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10,513</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,090,110</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2014</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">457,157</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">276,819</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,947,120</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10,515</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2,691,611</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R. Bryan Riggsbee (5)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">400,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">180,512</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2,037,500</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10,016</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2,628,028</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Financial Officer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2015</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">265,625</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">129,531</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,050,900</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">119,623</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,565,679</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bernard F. Tobin</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">412,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">192,092</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2,119,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">11,433</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2,734,525</TD>
<TD NOWRAP VALIGN="top">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President, Crescendo</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bioscience, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Mark C. Capone commenced service as our President and CEO on July 1, 2016.&nbsp;For fiscal years 2015 and 2014, Mr. Capone served as the President of Myriad Genetic Laboratories, Inc.</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Except as described in note 5 below, amounts shown reflect the aggregate grant date fair value of restricted stock unit awards granted in each year presented calculated in accordance with FASB ASC Topic 718. Amounts
reflect the maximum potential value of each award assuming the highest level of performance associated with the award and is based on the closing stock price of our common stock on the NASDAQ Global Market on September 15, 2015 of $40.75.&nbsp;In
September 2016, the number of shares underlying the fiscal year 2016 restricted stock unit awards was reduced by 4.6 percent based on the degree of achievement of the applicable performance criteria established on the grant date for these
awards.</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">The amounts shown reflect the aggregate grant date fair value of option awards granted in each year presented calculated in accordance with FASB ASC Topic 718.&nbsp;Information regarding the assumptions used in the
valuation of option awards can be found in the footnote to our financial statements entitled &#147;Share-Based Compensation&#148; in our Annual Report on Form 10-K for the fiscal year ended June 30, 2016, as amended, filed with the SEC.&nbsp;Our
executive officers will not realize the value of these awards in cash unless and until these awards are exercised and the underlying shares are subsequently sold.&nbsp;See also our discussion of stock-based compensation under &#147;Management&#146;s
Discussion and Analysis of Financial Condition and Results of Operations &#150; Critical Accounting Policies&#148; in our Annual Report on Form&nbsp;10-K, as amended. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">For fiscal year 2015, the amounts reported in this column reflect the actual cash awards paid under our long-term, three-year cash incentive bonus plan which concluded in fiscal year 2015.&nbsp;No payment was made under
our long-term, three-year cash incentive bonus plan which concluded in fiscal year 2016 as our performance goals were not achieved.&nbsp;For Mr. Capone, for fiscal years 2016 and 2014, the amounts reported in this column reflects the actual cash
awards paid under our 2013 Executive Incentive Plan to Mr. Capone pursuant to his annual cash incentive bonus award, calculated based on measurement against plan metrics and performance results for fiscal years 2016 and 2014. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">Except as described in note 5 below, all amounts shown for fiscal year 2016 consist of $48 per month of premiums paid by us with respect to term life insurance for the benefit of each NEO for their respective periods
served and the balance of the amount shown for matching contributions made under our 401(k) plan on behalf of each NEO. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top">On October 16, 2014, R. Bryan Riggsbee commenced service as our CFO.&nbsp;Mr. Riggsbee&#146;s fiscal year 2015 annual salary and annual bonus were prorated for the year based on his hire date.&nbsp;The Bonus amount
includes a $10,000 signing bonus awarded to Mr. Riggsbee upon his hire.&nbsp;Mr. Riggsbee&#146;s fiscal 2015 Stock Award represents the initial award of 30,000 restricted stock units made to him upon hiring, which vest one-fourth per year, and is
based on the closing stock price of our common stock on the NASDAQ Global Market of $35.03 on October 17, 2014, the date of grant of the RSUs.&nbsp;The amounts reported in the All Other Compensation column for Mr. Riggsbee for fiscal year 2015
includes $114,179 paid to Mr. Riggsbee for relocation expenses.</TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2016 Fiscal Year Grants of Plan-Based Awards </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables show information regarding grants of non-equity and equity awards that we made during the fiscal year ended June 30, 2016
to each of the executive officers named in the Summary Compensation Table.</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Estimated&nbsp;Future&nbsp;Payouts&nbsp;Under&nbsp;Non-</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Equity Incentive Plan Awards&nbsp;($) (1)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center"><B>Estimated Future<BR>Payouts&nbsp;Under&nbsp;Equity<BR>Incentive&nbsp;Plan&nbsp;Awards<BR>(#) (2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant Date<BR>Fair<BR>Value&nbsp;of<BR>Stock and<BR>Option<BR>Awards<BR>($)&nbsp;(3)</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant Date</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Threshold</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Maximum</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Threshold</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark C. Capone</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">9/15/2015</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,361,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">FY18&nbsp;3-YR</FONT><BR>Award</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">160,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">240,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jerry S. Lanchbury, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">9/15/2015</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,986,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">FY18 3-YR<BR>Award</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,933</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,910</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,865</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard M. Marsh, Esq.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">9/15/2015</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,075</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,925,438</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">FY18 3-YR<BR>Award</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,933</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,910</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,865</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R. Bryan Riggsbee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">10/15/2015</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,037,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">FY18 3-YR<BR>Award</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bernard F. Tobin</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">9/15/2015</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,119,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">FY18 3-YR<BR>Award</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46,350</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">92,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">The amounts represent the threshold, target, and maximum amounts awarded to our NEOs under our Three-Year Cash Incentive Bonus Plan ending in fiscal 2018. The metrics against which performance is to be measured are
discussed in the Compensation Discussion and Analysis under the heading &#147;Fiscal Year 2016 Named Executive Officer Compensation- Long Term Incentive Awards- Three Year Cash Incentive Bonus Plan.&#148; <U></U> </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">The amounts represent the threshold and target (which is the maximum) number of our shares that may be awarded with respect to the restricted stock unit awards made to our NEOs on September 15, 2015.&nbsp;In September
2016, the number of shares underlying these awards was reduced by 4.6 percent based on the degree of achievement of the revenue performance criteria established for these awards.&nbsp;These shares vest one-fourth per year beginning September 30,
2016. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">The amounts represent the grant date fair value calculated in accordance with FASB ASC Topic 718 and is based on the closing stock price of our common stock on the NASDAQ Global Market on September 15, 2015 of
$40.75.</TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Narrative Disclosure to Summary Compensation Table and 2016 Fiscal Year Grants of Plan-Based Awards Table </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have entered into standard form employment agreements with no defined term with each of our NEOs.&nbsp;Pursuant to these agreements, either
party may terminate employment without cause at any time upon 15 days written notice to the other party or immediately with cause upon written notice to the other party.&nbsp;Each employment agreement also provides that the employee will not
disclose confidential information of ours during and after employment and will not compete with us during the term of employment.&nbsp;Since the dates of these agreements entered into with our NEOs, the compensation paid to each NEO has been
increased and additional stock options and restricted stock units have been granted as discussed below.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Previously, we have entered into
an Executive Retention Agreement with each of our NEOs under which they are entitled to certain benefits upon a change-in-control, as discussed below under &#147;Executive Compensation &#150; Potential Payments Upon Termination or
Change-in-Control.&#148;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr. Capone was appointed to the position of President and CEO of the Company beginning July 1, 2015. He had
previously entered into the Company&#146;s standard form of employment agreement when he was initialed hired by the Company in October 2002 as the Vice President of Sales for MGL.&nbsp;Thereafter, in September 2005, he was appointed to the position
of Senior Vice President of Sales for MGL.&nbsp;In February 2006, he was appointed to the position of Chief Operating Officer for MGL, and then in March 2010 he was appointed President of MGL.&nbsp;As determined by our Compensation Committee, he
received an annual salary of $800,000 for the fiscal year ended June 30, 2016.&nbsp;Mr. Capone will be paid an annual base salary of $852,000 as our President and CEO for the fiscal year ending June 30, 2017.&nbsp;His annual cash incentive bonus for
fiscal 2016 was $727,200 as approved by our Compensation Committee based on the level of achievement of pre-established performance goals.&nbsp;Additionally, in September 2015, the Compensation Committee approved a three-year cash incentive award
under our 2013 Executive Incentive Plan pursuant to which Mr. Capone will be entitled to receive up to $240,000 as of the end of fiscal 2018 if we achieve the performance goals discussed above in the Compensation Discussion and Analysis under the
heading &#147;Fiscal Year 2016 Named Executive Officer Compensation &#150; Long-Term Incentive Awards &#150; Three-Year Cash Incentive Bonus.&#148;&nbsp;On September 15, 2015, Mr. Capone was granted a restricted stock unit award of 82,500 shares of
the Company, subject to time-based and performance-based vesting requirements.&nbsp;Based on the level of accomplishment of the performance-based metric for fiscal 2016, the restricted stock unit award was reduced to 78,705 shares.&nbsp;On September
14, 2016, he was granted a restricted stock unit award of 165,000 shares of the Company, subject to time-based and performance-based vesting requirements.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr. Riggsbee was appointed to the position of Chief Financial Officer and Treasurer in October, 2014, and entered into the Company&#146;s
standard form of employment agreement at that time.&nbsp;As determined by our Compensation Committee, he received an annual salary of $400,000 for the fiscal year ended June 30, 2016.&nbsp;Mr. Riggsbee will be paid an annual base salary of $432,000
for the fiscal year ending June 30, 2017.&nbsp;His annual cash incentive bonus for fiscal 2016 was $180,000 as determined by our Compensation Committee.&nbsp;Additionally, in September 2015, the Compensation Committee approved a three-year cash
incentive award under our 2013 Executive Incentive Plan pursuant to which Mr. Riggsbee will be entitled to receive up to $90,000 as of the end of fiscal 2018 if we achieve the performance goals discussed above in the Compensation Discussion and
Analysis under the heading &#147;Fiscal Year 2016 Named Executive Officer Compensation &#150; Long-Term Incentive Awards &#150; Three-Year Cash Incentive Bonus.&#148;&nbsp;On September 15, 2015, he was granted a restricted stock unit award of 50,000
shares of the Company, subject to time-based and performance-based vesting requirements.&nbsp;Based on the level of accomplishment of the performance-based metric for fiscal 2016, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
restricted stock unit award was reduced to 47,700 shares.&nbsp;On September 14, 2016, Mr. Riggsbee was granted a restricted stock unit award of 60,000 shares of the Company, subject to time-based
and performance-based vesting requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dr. Lanchbury was appointed to the position of Senior Vice President, Research in November
2002 and entered into the Company&#146;s standard form of employment agreement at that time.&nbsp;In September 2005, he was promoted to Executive Vice President, Research.&nbsp;In February 2010, Dr. Lanchbury was appointed Chief Scientific
Officer.&nbsp;As determined by our Compensation Committee, he received an annual salary of $479,400 for the fiscal year ended June 30, 2016.&nbsp;Dr. Lanchbury will be paid an annual base salary of $493,782 for the fiscal year ending June 30,
2017<I>.</I>&nbsp;His annual cash incentive bonus for fiscal 2016 was $215,730 as determined by our Compensation Committee.&nbsp;Additionally, in September 2015, the Compensation Committee approved a three-year cash incentive award under our 2013
Executive Incentive Plan pursuant to which Dr. Lanchbury will be entitled to receive up to $107,888 as of the end of fiscal 2018 if we achieve the performance goals discussed above in the Compensation Discussion and Analysis under the heading
&#147;Fiscal Year 2016 Named Executive Officer Compensation &#150; Long-Term Incentive Awards &#150; Three-Year Cash Incentive Bonus.&#148;&nbsp;On September 15, 2015, he was granted a restricted stock unit award of 48,750 shares of the Company,
subject to time-based and performance-based vesting requirements.&nbsp;Based on the level of accomplishment of the performance-based metric for fiscal 2016, the restricted stock unit award was reduced to 46,508 shares.&nbsp;On September 14, 2016,
Dr. Lanchbury was granted a restricted stock unit award of 50,000 shares of the Company, subject to time-based and performance-based vesting requirements.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr. Marsh was appointed to the position of Vice President, General Counsel and Secretary in November 2002 and entered into the Company&#146;s
standard form of employment agreement at that time.&nbsp;In September 2005, he was promoted to Executive Vice President, General Counsel and Secretary.&nbsp;As determined by our Compensation Committee, Mr. Marsh received an annual salary of $479,400
for the fiscal year ended June 30, 2016, and will be paid an annual base salary of $493,782 for the fiscal year ending June 30, 2017.&nbsp;His annual cash incentive bonus for fiscal 2016 was $218,127 as determined by our Compensation
Committee.&nbsp;Additionally, in September 2015, the Compensation Committee approved a three-year cash incentive award under our 2013 Executive Incentive Plan pursuant to which Mr. Marsh will be entitled to receive up to $107,888 as of the end of
fiscal 2018 if we achieve the performance goals discussed above in the Compensation Discussion and Analysis under the heading &#147;Fiscal Year 2016 Named Executive Officer Compensation &#150; Long-Term Incentive Awards &#150; Three-Year Cash
Incentive Bonus.&#148;&nbsp;On September 15, 2015, he was granted a restricted stock unit award of 47,250 shares of the Company, subject to time-based and performance-based vesting requirements.&nbsp;Based on the level of accomplishment of the
performance-based metric for fiscal 2016, the restricted stock unit award was reduced to 45,077 shares.&nbsp;On September 14, 2016, Mr. Marsh was granted a restricted stock unit award of 50,000 shares of the Company, subject to time-based and
performance-based vesting requirements.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr. Tobin was appointed President of Crescendo Bioscience, Inc. in January 2015 and entered into
the Company&#146;s standard form of employment agreement at that time.&nbsp;As determined by our Compensation Committee, Mr. Tobin received an annual salary of $412,000 for the fiscal year ended June 30, 2016, and will be paid an annual base salary
of $424,360 for the fiscal year ending June 30, 2017.&nbsp;His annual cash incentive bonus for fiscal 2016 was $191,580 as determined by our Compensation Committee.&nbsp;Additionally, in September 2015, the Compensation Committee approved a
three-year cash incentive award under our 2013 Executive Incentive Plan pursuant to which Mr. Tobin will be entitled to receive up to $92,700 as of the end of fiscal 2018 if we achieve the performance goals discussed above in the Compensation
Discussion and Analysis under the heading &#147;Fiscal Year 2016 Named Executive Officer Compensation &#150; Long-Term Incentive Awards &#150; Three-Year Cash Incentive Bonus.&#148;&nbsp;On September 15, 2015, he was granted a restricted stock unit
award of 52,000 shares of the Company, subject to time-based and performance-based vesting requirements.&nbsp;Based on the level of accomplishment of the performance-based metric for fiscal 2016, the restricted stock unit award was reduced to 49,608
shares.&nbsp;On September 14, 2016, Mr. Tobin was granted a restricted stock unit award of 40,000 shares of the Company, subject to time-based and performance-based vesting requirements.</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All annual restricted stock unit awards granted to our NEOs are subject to a predetermined,
formula-based financial performance metric that must be met in order for these awards to vest annually over a four-plus year period.&nbsp;In addition to the annual cash incentive bonus paid to each of our NEOs, all employees, including the named
executive officers, received a holiday bonus of $512 in fiscal 2016. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In September 2016, the Compensation Committee approved a three-year
cash incentive award under our 2013 Executive Incentive Plan pursuant to which our executive officers and other key management members may be entitled to receive compensation at the end of fiscal 2019 if certain predetermined performance goals are
achieved.&nbsp;Following are the amounts that may be earned for our NEOs for the awards under our three-year cash incentive awards: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="59%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Award<BR>Period</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>Estimated Future Payouts Under Non-<BR>Equity Incentive Plan Awards ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Threshold</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Maximum</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark C. Capone</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">FY17-19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">127,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">170,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">255,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jerry S. Lanchbury, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">FY17-19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,550</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74,067</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard M. Marsh, Esq.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">FY17-19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,550</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74,067</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R. Bryan Riggsbee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">FY17-19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bernard F. Tobin</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">FY17-19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,741</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,654</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,481</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Outstanding Equity Awards at 2016 Fiscal Year End </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows the grants of stock options and restricted stock units outstanding on the last day of the fiscal year ended June 30,
2016, to each of our NEOs.&nbsp;We have not granted any stock options that are subject to performance conditions.&nbsp;The restricted stock units granted to our NEOs are subject to performance conditions, except for the initial RSU grant made to Mr.
Riggsbee and Mr. Tobin upon hiring. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center"><B>Option Awards (1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>Stock Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Date of<BR>Grant</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>Exercisable<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>Unexercisable<BR>(#) (2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Exercise<BR>Price<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option</B><br><B>Expiration<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Shares</B><br><B>or Units&nbsp;of<BR>Stock&nbsp;that<BR>Have not<BR>Vested (#)<BR>(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market<BR>Value&nbsp;of<BR>Shares&nbsp;or<BR>Units&nbsp;of<BR>Stock<BR>that<BR>Have not<BR>Vested</B><br><B>($) (4)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Number&nbsp;of<BR>Unearned<BR>Shares,</B><br><B>Units</B><br><B>or Other</B><br><B>Rights<BR>that Have<BR>not
Vested<BR>(#) (2)(3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Market&nbsp;or<BR>Payout</B><br><B>Value&nbsp;of<BR>Unearned</B><br><B>Shares,<BR>Units</B><br><B>or
Other<BR>Rights<BR>that Have<BR>not<BR>Vested</B><br><B>($) (4)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Mark C. Capone</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/10/2008</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22.93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/10/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/18/2009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/18/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/15/2009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30.34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/15/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/03/2010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23.11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/15/2010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,001</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16.53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/15/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">02/23/2011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">18.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/23/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/13/2011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">144,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/13/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/07/2012</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/7/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/12/2012</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">225,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">27.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/12/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/17/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">165,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">165,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26.49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/17/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/17/2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74,572</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,281,903</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/15/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,524,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Jerry S. Lanchbury, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/18/2009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/18/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/15/2009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30.34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/15/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/03/2010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23.11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">02/23/2011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">18.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/23/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/13/2011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">128,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/13/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/07/2012</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/7/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/12/2012</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">27.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/12/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/17/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26.49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/17/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/17/2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,066</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,348,420</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/15/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,491,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Richard M. Marsh, Esq.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/18/2009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">77,654</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/18/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/15/2009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66,139</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30.34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/15/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/03/2010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23.11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/15/2010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79,999</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16.53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/15/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">02/23/2011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">18.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/23/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/13/2011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">144,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/13/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/07/2012</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,830</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/7/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/12/2012</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">135,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">27.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/12/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/17/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26.49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/17/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/17/2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42,710</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,306,926</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/15/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,445,850</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">R. Bryan Riggsbee</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/17/2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">688,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/15/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,530,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Bernard F. Tobin</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">01/02/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">642,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/15/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,591,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Stock Option Vesting Schedules: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Options granted on and between September 14, 2005 through and including September 15, 2010 were granted pursuant to our 2003 Employee, Director and Consultant Stock Option Plan, as amended (the &#147;2003 Plan&#148;)
and vest 25 percent of the shares per year on each anniversary of the date of grant. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Options granted beginning on and after February 23, 2011 were granted pursuant to our 2010 Plan and vest 25 percent of the shares per year on each anniversary date of the grant. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Restricted stock units vest <SUP STYLE="vertical-align:top">&nbsp;1</SUP>&#8260;<SUB STYLE="vertical-align:bottom">4</SUB> per year from the last day of the month in which the restricted stock units were
granted.&nbsp;Restricted stock units awarded to Mr. Riggsbee and Mr. Tobin in connection with their commencement of employment vest <SUP STYLE="vertical-align:top">&nbsp;1</SUP>&#8260;<SUB STYLE="vertical-align:bottom">4</SUB> per year from the date
of grant.&nbsp;The vesting of unvested options and restricted stock unit awards held by our NEOs will accelerate upon a change of control of Myriad in accordance with the Executive Retention Agreements described below under &#147;Potential Payments
Upon Termination or Change-in-Control.&#148;</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">On September 14, 2016, based on the degree of accomplishment of the applicable performance criteria for our fiscal year 2016, the number of shares actually awarded was reduced by 4.6 percent.&nbsp;The adjusted number of
restricted stock units will vest 1/4 per year beginning on September 30, 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">The market value of stock awards is determined by multiplying the number of shares by $30.60, the closing price of our common stock on the NASDAQ Global Market on June 30, 2016, the last day of our fiscal year.
</TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2016 Fiscal-Year Option Exercises and Stock Vested </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows information regarding exercises of options to purchase our common stock and vesting of restricted stock unit awards
by our NEOs during the fiscal year ended June 30, 2016. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Option Awards</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Restricted Stock Awards</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:19.10pt; font-size:8pt; font-family:Times New Roman">Name</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number&nbsp;of&nbsp;Shares<BR>Acquired on<BR>Exercise (#)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Value&nbsp;Realized&nbsp;on<BR>Exercise ($) (1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number&nbsp;of&nbsp;Shares<BR>Acquired&nbsp;on&nbsp;Vesting<BR>(#)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Value&nbsp;Realized<BR>on&nbsp;Vesting ($)</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark C. Capone</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">None</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,857</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,028,831</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jerry S. Lanchbury, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">135,999</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,950,688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">607,936</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard M. Marsh, Esq.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,378</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,478,730</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,236</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">589,228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R. Bryan Riggsbee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">None</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">294,825</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bernard F. Tobin</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">None</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">299,810</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Amounts shown in this column do not necessarily represent the actual value realized from the sale of the shares acquired upon exercise of the options because the shares may not be sold on exercise but continue to be
held by the executive officer exercising the option.&nbsp;The amounts shown represent the difference between the option exercise price and the market price on the date of exercise, which is the amount that would have been realized if the shares had
been sold immediately upon exercise. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Pension Benefits </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not have any qualified or non-qualified defined pension benefit plans. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Nonqualified Deferred Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do
not have any nonqualified defined contribution plans or other deferred compensation plans. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Potential Payments Upon Termination or Change-in-Control
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February 17, 2005 (and thereafter for subsequently appointed executive officers), we entered into Executive Retention Agreements,
or the Retention Agreements, with our executive officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the terms of the Retention Agreements, if the employment of an executive
officer is terminated without &#147;Cause&#148; or if the executive officer separates from Myriad for &#147;Good Reason&#148; within 24 months of a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
&#147;Change in Control&#148; (each is defined in the agreement and set forth below), the executive officer will receive: (i) all salary earned through the date of termination, as well as a
prorated bonus and any compensation previously deferred; (ii) an amount equal to three times the executive&#146;s highest annual base salary and three times the executive&#146;s highest annual bonus at Myriad during the three-year period prior to
the Change in Control; (iii) continued benefits for 36 months after the date of termination; and (iv) outplacement services in an aggregate amount of up to $25,000.&nbsp;If the employment of an executive officer is terminated by the executive
officer for no reason, during the 90-day period beginning on the first anniversary of the &#147;Change in Control Date&#148; (as defined in the agreement and set forth below), then the termination shall be deemed to be termination for Good Reason
for all purposes of the Retention Agreement except that the payment of an amount equal to three times the executive&#146;s highest annual base salary and bonus shall be reduced by one-half.&nbsp;In addition, upon the occurrence of a Change in
Control, all of the executive&#146;s unvested equity incentive compensation shall become fully vested, whether or not the executive is terminated.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October 12, 2007, the Retention Agreements were amended to provide that all payments under the agreement are to be made in a lump sum, in
cash, six months following the date of termination of employment, unless an earlier payment, in whole or in part, following the date of termination of employment is permitted under Section 409A of the Internal Revenue Code of 1986, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September 29, 2015, the Retention Agreements were amended to delete the tax gross-up provision that previously allowed for a payment to be
made by the Company to an executive officer in connection with a change in control of the Company to offset any excise taxes or penalties incurred by the executive officer under Section 4999 of the Code in connection with a &#147;parachute
payment&#148; within the meaning of Section 280G of the Code.&nbsp;No such payment is now permitted under the Retention Agreements and any excise taxes due shall be borne solely by the executive officer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the terms of the Retention Agreement are either satisfied or expire on a date that is 24 months after a Change in Control, the
Retention Agreement will continue to be in effect through December 31, 2016 and thereafter for one-year terms unless we provide notice of non-renewal at least 90 days prior to the end of each term. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As defined in the Retention Agreements: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">&#147;<I>Cause</I>&#148; means (a)&nbsp;the Executive&#146;s willful and continued failure to substantially perform his or her reasonable assigned duties (other than any such failure resulting from incapacity due to
physical or mental illness or any failure after the Executive gives notice of termination for Good Reason) that is not cured within 30&nbsp;days after a written demand for substantial performance is received by the Executive from the board of
directors, which specifically identifies the manner in which the board believes the Executive has not substantially performed the Executive&#146;s duties; or (b)&nbsp;the Executive&#146;s willful engagement in illegal conduct or gross misconduct
that is materially and demonstrably injurious to the Company.&nbsp;No act or failure to act by the Executive shall be considered &#147;willful&#148; unless it is done, or omitted, in bad faith and without reasonable belief that the Executive&#146;s
action or omission was in the best interests of the Company. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;<I>Good Reason</I>&#148; means the occurrence, without the Executive&#146;s written consent, of any of the
following events or circumstances: (a)&nbsp;The assignment to the Executive of duties inconsistent in any material respect with the Executive&#146;s position (including status, offices, titles and reporting requirements), authority or
responsibilities in effect immediately prior to the earliest to occur of (i)&nbsp;the Change in Control Date; (ii)&nbsp;the date of the execution by the Company of the initial written agreement or instrument providing for the Change in Control; or
(iii)&nbsp;the date of the adoption by the board of directors of a resolution providing for the Change in Control (with the earliest of such dates referred to herein as the &#147;Measurement Date&#148;), or any other action or omission by the
Company that results in a material diminution in the Executive&#146;s position, authority or responsibilities. (b)&nbsp;A reduction in the Executive&#146;s annual base salary that was in effect on the Measurement Date. (c)&nbsp;The failure by the
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
Company to (i)&nbsp;continue in effect any material compensation, pension, retirement or benefit plan or program (including without limitation any 401(k), life insurance, medical, health and
accident or disability plan and any vacation program or policy) (a &#147;Benefit Plan&#148;) in which the Executive participates or that is applicable to the Executive immediately prior to the Measurement Date, unless an equitable arrangement
(embodied in an ongoing substitute or alternative plan) has been made with respect to such plan or program; (ii)&nbsp;continue the Executive&#146;s participation therein (or in a substitute or alternative plan) on a basis not materially less
favorable, both in terms of the amount of benefits provided and the level of the Executive&#146;s participation relative to other participants, than the basis that existed immediately prior to the Measurement Date; or (iii)&nbsp;award cash bonuses
to the Executive in amounts and in a manner substantially consistent with past practice. (d)&nbsp;A change by the Company in the location at which the Executive performs his or her principal duties for the Company to a new location that is both
(i)&nbsp;outside a radius of 50 miles from the Executive&#146;s principal residence immediately prior to the Measurement Date and (ii)&nbsp;more than 50 miles from the location at which the Executive performed his or her principal duties for the
Company immediately prior to the Measurement Date; or (iii) a requirement by the Company that the Executive travel on Company business to a substantially greater extent than required immediately prior to the Measurement Date. (e)&nbsp;The failure by
the Company to obtain the agreement from any successor to the Company to assume and agree to perform the Retention Agreement.; Or (f)&nbsp;any failure of the Company to pay or provide to the Executive any portion of the Executive&#146;s compensation
or benefits due under any Benefit Plan within seven days of the date such compensation or benefits are due, any material breach by the Company of the Retention Agreement, or any employment agreement with the Executive. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;<I>Change in Control</I>&#148; means an event or occurrence set forth in any one or more of the following
events (including an event or occurrence that constitutes a Change in Control under one of such subsections but is specifically exempted from another subsection): (a)&nbsp;The acquisition by an individual, entity or group [within the meaning of
Section&nbsp;13(d) or 14(d) of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;)] (a &#147;Person&#148;) of beneficial ownership of any capital stock of the Company if, after such acquisition, that Person beneficially
owns (within the meaning of Rule&nbsp;13d-3 promulgated under the Exchange Act) 20 percent or more of either (i)&nbsp;the then-outstanding shares of common stock of the Company (the &#147;Outstanding Company Common Stock&#148;) or (ii)&nbsp;the
combined voting power of the then-outstanding securities of the Company entitled to vote generally in the election of directors (the &#147;Outstanding Company Voting Securities&#148;); <I>provided</I>, however, that for purposes of this subsection
(a), the following acquisitions shall not constitute a Change in Control: (i)&nbsp;any acquisition directly from the Company (excluding an acquisition pursuant to the exercise, conversion or exchange of any security exercisable for, convertible into
or exchangeable for common stock or voting securities of the Company, unless the Person exercising, converting or exchanging such security acquired such security directly from the Company or an underwriter or agent of the Company); (ii)&nbsp;any
acquisition by the Company; or (iii)&nbsp;any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any corporation controlled by the Company. Or (b) such time as the Continuing Directors (as defined
below) do not constitute a majority of the board (or, if applicable, the board of directors of a successor corporation to the Company), where the term &#147;Continuing Director&#148; means at any date a member of the board (i)&nbsp;who was a member
of the board on the date of the execution of the Retention Agreement or (ii)&nbsp;who was nominated or elected subsequent to such date by at least a majority of the directors who were Continuing Directors at the time of such nomination or election
or whose election to the board was recommended or endorsed by at least a majority of the directors who were Continuing Directors at the time of such nomination or election; <I>provided</I>, <I>however</I>, that excluded from this clause&nbsp;(ii) is
any individual whose initial assumption of office occurred as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents, by or on
behalf of a person other than the board. (c)&nbsp;The consummation of a merger, consolidation, reorganization, recapitalization or share exchange involving the Company or a sale or other disposition of all or substantially all of the assets of the
Company in one or a series of transactions (a &#147;Business </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
Combination&#148;), unless, immediately following such Business Combination, the following condition is satisfied: all or substantially all of the individuals and entities who were the beneficial
owners of the Outstanding Company Common Stock and Outstanding Company Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50 percent of the then-outstanding shares of common stock and
the combined voting power of the then-outstanding securities entitled to vote generally in the election of directors, respectively, of the resulting or acquiring corporation in such Business Combination (which shall include, without limitation, a
corporation that, as a result of the transaction, owns the Company or substantially all of the Company&#146;s assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership, immediately prior to
the Business Combination, of the Outstanding Company Common Stock and Outstanding Company Voting Securities, respectively, or (d)&nbsp;approval by the stockholders of the Company of a complete liquidation or dissolution of the Company.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">&#147;<I>Change in Control Date</I>&#148; means the first date during the Term (as defined in the Retention Agreement) on which a Change in Control occurs. Anything in the Retention Agreement to the contrary
notwithstanding, if (a)&nbsp;a Change in Control occurs, (b)&nbsp;the Executive&#146;s employment with the Company is terminated prior to the date on which the Change in Control occurs, and (c)&nbsp;it is reasonably demonstrated by the Executive
that such termination of employment (i)&nbsp;was at the request of a third party who has taken steps reasonably calculated to effect a Change in Control or (ii)&nbsp;otherwise arose in connection with or in anticipation of a Change in Control, then
for all purposes of the Retention Agreement the &#147;Change in Control Date&#148; shall mean the date immediately prior to the date of the termination of employment. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing summary of the Retention Agreements is qualified in its entirety by the full text of the agreements, which has been filed as an
exhibit to our Annual Report on Form 10-K, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, under the terms of the award agreements for options and restricted
stock units granted to our NEOs, all of the NEO&#146;s restricted stock units shall become fully vested upon the occurrence of a Change in Control, as defined in the Retention Agreements, whether or not the executive is terminated. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the potential payments to each of our NEOs upon either a change in
control or termination following a change in control, assuming the occurrence of the different triggers of the Retention Agreement, as of the close of business on June 30, 2016, the last business day of our most recent fiscal year<B>.</B><B> </B>
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="29%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Executive&nbsp;Benefits</B><br><B>and&nbsp;Payments&nbsp;Upon</B><br><B>Termination</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change in<BR>Control ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change&nbsp;in&nbsp;Control<BR>and Involuntary<BR>Termination&nbsp;Without<BR>Cause or for Good<BR>Reason ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change in<BR>Control and<BR>Voluntary<BR>Termination&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark C. Capone</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Base salary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Bonus</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,181,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,090,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Stock&nbsp;option&nbsp;and&nbsp;RSU&nbsp;acceleration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,991,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,991,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,991,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Cobra benefits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Outplacement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,991,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,655,723</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,364,923</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R. Bryan Riggsbee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Base salary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">600,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Bonus</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">540,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">270,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Stock option and RSU acceleration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,218,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,218,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,218,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Cobra benefits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Outplacement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,218,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,040,723</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,170,723</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jerry S. Lanchbury, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Base salary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,438,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">719,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Bonus</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">647,190</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">323,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Stock option and RSU acceleration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,494,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,494,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,494,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Cobra benefits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Outplacement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,494,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,662,213</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,619,518</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard M. Marsh, Esq.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Base salary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,438,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">719,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Bonus</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">654,381</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">327,191</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Stock option and RSU acceleration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,441,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,441,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,441,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Cobra benefits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Outplacement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,441,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,615,804</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,569,514</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bernie F. Tobin</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Base salary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,236,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">618,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Bonus</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">574,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">287,370</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Stock option and RSU acceleration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,233,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,233,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,233,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Cobra benefits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Outplacement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,233,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,126,763</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,221,393</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a description of the assumptions that were used in creating the above table. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Vesting Acceleration Calculation &#150; The value of the vesting acceleration was calculated by multiplying the number of unvested in-the-money stock options as of June 30, 2016 by the spread between the closing price
of our stock as of June 30, 2016, which was $30.60 per share, and the exercise price of such unvested option.&nbsp;Additionally, the total includes the number of unvested restricted stock units multiplied by the closing price of our stock as of June
30, 2016 which was $30.60. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows the total compensation paid or accrued during the fiscal year ended June 30, 2016 to each of our nonemployee
directors who served during fiscal 2016.&nbsp;Directors who are employed by Myriad are not compensated for their service on our board of directors.</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="52%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fees&nbsp;Earned&nbsp;or<BR>Paid&nbsp;in&nbsp;Cash&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Restricted&nbsp;Stock<BR>Unit</B><br><B>Awards ($) (1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lawrence C. Best</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">318,525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">399,025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Heiner Dreismann, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">318,525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">407,525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Walter Gilbert, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">318,525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">390,525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John T. Henderson, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">186,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">318,525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">505,025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dennis H. Langer, M.D., J.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">318,525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">409,025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">S. Louise Phanstiel</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">318,525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">416,025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Amounts shown reflect the aggregate grant date fair value of 7,500 restricted stock units awarded to each nonemployee director who served during fiscal 2016 calculated in accordance with FASB ASC Topic 718 and is
determined by multiplying the number of shares by $42.47, the closing price of our common stock on the NASDAQ Global Market on December 3, 2015, the date of the grant.&nbsp;RSUs awarded to our nonemployee directors vest in full upon one year from
date of grant. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows outstanding and vested options and RSUs for each nonemployee director as of June
30, 2016. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="65%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Options<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Vested<BR>Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>RSUs</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lawrence C. Best</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Heiner Dreismann, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Walter Gilbert, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John T. Henderson, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">240,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">240,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dennis H. Langer, M.D., J.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">S. Louise Phanstiel</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows the grant date fair value for restricted stock unit awards granted to each
nonemployee director in our fiscal year ended June 30, 2016. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="56%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Granted&nbsp;(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant</B><br><B>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant&nbsp;Date<BR>Fair&nbsp;Value&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lawrence C. Best</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/3/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">318,525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Heiner Dreismann, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/3/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">318,525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Walter Gilbert, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/3/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">318,525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John T. Henderson, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/3/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">318,525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dennis H. Langer, M.D., J.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/3/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">318,525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">S. Louise Phanstiel</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/3/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">318,525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Director Compensation Policy </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our nonemployee directors are compensated on a role-based model and are paid cash fees based on the annual retainers (25 percent paid following
each quarter of service).&nbsp;The following is a description of the standard compensation arrangements under which our nonemployee directors are compensated for their service as directors, including as members of the various board committees: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="77%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:49.90pt; font-size:8pt; font-family:Times New Roman">Annual retainer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All members</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$60,000</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chairman of the Board</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$100,000&nbsp;additional</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chair of the Audit Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$28,000 additional</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chairman of the Compensation Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$20,000 additional</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chairman of the Nominating and Governance Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$15,000 additional</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Members of the Audit Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$13,500 additional</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Members of the Compensation Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$10,000 additional</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Members of the Nominating and Governance Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$7,500 additional</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Members of the Strategic Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$5,000 additional</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Attendance </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Board Meetings:&nbsp;In addition to the annual retainer amounts, we pay each nonemployee director a per-meeting cash fee of $2,000 for attendance at board meetings in excess of five in-person meetings and four
telephonic meetings per fiscal year.</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Committee Meetings other than Strategic Committee:&nbsp;We also pay each nonemployee director a per-meeting cash fee of $2,000 for attendance at committee meetings in excess of four meetings (per each committee),
whether in person or telephonic, per fiscal year.</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Strategic Committee:&nbsp;No per meeting fee will be paid for meetings of the Strategic Committee. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All directors are also reimbursed for their out-of pocket expenses incurred in attending meetings. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Stock Option, Restricted and Unrestricted Stock Grants and Other Stock-Based Awards </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under our 2010 Plan, our nonemployee directors may be awarded stock options, restricted and unrestricted stock grants and/or other stock-based
awards.&nbsp;In fiscal year 2016, as recommended and determined by our Compensation Committee, and approved by our Board of Directors, the Company granted to each nonemployee director a restricted stock unit award of 7,500 shares of the
Company&#146;s common stock.&nbsp;Beginning in fiscal year 2017, as recommended and determined by our Compensation Committee, and approved by our Board of Directors, on each date of our annual meeting of stockholders, the Company shall grant to each
nonemployee director, other than new nonemployee directors appointed within six months of the annual meeting, a restricted stock unit award equal to $250,000 divided by the closing stock price of the Company&#146;s common stock on the applicable
date of our annual meeting of stockholders.&nbsp;In addition, it is our policy to grant a restricted stock unit award for 7,500 shares of common stock to each new nonemployee director upon initial appointment to the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Options and restricted stock units granted to our nonemployee directors vest in full upon completion of one full year of service on the Board
(generally on the earlier of the first anniversary of the date of grant or the date of the next annual meeting of stockholders).&nbsp;Options granted to our nonemployee directors are exercisable after the termination of the director&#146;s service
on the Board to the extent exercisable on the date of such termination for the remainder of the life of the option.&nbsp;All options or restricted stock units granted to our nonemployee directors will become fully exercisable upon a change of
control of Myriad or upon their death as provided for under the forms of award agreement for directors under our 2010 Plan.</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Compensation Policies and Practices </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the fiscal year ended June 30, 2016, the Compensation Committee conducted a risk assessment of our compensation policies and practices
for our employees and concluded that our policies and practices do not create risks that are reasonably likely to have a material adverse effect on the Company.&nbsp;For this purpose, we considered the compensation structure of the Company for its
employees including executive officers, which is based on an annual salary, annual bonus (for bonus-eligible employees), three-year cash incentive bonuses for executive officers, sales commissions and bonuses (for sales staff and managers), and
equity incentive compensation in the form of stock option or restricted stock unit grants.&nbsp;We do not believe we offer any short-term incentives that might result in high-risk actions or conduct by our employees.&nbsp;For example, incentive
compensation for executive officers in the form of an annual cash bonus or long-term three-year cash incentive bonus is based on a predetermined formula and management objectives approved by the Compensation Committee and is subject to a cap. There
is no unique operational division or group of employees who are specially compensated, or who, as a group, are responsible for a material portion of our revenues or profits.&nbsp;We do not believe that the awarding of long-term incentive
compensation under our three-year cash incentive bonus or equity incentive compensation in the form of stock options or restricted stock units creates any undue compensation risks to the Company.&nbsp;Additionally, we believe that we have
appropriate internal controls that support the accurate and timely recognition of Company revenues.&nbsp;Accordingly, we believe that we have a balanced pay and performance program that does not promote undue or excessive risk taking. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Tax Deductibility of Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 162(m) of the Internal Revenue Code limits the deduction a public company is permitted for compensation paid to the chief executive
officer and to the three most highly compensated executive officers other than the chief financial officer.&nbsp;Generally, amounts paid in excess of $1,000,000 to a covered executive cannot be deducted, unless the compensation is paid pursuant to a
plan that is performance related, nondiscretionary and has been approved by stockholders.&nbsp;In fiscal 2013, we adopted our 2013 Executive Incentive Plan under which incentive compensation paid to designated executive officers may be deductible
for purposes of Section 162(m) of the Internal Revenue Code of 1986, as amended.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In its deliberations, the Compensation Committee
considers ways to maximize the deductibility of executive compensation, but nonetheless retains the discretion to compensate executive officers at levels the Compensation Committee considers commensurate with their responsibilities and achievements
in which the compensation may not be deductible under Section 162(m).&nbsp;For fiscal 2016, we had not adopted a policy that all executive compensation be fully deductible; however, we believe that all of our restricted stock unit awards are
deductible under Section 162(m).&nbsp;In order to retain flexibility to incentivize and reward our executives, we may award compensation that is not deductible for purposes of Section 162(m). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Equity Compensation Plan Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides certain aggregate information with respect to all of the Company&#146;s equity compensation plans in effect as of
June 30, 2016.</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="57%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:46.85pt; font-size:8pt; font-family:Times New Roman"><B>Plan category</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(a)</B><br><B>Number of<BR>securities&nbsp;to&nbsp;be<BR>issued upon<BR>exercise of<BR>outstanding<BR>options,&nbsp;warrants<BR>and rights</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(b)</B><br><B>Weighted-<BR>average&nbsp;exercise<BR>price of<BR>outstanding<BR>options,<BR>warrants and<BR>rights</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(c)</B><br><B>Number&nbsp;of&nbsp;securities<BR>remaining&nbsp;available&nbsp;for<BR>future issuance under<BR>equity compensation<BR>plans
(excluding<BR>securities reflected in<BR>column (a))</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation plans approved by security holders (1)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,154,307</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24.52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,819,870</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation plans not approved by security holders</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,154,307</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24.52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,819,870</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">These plans consist of our&nbsp;2003 Employee, Director and Consultant Stock Option Plan, as amended (the &#147;2003 Plan&#148;), our 2010 Employee, Director and Consultant Equity Plan, as amended (the &#147;2010
Plan&#148;), and our Employee Stock Purchase Plan, as amended.</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Column (c) includes 1,335,819 shares available for future issuance under our Employee Stock Purchase Plan and 2,484,051 shares available for future issuance under the 2010 Plan as of June 30, 2016.&nbsp;No shares are
available for issuance under the 2003 Plan.&nbsp;On September 14, 2016 we awarded 998,160 restricted stock units to our employees and executive officers under the 2010 Plan.&nbsp;Because we reduce the shares available for grant by two shares for
each restricted stock unit awarded, we further reduced the number of shares available for future issuance under our 2010 Plan by 1,996,320.&nbsp;Accordingly, the balance of shares available for future issuance under our 2010 Plan, as of October 5,
1016, was 330,690 shares. </TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMPENSATION COMMITTEE REPORT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee of our Board of Directors has reviewed and discussed the Compensation Discussion and Analysis required by Item
402(b) of Regulation S-K, which appears elsewhere in this proxy statement, with our management.&nbsp;Based on this review and discussion, the Compensation Committee has recommended to the Board that the Compensation Discussion and Analysis be
included in this proxy statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:50%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">MEMBERS&nbsp;OF&nbsp;THE&nbsp;COMPENSATION&nbsp;COMMITTEE: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:50%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Heiner Dreismann, Ph.D., Chair </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:50%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Walter Gilbert, Ph.D. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:50%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">John T. Henderson, M.D. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AUDIT COMMITTEE REPORT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee of the Board of Directors, which consists entirely of directors who meet the independence and experience requirements of
the NASDAQ Stock Market LLC, has furnished the following report: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee assists the Board in overseeing and monitoring the
integrity of our financial reporting process, compliance with legal and regulatory requirements and the quality of internal and external audit processes. This committee&#146;s role and responsibilities are set forth in the Audit Committee Charter
adopted by the Board, which is available in the Investors &#150; Understanding Myriad/Corporate Governance section of our website at <I>www.myriad.com</I>. This committee reviews and reassesses the Audit Committee Charter annually and recommends any
changes to the Board for approval. The Audit Committee is responsible for overseeing our overall financial reporting process and for the appointment, compensation, retention, and oversight of the work of our independent registered public accounting
firm. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In fulfilling its responsibilities for the financial statements for the fiscal year ended June 30, 2016, the Audit Committee took
the following actions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Reviewed and discussed the audited financial statements for the fiscal year ended June 30, 2016 with management and Ernst &amp; Young LLP, our independent registered public accounting firm; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Discussed with Ernst &amp; Young LLP the matters required to be discussed in accordance with Statement on Auditing Standards No. 16, <I>Communications with Audit Committees</I>; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Received written disclosures from Ernst &amp; Young LLP regarding its independence as required by PCAOB Ethics and Independence Rule 3526, <I>Communication with Audit Committees Concerning Independence, </I>and has
discussed with the independent auditors, the independent auditors&#146; independence; and</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The Audit Committee also considered the status of pending litigation, taxation matters and other areas of oversight relating to the financial reporting and audit process that the committee determined
appropriate.</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the Audit Committee&#146;s review of the audited financial statements and discussions
with management and Ernst &amp; Young LLP, the Audit Committee recommended to the Board that the audited financial statements be included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2016 for filing with the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">MEMBERS OF THE AUDIT COMMITTEE </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">S. Louise Phanstiel, Chair </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Lawrence C. Best </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Dennis H. Langer, M.D., J.D. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our records reflect that all reports that were required to be filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, as
amended, were filed on a timely basis.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An Annual Statement of Beneficial Ownership on Form 5 is not required to be filed if there are no
previously unreported transactions or holdings to report.&nbsp;Nevertheless, we are required to disclose the names of directors, officers and 10 percent stockholders who did not file a Form 5 unless we have obtained a written statement that no
filing is required or if we otherwise know that no Form 5 is required.&nbsp;We received either a written statement from our directors, officers and 10 percent stockholders or know from other means that no Forms 5 filings were required. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We were not a party to any transactions with related persons since July 1, 2016 that would be required to be disclosed pursuant to Item 404(a)
of Regulation S-K. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Policy on Approval of Related Person Transactions </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have adopted a Policy on Related Person Transactions (the &#147;Policy&#148;) under which the Audit Committee reviews, approves or ratifies
all related person transactions.&nbsp;Under our Policy, a related person transaction is one in which Myriad is a participant, and the amount involved exceeds $120,000, and in which any of the following persons have or will have a direct or indirect
material interest: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Executive officers of the Company; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Members of the Board; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Beneficial holders of more than 5 percent of Myriad&#146;s securities; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Immediate family members, as defined by Item 404 of Regulation S-K under the Securities Act, of any of the foregoing persons; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Any firm, corporation or other entity in which any of the foregoing persons is employed or is a partner or principal. is in a similar position or in which the person has a 5 percent or greater beneficial ownership
interest; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Any other persons whom the Board determines may be considered to be related persons as defined by Item 404 of Regulation S-K under the Securities Act. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Policy, the Audit Committee will approve only those related person transactions that are determined to be in, or not inconsistent
with, the best interests of Myriad and its stockholders, taking into account all available facts and circumstances as the Audit Committee, determines in good faith to be necessary.&nbsp;These facts and circumstances will typically include, but not
be limited to, the benefits of the transaction to Myriad; the impact on a director&#146;s independence in the event the related person is a director, an immediate family member of a director or an entity in which a director is a partner, stockholder
or executive officer; the availability of other </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
sources for comparable products or services; the terms of the transaction; and the terms of comparable transactions that would be available to unrelated third parties or to employees
generally.&nbsp;No member of the Audit Committee shall participate in any review, consideration or approval of any related person transaction with respect to which the member or any of his or her immediate family members is the related person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In reviewing and approving these transactions, the Audit Committee will obtain, or will direct management to obtain on its behalf, all
information that the Audit Committee believes to be relevant and important to a review of the transaction prior to its approval.&nbsp;Following receipt of the necessary information, a discussion of the relevant factors will be held if it is deemed
to be necessary by the Audit Committee prior to approval. If a discussion is not deemed to be necessary, approval may be given by written consent of the Audit Committee. This approval authority may also be delegated to the Chairperson of the Audit
Committee in some circumstances. It is contemplated that no related person transaction will be entered into prior to the completion of these procedures; however, where permitted, a related person transaction may be ratified upon completion of these
procedures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee may adopt any further policies and procedures relating to the approval of related person transactions
that it deems necessary or advisable from time to time.&nbsp;A copy of our Policy on Related Person Transactions is publicly available in the Investor Information &#150; Understanding Myriad/Corporate Governance section of our website at
<I>www.myriad.com</I>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 1: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ELECTION OF DIRECTORS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Board of Directors currently consists of seven members, classified as follows: John T. Henderson, M.D. and S. Louise Phanstiel constitute a class with a term ending at the 2018 Annual Meeting (the &#147;Class I Directors&#148;); Mark C. Capone and
Heiner Dreismann, Ph.D. constitute a class with a term ending at the 2016 Annual Meeting (the &#147;Class II Directors&#148;); and Walter Gilbert, Ph.D., Dennis H. Langer, M.D., J.D. and Lawrence C. Best constitute a class with a term ending at the
2017 Annual Meeting (the &#147;Class III Directors&#148;).&nbsp;At each Annual Meeting, directors are elected for a term of three years to succeed those directors whose terms are expiring.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September 15, 2016, the Board of Directors accepted the recommendation of the Nominating and Governance Committee and voted to nominate
Mark C. Capone and Heiner Dreismann for election at the Annual Meeting for a term of three years to serve until the 2019 Annual Meeting, and until their successors have been elected and qualified, or until their earlier death, resignation,
retirement or removal.&nbsp;Unless the authority to vote for any of these nominees is withheld, the shares represented by a valid proxy will be voted FOR the election of Mark C. Capone and Heiner Dreismann as directors.&nbsp;In the event that any
nominee should become unable or unwilling to serve, the shares represented by a valid proxy will be voted for the election of another person who the Board of Directors recommends, unless the Board chooses to reduce the number of directors serving on
the Board.&nbsp;We have no reason to believe that any nominee will be unable or unwilling to serve as a director. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An affirmative vote of
the plurality of the shares voted affirmatively or negatively at the Annual Meeting is required to elect each nominee as a director. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
have adopted a policy on plurality votes for the election of directors. Under this policy, in non-contested elections, if a director receives a greater number of WITHHOLD votes than FOR votes, the Board will decide, through a process managed by the
Nominating and Governance Committee and excluding the nominee in question, whether it should request that the director submit his or her resignation, maintain the director but address what the Nominating and Governance Committee believes is the
underlying cause of the WITHHOLD votes, or resolve not to re-nominate the director in the future for election.&nbsp;A copy of this policy is publicly available in the Investor Information &#150; Understanding Myriad/Corporate Governance section of
our website at <I>www.myriad.com</I>.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THE BOARD OF DIRECTORS RECOMMENDS THE ELECTION OF MARK C. CAPONE AND HEINER DREISMANN AS
DIRECTORS, AND PROXIES SOLICITED BY THE BOARD WILL BE VOTED IN FAVOR THEREOF UNLESS A STOCKHOLDER HAS INDICATED OTHERWISE ON THE PROXY. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 2: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>APPROVAL OF AN AMENDMENT TO OUR 2010 EMPLOYEE, DIRECTOR AND CONSULTANT EQUITY INCENTIVE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of October 5, 2016, we had
330,690 remaining shares of common stock available for issuance under our 2010 Employee, Director and Consultant Equity Incentive Plan (the &#147;2010 Plan&#148;).&nbsp;Because we intend to continue to issue restricted stock units instead of stock
options as our long-term equity incentive compensation, our available shares are reduced by 2 shares for each restricted stock unit awarded.&nbsp;Therefore, we may only grant up to 165,345 restricted stock units based on the remaining available
shares under the 2010 Plan.&nbsp;Accordingly, we are seeking an approval to be able to award up to 1,250,000 additional restricted stock units by increasing the aggregate number of shares of common stock available for the grant of awards under the
2010 Plan by an additional 2,500,000 shares.&nbsp;An approval of an additional 2,500,000 shares will allow us to award up to 1,250,000 additional restricted stock units which we expect will provide us with enough shares to grant restricted stock
units to our employees, executive officers and directors pursuant to our fiscal year 2017compensation programs.&nbsp;Without approval of this amendment to increase the shares authorized under the 2010 Plan, we will not have enough authorized shares
under the 2010 Plan to compensate our employees with equity and we will need to substantially revise our compensation programs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our 2010
Plan was approved by our Board of Directors and stockholders in 2010.&nbsp;We anticipate the need to continue requesting each year additional shares for authorization under the 2010 Plan to fund our equity compensation programs. As of October 5,
2016, options to purchase 5,657,550 shares of common stock and restricted stock units representing 2,047,537 shares of common stock are outstanding under the 2010 Plan.&nbsp;As of October 5, 2016, options to purchase 2,432,291 shares of common stock
are outstanding under the 2003 Plan.&nbsp;No further shares are available for issuance under the 2003 Plan.&nbsp;Shares may be transferred back into the 2010 Plan from previously issued options and RSUs which are cancelled or expire under our
existing plans.&nbsp;By its terms, the 2010 Plan may be amended by the Board of Directors, provided that any amendment that the Board determines requires stockholder approval is subject to receiving such approval.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September 15, 2016, the Board of Directors voted to approve an amendment to the 2010 Plan to allow for the award of up to 1,250,000
additional RSUs by increasing the aggregate number of shares of common stock available for the grant of awards under the 2010 Plan by an additional 2,500,000 shares as the Company reduces the number of available shares on a 2:1 ratio for each RSU
granted.&nbsp;This amendment to increase the number of shares available for grant under the 2010 Plan is being submitted for approval at the Annual Meeting in order to ensure (i) that we have an adequate number of shares available for issuance in
order to grant equity incentive compensation awards to our employees, executive officers and directors pursuant to our compensation programs; (ii) favorable federal income tax treatment for grants of incentive stock options under Section 422 of the
Internal Revenue Code of 1986, as amended (the &#147;Code&#148;), and (iii) continued eligibility to receive a federal income tax deduction for certain compensation paid under the 2010 Plan by complying with Section 162(m) of the Code. Approval by
our stockholders of this amendment to the 2010 Plan is also required by the listing rules of The NASDAQ Stock Market LLC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board, the
Compensation Committee and management believe that the effective use of stock-based, long-term incentive compensation is vital to our ability to achieve strong performance in the future. The 2010 Plan maintains and enhances the key policies and
practices adopted by our management and Board of Directors to align employee and stockholder interests. In addition, our future success depends, in large part, upon our ability to maintain a competitive position in attracting, retaining and
motivating key personnel. We believe the authorization of an additional 2,500,000 shares for issuance under our 2010 Plan is essential to permit our management to continue to provide long-term, equity-based incentives to present and future key
employees, consultants and directors.&nbsp;Additionally, in continued response to recommendations from our stockholders, we intend to continue to issue restricted stock unit awards to reduce the dilutive effect on stockholders from our
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
equity incentive compensation program.&nbsp;Accordingly, our Board of Directors believes approval of the amendment to our 2010 Plan is in our best interests and those of its stockholders and
recommends a vote &#147;FOR&#148; the approval of the amendment to the 2010 Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A complete copy of the 2010 Plan, as it is proposed to
be amended, is attached as Appendix B.&nbsp;The following summary description of the 2010 Plan is qualified in its entirety by reference to Appendix B. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Equity Plan Information for Stock Options </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of October 5, 2016, there were 8,089,841 stock options outstanding with a weighted average exercise price of $24.59 and a weighted average
remaining life of 4.5 years.&nbsp;All options granted vest 25 percent per year on the anniversary of the grant date. The following table provides additional information regarding vested stock options outstanding as of that date: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="58%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Vested&nbsp;Options<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;Average<BR>Exercise Price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;Average<BR>Remaining&nbsp;Years&nbsp;of</B><br><B>Contractual Life</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Substantially in-the-money options outstanding in excess of four years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,939,906</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">18.23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other options outstanding in excess of four years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,889,207</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26.61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All options outstanding less than four years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,726,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26.56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total vested options outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,555,810</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Substantially in-the-money options outstanding in excess of four years is defined as options with an exercise price of less
than $20.00.&nbsp;On October 5, 2016, the closing price of our common stock was $21.19.&nbsp;Additional information regarding these options is a follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="70%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Remaining</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Contractual&nbsp;Life</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Exercise</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Vested</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:38.85pt; font-size:8pt; font-family:Times New Roman"><B>Grant Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12/15/06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10.83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">01/26/07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12.72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">02/21/07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12.17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,535</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">08/03/07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13.38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">09/26/07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">18.06</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,618</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11/15/07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16.46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">02/28/08</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42,497</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">05/28/08</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16.99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">06/17/08</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16.48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">06/22/2010</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">08/03/2010</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14.88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">09/14/2010</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16.42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">09/15/2010</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16.53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">311,847</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">02/23/2011</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">18.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">472,291</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">03/22/2011</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">09/13/2011</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">964,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10/04/2011</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19.03</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total substantially in-the-money-options outstanding in excess of four years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,939,906</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Material Features of the 2010 Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Eligibility.</B><B>&nbsp;</B>The 2010 Plan allows us, under the direction of our Compensation Committee, to make grants of stock options,
restricted and unrestricted stock awards and other stock-based awards to employees, consultants and directors who, in the opinion of the Compensation Committee, are in a position to make a significant contribution to our long-term success. The
purpose of these awards is to attract and retain key individuals, further align employee and stockholder interests and to closely link compensation with Company performance. The 2010 Plan provides an essential component of the total compensation
package, reflecting the importance that we place on aligning the interests of key individuals with those of our stockholders.&nbsp;All employees, members of the Board of Directors and consultants of the Company and its affiliates are eligible to
participate in the 2010 Plan.&nbsp;As of October 5, 2016 we had approximately 2,250 individuals eligible to participate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Limitations
on Grants. </B>If this Proposal 2 is approved by our stockholders, the 2010 Plan will provide for the issuance of up to 2,500,000 additional shares (as approved by shareholders in this proposal), plus 330,690 shares which presently remain available
for issuance under the 2010 Plan.&nbsp;Additionally, up to 2,432,291 additional shares under the 2010 Plan may be issued if options outstanding under our 2003 Plan are cancelled or expire in the future without the issuance of shares of common stock,
and up to 9,752,624 additional shares under the 2010 Plan may be issued if options and RSUs outstanding under our 2010 Plan are cancelled or expire in the future without the issuance of shares of common stock.&nbsp;No additional shares may be issued
under our 2003 Plan.&nbsp;In addition, each share of common stock issued as restricted stock units, performance share units or other types of awards, other than stock options or stock appreciation rights, counts against the number of total shares
available for issuance under the 2010 Plan as 2 shares, and each share of common stock issued as options or stock appreciation rights counts against the total shares available for issuance under the 2010 Plan as one share. Hence, as the Company
intends to continue to issue restricted stock unit awards, the actual number of underlying shares available for issuance is one-half of the shares available under the 2010 Plan.&nbsp;In addition, shares of common stock reserved for awards under the
2010 Plan that lapse or are canceled will be added back to the share reserve available for future awards at the same rate as they were deducted from the authorized shares.&nbsp;However, shares of common stock tendered in payment for an award or
shares of common stock withheld for taxes will not be available again for grant and any stock appreciation right to be settled in shares of common stock will be counted in full against the number of shares available for issuance under the 2010 Plan
regardless of the number of exercise gain shares issued upon the settlement of the stock appreciation right. The 2010 Plan provides that no participant may receive awards for more than 1,000,000 shares of common stock in any fiscal year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Stock Options</B>.&nbsp;Stock options granted under the 2010 Plan may either be incentive stock options, which are intended to satisfy the
requirements of Section 422 of the Code, or nonqualified stock options, which are not intended to meet those requirements. Incentive stock options may be granted to employees of the Company and its affiliates.&nbsp;Nonqualified options may be
granted to employees, directors and consultants of the Company and its affiliates. The exercise price of a stock option may not be less than 100 percent of the fair market value of our common stock on the date of the grant. If an incentive stock
option is granted to an individual who owns more than 10 percent of the combined voting power of all classes of our capital stock, the exercise price may not be less than 110 percent of the fair market value of our common stock on the date of the
grant and the term of the option may not be longer than five years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The term of each option is fixed by our Board of Directors or an
authorized committee and has been set at eight years for all outstanding option grants.&nbsp;Our Board or an authorized committee is responsible for establishing the vesting schedule of each option at the time of grant.&nbsp;Options granted to
employees vest in equal annual installments over four years. Options may be made exercisable in installments and the exercisability of options may be accelerated by our Board or an authorized committee. Options granted under the 2010 Plan are
generally exercisable after the termination of the participant&#146;s employment with the Company (other than by reason of death, disability or termination for cause as defined in the 2010 Plan) to the extent exercisable on the date of such
termination, at any time prior to the earlier of the option&#146;s specified expiration date or three months after such termination for incentive stock options and for nonqualified options, until the option&#146;s specified
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
expiration date. Generally, in the event of the participant&#146;s death, all incentive stock options and nonqualified stock options will immediately vest and may be exercised by the
participant&#146;s survivors at any time until the option&#146;s specified expiration date. In the event of the participant&#146;s termination due to disability, incentive stock options and nonqualified stock options generally may be exercised, to
the extent exercisable on the date of termination due to disability (plus a pro rata portion of the option if the option vests periodically), by the participant at any time prior to the earlier of the option&#146;s specified expiration date or one
year from the date of the participant&#146;s termination due to disability for incentive stock options and for nonqualified stock options until the option&#146;s specified expiration date. In the event of the participant&#146;s termination for
cause, all outstanding and unexercised options will be forfeited. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Restricted Stock.</B>&nbsp;Restricted stock is common stock that is
subject to restrictions, including a prohibition against transfer and a substantial risk of forfeiture, until the end of a &#147;restricted period&#148; during which the grantee must satisfy certain vesting conditions. If the grantee does not
satisfy the vesting conditions by the end of the restricted period, the restricted stock is forfeited. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the restricted period, the
holder of restricted stock has the rights and privileges of a regular stockholder, except that the restrictions set forth in the applicable award agreement apply. For example, the holder of restricted stock may vote and receive dividends on the
restricted shares; but he or she may not sell the shares until the restrictions are lifted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Other Stock-Based Awards</B>.&nbsp;The
2010 Plan also authorizes the grant of other types of stock-based compensation including, but not limited to, stock appreciation rights, phantom stock awards and stock units. Our Board of Directors or an authorized committee may award such
stock-based awards subject to such conditions and restrictions&nbsp;it may determine. These conditions and restrictions may include continued employment with us through a specified restricted period or achievement of specified financial performance
metrics. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Plan Administration</B>.&nbsp;In accordance with the terms of the 2010 Plan, our Board of Directors has authorized our
Compensation Committee to administer the 2010 Plan. The Compensation Committee may delegate part of its authority and powers under the 2010 Plan to one or more of our directors and/or officers, but only the Compensation Committee can make awards to
participants who are directors or executive officers of the Company. In accordance with the provisions of the 2010 Plan, our Compensation Committee determines the terms of awards, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Which employees, directors and consultants will be granted awards; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The number of shares subject to each award; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The vesting provisions of each award; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The termination or cancellation provisions applicable to awards; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">All other terms and conditions upon which each award may be granted in accordance with the 2010 Plan. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, our Compensation Committee may, in its discretion, amend any term or condition of an outstanding award, including, without
limitation, accelerate the vesting schedule or extend the expiration date, provided (i) such term or condition as amended is permitted by the 2010 Plan; and (ii) any such amendment is be made only with the consent of the participant to whom the
award was made, if the amendment is adverse to the participant, and provided further that without the prior approval of our stockholders, options and stock appreciation rights will not be repriced, replaced, or regranted through cancellation, or by
lowering the exercise price of a previously granted award or&nbsp;repurchased for cash when the fair market value of our common stock is less than the exercise price.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Stock Dividends and Stock Splits</B>.&nbsp;If our common stock is subdivided or combined into a greater or smaller number of shares or if
we issue any shares of common stock as a stock dividend, the number of shares of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
our common stock deliverable upon exercise of an option issued or upon issuance of an award will be appropriately increased or decreased proportionately, and adjustments will be made, including
in the exercise or the purchase price per share, to reflect the subdivision, combination or stock dividend. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Corporate
Transactions</B>.&nbsp;Upon a merger or other reorganization event, our Board of Directors or an authorized committee, may, in its sole discretion, take any one or more of the following actions pursuant to the 2010 Plan, as to some or all
outstanding awards: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Provide that all outstanding options shall be assumed or substituted by the successor corporation; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Upon written notice to a participant, provide that the participant&#146;s unexercised options will terminate immediately prior to the consummation of such transaction unless exercised by the participant (either (a) to
the extent then exercisable or, (b) at the discretion of the Board of Directors or an authorized committee, including upon a change of control, when the options are made fully exercisable); </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">In the event of a merger in which holders of our common stock will receive a cash payment for each share surrendered in the merger, make or provide for a cash payment to the participants equal to the difference between
the merger price times the number of shares of our common stock subject to such outstanding options (either (a) to the extent then they are exercisable or, (b) at the discretion of the Board of Directors or an authorized committee the options are
made fully exercisable), and the aggregate exercise price of all such outstanding options, in exchange for the termination of the options; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Provide that all outstanding awards will be assumed or substituted by the successor corporation, become realizable or deliverable, or restrictions applicable to an award will lapse, in whole or in part, prior to or upon
the merger or reorganization event; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">With respect to stock grants and in lieu of any of the foregoing policy, the Board of Directors or an authorized committee may provide that, upon consummation of the transaction, each outstanding stock grant will be
terminated in exchange for payment of an amount equal to the consideration payable upon consummation of such transaction to a holder of the number of shares of common stock comprising such award (to the extent the stock grant is no longer subject to
any forfeiture or repurchase rights then in effect or, at the discretion of the Board of Directors or an authorized committee, all forfeiture and repurchase rights being&nbsp;waived upon such transaction). </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Amendments and Termination</B>.&nbsp;The 2010 Plan may be amended by our stockholders. It may also be amended by our Board of Directors,
provided that any amendment approved by the Board that is of a scope that requires stockholder approval as required by the rules of The NASDAQ Stock Market LLC, in order to ensure favorable federal income tax treatment for any incentive stock
options under Section 422 of the Code, or for any other reason is subject to obtaining such stockholder approval. However, no such action may adversely affect any rights under an outstanding award without the holder&#146;s consent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Duration of 2010 Stock Plan</B>.&nbsp;The 2010 Plan will expire on September 15, 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>New Plan Benefits </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other than grants to
our nonemployee directors as described above under &#147;Executive Compensation, Director Compensation, Stock Option, Restricted and Unrestricted Stock Grants and Other Stock-Based Awards,&#148; the amounts of future awards under the 2010 Plan are
not determinable and will be granted at the sole discretion of the Board of Directors or authorized committee, and we cannot determine at this time either the persons who will receive awards under the 2010 Plan although we anticipate that most of
our grants will be in the form of RSUs and we will use most of the 2,500,000 shares authorized to make grants in fiscal 2017. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Existing Plan Benefits</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a list of options and restricted stock unit awards issued as of October 5, 2016 to our executives, directors, and employees
since the initial approval of the 2010 Plan: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Shares</B><br><B>Underlying&nbsp;Options</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Shares</B><br><B>Underlying RSUs</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:100.60pt; font-size:8pt; font-family:Times New Roman"><B>Name and Position, or Group</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Named Executive Officers:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark C. Capone, President and CEO*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,015,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">343,134</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R. Bryan Riggsbee, CFO and Treasurer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">137,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jerry S. Lanchbury, Ph.D., Chief Scientific Officer*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">580,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">155,262</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard M. Marsh, Executive Vice President, General Counsel and Secretary*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">640,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">152,023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bernard F. Tobin, President, Crescendo Bioscience, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">129,068</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All current executive officers as a group</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,013,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,310,227</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All current directors who are not executive officers as a group</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">540,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">105,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nominees for Director:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Heiner Dreismann, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark C. Capone</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">See&nbsp;above</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">See&nbsp;above</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Each associate of directors, executive officers, or nominees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All employees, including all current officers who are not executive officers, as a group</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,462,056</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,610,718</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Mr. Capone, Dr. Lanchbury and Mr. Marsh each have received greater than 5 percent of the total awards granted to date under the 2010 Plan. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October 5, 2016, the closing price per share of our common stock was $21.19 as reported on The NASDAQ Global Select Market. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Federal Income Tax Considerations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The material Federal income tax consequences of the issuance and exercise of stock options and other awards under the 2010 Plan, based on the
current provisions of the Code and regulations, are as follows. Changes to these laws could alter the tax consequences described below. This summary assumes that all awards granted under the 2010 Plan are exempt from or comply with, the rules under
Section 409A of the Code related to nonqualified deferred compensation. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Incentive Stock Options:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Incentive stock options are intended to qualify for treatment under Section&nbsp;422 of the Code.&nbsp;An incentive stock option does not result in taxable income to the optionee or deduction to us at the time it is granted or
exercised, provided that no disposition is made by the optionee of the shares acquired pursuant to the option within two years after the date of the grant of the option nor within one year after the date of issuance of shares to the optionee
(referred to as the &#147;ISO holding period&#148;).&nbsp;However, the difference between the fair market value of the shares on the date of exercise and the option price will be an item of tax preference includible in &#147;alternative minimum
taxable income&#148; of the optionee.&nbsp;Upon disposition of the shares after the expiration of the ISO holding period, the optionee will generally recognize long-term capital gain or loss based on the difference between the disposition proceeds
and the option price paid for the shares.&nbsp;If the shares are disposed of prior to the expiration of the ISO holding period, the optionee generally will recognize taxable compensation, and we will have a corresponding deduction, in the year of
the disposition, equal to the excess of the fair market value of the shares on the date of exercise of the option over the option price.&nbsp;Any additional gain realized on the disposition will normally constitute a capital gain.&nbsp;If the amount
realized upon such a disqualifying disposition is less than the fair market value of the shares on the date of exercise, the amount of compensation income will be limited to the excess of the amount realized over the optionee&#146;s adjusted basis
in the shares.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Nonqualified Options:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Options otherwise qualifying as incentive stock options, to the extent the aggregate fair market value of shares with respect to which such options are first exercisable by an individual in any calendar year exceeds $100,000, and
options designated as nonqualified options will be treated as options that are not incentive stock options.</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">A nonqualified option ordinarily will not result in income to the optionee or deduction to us at the time of grant.&nbsp;The optionee will recognize compensation income at the time of exercise of such nonqualified option in an
amount equal to the excess of the then value of the shares over the option price per share.&nbsp;Such compensation income may be subject to withholding taxes, and a deduction may then be allowable to us in an amount equal to the optionee&#146;s
compensation income.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">An optionee&#146;s initial basis in shares acquired in this way will be the amount paid on exercise of the nonqualified option plus the amount of any corresponding compensation income.&nbsp;Any gain or loss as a result of a
subsequent disposition of the shares so acquired will be capital gain or loss.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Stock Grants:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">With respect to stock grants under the 2010 Plan that result in the issuance of shares that are either not restricted as to transferability or not subject to a substantial risk of forfeiture, the grantee must generally recognize
ordinary income equal to the fair market value of the shares received.&nbsp;Thus, deferral of the time of issuance will generally result in the deferral of the time the grantee will be liable for income taxes with respect to such issuance.&nbsp;We
generally will be entitled to a deduction in an amount equal to the ordinary income recognized by the grantee.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">With respect to stock grants involving the issuance of shares that are restricted as to transferability and subject to a substantial risk of forfeiture, the grantee must generally recognize ordinary income equal to the fair
market value of the shares received at the first time the shares become transferable or are not subject to a substantial risk of forfeiture, whichever occurs earlier.&nbsp;A grantee may elect to be taxed at the time of receipt of shares rather than
upon lapse of restrictions on transferability or substantial risk of forfeiture, but if the grantee subsequently forfeits the shares, the grantee would not be entitled to any tax deduction, including as a capital loss, for the value of the shares on
which he or she previously paid tax.&nbsp;The grantee must file such election with the Internal Revenue Service within 30 days of the receipt of the shares.&nbsp;We generally will be entitled to a deduction in an amount equal to the ordinary income
recognized by the grantee.</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Stock Units:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">The grantee recognizes no income until the issuance of the shares.&nbsp;At that time, the grantee must generally recognize ordinary income equal to the fair market value of the shares received.&nbsp;We generally will be entitled
to a deduction in an amount equal to the ordinary income recognized by the grantee.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The affirmative vote of a majority of the shares voted affirmatively or negatively for the proposal at the
Annual Meeting is required to approve the amendment to the 2010 Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THE BOARD OF DIRECTORS RECOMMENDS APPROVAL OF THE AMENDMENT TO
THE 2010 EMPLOYEE, DIRECTOR AND CONSULTANT EQUITY INCENTIVE PLAN.&nbsp;PROXIES SOLICITED BY THE BOARD WILL BE VOTED IN FAVOR OF THE AMENDMENTS TO THE 2010 PLAN UNLESS A STOCKHOLDER HAS INDICATED OTHERWISE ON THE PROXY. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 3: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee has appointed Ernst &amp; Young LLP (&#147;EY&#148;) as our independent registered public accounting firm, to audit our
financial statements for the fiscal year ending June 30, 2017.&nbsp;The Board proposes that the stockholders ratify this selection, although such ratification is not required under Delaware law or our Restated Certificate of Incorporation, as
amended, or our Restated By-Laws.&nbsp;EY has audited our financial statements since our fiscal year ended June 30, 2007.&nbsp;We expect that representatives of EY will be present at the Annual Meeting, will be able to make a statement if they so
desire, and will be available to respond to appropriate questions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In deciding to appoint EY, the Audit Committee reviewed auditor
independence issues and existing commercial relationships with EY and concluded that EY has no commercial relationship with Myriad that would impair its independence for the fiscal year ending June 30, 2017.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents fees for professional audit services provided by EY during the last two fiscal years: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="56%"></TD>
<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:40.00pt; font-size:8pt; font-family:Times New Roman"><B>Type of Fee</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fiscal&nbsp;Year&nbsp;Ended<BR>June 30, 2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fiscal&nbsp;Year&nbsp;Ended<BR>June 30, 2015</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">800,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">693,573</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Related Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#9679;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#9679;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#9679;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#9679;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Other Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#9679;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#9679;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">800,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">693,573</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Audit Fees &#150; </I>Fees include audits of consolidated financial statements, quarterly reviews, reviews
of registration statement filings, and consents related to SEC filings.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Audit-Related Fees &#150;</I> Fees include services for
assurance and related services that are reasonably related to the performance of the audit or review of our financial statements that are not reported under &#147;audit fees.&#148;&nbsp;We did not engage EY to perform any audit related services.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Tax Fees &#150; </I>We did not engage EY to perform any tax related services. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>All Other Fees &#150; </I>We did not engage EY to perform any other services other than those listed separately above for the fiscal years
indicated. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Policy on Audit Committee Preapproval of Audit and Permissible Non-Audit Services of Independent Public Accountant </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Consistent with SEC policies regarding auditor independence, the Audit Committee has responsibility for appointing, setting compensation and
overseeing the work of the independent public accounting firm. In recognition of this responsibility, the Audit Committee has established a policy to preapprove all audit and permissible non-audit services provided by our independent public
accounting firm. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to engagement of an independent registered public accounting firm for the next year&#146;s audit, management will
submit an aggregate of services expected to be rendered during that year for each of four categories of services to the Audit Committee for approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&nbsp;Audit services include audit work performed in the preparation of financial statements, as well as work that generally only an
independent registered public accounting firm can reasonably be expected to provide, including comfort letters, statutory audits, and attest services and consultation regarding financial accounting and/or reporting standards. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&nbsp;Audit-Related services are for assurance and related services that are traditionally
performed by an independent registered public accounting firm, including due diligence related to mergers and acquisitions, employee benefit plan audits, and special procedures required to meet certain regulatory requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&nbsp;Tax services include all services performed by an independent registered public accounting firm&#146;s tax personnel except those
services specifically related to the audit of the financial statements, and includes fees in the areas of tax compliance, tax planning, and tax advice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.&nbsp;Other Fees are those associated with services not captured in the other categories.&nbsp;The Company generally does not request such
services from our independent registered public accounting firm. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to engagement of the independent registered public accounting
firm, engagement letters describing the scope of service and the anticipated fees are negotiated and approved by the Audit Committee.&nbsp;During the year, circumstances may arise in which it may become necessary to engage our independent registered
public accounting firm for additional services not contemplated in the original preapproval.&nbsp;In those instances, the Audit Committee requires specific preapproval before engaging our independent registered public accounting firm.&nbsp;The Audit
Committee may delegate preapproval authority to one or more of its members. The member to whom such authority is delegated must report, for informational purposes only, any pre-approval decisions to the Audit Committee at its next scheduled meeting.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The affirmative vote of a majority of the shares voted affirmatively or negatively at the Annual Meeting is required to ratify the
selection of our independent registered public accounting firm. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If our stockholders ratify the selection of EY, the Audit Committee may
still, in its discretion, decide to select a different independent auditor at any time during the fiscal year ending June 30, 2017, if it concludes that such a change would be in the best interests of Myriad and our stockholders. If our stockholders
fail to ratify the selection, the Audit Committee will reconsider, but not necessarily rescind, the selection. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THE BOARD OF DIRECTORS
RECOMMENDS A VOTE TO RATIFY THE SELECTION OF ERNST &amp; YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, AND PROXIES SOLICITED BY THE BOARD WILL BE VOTED IN FAVOR OF SUCH RATIFICATION UNLESS A STOCKHOLDER HAS INDICATED OTHERWISE ON
THE PROXY. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 4: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THIS PROXY STATEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are seeking your approval, on advisory basis, as required by Section 14A of the Securities Exchange Act of 1934, as amended, of the
compensation of our named executive officers, as disclosed in this proxy statement. More specifically, we ask that you support the compensation of our named executive officers as disclosed in the Compensation Discussion and Analysis section, the
compensation tables and any related material contained in this proxy statement with respect to our executive officers named in the Summary Compensation Table.&nbsp;Because your vote is advisory, it will not be binding on our Compensation Committee
or our Board of Directors. However, the Compensation Committee and our Board will review the voting results and take them into consideration when making future decisions regarding the compensation of our named executive officers. We have determined
to hold an advisory vote to approve the compensation of our named executive officers annually, and the next such advisory vote will occur at the 2017 Annual Meeting of Stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our compensation philosophy is designed to align each executive&#146;s compensation with our short- and long-term performance and to provide
the compensation and incentives needed to attract, motivate and retain key executives who are crucial to our long-term success.&nbsp;Consistent with this philosophy, a significant portion of the total compensation opportunity for each of our named
executive officers is directly related to performance factors that measure our progress against the goals of our strategic and operating plans, as well as our performance against that of our peer companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stockholders are urged to read the Compensation Discussion and Analysis section of this proxy statement, which discusses how our compensation
policies and procedures implement our compensation philosophy.&nbsp;The Compensation Committee and the Board of Directors believe that these policies and procedures are effective in implementing our compensation philosophy and in achieving its
goals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As discussed in the Compensation Discussion and Analysis section, we believe the compensation paid to our President and CEO and
other named executive officers is appropriate as supported by our accomplishments in fiscal 2016.&nbsp;This is evidenced by our financial and operational performance where, among other accomplishments, we have returned to growth in fiscal year 2016
with revenues up 4% to $754 million, and a 12% year over year growth in pro forma adjusted earnings per share to $1.63.&nbsp;We have made substantial progress on our strategic objectives that we believe position the Company for long-term growth, as
well as progress on our three strategic imperatives to: i) transition and expand our hereditary cancer testing business, ii) diversify our product portfolio, and iii) increase our international contribution.&nbsp;For example, we completed the
acquisitions of Sividon Diagnostics and Assurex Health which diversifies our product portfolio, increases our non-hereditary cancer testing revenues, and will grow our profitability over time.&nbsp;We continued generating strong cash flows from
operations and in fiscal 2016 generated $166 million in operating cash flow.&nbsp;We ended the year with $239 million in cash, cash equivalents, and marketable investment securities and plan to continue to exercise a balanced approach to capital
deployment, including investing for future growth, business development activities and returning cash to stockholders.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on this
performance, we believe that the salary and annual cash incentive bonus paid to our President and CEO and our other named executive officers are in line with our compensation philosophy and goals.&nbsp;Similarly, we believe that the equity
compensation awarded to our President and CEO and our other named executive officers is consistent with our multi-year growth in revenue, operating income and stock performance, and provides the appropriate incentives to reward and foster long-term
growth and stockholder value. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with the rules of the SEC, the following resolution, commonly known as a
&#147;Say-on-Pay&#148; vote, is being submitted for a stockholder vote at the Annual Meeting: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;RESOLVED, that the compensation paid
to the named executive officers of Myriad Genetics, Inc., as disclosed pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Compensation Discussion and Analysis, the compensation tables and any related material disclosed in this proxy statement, is hereby APPROVED.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The affirmative vote of a majority of the shares voted affirmatively or negatively at the Annual Meeting is required to approve, on an
advisory basis, this resolution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR
NAMED EXECUTIVE OFFICERS, AND PROXIES SOLICITED BY THE BOARD WILL BE VOTED IN FAVOR OF SUCH APPROVAL UNLESS A STOCKHOLDER HAS INDICATED OTHERWISE ON THE PROXY. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CORPORATE CODE OF CONDUCT AND ETHICS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have adopted a Corporate Code of Conduct and Ethics that applies to all of our employees, including our Chief Executive Officer and Chief
Financial Officer, and every member of our Board of Directors. A copy of the Corporate Code of Conduct and Ethics is publicly available in the Investor Information &#150; Understanding Myriad/Corporate Governance section of our website at
<I>www.myriad.com</I>. Disclosure regarding any amendments to, or waivers from, provisions of our Corporate Code of Conduct and Ethics that apply to our directors and principal executive and financial officers will be included in a Current Report on
Form 8-K within four business days following the date of the amendment or waiver, unless website posting or the issuance of a press release of such amendments or waivers is then permitted by the rules of The NASDAQ Stock Market LLC. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OTHER MATTERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board
of Directors knows of no other business that will be presented at the Annual Meeting.&nbsp;If any other business is properly brought before the Annual Meeting, proxies will be voted in accordance with the judgment of the persons voting the proxies.
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCKHOLDER PROPOSALS AND NOMINATIONS FOR DIRECTOR </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To be considered for inclusion in the proxy statement relating to our Annual Meeting of Stockholders being held in 2017 (the &#147;2017
Meeting&#148;), we must receive stockholder proposals (other than for director nominations) no later than June 13, 2017.&nbsp;To be considered for presentation at the 2017 Meeting, although not included in the proxy statement, proposals (including
director nominations that are not requested to be included in our proxy statement) must be received no earlier than September 1, 2017 and no later than October 2, 2017.&nbsp;Notwithstanding the foregoing, in the event that the number of directors is
to be increased at the 2017 Meeting and we do not issue a public announcement naming the nominees and specifying the size of the increase by September 22, 2017, to be considered for presentation at the 2017 Meeting, although not included in the
proxy statement, nominations must be received no later than the tenth day following the day on which such public announcement is made. Proposals not received in a timely manner will not be voted on at the 2017 Meeting.&nbsp;If a proposal is received
in a timely manner, the proxies that management solicits for the 2017 Meeting may still exercise discretionary voting authority on the proposal under circumstances consistent with the proxy rules of the SEC.&nbsp;All stockholder proposals must also
comply with our Restated By-Laws, a copy of which is available by contacting our Secretary, and the corporate governance policies applicable to recommendations for the nomination of directors, copies of which are available in the Investor
Information &#150; Understanding Myriad/Corporate Governance section of our website at <I>www.myriad.com</I>.&nbsp;All stockholder proposals should be marked for the attention of: Secretary, Myriad Genetics, Inc., 320 Wakara Way, Salt Lake City,
Utah 84108.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHETHER OR NOT YOU INTEND TO BE PRESENT AT THE ANNUAL MEETING, YOU ARE URGED TO VOTE YOUR SHARES AT YOUR EARLIEST
CONVENIENCE. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Salt Lake City, Utah </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October 11, 2016
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>OUR ANNUAL REPORT ON FORM 10-K FOR THE FISCAL YEAR ENDED JUNE 30, 2016, AS AMENDED, (OTHER THAN EXHIBITS THERETO) FILED WITH THE
SECURITIES AND EXCHANGE COMMISSION, WHICH PROVIDES ADDITIONAL INFORMATION ABOUT US, IS AVAILABLE ON THE INTERNET AT </B><B><I>WWW.MYRIAD.COM</I></B><B> AND IS AVAILABLE IN PAPER FORM TO BENEFICIAL OWNERS OF OUR COMMON STOCK WITHOUT CHARGE UPON
WRITTEN REQUEST TO: RICHARD M. MARSH, SECRETARY, MYRIAD GENETICS, INC., 320 WAKARA WAY, SALT LAKE CITY, UTAH 84108 (801-584-3600). </B></P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>APPENDIX A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>GAAP to Non-GAAP Reconciliation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Condensed Consolidated Statements of Income &#150; Operating Basis </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><I>(Unaudited data in millions, except per share amount)</I> </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years ended June 30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2015</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>GAAP Net Income</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">125.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">80.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Severance &#150; executive severance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Discontinued operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquisition costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquisition &#150; amortization of intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax expense associated with R&amp;D tax credit reserves</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6.0</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax impact related to equity compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12.7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other tax expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax expense associated with non-GAAP adjustments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7.7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Non-GAAP Net Income</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">119.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">108.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>GAAP Diluted EPS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustment to net income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">($</TD>
<TD VALIGN="bottom" ALIGN="right">0.08</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Non-GAAP Diluted EPS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Use of Non-GAAP Financial Measures </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We supplement our consolidated financial statements presented on a GAAP basis by providing additional measures which may be considered &#147;non-GAAP&#148;
financial measures under applicable SEC rules. We believe that the disclosure of these non-GAAP financial measures provides additional insight into the ongoing economics of our business and reflects how we manage our business internally, set
operational goals and forms the basis of our management incentive programs. These non-GAAP financial measures are not in accordance with generally accepted accounting principles in the United States and should not be viewed in isolation or as a
substitute for reported, or GAAP, net income and diluted earnings per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our &#147;Non-GAAP Net Income&#148; and &#147;Non-GAAP diluted EPS&#148;
financial measures exclude the following items from GAAP net income and diluted earnings per share: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>1.&nbsp;Severance &#150; executive severance
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Represents one-time severance expenses associated with the departure of executive officers of Myriad Genetics, Inc. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2.&nbsp;Discontinued operations </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One-time charges
associated with the closing of business units. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>3.&nbsp;Acquisition costs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Closing and restructuring costs associated with acquired companies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>4.&nbsp;Acquisition &#150; amortization of intangible assets </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Represents recurring amortization charges resulting from the acquisition of intangible assets, including developed technology and database rights. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>5.&nbsp;Tax expense associated with R&amp;D tax credit reserves </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One time net benefits associated with the release of R&amp;D tax credit reserves. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>6.&nbsp;Tax impact related to equity compensation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Changes in effective tax rate based upon ASU 2016-09 </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>7.&nbsp;Other tax expense </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain deferred tax
assets and liabilities that were established as a result of the acquisition of Myriad RBM were evaluated and determined that no tax basis is available for the related intangible assets. As a result, the Company recorded a one-time adjustment to
properly reflect the value of the deferred tax assets and liabilities associated with Myriad RBM. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Appendix B </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MYRIAD GENETICS, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2010 EMPLOYEE, DIRECTOR AND CONSULTANT EQUITY INCENTIVE PLAN, AS AMENDED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(as proposed to be amended on December 1, 2016) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"><U>DEFINITIONS.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise specified or unless the context otherwise requires, the
following terms, as used in this Myriad Genetics, Inc. 2010 Employee, Director and Consultant Equity Incentive Plan, as amended, have the following meanings: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Administrator</U> means the Board of Directors, unless it has delegated power to act on its behalf to the Committee, in which case the
Administrator means the Committee. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Affiliate</U> means a corporation which, for purposes of Section 424 of the Code, is a parent or
subsidiary of the Company, direct or indirect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Agreement</U> means an agreement between the Company and a Participant delivered
pursuant to the Plan and pertaining to a Stock Right, in such form as the Administrator shall approve. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Board of Directors</U> means the
Board of Directors of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Cause</U> means, with respect to a Participant (a) dishonesty with respect to the Company or any
Affiliate, (b) insubordination, substantial malfeasance or <FONT STYLE="white-space:nowrap">non-feasance</FONT> of duty, (c) unauthorized disclosure of confidential information, (d)breach by a Participant of any provision of any employment,
consulting, advisory, nondisclosure, non-competition or similar agreement between the Participant and the Company or any Affiliate, and (e) conduct substantially prejudicial to the business of the Company or any Affiliate; provided, however, that
any provision in an agreement between a Participant and the Company or an Affiliate, which contains a conflicting definition of Cause for termination and which is in effect at the time of such termination, shall supersede this definition with
respect to that Participant.&nbsp;The determination of the Administrator as to the existence of Cause will be conclusive on the Participant and the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Change of Control</U> means the occurrence of any of the following events: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"><I>Ownership</I>.&nbsp;Any &#147;Person&#148; (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becomes the &#147;Beneficial Owner&#148; (as defined in Rule 13d-3 under the Exchange Act), directly
or indirectly, of securities of the Company representing 50% or more of the total voting power represented by the Company&#146;s then outstanding voting securities (excluding for this purpose any such voting securities held by the Company or its
Affiliates or by any employee benefit plan of the Company) pursuant to a transaction or a series of related transactions which the Board of Directors does not approve; or </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"><I>Merger/Sale of Assets</I>.&nbsp;(A) A merger or consolidation of the Company whether or not approved by the Board of Directors, other than a merger or consolidation which would result in the voting securities of the
Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or the parent of such corporation) more than 50% of the total voting power
represented by the voting securities of the Company or such surviving entity or parent of such corporation, as the case may be, outstanding immediately after such merger or consolidation; or (B) the sale or disposition by the Company of all or
substantially all of the Company&#146;s assets in a transaction requiring stockholder approval; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top">&#147;Change of Control&#148; shall be interpreted, if applicable, in a manner, and limited to the extent necessary, so that it will not cause adverse tax consequences under Section 409A. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Code</U> means the United States Internal Revenue Code of 1986, as amended including any successor statute, regulation and guidance thereto.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Committee</U> means the committee of the Board of Directors to which the Board of Directors
has delegated power to act under or pursuant to the provisions of the Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Common Stock</U> means shares of the Company&#146;s common
stock, $.01 par value per share. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Company</U> means Myriad Genetics, Inc., a Delaware corporation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Consultant</U> means any natural person who is an advisor or consultant that provides bona fide services to the Company or its Affiliates,
provided that such services are not in connection with the offer or sale of securities in a capital raising transaction, and do not directly or indirectly promote or maintain a market for the Company&#146;s or its Affiliates&#146; securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Disability</U> or <U>Disabled</U> means permanent and total disability as defined in Section 22(e)(3) of the Code. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Employee</U> means any employee of the Company or of an Affiliate (including, without limitation, an employee who is also serving as an
officer or director of the Company or of an Affiliate), designated by the Administrator to be eligible to be granted one or more Stock Rights under the Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Exchange Act</U> means the Securities Exchange Act of 1934, as amended. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Fair Market Value</U> of a Share of Common Stock means: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;If the Common Stock is listed on a national securities exchange or traded in the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market and sales prices are regularly reported for the Common Stock, the closing or, if not applicable, the last price of the Common Stock on the composite tape or other comparable reporting
system for the trading day on the applicable date and if such applicable date is not a trading day, the last market trading day prior to such date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;If the Common Stock is not traded on a national securities exchange but is traded on the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, if sales prices are not regularly reported for the Common Stock for the trading day referred to in clause(1), and if bid and asked prices for the
Common Stock are regularly reported, the mean between the bid and the asked price for the Common Stock at the close of trading in the over-the-counter market for the trading day on which Common Stock was traded on the applicable date and if such
applicable date is not a trading day, the last market trading day prior to such date; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;If the Common Stock is
neither listed on a national securities exchange nor traded in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, such value as the Administrator, in good faith, shall determine. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>ISO</U> means an option intended to qualify as an incentive stock option under Section&nbsp;422 of the Code. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Non</U><U></U><U><FONT STYLE="white-space:nowrap">-Qualified</FONT> Option</U> means an option which is not intended to qualify as an ISO.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Option</U> means an ISO or <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Option granted under the Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Participant</U> means an Employee, director or Consultant of the Company or an Affiliate to whom one or more Stock Rights are granted under
the Plan. As used herein, &#147;Participant&#148; shall include &#147;Participant&#146;s Survivors&#148; where the context requires. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Plan</U> means this Myriad Genetics, Inc. 2010 Employee, Director and Consultant Equity Incentive Plan, as amended. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Securities Act</U> means the Securities Act of 1933, as amended. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Shares</U> means shares of the Common Stock as to which Stock Rights have been or may be granted under the Plan or any shares of capital
stock into which the Shares are changed or for which they are exchanged within the provisions of Paragraph&nbsp;3 of the Plan.&nbsp;The Shares issued under the Plan may be authorized and unissued shares or shares held by the Company in its treasury,
or both. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Stock Appreciation Right</U> means a Stock-Based Award providing for the right to receive an amount equal to the excess of the
Fair Market Value of the Shares on the date of exercise over the exercise price of the Stock Appreciation Right, which exercise price shall not be less than the Fair Market Value of the Shares on the date of grant and a term of not more than ten
years provided that such term shall be no more than eight years for each Stock Appreciation Right granted on or after December 5, 2012. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Stock-Based Award</U> means a grant by the Company under the Plan of an equity award or an
equity based award which is not an Option or a Stock Grant. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Stock Grant</U> means a grant by the Company of Shares under the Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Stock Right</U> means a right to Shares or the value of Shares of the Company granted pursuant to the Plan &#150; an ISO, a Non-Qualified
Option, a Stock Grant or a Stock-Based Award. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Survivor</U> means a deceased Participant&#146;s legal representatives and/or any person
or persons who acquired the Participant&#146;s rights to a Stock Right by will or by the laws of descent and distribution. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"><U>PURPOSES OF THE PLAN.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan is intended to encourage ownership of Shares by
Employees and directors of and certain Consultants to the Company and its Affiliates in order to attract and retain such people, to induce them to work for the benefit of the Company or of an Affiliate and to provide additional incentive for them to
promote the success of the Company or of an Affiliate.&nbsp;The Plan provides for the granting of ISOs, <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Options, Stock Grants and Stock-Based Awards. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"><U>SHARES SUBJECT TO THE PLAN.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;Commencing on December 1, 2016, the additional
number of Shares which may be issued from time to time pursuant to this Plan shall not exceed (i) 2,830,690<SUP STYLE="font-size:85%; vertical-align:top">1</SUP> shares of Common Stock plus (ii) any shares of Common Stock that are represented by
options previously granted under the Company&#146;s 2003 Employee, Director and Consultant Stock Option Plan, as amended, that expire or are cancelled without delivery of shares of Common Stock, or the equivalent of such number of Shares after the
Administrator, in its sole discretion, has interpreted the effect of any stock split, stock dividend, combination, recapitalization or similar transaction in accordance with Paragraph 24 of this Plan; provided, however, that as of December 1, 2016
no more than 2,432,291<SUP STYLE="font-size:85%; vertical-align:top">2</SUP> Shares shall be added to the Plan pursuant to subsection (ii). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;The grant of any Stock Right other than an Option or a Stock Appreciation Right shall for purposes of Paragraph 3(a), reduce the
number of Shares available for issuance under this Plan by 2 Shares for each such Share actually subject to the Stock Right and shall be deemed for purposes of this Paragraph 3, as a Stock Right of 2 Shares for each such Share actually subject to
the Stock Right. The grant of an Option or a Stock Appreciation Right shall be deemed for purposes of this Paragraph 3, as a Stock Right for one Share for each such Share actually subject to the Stock Right.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;If an Option ceases to be &#147;outstanding&#148;, in whole or in part (other than by exercise), or if the Company shall reacquire
(at not more than its original issuance price) any Shares issued pursuant to a Stock Grant or Stock-Based Award, or if any Stock Right expires or is forfeited, cancelled, or otherwise terminated or results in any Shares not being issued, the
unissued or reacquired Shares which were subject to such Stock Right shall again be available for issuance from time to time pursuant to this Plan and in accordance with the provisions of Paragraph 3(b) above.<SUP
STYLE="font-size:85%; vertical-align:top">3</SUP> Notwithstanding the foregoing, if a Stock Right is exercised, in whole or in part, by tender of Shares or if the Company or an Affiliate&#146;s tax withholding obligation is satisfied by withholding
Shares, the number of Shares deemed to have been issued under the Plan for purposes of the limitation set forth in Paragraph 3(a) above shall be the number of Shares that were subject to the Stock Right or portion thereof, and not the net number of
Shares actually issued and any Stock Appreciation Right to be settled in shares of Common Stock shall be counted in full against the number of Shares available for issuance under the Plan, regardless of </P>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Balance consists of 330,690 remaining shares available for issuance under the Plan as of October 5, 2016 and 2,500,000 additional shares subject to stockholder approval at the Annual Meeting of Stockholders to be held
on December 1, 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">2</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">This number consists of options to purchase 2,432,291 shares of common stock that are outstanding under the 2003 Plan as of October 5, 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">3</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">As of October 5, 2016, options to purchase 5,657,550 shares of common stock and restricted stock units representing 2,047,537 shares of common stock are outstanding under the Plan. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the number of exercise gain Shares issued upon the settlement of the Stock Appreciation Right. However, in the case of ISOs, the foregoing provisions shall be subject to any limitations under the
Code. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"><U>ADMINISTRATION OF THE PLAN.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Administrator of the Plan will be the Board of
Directors, except to the extent the Board of Directors delegates its authority to the Committee, in which case the Committee shall be the Administrator.&nbsp;Subject to the provisions of the Plan, the Administrator is authorized to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Interpret the provisions of the Plan and all Stock Rights and to make all rules and determinations which it deems necessary
or advisable for the administration of the Plan; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Determine which Employees, directors and Consultants shall be granted
Stock Rights; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Determine the number of Shares for which a Stock Right or Stock Rights shall be granted, provided,
however, that in no event shall Stock Rights with respect to more than 1,000,000 Shares be granted to any Participant in any fiscal year; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Specify the terms and conditions upon which a Stock Right or Stock Rights may be granted; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Make changes to any outstanding Stock Right, including, without limitation, to reduce or increase the exercise price or
purchase price, accelerate the vesting schedule or extend the expiration date, provided that no such change shall impair the rights of a Participant under any grant previously made without such Participant&#146;s consent and further provided that
without the prior approval of the Company&#146;s shareholders, Options and Stock Appreciation Rights issued will not be repriced, replaced, or regranted through cancellation, or by lowering the exercise price of a previously granted award, or
repurchased for cash when the Fair Market Value is less than the exercise price; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Adopt any sub-plans applicable to
residents of any specified jurisdiction as it deems necessary or appropriate in order to comply with or take advantage of any tax or other laws applicable to the Company, any Affiliate or to Participants or to otherwise facilitate the administration
of the Plan, which sub-plans may include additional restrictions or conditions applicable to Stock Rights or Shares issuable pursuant to a Stock Right; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided, however, that all such interpretations, rules, determinations, terms and conditions shall be made and prescribed in the context of not causing any
adverse tax consequences under Section 409A of the Code and preserving the tax status under Section 422 of the Code of those Options which are designated as ISOs.&nbsp;Subject to the foregoing, the interpretation and construction by the
Administrator of any provisions of the Plan or of any Stock Right granted under it shall be final, unless otherwise determined by the Board of Directors, if the Administrator is the Committee.&nbsp;In addition, if the Administrator is the Committee,
the Board of Directors may take any action under the Plan that would otherwise be the responsibility of the Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent
permitted under applicable law, the Board of Directors or the Committee may allocate all or any portion of its responsibilities and powers to any one or more of its members and may delegate all or any portion of its responsibilities and powers to
any other person selected by it. The Board of Directors or the Committee may revoke any such allocation or delegation at any time.&nbsp;Notwithstanding the foregoing, only the Board of Directors or the Committee shall be authorized to grant a Stock
Right to any director of the Company or to any &#147;officer&#148; of the Company (as defined by Rule 16a-1 under the Exchange Act). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"><U>ELIGIBILITY FOR PARTICIPATION.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Administrator will, in its sole discretion, name the
Participants in the Plan; provided, however, that each Participant must be an Employee, director or Consultant of the Company or of an Affiliate at the time a Stock Right is granted.&nbsp;Notwithstanding the foregoing, the Administrator may
authorize the grant of a Stock Right to a person not then an Employee, director or Consultant of the Company or of an Affiliate; provided, however, that </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the actual grant of such Stock Right shall be conditioned upon such person becoming eligible to become a Participant at or prior to the time of the execution of the Agreement evidencing such
Stock Right.&nbsp;ISOs may be granted only to Employees who are deemed to be residents of the United States for tax <FONT STYLE="white-space:nowrap">purposes.&nbsp;Non-Qualified</FONT> Options, Stock Grants and Stock-Based Awards may be granted to
any Employee, director or Consultant of the Company or an Affiliate.&nbsp;The granting of any Stock Right to any individual shall neither entitle that individual to, nor disqualify him or her from, participation in any other grant of Stock Rights or
any grant under any other benefit plan established by the Company or any Affiliate for Employees, directors or Consultants. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"><U>TERMS AND CONDITIONS OF OPTIONS.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Option shall be set forth in writing in an Option
Agreement, duly executed by the Company and, to the extent required by law or requested by the Company, by the Participant.&nbsp;The Administrator may provide that Options be granted subject to such terms and conditions, consistent with the terms
and conditions specifically required under this Plan, as the Administrator may deem appropriate including, without limitation, subsequent approval by the shareholders of the Company of this Plan or any amendments thereto.&nbsp;The Option Agreements
shall be subject to at least the following terms and conditions: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Non</U><U>&nbsp;</U><U><FONT
STYLE="white-space:nowrap">-Qualified</FONT> Options</U>:&nbsp;Each Option intended to be a <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Option shall be subject to the terms and conditions which the Administrator determines to be
appropriate and in the best interest of the Company, subject to the following minimum standards for any such <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Option: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"><U>Exercise Price</U>: Each Option Agreement shall state the exercise price (per share) of the Shares covered by each Option, which exercise price shall be determined by the Administrator and shall be at least equal to
the Fair Market Value per share of the Common Stock on the date of grant of the Option. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"><U>Number of Shares</U>: Each Option Agreement shall state the number of Shares to which it pertains. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"><U>Option Periods</U>:&nbsp;Each Option Agreement shall state the date or dates on which it first is exercisable and the date after which it may no longer be exercised, provided that each Non-Qualified Option shall
terminate not more than ten years from the date of grant provided that such term shall be no more than eight years from the date of grant for each Non-Qualified Option granted on or after December 5, 2012.&nbsp;Each Option Agreement may provide that
the Option rights accrue or become exercisable in installments over a period of months or years, or upon the occurrence of certain conditions or the attainment of stated goals or events.</TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"><U>Option Conditions</U>:&nbsp;Exercise of any Option may be conditioned upon the Participant&#146;s execution of a Share purchase agreement in form satisfactory to the Administrator providing for certain protections
for the Company and its other shareholders, including requirements that: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top">The Participant&#146;s or the Participant&#146;s Survivors&#146; right to sell or transfer the Shares may be restricted; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top">The Participant or the Participant&#146;s Survivors may be required to execute letters of investment intent and must also acknowledge that the Shares will bear legends noting any applicable restrictions.
</TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;<U>ISOs</U>:&nbsp;Each Option intended to be an ISO shall be issued only to an Employee who is
deemed to be a resident of the United States for tax purposes, and shall be subject to the following terms and conditions, with such additional restrictions or changes as the Administrator determines are appropriate but not in conflict with Section
422 of the Code and relevant regulations and rulings of the Internal Revenue Service: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"><U>Minimum standards</U>:&nbsp;The ISO shall meet the minimum standards required of <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Options, as described in Paragraph 6(a) above, except for clause (i) thereunder.
</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"><U>Exercise Price</U>:&nbsp;Immediately before the ISO is granted, if the Participant owns, directly or by reason of the applicable attribution rules in Section&nbsp;424(d) of the Code: </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top">10% <U>or less</U> of the total combined voting power of all classes of stock of the Company or an Affiliate, the exercise price per share of the Shares covered by each ISO shall not be less than 100% of the Fair Market
Value per share of the Common Stock on the date of grant of the Option; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top">More than 10% of the total combined voting power of all classes of stock of the Company or an Affiliate, the exercise price per share of the Shares covered by each ISO shall not be less than 110% of the Fair Market
Value per share of the Common Stock on the date of grant of the Option. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"><U>Term of Option</U>:&nbsp;For Participants who own: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top">10% <U>or less</U> of the total combined voting power of all classes of stock of the Company or an Affiliate, each ISO shall terminate not more than ten years from the date of the grant or at such earlier time as the
Option Agreement may provide provided that such term shall be no more than eight years from the date of grant for each ISO granted on or after December 5, 2012; or </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top">More than 10% of the total combined voting power of all classes of stock of the Company or an Affiliate, each ISO shall terminate not more than five years from the date of the grant or at such earlier time as the Option
Agreement may provide. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"><U>Limitation on Yearly Exercise</U>:&nbsp;The Option Agreements shall restrict the amount of ISOs which may become exercisable in any calendar year (under this or any other ISO plan of the Company or an Affiliate) so
that the aggregate Fair Market Value (determined on the date each ISO is granted) of the stock with respect to which ISOs are exercisable for the first time by the Participant in any calendar year does not exceed $100,000. </TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"><U>TERMS AND CONDITIONS OF STOCK GRANTS.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Stock Grant to a Participant shall state the
principal terms in an Agreement duly executed by the Company and, to the extent required by law or requested by the Company, by the Participant.&nbsp;The Agreement shall be in a form approved by the Administrator and shall contain terms and
conditions which the Administrator determines to be appropriate and in the best interest of the Company, subject to the following minimum standards: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;Each Agreement shall state the purchase price per share, if any, of the Shares covered by each Stock Grant, which
purchase price shall be determined by the Administrator but shall not be less than the minimum consideration required by the Delaware General Corporation Law, if any, on the date of grant of the Stock Grant; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;Each Agreement shall state the number of Shares to which the Stock Grant pertains; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;Each Agreement shall include the terms of any right of the Company to restrict or reacquire the Shares subject to the
Stock Grant, including the time and events upon which such rights shall accrue and the purchase price therefor, if any. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"><U>TERMS AND CONDITIONS OF OTHER STOCK-BASED AWARDS.</U></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Administrator shall have the right
to grant other Stock-Based Awards based upon the Common Stock having such terms and conditions as the Administrator may determine, including, without limitation, the grant of Shares based upon certain conditions, the grant of securities convertible
into Shares and the grant of Stock Appreciation Rights, phantom stock awards or stock units.&nbsp;The principal terms of each Stock-Based Award shall be set forth in an Agreement, duly executed by the Company and, to the extent required by law or
requested by the Company, by the Participant.&nbsp;The Agreement shall be in a form approved by the Administrator and shall contain terms and conditions which the Administrator determines to be appropriate and in the best interest of the Company.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company intends that the Plan and any Stock-Based Awards granted hereunder be exempt from the
application of Section 409A of the Code or meet the requirements of paragraphs (2), (3) and (4) of subsection (a) of Section 409A of the Code, to the extent applicable, and be operated in accordance with Section 409A so that any compensation
deferred under any Stock-Based Award (and applicable investment earnings) shall not be included in income under Section 409A of the Code.&nbsp;Any ambiguities in the Plan shall be construed to effect the intent as described in this Paragraph 8. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"><U>EXERCISE OF OPTIONS AND ISSUE OF SHARES.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An Option (or any part or installment thereof)
shall be exercised by giving written notice to the Company or its designee (in a form acceptable to the Administrator, which may include electronic notice), together with provision for payment of the aggregate exercise price in accordance with this
Paragraph for the Shares as to which the Option is being exercised, and upon compliance with any other condition(s) set forth in the Option Agreement.&nbsp;Such notice shall be signed by the person exercising the Option (which signature may be
provided electronically in a form acceptable to the Administrator), shall state the number of Shares with respect to which the Option is being exercised and shall contain any representation required by the Plan or the Option Agreement.&nbsp;Payment
of the exercise price for the Shares as to which such Option is being exercised shall be made (a)&nbsp;in United States dollars in cash or by check, or (b)&nbsp;at the discretion of the Administrator, through delivery of shares of Common Stock held
for at least six months (if required to avoid negative accounting treatment) having a Fair Market Value equal as of the date of the exercise to the aggregate cash exercise price for the number of Shares as to which the Option is being exercised, or
(c)&nbsp;at the discretion of the Administrator, by having the Company retain from the Shares otherwise issuable upon exercise of the Option, a number of Shares having a Fair Market Value equal as of the date of exercise to the aggregate exercise
price for the number of Shares as to which the Option is being exercised, or (d) at the discretion of the Administrator, in accordance with a cashless exercise program established with a securities brokerage firm, and approved by the Administrator,
or (e)&nbsp;at the discretion of the Administrator, by any combination of (a), (b), (c) and (d) above or (f) at the discretion of the Administrator, by payment of such other lawful consideration as the Administrator may determine. Notwithstanding
the foregoing, the Administrator shall accept only such payment on exercise of an ISO as is permitted by Section 422 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company shall then reasonably promptly deliver the Shares as to which such Option was exercised to the Participant (or to the Participant&#146;s Survivors, as the case may be).&nbsp;In determining what constitutes &#147;reasonably promptly,&#148; it
is expressly understood that the issuance and delivery of the Shares may be delayed by the Company in order to comply with any law or regulation (including, without limitation, state securities or &#147;blue sky&#148; laws) which requires the
Company to take any action with respect to the Shares prior to their issuance.&nbsp;The Shares shall, upon delivery, be fully paid, non-assessable Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Administrator shall have the right to accelerate the date of exercise of any installment of any Option; provided that the Administrator
shall not accelerate the exercise date of any installment of any Option granted to an Employee as an ISO (and not previously converted into a Non-Qualified Option pursuant to Paragraph 27) without the prior approval of the Employee if such
acceleration would violate the annual vesting limitation contained in Section 422(d) of the Code, as described in Paragraph 6(b)(iv). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Administrator may, in its discretion, amend any term or condition of an outstanding Option provided (i) such term or condition as amended is permitted by the Plan, (ii) any such amendment shall be made only with the consent of the Participant to
whom the Option was granted, or in the event of the death of the Participant, the Participant&#146;s Survivors, if the amendment is adverse to the Participant, and (iii) any such amendment of any Option shall be made only after the Administrator
determines whether such amendment would constitute a &#147;modification&#148; of any Option which is an ISO (as that term is defined in Section 424(h) of the Code) or would cause any adverse tax consequences for the holder of any Option including,
but not limited to, pursuant to Section 409A of the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"><U>ACCEPTANCE OF STOCK GRANTS AND STOCK-BASED AWARDS AND ISSUE OF SHARES.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A Stock Grant or
Stock-Based Award (or any part or installment thereof) shall be accepted by executing the applicable Agreement and delivering it to the Company or its designee, together with provision for payment of the purchase price, if any, in accordance with
this Paragraph for the Shares as to which such Stock Grant or Stock-Based Award is being accepted, and upon compliance with any other conditions set forth in the applicable Agreement.&nbsp;Payment of the purchase price for the Shares as to which
such Stock Grant or Stock-Based Award is being accepted shall be made (a) in United States dollars in cash or by check, or (b) at the discretion of the Administrator, through delivery of shares of Common Stock held for at least six months (if
required to avoid negative accounting treatment) and having a Fair Market Value equal as of the date of acceptance of the Stock Grant or Stock Based-Award to the purchase price of the Stock Grant or Stock-Based Award, or (c) at the discretion of the
Administrator, by any combination of (a) and (b) above; or (c) at the discretion of the Administrator, by payment of such other lawful consideration as the Administrator may determine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company shall then, if required by the applicable Agreement, reasonably promptly deliver the Shares as to which such Stock Grant or
Stock-Based Award was accepted to the Participant (or to the Participant&#146;s Survivors, as the case may be), subject to any escrow provision set forth in the applicable Agreement.&nbsp;In determining what constitutes &#147;reasonably
promptly,&#148; it is expressly understood that the issuance and delivery of the Shares may be delayed by the Company in order to comply with any law or regulation (including, without limitation, state securities or &#147;blue sky&#148; laws) which
requires the Company to take any action with respect to the Shares prior to their issuance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Administrator may, in its discretion,
amend any term or condition of an outstanding Stock Grant, Stock-Based Award or applicable Agreement provided (i) such term or condition as amended is permitted by the Plan, (ii) any such amendment shall be made only with the consent of the
Participant to whom the Stock Grant or Stock-Based Award was made, if the amendment is adverse to the Participant, and (iii) any such amendment shall be made only after the Administrator determines whether such amendment would cause any adverse tax
consequences to the Participant, including, but not limited to, pursuant to Section 409A of the Code. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"><U>RIGHTS AS A SHAREHOLDER.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No Participant to whom a Stock Right has been granted shall
have rights as a shareholder with respect to any Shares covered by such Stock Right, except after due exercise of the Option or acceptance of the Stock Grant or as set forth in any Agreement, and tender of the aggregate exercise or purchase price,
if any, for the Shares being purchased pursuant to such exercise or acceptance and registration of the Shares in the Company&#146;s share register in the name of the Participant. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"><U>ASSIGNABILITY AND TRANSFERABILITY OF STOCK RIGHTS.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By its terms, a Stock Right granted
to a Participant shall not be transferable by the Participant other than (i) by will or by the laws of descent and distribution, or (ii) as approved by the Administrator in its discretion and set forth in the applicable Agreement provided that no
Stock Right may be transferred by a Participant for value.&nbsp;Notwithstanding the foregoing, an ISO transferred except in compliance with clause (i) above shall no longer qualify as an ISO.&nbsp;The designation of a beneficiary of a Stock Right by
a Participant, with the prior approval of the Administrator and in such form as the Administrator shall prescribe, shall not be deemed a transfer prohibited by this Paragraph.&nbsp;Except as provided above, a Stock Right shall only be exercisable or
may only be accepted, during the Participant&#146;s lifetime, by such Participant (or by his or her legal representative) and shall not be assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and shall not be
subject to execution, attachment or similar process.&nbsp;Any attempted transfer, assignment, pledge, hypothecation or other disposition of any Stock Right or of any rights granted thereunder contrary to the provisions of this Plan, or the levy of
any attachment or similar process upon a Stock Right, shall be null and void. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"><U>EFFECT ON OPTIONS OF TERMINATION OF SERVICE OTHER THAN FOR CAUSE OR DEATH OR DISABILITY.</U> </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided in a Participant&#146;s Option Agreement, in the event of a termination of service (whether as an Employee,
director or Consultant) with the Company or an Affiliate before the Participant has exercised an Option, the following rules apply: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;A Participant who ceases to be an Employee, director or Consultant of the Company or of an Affiliate (for any reason
other than termination for Cause, Disability, or death for which events there are special rules in Paragraphs 14, 15, and 16, respectively), may exercise any Option granted to him or her to the extent that the Option is exercisable on the date of
such termination of service, but only within such term as the Administrator has designated in a Participant&#146;s Option Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;Except as provided in Subparagraph (c) below, or Paragraph 15 or 16, in no event may an Option intended to be an ISO,
be exercised later than three months after the Participant&#146;s termination of employment.</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;The provisions of
this Paragraph, and not the provisions of Paragraph 15 or 16, shall apply to a Participant who subsequently becomes Disabled or dies after the termination of employment, director status or consultancy; provided, however, in the case of a
Participant&#146;s Disability or death within three months after the termination of employment, director status or consultancy, the Participant or the Participant&#146;s Survivors may exercise the Option within one year after the date of the
Participant&#146;s termination of service, but in no event after the date of expiration of the term of the Option. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;Notwithstanding anything herein to the contrary, if subsequent to a Participant&#146;s termination of employment,
termination of director status or termination of consultancy, but prior to the exercise of an Option, the Administrator determines that, either prior or subsequent to the Participant&#146;s termination, the Participant engaged in conduct which would
constitute Cause, then such Participant shall forthwith cease to have any right to exercise any Option. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;A
Participant to whom an Option has been granted under the Plan who is absent from the Company or an Affiliate because of temporary disability (any disability other than a Disability as defined in Paragraph 1 hereof), or who is on leave of absence for
any purpose, shall not, during the period of any such absence, be deemed, by virtue of such absence alone, to have terminated such Participant&#146;s employment, director status or consultancy with the Company or with an Affiliate, except as the
Administrator may otherwise expressly provide; provided, however, that, for ISOs, any leave of absence granted by the Administrator of greater than ninety days, unless pursuant to a contract or statute that guarantees the right to reemployment,
shall cause such ISO to become a Non-Qualified Option on the 181<SUP STYLE="font-size:85%; vertical-align:top">st</SUP> day following such leave of absence. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;Except as required by law or as set forth in a Participant&#146;s Option Agreement, Options granted under the Plan
shall not be affected by any change of a Participant&#146;s status within or among the Company and any Affiliates, so long as the Participant continues to be an Employee, director or Consultant of the Company or any Affiliate. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"><U>EFFECT ON OPTIONS OF TERMINATION OF SERVICE FOR CAUSE.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided in
a Participant&#146;s Option Agreement, the following rules apply if the Participant&#146;s service (whether as an Employee, director or Consultant) with the Company or an Affiliate is terminated for Cause prior to the time that all his or her
outstanding Options have been exercised: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;All outstanding and unexercised Options as of the time the Participant
is notified his or her service is terminated for Cause will immediately be forfeited. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;Cause is not limited to
events which have occurred prior to a Participant&#146;s termination of service, nor is it necessary that the Administrator&#146;s finding of Cause occur prior to termination.&nbsp;If the Administrator determines, subsequent to a Participant&#146;s
termination of service but prior to the exercise of an Option, that either prior or subsequent to the Participant&#146;s termination the Participant engaged in conduct which would constitute Cause, then the right to exercise any Option is forfeited.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">15.</TD>
<TD ALIGN="left" VALIGN="top"><U>EFFECT ON OPTIONS OF TERMINATION OF SERVICE FOR DISABILITY.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise
provided in a Participant&#146;s Option Agreement: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;A Participant who ceases to be an Employee, director or
Consultant of the Company or of an Affiliate by reason of Disability may exercise any Option granted to such Participant: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top">To the extent that the Option has become exercisable but has not been exercised on the date of the Participant&#146;s termination of service due to Disability; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top">In the event rights to exercise the Option accrue periodically, to the extent of a pro rata portion through the date of the Participant&#146;s termination of service due to Disability of any additional vesting rights
that would have accrued on the next vesting date had the Participant not become Disabled.&nbsp;The proration shall be based upon the number of days accrued in the current vesting period prior to the date of the Participant&#146;s termination of
service due to Disability. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;A Disabled Participant may exercise the Option only within (i) if the
Option is an ISO, the period ending one year after the date of the Participant&#146;s termination due to Disability or, if earlier, within the originally prescribed term of the Option, or (ii) if the Option is a Non-Qualified Option, within the
remaining term of the Option, notwithstanding that the Participant might have been able to exercise the Option as to some or all of the Shares on a later date if the Participant had not become Disabled and had continued to be an Employee, director
or Consultant. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;The Administrator shall make the determination both of whether Disability has occurred and the
date of its occurrence (unless a procedure for such determination is set forth in another agreement between the Company and such Participant, in which case such procedure shall be used for such determination).&nbsp;If requested, the Participant
shall be examined by a physician selected or approved by the Administrator, the cost of which examination shall be paid for by the Company. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">16.</TD>
<TD ALIGN="left" VALIGN="top"><U>EFFECT ON OPTIONS OF DEATH WHILE AN EMPLOYEE, DIRECTOR OR CONSULTANT.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as
otherwise provided in a Participant&#146;s Option Agreement: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;In the event of the death of a Participant while the
Participant is an Employee, director or Consultant of the Company or of an Affiliate, such Option shall become fully exercisable as of the date of the Participant&#146;s death. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;If the Participant&#146;s Survivors wish to exercise the Option, they must take all necessary steps to exercise the
Option within the originally prescribed term of the Option. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">17.</TD>
<TD ALIGN="left" VALIGN="top"><U>EFFECT OF TERMINATION OF SERVICE ON UNACCEPTED STOCK GRANTS.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a
termination of service (whether as an Employee, director or Consultant) with the Company or an Affiliate for any reason before the Participant has accepted a Stock Grant, such offer shall terminate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this Paragraph 17 and Paragraph 18 below, a Participant to whom a Stock Grant has been offered and accepted under the Plan who
is absent from work with the Company or with an Affiliate because of temporary disability (any disability other than a Disability as defined in Paragraph 1 hereof), or who is on leave of absence for any purpose, shall not, during the period of any
such absence, be deemed, by virtue of such absence alone, to have terminated such Participant&#146;s employment, director status or consultancy with the Company or with an Affiliate, except as the Administrator may otherwise expressly provide. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, for purposes of this Paragraph 17 and Paragraph 18 below, any change of employment or other service within or among the Company
and any Affiliates shall not be treated as a termination of employment, director status or consultancy so long as the Participant continues to be an Employee, director or Consultant of the Company or any Affiliate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">18.</TD>
<TD ALIGN="left" VALIGN="top"><U>EFFECT ON STOCK GRANTS OF TERMINATION OF SERVICE OTHER THAN FOR CAUSE OR DEATH OR DISABILITY.</U> </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided in a Participant&#146;s Stock Grant Agreement, in the event of a termination of service (whether as an Employee,
director or Consultant), other than termination for Cause, Disability, or death for which events there are special rules in Paragraphs 19, 20, and 21, respectively, before all forfeiture provisions or Company rights of repurchase shall have lapsed,
then the Company shall have the right to cancel or repurchase that number of Shares subject to a Stock Grant as to which the Company&#146;s forfeiture or repurchase rights have not lapsed. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">19.</TD>
<TD ALIGN="left" VALIGN="top"><U>EFFECT ON STOCK GRANTS OF TERMINATION OF SERVICE FOR CAUSE.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise
provided in a Participant&#146;s Stock Grant Agreement, the following rules apply if the Participant&#146;s service (whether as an Employee, director or Consultant) with the Company or an Affiliate is terminated for Cause: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;All Shares subject to any Stock Grant that remain subject to forfeiture provisions or as to which the Company shall have a repurchase
right shall be immediately forfeited to the Company as of the time the Participant is notified his or her service is terminated for Cause. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;Cause is not limited to events which have occurred prior to a Participant&#146;s termination of service, nor is it necessary that the
Administrator&#146;s finding of Cause occur prior to termination.&nbsp;If the Administrator determines, subsequent to a Participant&#146;s termination of service, that either prior or subsequent to the Participant&#146;s termination the Participant
engaged in conduct which would constitute Cause, then all Shares subject to any Stock Grant that remained subject to forfeiture provisions or as to which the Company had a repurchase right on the date of termination shall be immediately forfeited to
the Company. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">20.</TD>
<TD ALIGN="left" VALIGN="top"><U>EFFECT ON STOCK GRANTS OF TERMINATION OF SERVICE FOR DISABILITY.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise
provided in a Participant&#146;s Stock Grant Agreement, the following rules apply if a Participant ceases to be an Employee, director or Consultant of the Company or of an Affiliate by reason of Disability:&nbsp;to the extent the forfeiture
provisions or the Company&#146;s rights of repurchase have not lapsed on the date of the Participant&#146;s termination due to Disability, they shall be exercisable; provided, however, that in the event such forfeiture provisions or rights of
repurchase lapse periodically, such provisions or rights shall lapse to the extent of a pro rata portion of the Shares subject to such Stock Grant through the date of the Participant&#146;s termination due to Disability as would have lapsed had the
Participant not been terminated due to Disability.&nbsp;The proration shall be based upon the number of days accrued prior to the date of the Participant&#146;s termination due to Disability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Administrator shall make the determination both as to whether Disability has occurred and the date of its occurrence (unless a procedure
for such determination is set forth in another agreement between the Company and such Participant, in which case such procedure shall be used for such determination).&nbsp;If requested, the Participant shall be examined by a physician selected or
approved by the Administrator, the cost of which examination shall be paid for by the Company. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">21.</TD>
<TD ALIGN="left" VALIGN="top"><U>EFFECT ON STOCK GRANTS OF DEATH WHILE AN EMPLOYEE, DIRECTOR OR CONSULTANT.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as
otherwise provided in a Participant&#146;s Stock Grant Agreement, the following rules apply in the event of the death of a Participant while the Participant is an Employee, director or Consultant of the Company or of an Affiliate:&nbsp;to the extent
the forfeiture provisions or the Company&#146;s rights of repurchase have not lapsed on the date of death, they shall lapse in full on the Participant&#146;s date of death. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">22.</TD>
<TD ALIGN="left" VALIGN="top"><U>PURCHASE FOR INVESTMENT.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the offering and sale of the Shares to be issued upon
the particular exercise or acceptance of a Stock Right shall have been effectively registered under the Securities Act, the Company shall be under no obligation to issue the Shares covered by such exercise unless and until the following conditions
have been fulfilled: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;The person who exercises or accepts such Stock Right shall warrant to the Company, prior to
the receipt of such Shares, that such person is acquiring such Shares for his or her own account, for investment, and not with a view to, or for sale in connection with, the distribution of any such Shares, in which event the person acquiring such
Shares shall be bound by the provisions of the following legend (or a legend in substantially similar form) which shall be endorsed upon the certificate evidencing the Shares issued pursuant to such exercise or such grant: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">&#147;The shares represented by this certificate have been taken for investment and they may not be sold or otherwise transferred by any
person, including a pledgee, unless (1) either (a) a Registration Statement with respect to such shares shall be effective under the Securities Act of 1933, as amended, or (b) the Company shall have received an opinion of counsel satisfactory to it
that an exemption from registration under such Act is then available, and (2) there shall have been compliance with all applicable state securities laws.&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;At the discretion of the Administrator, the Company shall have received an opinion of its counsel that the Shares may
be issued upon such particular exercise or acceptance in compliance with the Securities Act without registration thereunder. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">23.</TD>
<TD ALIGN="left" VALIGN="top"><U>DISSOLUTION OR LIQUIDATION OF THE COMPANY.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the dissolution or liquidation of the
Company, all Options granted under this Plan which as of such date shall not have been exercised and all Stock Grants and Stock-Based Awards which have not been accepted will terminate and become null and void; provided, however, that if the rights
of a Participant or a Participant&#146;s Survivors have not otherwise terminated and expired, the Participant or the Participant&#146;s Survivors will have the right immediately prior to such dissolution or liquidation to exercise or accept any
Stock Right to the extent that the Stock Right is exercisable or subject to acceptance as of the date immediately prior to such dissolution or liquidation.&nbsp;Upon the dissolution or liquidation of the Company, any outstanding Stock-Based Awards
shall immediately terminate unless otherwise determined by the Administrator or specifically provided in the applicable Agreement. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">24.</TD>
<TD ALIGN="left" VALIGN="top"><U>ADJUSTMENTS.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the occurrence of any of the following events, a Participant&#146;s
rights with respect to any Stock Right granted to him or her hereunder shall be adjusted as hereinafter provided, unless otherwise specifically provided in a Participant&#146;s Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;<U>Stock Dividends and Stock Splits</U>.&nbsp;If (i)&nbsp;the shares of Common Stock shall be subdivided or combined
into a greater or smaller number of shares or if the Company shall issue any shares of Common Stock as a stock dividend on its outstanding Common Stock, or (ii)&nbsp;additional shares or new or different shares or other securities of the Company or
other non-cash assets are distributed with respect to such shares of Common Stock, the number of shares of Common Stock deliverable upon the exercise of an Option or acceptance of a Stock Grant shall be appropriately increased or decreased
proportionately, and appropriate adjustments shall be made including, in the exercise or purchase price per share, to reflect such events.&nbsp;The number of Shares subject to the limitations in Paragraph 3(a) and 4(c) shall also be proportionately
adjusted upon the occurrence of such events. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;<U>Corporate Transactions</U>.&nbsp;If the Company is to be
consolidated with or acquired by another entity in a merger, consolidation, or sale of all or substantially all of the Company&#146;s assets other than a transaction to merely change the state of incorporation (a &#147;Corporate Transaction&#148;),
the Administrator or the board of directors of any entity assuming the obligations of the Company hereunder (the &#147;Successor Board&#148;), shall, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
as to outstanding Options, either (i) make appropriate provision for the continuation of such Options by substituting on an equitable basis for the Shares then subject to such Options either the
consideration payable with respect to the outstanding shares of Common Stock in connection with the Corporate Transaction or securities of any successor or acquiring entity; or (ii) upon written notice to the Participants, provide that such Options
must be exercised (either (A) to the extent then exercisable or, (B) at the discretion of the Administrator, including upon a Change of Control of the Company, any such Options being made fully exercisable for purposes of this Subparagraph), within
a specified number of days of the date of such notice, at the end of which period such Options which have not been exercised shall terminate; or (iii) terminate such Options in exchange for payment of an amount equal to the consideration payable
upon consummation of such Corporate Transaction to a holder of the number of shares of Common Stock into which such Option would have been exercisable (either (A) to the extent then exercisable or, (B) at the discretion of the Administrator, any
such Options being made fully exercisable for purposes of this Subparagraph) <U>less the aggregate</U> exercise price thereof.&nbsp;For purposes of determining the payments to be made pursuant to Subclause (iii) above, in the case of a Corporate
Transaction the consideration for which, in whole or in part, is other than cash, the consideration other than cash shall be valued at the fair value thereof as determined in good faith by the Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With respect to outstanding Stock Grants, the Administrator or the Successor Board, shall make appropriate provision for the continuation of
such Stock Grants on the same terms and conditions by substituting on an equitable basis for the Shares then subject to such Stock Grants either the consideration payable with respect to the outstanding Shares of Common Stock in connection with the
Corporate Transaction or securities of any successor or acquiring entity.&nbsp;In lieu of the foregoing, in connection with any Corporate Transaction, the Administrator may provide that, upon consummation of the Corporate Transaction, each
outstanding Stock Grant shall be terminated in exchange for payment of an amount equal to the consideration payable upon consummation of such Corporate Transaction to a holder of the number of shares of Common Stock comprising such Stock Grant (to
the extent such Stock Grant is no longer subject to any forfeiture or repurchase rights then in effect or, at the discretion of the Administrator, all forfeiture and repurchase rights being waived upon such Corporate Transaction). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In taking any of the actions permitted under this Paragraph 24(b), the Administrator shall not be obligated by the Plan to treat all Stock
Rights, all Stock Rights held by a Participant, or all Stock Rights of the same type, identically. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;<U>Recapitalization or Reorganization</U>.&nbsp;In the event of a recapitalization or reorganization of the Company
other than a Corporate Transaction pursuant to which securities of the Company or of another corporation are issued with respect to the outstanding shares of Common Stock, a Participant upon exercising an Option or accepting a Stock Grant after the
recapitalization or reorganization shall be entitled to receive for the price paid upon such exercise or acceptance if any, the number of replacement securities which would have been received if such Option had been exercised or Stock Grant accepted
prior to such recapitalization or reorganization. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;<U>Adjustments to Stock-Based Awards</U>.&nbsp;Upon the
happening of any of the events described in Subparagraphs (a), (b) or (c) above, any outstanding Stock-Based Award shall be appropriately adjusted to reflect the events described in such Subparagraphs.&nbsp;The Administrator or the Successor Board
shall determine the specific adjustments to be made under this Paragraph 24, including, but not limited to the effect of any, Corporate Transaction or Change of Control and, subject to Paragraph 4, its determination shall be conclusive. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;<U>Modification of Options</U>.&nbsp;Notwithstanding the foregoing, any adjustments made pursuant to Subparagraph (a),
(b) or (c) above with respect to Options shall be made only after the Administrator determines whether such adjustments would constitute a &#147;modification&#148; of any ISOs (as that term is defined in Section&nbsp;424(h) of the Code) or would
cause any adverse tax consequences for the holders of Options, including, but not limited to, pursuant to Section 409A of the Code.&nbsp;If the Administrator determines that </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
such adjustments made with respect to Options would constitute a modification or other adverse tax consequence, it may refrain from making such adjustments, unless the holder of an Option
specifically agrees in writing that such adjustment be made and such writing indicates that the holder has full knowledge of the consequences of such &#147;modification&#148; on his or her income tax treatment with respect to the Option.&nbsp;This
paragraph shall not apply to the acceleration of the vesting of any ISO that would cause any portion of the ISO to violate the annual vesting limitation contained in Section 422(d) of the Code, as described in Paragraph 6(b)(iv). </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">25.</TD>
<TD ALIGN="left" VALIGN="top"><U>ISSUANCES OF SECURITIES.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as expressly provided herein, no issuance by the
Company of shares of stock of any class, or securities convertible into shares of stock of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of shares subject to Stock Rights.&nbsp;Except
as expressly provided herein, no adjustments shall be made for dividends paid in cash or in property (including without limitation, securities) of the Company prior to any issuance of Shares pursuant to a Stock Right. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">26.</TD>
<TD ALIGN="left" VALIGN="top"><U>FRACTIONAL SHARES.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No fractional shares shall be issued under the Plan and the person
exercising a Stock Right shall receive from the Company cash in lieu of such fractional shares equal to the Fair Market Value thereof. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">27.</TD>
<TD ALIGN="left" VALIGN="top"><U>CONVERSION OF ISOS INTO <FONT STYLE="white-space:nowrap">NON-QUALIFIED</FONT> OPTIONS; TERMINATION OF ISOS.</U> </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Administrator, at the written request of any Participant, may in its discretion take such actions as may be necessary to convert such
Participant&#146;s ISOs (or any portions thereof) that have not been exercised on the date of conversion into <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Options at any time prior to the expiration of such ISOs, regardless of whether the
Participant is an Employee of the Company or an Affiliate at the time of such conversion.&nbsp;At the time of such conversion, the Administrator (with the consent of the Participant) may impose such conditions on the exercise of the resulting <FONT
STYLE="white-space:nowrap">Non-Qualified</FONT> Options as the Administrator in its discretion may determine, provided that such conditions shall not be inconsistent with this Plan.&nbsp;Nothing in the Plan shall be deemed to give any Participant
the right to have such Participant&#146;s ISOs converted into <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Options, and no such conversion shall occur until and unless the Administrator takes appropriate action.&nbsp;The Administrator, with
the consent of the Participant, may also terminate any portion of any ISO that has not been exercised at the time of such conversion. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">28.</TD>
<TD ALIGN="left" VALIGN="top"><U>WITHHOLDING.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that any federal, state, or local income taxes, employment
taxes, Federal Insurance Contributions Act (&#147;F.I.C.A.&#148;) withholdings or other amounts are required by applicable law or governmental regulation to be withheld from the Participant&#146;s salary, wages or other remuneration in connection
with the exercise or acceptance of a Stock Right or in connection with a Disqualifying Disposition (as defined in Paragraph 29) or upon the lapsing of any forfeiture provision or right of repurchase or for any other reason required by law, the
Company may withhold from the Participant&#146;s compensation, if any, or may require that the Participant advance in cash to the Company, or to any Affiliate of the Company which employs or employed the Participant, the statutory minimum amount of
such withholdings unless a different withholding arrangement, including the use of shares of the Company&#146;s Common Stock or a promissory note, is authorized by the Administrator (and permitted by law).&nbsp;For purposes hereof, the fair market
value of the shares withheld for purposes of payroll withholding shall be determined in the manner set forth under the definition of Fair Market Value provided in Paragraph 1 above, as of the most recent practicable date prior to the date of
exercise.&nbsp;If the Fair Market Value of the shares withheld is less than the amount of payroll withholdings required, the Participant may be required to advance the difference in cash to the Company or the Affiliate employer.&nbsp;The
Administrator in its discretion may condition the exercise of an Option for less than the then Fair Market Value on the Participant&#146;s payment of such additional withholding.</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">29.</TD>
<TD ALIGN="left" VALIGN="top"><U>NOTICE TO COMPANY OF DISQUALIFYING DISPOSITION.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Employee who receives an ISO must
agree to notify the Company in writing immediately after the Employee makes a Disqualifying Disposition of any Shares acquired pursuant to the exercise of an ISO.&nbsp;A Disqualifying Disposition is defined in Section 424(c) of the Code and includes
any disposition (including any sale or gift) of such Shares before the later of (a) two years after the date the Employee was granted the ISO, or (b) one year after the date the Employee acquired Shares by exercising the ISO, except as otherwise
provided in Section 424(c) of the Code.&nbsp;If the Employee has died before such Shares are sold, these holding period requirements do not apply and no Disqualifying Disposition can occur thereafter. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">30.</TD>
<TD ALIGN="left" VALIGN="top"><U>TERMINATION OF THE PLAN.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan will terminate on September 15, 2020, the date which
is ten years from the <U>earlier</U> of the date of its adoption by the Board of Directors and the date of its approval by the shareholders of the Company.&nbsp;The Plan may be terminated at an earlier date by vote of the shareholders or the Board
of Directors of the Company; provided, however, that any such earlier termination shall not affect any Agreements executed prior to the effective date of such termination.&nbsp;Termination of the Plan shall not affect any Stock Rights theretofore
granted. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">31.</TD>
<TD ALIGN="left" VALIGN="top"><U>AMENDMENT OF THE PLAN AND AGREEMENTS.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan may be amended by the shareholders of
the Company.&nbsp;The Plan may also be amended by the Administrator, including, without limitation, to the extent necessary to qualify any or all outstanding Stock Rights granted under the Plan or Stock Rights to be granted under the Plan for
favorable federal income tax treatment as may be afforded incentive stock options under Section 422 of the Code (including deferral of taxation upon exercise), and to the extent necessary to qualify the shares issuable upon exercise or acceptance of
any outstanding Stock Rights granted, or Stock Rights to be granted, under the Plan for listing on any national securities exchange or quotation in any national automated quotation system of securities dealers.&nbsp;Any amendment approved by the
Administrator which the Administrator determines is of a scope that requires shareholder approval shall be subject to obtaining such shareholder approval.&nbsp;Any modification or amendment of the Plan shall not, without the consent of a
Participant, adversely affect his or her rights under a Stock Right previously granted to him or her.&nbsp;With the consent of the Participant affected, the Administrator may amend outstanding Agreements in a manner which may be adverse to the
Participant but which is not inconsistent with the Plan.&nbsp;In the discretion of the Administrator, outstanding Agreements may be amended by the Administrator in a manner which is not adverse to the Participant. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">32.</TD>
<TD ALIGN="left" VALIGN="top"><U>EMPLOYMENT OR OTHER RELATIONSHIP.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nothing in this Plan or any Agreement shall be deemed
to prevent the Company or an Affiliate from terminating the employment, consultancy or director status of a Participant, nor to prevent a Participant from terminating his or her own employment, consultancy or director status or to give any
Participant a right to be retained in employment or other service by the Company or any Affiliate for any period of time. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">33.</TD>
<TD ALIGN="left" VALIGN="top"><U>GOVERNING LAW.</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Plan shall be construed and enforced in accordance with the law of
the State of Delaware. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Arial Narrow"><B><I>MYRIAD GENETICS, INC.</I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Arial Narrow"><B><I>ATTN: CORPORATE SECRETARY</I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Arial Narrow"><B><I>320 WAKARA WAY</I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; font-size:10pt; font-family:Arial Narrow"><B><I>SALT LAKE CITY, UT 84108</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial Narrow"><B>VOTE BY INTERNET <FONT STYLE="white-space:nowrap">-</FONT> <U>www.proxyvote.com</U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial Narrow" ALIGN="justify">Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 P.M. Eastern Time on
November&nbsp;30, 2016. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Arial Narrow" ALIGN="justify"><B>ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial Narrow" ALIGN="justify">If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future notices of
availability of proxy materials or proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted,
indicate that you agree to receive or access proxy materials electronically in future years.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Arial Narrow" ALIGN="justify"><B>VOTE BY PHONE - 1-800-690-6903</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial Narrow" ALIGN="justify">Use
any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. Eastern Time on November&nbsp;30, 2016. Have your proxy card in hand when you call and then follow the instructions.</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Arial Narrow" ALIGN="justify"><B>VOTE BY MAIL</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial Narrow" ALIGN="justify">Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51
Mercedes Way, Edgewood, NY 11717.</P></TD></TR>
</TABLE> <P STYLE="margin-top:30pt; margin-bottom:0pt; font-size:8pt; font-family:Arial Narrow">TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial Narrow" ALIGN="right">E13517-P82620&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;KEEP THIS PORTION FOR YOUR RECORDS </P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px dashed #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial Narrow" ALIGN="right">DETACH AND RETURN THIS PORTION ONLY </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial Narrow" ALIGN="center"><B>THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="width:100%;margin-left:0%; margin-right:0%;border:solid 1.50pt;padding-top:2pt;padding-bottom:3pt">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" COLSPAN="3" ROWSPAN="2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial Narrow"><B>&nbsp;&nbsp;MYRIAD GENETICS, INC.</B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:4pt; margin-bottom:1pt; margin-left:1.00em; font-size:8pt; font-family:Arial Narrow" ALIGN="justify"><B>The Board of Directors recommends that you vote FOR the following:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial Narrow" ALIGN="center"><B>For</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial Narrow" ALIGN="center"><B>All</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial Narrow" ALIGN="center"><B>Withhold</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial Narrow" ALIGN="center"><B>All</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"><FONT STYLE="font-family:Arial Narrow; "><B>For&nbsp;All Except</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD ROWSPAN="2" VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" ROWSPAN="2"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial Narrow; font-size:8pt">To withhold authority to vote for any individual nominee(s), mark &#147;For All Except&#148; and write
the number(s) of the nominee(s) on the line below.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #000000; BORDER-RIGHT:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; font-size:8pt; font-family:Arial Narrow"><B>Vote on Directors</B></P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow" ALIGN="center"><B></B><FONT STYLE="font-family:Times New Roman">&#9744;</FONT></P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow" ALIGN="center"><B></B><FONT STYLE="font-family:Times New Roman">&#9744;</FONT></P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow" ALIGN="center"><B></B><FONT STYLE="font-family:Times New Roman">&#9744;</FONT></P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:8pt; font-family:Arial Narrow">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1.50pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; font-size:8pt; font-family:Arial Narrow">1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial Narrow" ALIGN="justify">Election of two Class II Directors (or if any nominee is not available for election, such substitute as the Board of Directors
may designate) for a three-year term.</P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Arial Narrow"><B>Nominees:</B></P>
<P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Arial Narrow">01)&nbsp;&nbsp;Mark C. Capone</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial Narrow">02)&nbsp;&nbsp;Heiner Dreismann</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="15"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:1.00em; font-size:8pt; font-family:Arial Narrow"><B>Vote on Proposals</B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:1pt; margin-left:1.00em; font-size:8pt; font-family:Arial Narrow"><B>The Board of Directors recommends you vote FOR the following
proposals:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial Narrow" ALIGN="center"><B>For</B></P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial Narrow" ALIGN="center"><B>Against</B></P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial Narrow" ALIGN="center"><B>Abstain</B></P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:2pt; margin-bottom:1pt; margin-left:1.00em; font-size:8pt; font-family:Arial Narrow">2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="13"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:2pt; margin-bottom:1pt; font-size:8pt; font-family:Arial Narrow" ALIGN="justify">To approve a proposed amendment to the
Company&#146;s 2010 Employee, Director and Consultant Equity Incentive Plan.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow" ALIGN="center"><FONT STYLE="font-family:Times New Roman">&#9744;</FONT></P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow" ALIGN="center"><FONT STYLE="font-family:Times New Roman">&#9744;</FONT></P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow" ALIGN="center"><FONT STYLE="font-family:Times New Roman">&#9744;</FONT></P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:2pt; margin-bottom:1pt; margin-left:1.00em; font-size:8pt; font-family:Arial Narrow">3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="13"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:2pt; margin-bottom:1pt; font-size:8pt; font-family:Arial Narrow" ALIGN="justify">To ratify the appointment of Ernst &amp; Young
LLP as the Company&#146;s independent registered public accounting firm for the fiscal year ending June 30, 2017.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow" ALIGN="center"><FONT STYLE="font-family:Times New Roman">&#9744;</FONT></P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow" ALIGN="center"><FONT STYLE="font-family:Times New Roman">&#9744;</FONT></P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow" ALIGN="center"><FONT STYLE="font-family:Times New Roman">&#9744;</FONT></P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:2pt; margin-bottom:1pt; margin-left:1.00em; font-size:8pt; font-family:Arial Narrow">4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="13"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:2pt; margin-bottom:1pt; font-size:8pt; font-family:Arial Narrow">To approve, on an advisory basis, the compensation of the
Company&#146;s named executive officers.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow" ALIGN="center"><FONT STYLE="font-family:Times New Roman">&#9744;</FONT></P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow" ALIGN="center"><FONT STYLE="font-family:Times New Roman">&#9744;</FONT></P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow" ALIGN="center"><FONT STYLE="font-family:Times New Roman">&#9744;</FONT></P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="15"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" COLSPAN="15"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; font-size:8pt; font-family:Arial Narrow" ALIGN="justify">In their discretion, the proxies are authorized to vote upon such other matters as may properly
come before the meeting or any adjournments or postponements thereof. This Proxy, when executed, will be voted in the manner directed herein. If no direction is made, this proxy will be voted in accordance with the Board of Directors&#146;
recommendations.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:1.00em; font-size:8pt; font-family:Arial Narrow"><B>PLEASE MARK, SIGN, DATE AND RETURN
PROMPTLY IN THE ENCLOSED ENVELOPE.</B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:1.00em; font-size:8pt; font-family:Arial Narrow"><B>NOTE:</B> Please sign
exactly as name(s) appear(s) hereon. Joint owners should each</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; font-size:8pt; font-family:Arial Narrow">sign. When signing as attorney, executor, administrator, trustee or guardian,
please</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; font-size:8pt; font-family:Arial Narrow" ALIGN="justify">give full title as such.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial Narrow; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD></TR>


<TR STYLE="font-size:1px; font-family:Arial Narrow; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-size:1px; font-family:Arial Narrow; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Arial Narrow; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial Narrow; font-size:8pt">Signature&nbsp;[PLEASE&nbsp;SIGN&nbsp;WITHIN&nbsp;BOX]</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial Narrow; font-size:8pt">Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial Narrow; font-size:8pt">Signature (Joint Owners)</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial Narrow; font-size:8pt">Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Arial Narrow; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> </div>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:120pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow" ALIGN="center"><B>Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow" ALIGN="center">The Notice and Proxy Statement and Annual Report are available at www.proxyvote.com. </P>
<P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px dashed #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial Narrow" ALIGN="right">E13518-P82620 </P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="92%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="1%"></TD></TR>


<TR STYLE="font-family:ARIAL; font-size:12pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:2.00pt solid #000000; BORDER-TOP:2.00pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000"> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Arial Narrow" ALIGN="center"><B>MYRIAD
GENETICS, INC.</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Arial Narrow" ALIGN="center">320 Wakara Way</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Arial Narrow" ALIGN="center">Salt Lake City, Utah 84108</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Arial Narrow" ALIGN="center"><B>ANNUAL MEETING OF STOCKHOLDERS DECEMBER 1, 2016</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Arial Narrow" ALIGN="center"><B>THIS PROXY IS BEING SOLICITED BY MYRIAD GENETICS, INC.&#146;S</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:12pt; font-family:Arial Narrow" ALIGN="center"><B>BOARD OF DIRECTORS</B></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #000000; BORDER-RIGHT:2.00pt solid #000000; padding-right:8pt">&nbsp;</TD></TR>
<TR STYLE="font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:2.00pt solid #000000; BORDER-BOTTOM:2.00pt solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #000000"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Arial Narrow" ALIGN="justify">The undersigned, revoking any previous proxies relating to these shares, hereby acknowledges receipt of the Notice Regarding
the Availability of Proxy Materials in connection with the 2016 Annual Meeting of Stockholders to be held at 9:00 a.m., MST, on Thursday, December&nbsp;1, 2016, at the offices of Myriad Genetics, Inc., 320 Wakara Way, Salt Lake City, Utah 84108 and
hereby appoints Mark C. Capone and R. Bryan Riggsbee, and each of them (with full power to act alone), the attorneys and proxies of the undersigned, with power of substitution to each, and authorizes each of them to represent the undersigned and to
vote all shares of the Common Stock of MYRIAD GENETICS, INC. registered in the name provided herein which the undersigned is/are entitled to vote at the 2016 Annual Meeting of Stockholders, and at any adjournments or postponements thereof, with all
the powers the undersigned would have if personally present. Without limiting the general authorization hereby given, said proxies are, and each of them is, instructed to vote or act on the proposals set forth in said Proxy as specified by the
undersigned</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow" ALIGN="justify">SEE REVERSE SIDE FOR ALL PROPOSALS. <B>The
proxies will vote in accordance with the Board of Directors&#146; recommendations where a choice is not specified and in their discretion on any other matters as may properly come before the meeting or any adjournments or postponements thereof.
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow" ALIGN="center"><B>Continued and to be signed on reverse side</B></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:2.00pt solid #000000; BORDER-BOTTOM:2.00pt solid #000000; padding-right:8pt">&nbsp;</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g257749g00t28.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g257749g00t28.jpg
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M 0$! ?_  !$( 1T"0 ,!$0 "$0$#$0'_Q  ?  $  04! 0$! 0
M"04&!P@* @,$ 0O_Q !*$   !P " 00! 00%"08$! <! @,$!08'  @2"1$3
M%!46%R$B(S$R-W*Q"AA7=7>6M+;5)"4F,T%1&2@X4B<V0G$T-4-&8661_\0
M& $! 0$! 0                $" P3_Q  U$0 " 0($!0,# P0" P$!
M 1$A,0)!46$2<8&1\*&QP2+1X3)"\0-28G*"LA.2PJ(C_]H # ,!  (1 Q$
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M*3^H7^Z7_ .0IZX X X X X X X X X X X X X X X X X X X X X X X
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M]B_M)S;_ %?>_P#@H/@CNN?PS)'!1P!P!P!P!P"+[U3F5B=9QU\-^D>SNF9
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MD_8R*3^H7^Z7_ .0IZX X X X X X X X X X X X X X X X X X X X X
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MX,HU;H,YY:TPD+NXJ^-:.M+31[[WG$SN"K1@/78 X& X'A8HP' X*@8#,4!
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MY9E.577->YAV?)^QD4G]0O\ =+_@'(4]< < < < < < < < MFZB(4VVB41
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M1 0CG(^X"4Z9@$/Z?<JB9@_I Y1_B #AO'Q.BY*8WL1070"J<#''^<+@53*
M;Y#CX&=+D6^0R@J^#TRIG(.GH2HU._6O\\X=*Q=I^U!$_P !A+XG%3R$@C[_
M +U$URG YQ X#\972AU!.)OD^-V4PG.X=B]";_$^/KOFVRHO!#XHWW__ *D>
MN!BG]A]B?D90"** <JGR?+]MTDJ)@4()&KU-5-4B\@C*A,*<W>KF[Z9<YVH=
MP=<$1KT"(^_N,-%B/N(B/O\ 10]_<3&.81]_Z1,<XC_ZF,/[Q&2L\ < < <
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M+/>+97WJV2(.E$_CBOXR?PQPCY"8#>Y!DW0(%$3')[ 0S590?<2%4!==114
M%XO'C$3$Z9SK'S&MYR9C/0\^I.J4J<I-[A6<_6I9)9-PR<CXJMUTP*5!\Q=^
MR;EA*ME2?99OT!0=-%C*F*+<OVP8@F\.+Z>GI>:N=%>L$N77GM-V=](>OXOF
M_?&;L.^>GCH];HB.'=WFD9(2EPZX.;1#1KB(R#LU'-DG,DXJ<8H[3BJEH!4E
M5B,D6Z* .VASU'/16EBLDL6>&R>^'[=CI?KUA@+; PUIJLW$V6LV.+8S=?L4
M!(LYB#G(:4;)O(V6B)6/6<,9*-D&:R+ID^9KK-G3=5-9!4Z9RF$<RL< < <
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MY"OE>0TW5+#9T&8Z85PIXW&F%/76-E7F0M0<!%5. K]6@VA(Z%KL='P42S3
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MK0XK><NTO!+#"9 _9S#^-UM*OZY5:A+RN;OVU?FOCMD4T>QS5W&.HR3.PE2
MR$.%TW<*&G72C>J[E=Z]]U<&[,V";J&=/[_#W&$JT)H!:?K&0ZEBEIL&9V=T
MX8UO3ZA ZM4JC)6S/IE\U78H6:!;OF3)_P# PE_QKQXR0< TU?W3]K=3-6Q?
MV1:G_LXO'_+,IRJZYKW,NSY/V,BD_J%_NE_P#D*>N . . . . . . :%^H_W
M@KO0?K)9=?6BC7/4+#(Q^:]?,I9IN'4SK&XW(56-&I\=',A_(O&@/ 4FK#]
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M^2!0 QAQQ.<3:LVWW9NEP0< QO8O[2<V_P!7WO\ X*#X([KG\,R1P4< < <
M< < B\]5"PN:_FO7XMB>=@ P:P=EJ]7.RT%U>A=BDMFM64O<NUEY'PT9(X7'
M.]#KU+3TV.S^6TY]!R58D9.AQLW6HB>7FYR-J]F&L-9M:DM)>K2Y&C/73M;U
MIZX]K92LX@W[_P 9U)LV+E+,5W3^N'J-ZM5"]A7%]@DJJ_RP-:RVZZ#0FJ-&
M-=$=5!\YK-#EGCO/WL*V?R,;8WK05IM2WAG;%@3B]:UVSOL9F]35QM%HTK#G
M,[T@H.T]>L"W6%MIG>Y=C^M]'QG<'%^R2RYJSBGE+U>5*I&7BDW31@<YT-EA
M)E.6L]7,WBX]L:RQ-CA!,-)^J)44F;SERU-E^C+ZMKWW7(:&Z!8ATXFZ:UAH
M"Z2.5W[J_;K"YFG8(33.CWB)P4 L-8=I1#MI9F+2Y)-DG3-VW=LD3 LFJ81S
MK/?Y)+."#@'+KV'E8_&>RWJTSNK]X+MU7T:PGSC8.JN;Q+O-(UGV$9H]7:%0
MZT1C3+Y2K+,=F8T=*H[[(W>+UT[QM'R)Y\#0Z,QH4=,D'156!<,Q*?=N]E1W
M?P;M]W](>:YZ=%[SA[$MO\XK),UZ*=A^SG7NFP\BZFZ-1VFPYCJ^DUYO76K9
MPHYC5ZEE>M1<9!1ZD@[>M*XZBCH'^=,JPSA55HY2>\1\KD:/>H/=:AW/TC<-
M6ZD6*&[$YCB?0*FH[1:,9?-M"KDZ#GO+UN[!DRQ&2K*DBPL%V;87B>US#ZC-
M%G4_&1MM9-'T:W6M#5NZ&E2F)1+I-,FK.REKZHHTZT/OZAEOJO>FZ[I>.F5C
MA>QE,RGTR+Y&:W/XU(M;W"6->Z]F>NVO5O% D(!1XPD] E,NQ?894:#\Q[,P
M:33-B^B6JEJ;(NP5$DZ3CPM2HHI3<]5V) */M^/]N_4RZ\:=U9T2I:W0L;Z4
M]A&^S:%G,NSL58BE=VT7KJ^QS+[-,1*B[:+O"_[,[]<#T28.UL5?8PZ[N6BX
MX[QJ5P]_O_!(C"Y4-O#$THEBE\JKQ$C^]-;<MF.B*0,Y6XV+3SFZ_E&<O59.
M;?O"A7Y(R@,))E<:^WC3&;^21#.(J5!-82KF*H0HMC:PQ*YK/\'+%,/D\OR9
MH)_4+_=+_@',FCUP!P!P!P!P!P#\4E)1T-'2$Q,/V<5$Q+)U)2DI(ND64?&Q
MS%!1T]?OWKDZ3=HS9MDE7#ITX431;H)G55.1,AC !SR=-XR1]6+O/+>I=?&#
MP_3;JE,6G)/3HILRU63CK]=F3W\7J':UW%O2$*J9Q),"PU#76; HS781P'1C
M+/G2SJ1'3%]"X?W.'BVTP^LOH= %W1%Q2[<W! 7(KU>?1!L#0S\7 JQ3L@(
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MT*JT,@:%#Y$A3AS1!(=?YVM:)0G:>!B)RZOGMU26RF5:C_3%3=F.@G&&%0B
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MX$I17<* 9940 5#F$ X!8VQ?V1:G_LXO'_+,IRJZYKW([/D_8R*3^H7^Z7_
M.0IZX X X X X X! 5ZIVIWWM_MN?>C7UHL;Z$L6RP[?0N].I5\X**X9U(:N
MFII.M&<I@HDUNNQBLU@V$4Z$OS0DG%1TNS/7;^:38#IA7"N-Y.,*UQ1?DK\R
M;3*,LH6'YG1,?RZN,:CG>:U:&IM.KD<02M8J!@F23!@W\SB99TX,DD"SY^Z4
M6>R+U5P_?+KO'*ZQQS=:N[*S=T?L4NWMQ0*Z!>KSZ(MC-"/RN/EB79/@,Q/
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M!C&-0_6O-DLG!D< < M^VD!6JV9,2%4!2OS1!3,D1<J@'C7)1(9%2.F"+%.
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MBRMXW])CIQ+1;JOK2ZSA=[X1P\2H%\Q.4%"@*OD &]B$5$#>1 1*'RB@5(?
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M?DFZ96#-XZ1</#*.#%0(#=-03+&*D7W.(%Y<*JN:.>)J'7)F:"?U"_W2_P"
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MQ;HJ (BL7R#KY2U:DA7II!_\Y6*" C[?@=)#Q+Y' I@H]O%4XF\1 A%@.@F
MB(%,#-%0YBJ.4BK#7[57*SYY>N<QL=4G!@< < < YA/5F 2]LS";R$I\_I0E
M#V4'^'Y9$GDF4Y"D4^-0AEC%(91,IT2?Q@NH9(!5[T]41P. 'XHGV$?8&)R@
M!?<_@H$G[G.7V 1_F>;9-,A?(5C,FX^WRNT$UQJ'"A^\7RA?FRA.$4H@"*2@
M H!1 QA^4##X![_7^,2G+Y?)\(&22+[>0&%!N5(5/G;?8$AO.D7<QRG[4.DS
MT<_;_-EN_L7P#]N-@]B?N]RA^SO+_8H@ B  4/X2^P^QB 50!$#@81ET)8^
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MFA@V<8Q6:I==+]9=76;ZG5+P8' ' ' .8'U9D1_SM3C\!R"M0*69,_U#D*X
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M4XY%G:UY52ZU]@SK=V/K-2I_?0.D>?C)J(O3Z.GGTHUB+]0(!0BP+%4O%Z=
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ME3 _B89DCE-T$B4%C@YGB21Y58RCJ['L9B[J-Z+1YNKNJ7ILDYTU^YQ 0;%
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M=@5?V'J]A?2YCZ]*>?F=UM677WMGKZVK&/2/XU6340-\<:+#^6X** PWX?\
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MNXE%9M277EYMW:59-2X2&A[K(6%WV(UP8Q7\\\RLI(^#)C>Q?VDYM_J^]_\
M!0?!'=<_AF2."C@#@#@#@#@$,7?EAVYPF]Q?8BF>H;0L0Z_3&U4YY+Y5IO7"
M[[;/1S]?";9F#//LF@,QT>"N&U-[Y?$*U=FV%1=9AY]*Y.I[36E\>,*>-$L
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M0 3%W2 $H>P@81&@:04?$X%'Q I1,H</D3^1,ADP\CF)["K/S-'.8]2*HE&
M("IY1:K8Q#F,M_(+(3*2:9BJ%> JBJ68DFQVOUUVYTWLJS&)41LDG Z0-X=N
M=]=*632_.=*,D15!WYG.8JHOA455,JY%7[0O!7.H)CR!W0*FEGJ;KY3R9Y,9
M*5%96PDL\C^TP51R:F/1*N<4ITJG+E!])4A3]K14.0PJ#F=P6]U3BX.107D,
M<QS*'!\!E?=^X4,Z*N54RS]^X"4.,V]=748Q?/POYZZ0WTY\&1P!P!P#E!]3
ME,JW<_9RJ?N(9EGZ(B<3+ *9LGJB D^,/M@+?XY-XW49"W4*JC(R3/\ &+(6
M*0A-#'3#;).'7MOEG*TR-#52%4!$3E,<ZJP&,114ZYCBND\!8JAS*/2+B8LF
M[5<&4,^^Z+Z4\E)0]D?&T(&DHLYTS5'KMO,K6M0?I$63CP. K@M%K-5"K"=W
M\B!Y"P)?&J5<LP#M%X6U3K9=J=O+-W:<[8&B\3,)7NPP/8(6J_2EDE1VBK[J
M\_!T^^E*<Q^H4$)EE%_*^Z&X%11=9P<RCZ?4D'*IU%Y&3.JLZ=NW#UV],Y<J
MRSURYF74S<'LBYO-G'/%,U4/SS\$D?!#&]B_M)S;_5][_P""@^".ZY_#,D<%
M' ' ' ' ' -1.W&#:-L#'%[QBMLIE4VWKAKO[9,Q'3(.5L>8V61?YKHN0V:H
MWJ/@GT?/,8V<HNI6=.,M%?55FZI8D8>::LI5JW?0\B*G$RI34/6Z<K>A8&!X
M9V9D.P<AVB[:3N&LKO$X[)X3F^;]>$;O(U&#J-FN=;OMSLMPO>B,X.PW"S3<
MW3:HS@HUK4ZY"4V)C94&YYM_9Y!VW!Q93$W?I16N\V:M=[H[M1IG8[$HB@]7
M^K&J5SK?>WF[U)AM/;B-K;G4J=)9'/Y=>Y6>PY[@5J<5 :3.Z4\;U/1T[/:6
M4%,PT9).XX4[.M!M!5"3KBET<*U94/B4VS7L9YZ#[L[W=YH$S'8=TRS^K5\C
M:#6NG4SMM0.SGW[0FZ,=W4+<6AXOFB%76CVH??3)(3$DY45$4ABV_M]C@8LJ
MXG_LH[5=R2;@R. . . . . . 8XV+^R+4_\ 9Q>/^693E5US7N1V?)^QD4G]
M0O\ =+_@'(4]< Y*?4/]D^YVXBEXE$)BKG,=/Q\3N!HM37%;S1*F<3D%&/14
M_?\ 836C?_.%RA%+,AI8H45[\_OKZPUI( @5JB!0 @ " H_T%%$"*-_J^P)@
M0#%:BV8?^6"8"+)/X2I>$/\ 0#BRK'/32FMJ?'#]3CXJI"4/$R95/']_L($(
M"7L7V3 OB!3-&1A,D)!(#("H 0I(SZ@<6=:;ZS?MMM1)+IO])< #K'-![E$P
M:G+E,)1()@ E&STB*:HE(4WFBV*B@!5!.5-))--K\3 C1L@&++DG_/4D]X,C
M@#@%LW7W_1MM\1$!_3,]["7R 0'\4[]A 2"4X#[_ -'@8IO?^J(#[#P#AX,0
MQOK@)@,<RA/8X?N\C'('F)"_O PJD='*F'O^X5T#@/N/!KA=+5\\Z9-3477[
MTHL!#W$T><QC%]C <B\D]!-,HF#^'X_G<G*3]Y#D?MS" $56*<7],9TR>NG3
MXT*5Y>2*QC%\BG.X]R>_L(@(F!0"'$!,;YC.%3E\A]P*Y2*83 *WF,N6Y\\]
MJ':M@ F'",4$YO,XY)FXG.'E[',-.AO(P>0F-_$/N/\ $8QOW_O$1_?P1W9E
MO@#@#@$;'JN (]2)3V\O;]>TDIP+Y>PD4=/$C%-["!1 WGXE!4#I&4$A3D'W
M#V Y=O(#(K"</,JAG'DGY" F PG^7Q./N8PK&76. F_?XN4P.)P%?Y19>K\\
M]^OHQ1'X $0,<RA/8X%#^,QR>Y_ O] BJ1TH4@"/\(.$#^_EY^05[^MOP2$^
MFI_%W,Q01 !$(+1U/,/$P"!Z1>C)$]S!Y$^(5G2H%+["*;]$X"4%7!3B_MS5
M)V==.JJ=4O!D< < < Y@?5E #]M50   PT"E% 2^'D(^,J40]BD 3J&2<'2
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MPC_G6@!S <QLQN B8?;^(_V8!43D P&$!$SA8_[A X$6 ?(14="L,R=.? '
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M[;[-.11RSL"_<5QY'3,6H6=BG<,2AD%55L^C75O:NFJ18>\B9HBU752092S
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M4 \!3,Z8F3$OM["0S)H8@AXBU;B'Q$0]'V9RE:KNBL_MER#_ $K9M_OS5_\
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M<[#C@=AJY7NO6;O+O98C#1<-V'[2K?$RTA6#UV-5EUU8!A6W*JE]FK%&SD%
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M-7K;Z8CVD]9&]=2:.+ X@(=PX3D)A&"0D&"TRK'-W"<8D^:*/3($<HF.!7N
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MM,E<6L[H[%K$017HRTJMI2\6)5XJ1%HYY]C.^+ZWW7[D[-1<TG^SDMU02_\
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CEXH\FI!LO-2JKN:D9*0> VW5N3-_!!P!P!P!P!P!P!P#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g257749g09i36.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g257749g09i36.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[0]"4&AO=&]S:&]P(#,N,  X0DE-! 0
M      \< 5H  QLE1QP"   "    .$))300E       0S<_Z?:C'O@D%<':N
MKP7#3CA"24T$.@     !'0   !     !       +<')I;G1/=71P=70    %
M     %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT    /
M<')I;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4    '0!<
M %P ,0 Y #( +@ Q #8 .  N #$ -  Q "X ,0 T %P 4 !( $T 00!% $<
M4 !2 $X ,@ S       /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\
M;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $     0FQT;F5N
M=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT
M   0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O
M;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP
M $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B
M;V]L      !);G1R8F]O;       0F-K9T]B:F,    !        4D="0P
M  ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0%DG.T
M   *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',     4&=0
M0P    !,969T56YT1B-2;'0               !4;W @56YT1B-2;'0
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M3009       $    'CA"24T#\P      "0           0 X0DE-)Q
M  H  0         !.$))30/T       2 #4    ! "T    &       !.$))
M30/W       <  #_____________________________ ^@  #A"24T$"
M    $     $   )    "0      X0DE-!!X       0     .$))300:
M  ,U    !@              +0   %@          0
M       !              !8    +0                     !
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M;&]N9P   "T     4F=H=&QO;F<   !8     W5R;%1%6%0    !
M;G5L;%1%6%0    !        37-G951%6%0    !       &86QT5&%G5$58
M5     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$58
M5     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@
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M       ! 0 X0DE-!!0       0    ).$))300,      5N     0   %@
M   M   !"   +F@   52 !@  ?_8_^T #$%D;V)E7T--  '_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1"  M %@# 2(  A$! Q$!_]T !  &_\0!/P   04! 0$! 0$
M         P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)
M"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$
M @(! @0$ P0%!@<'!@4U 0 "$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H # ,!  (1
M Q$ /P#T?/S*>E8+?2J'M#:L;'8 T$QMJJ8UOM:U9&;1U3#QZ^JWYCS;78U]
MM#2146..PTBO^3N_G%>OR,7)Z[3@;@Z[%K.2]O@?YJK_ ,^O>B_6%C7]'R0>
MS9'R,I*;WJ 5^HXPT"25G'ZQ]*;<*G6D2[8+(.S=,?SGT53PZG=>K9==8X=/
MK#6LJ'M%I ]UKW?Z/\U0^M]^%A=(;A-#:W7O974QHXAS7N>&_P!5B2GHQJ)2
M6/T;K].;CVV9!9COJM>PUN< YK6GV[VG]YJLV]=Z77H;PX]@P%T_Y@<DIT$E
MFU=?Z;9<*2\UO=&T/:6@S_*^@M))3$A).4H\4E+))))*?__0[NCIEE'7\[K-
M[V^A=5575V+6L$OW?]<5'ZV=;K_95F-C2^S)]@< 8#9:+':^W\]:.6X9/6*.
MFV?S-=1R2/WG!PJK;_9^DY5NK]*R<SJV!776&8-+7.M?QP6.]-H_E;&I*=#I
M[;J,2K'KI#&UL :)&FBHGH)NZP[JV6#?8T!N-2YP+*FQ[]@_.?99[]ZW0( '
M@DDIS+^GX5EILNP6OL<9<\!LD^+D>NRC'T;C.K\=K6_]\5U))3E]2LP,O#LQ
MLEKVLM')8="/HN!CZ37*O]6>J')Q#BY%@?EXKC59V+MGT;(_ELVK;(!$%<Q=
MTNB[ZQYF-] Y5->0RQAVN8]A-.]A;^<DIZ'(S<;'$W6!A/ )U5=O5L=YBMEM
MGFUA(4>G]$QL-LO+LJX@!UUYWN,?]%-U@=5%=/[+K8]XL!L]0[1L"2EKNN8>
M. [(9;362&^H^LA@+OH@N20!T&S-<RWJUWK!A#FXS!MJ!:?9N_.M224__]'T
M?J/2V9H:]MCJ,BL[J[F0"#'T7?OU?O,55N=U/IXV]1K&16/^U%()('_#5_\
MD%KA(QW24U\7J.'EM#J;&NGM.O\ F_25C19.;^P]Y]7;ZO\ P<[I_P"M_P#?
MD"L$Q]F=FADZ;F@C_IN:DIW4ZRPWJ<:66QVFNK_TJA7#('\^_)([^FUH'_0>
MY)3J7Y-&/6;+GAC1R2LKI;;,[JUW5G,-=3:_L^."(+FAV]]CO[:6+^R/5&_?
MZLZ?:)_[]^C6PS;M&SZ/:$E+E*0F*22EY23))*?_V3A"24T$(0      50
M  $!    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <    !, 00!D
M &\ 8@!E "  4 !H &\ = !O ', : !O '  ( !# %, -@    $ .$))300B
M      $N34T *@    @ !P$2  ,    !  $   $:  4    !    8@$;  4
M   !    :@$H  ,    !  (   $Q  (    >    <@$R  (    4    D(=I
M  0    !    I    -  #UHR   G$  /6C(  "<0061O8F4@4&AO=&]S:&]P
M($-3-B H5VEN9&]W<RD ,C Q-3HQ,#HQ,R P.3HQ.3HS,P   Z !  ,    !
M__\  * "  0    !    6* #  0    !    +0         & 0,  P    $
M!@   1H !0    $   $> 1L !0    $   $F 2@  P    $  @   @$ !
M  $   $N @( !     $              $@    !    2     $X0DE- _T
M      @          /_A 3!-30 J    "  ' 1(  P    $      1H !0
M  $   !B 1L !0    $   !J 2@  P    $  @   3$  @   !X   !R 3(
M @   !0   "0AVD !     $   "D    T    \     !   #P     %!9&]B
M92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*0 R,#$U.C$P.C$S(# Y.C$Y.C,S
M   #H $  P    '__P  H ( !     $   !8H , !     $    M
M  8! P #     0 &   !&@ %     0   1X!&P %     0   28!*  #
M 0 "   " 0 $     0   2X" @ $     0             #P     $   /
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( "L
M5 ,!$0 "$0$#$0'_Q  >   !! (# 0             (! 8'"0(%  $#"O_$
M #D0  $$ @$# P($ P0+      ,! @0%!@<1  @2$R$Q%"(5(U%A,D&!"187
M<3-"0W*1H;'!T?#Q_\0 % $!                     /_$ !01 0
M              #_V@ , P$  A$#$0 _ /LK[J][9;A9L/T_J&$&QW+MF9(K
M,=+)17P<4I(S1MO<VL1M$7UHV/B.P[8BHBR3> _A>@$V#ANU.USN8T&2^WOL
M3:-7NR/>X9F>.YCD,ZQI197"A.NH^3XU6&YC8U'*OJP6U,'R%XH-JJC&\M"Q
MC;.Y\$TOC[\CS[)H=-$5Y!1(I9(OQ">=L8T@<6%$1_KR9!E X(V#8[DJIY*U
M%YZ"&M+][&IMS; +K"I;E>.9M^$$OH%%F6.6-$>XI@J/U[&K)+"P4H(6%$\W
M@17L:]JN;[] 9G08M:C?9/X?E$_3_+]$_;]>@RZ!,>.IO?S5%3X14Y3_ +?^
MK[]!JGL<-RM=\IT&/0<Z !]';5UUOKO-[CVT());KMB'1Z>G29,9P6MR?)?5
MO\U]!Y/-7C%'H\7CQ7"5GD)TXJHHY8T:#(_M-<UI=45^@=L3QRG3,)VO6K";
M"'ZLN;)N0/K(5;"%PY32)\PS(ZL^&#>I'<M14Z"2M"=L,;)+6!W&=P8K#+=M
M9'#6XBXYE3A3,<U;%GE;.B4&,5*HL2.:OC.'&F3S-+(.=I7M<P:HWH*J.]?O
M8G4O?#(L^WG$Y>?Y'VNZFRB'FTVKK2VE'CLO-Y5/&M0WYJ]".CDQVC@%FA@-
M?ZZG.UB"8HWHH6]XQW]]M]EB5!9NV/76UQ/I8<Q]5319\VR)(<"/ZP5@CC*>
M,?Z@R!0,EHU]14:KD^>@[E][U(=ACXOI;>F20(X'R#6C, GUU:\0VJY[H,F2
M]Z3UX1?!!,;YKPB?/02GI#N<UWO&1;4M(V]QK,L?#&D7V"9O5OQS,:N/+:Q8
M\P]+)(\[Z\[W.9&G#5X3>"JGC\= 1O0(BQG%*KU5$;PB?O[?^?\ ET"21Z**
MUHO?A/N=S\_M^_\ GT"?H*[=1ZFP7L5RKN>V7F&?%RO)NZWN"S#<=?2#KGFO
MHL2Y;#BU.+559&/)FV$3&:V,*(2R1 1!A,)2# GLX -[N-R[*[B>\_M-T54X
M#,J,7Q;-TSS(8N7L#"!:2VT4FQI&VD*&ET9M=$B-&9DDHHZMG/8K1(YB.<%U
MCJ;;UOC9ZXTG#ZJ21%BH%8US(&E>Z(^(4'JLD!\RJKD,(_VM&YJ-4#E3GH!O
M[7^QS&>TC"[#$=:5./64G(#2+/.,MRX\Z_S#8>03%DDGWF87LF#ZME.F%DJU
MS5:.*(#6B8'G\Q F2LP2RH[ \^%I'6()C1$0MC52FUI98_M(4:B#0G>=Q'C1
M6C<1WD[Q:B+\] [ YOGH49")IFQ=&;PSU*>ZK$CM&J?[,-F&H(U4]^%14_HO
MMT%4O>_LJ1J':VH>[V!KC:.N9NN[^OPW;M@>G$M+D.J<HFI!(EC+K#3!34H;
M%T:TCHK3/\/4BB>#U?6Z"TC'>Z31]]A+L\!LK#V8_$C-)9FEWD"%.K)#FC\(
M%E6',DNOL2/*$(X$IC9))$F-'$PI9 4(# %W;5^5ND_X::QV9L.&'Q5EI5T;
MZ:D*Q[D:TBV5Y]&U!KSY-*T1!O:J*UR\] LM-X[.KX+YPNW^T*-J#55E[-U[
M6"&CG.&_ZJ5)GK&A^!D:-%D$8U5=Y$<%K57H-=VT]VN&]SV"7&<X?CF0U ,<
MSG)==7M=;.A')$R?$G0V7(8=A5%FUEM7L)-$V+9P))8LI$>HU^U>@C/!\AK<
M@[Y-TU^T_H8,K#\<U_7Z(C79@!9:T=M M)N=W./"F#:Z3*_'FPJ.S2*4C QX
M<?R$GU(WL#+ NSS(P=[^S>Z7/L@@W%--J:VEU=CL)A$2CC,AH*QF6!? 2K+5
MWY,=B>3&"5S?NYYZ"Q=5X15X5>/Y)[K_ $Z#R:9J_*.9_O)QT'HCVK\.3_CT
M&70"KWN8=4Y]VG;^QJV&A8\G5^631\,\R,DT]5(MXA&+QY,5DF$)?4:J*Q.7
M(O"+T E=K79UV\[HUYH'N=SO75)<;*M=4XG(D2O3+%JI4H]37F=-M*.&0%+=
MV0I,<1F65K!FG0@8YAN:<#3*%I<B K*LL&L0$(C(3HL%4$UH(RL#Z4?\D:-;
MZ(N&_E,1K?%/%O'05CX-V$[8NUNJKN/[C<FV)A4Z^O[2-AV'M7#(!X-K.65#
MJ;J> 2V4^OAA(:.^$PPA%:]BJ_R&Q>@L#UYJ'7&J,4K<(UYB--B>+5+7)!IJ
M>(./%$Y_CZIGKPXLF296HX\N40TD[D12E>J)P$;[U[6=6;\C0).3ULBNRZ@9
M(_NIG%),DUV2XR24<4F1^&SHQ1O:"2< 7R8Y/,1O31%:B<\@/*-[NNW(/T%?
M'+W(:^@F&V/(L[&NIMDP8OLC_6D/$D"_8Q.$$QRBE^"?<YSON4)EQ+O)T_</
M;6Y9/M=;Y$QB?4T^<TUA1$0G^L@3F$2*1J+\+]0G*?<GMT! U.P,'OD$M/E>
M/VOJL81C:^V@S5\7_P *K]*<R)S\?/0.4\Z#%8\LB0$(A,<0A2.1HQ#&BN>0
MA%^P8V-17/(YR,:U%<Y41%7H(TR/>>H\3:5;W8&,PW!:KGB2TCR"HG"+_HHS
MRDY7E/;QY_;H LWULG8G<OC\_3G;]03DQG-'-Q[,=LV(GUM1 Q2<UP;^-0AG
M@%(L;"5$<Z'YA0:##((5CN6] >&L\&J-7Z\PW7U()L>GPW&ZG'H V\^+(U7"
M#$'QRJJO*"Y]U555?E57H'1]8Y'N]D5BJOBGPJ?_ 'Y_KT'HLYG'LQW/Z*J?
M]>@3.EF5>45&I^B)T&WZ#I41R<.1%1?E%1%1?Z+T#/R+"\2R$"1;[&Z:XB^[
MOI+*OC38JN5>%<Z-(&0#G<*J>3AJO'MST$-2.V/0Y7E<W7%/%4HF ?\ ATJX
MJT40^%8UJ5ME%1G"HGW,1KE_FJ] F9VNZ,&J*W"2(B<?:N5YHYB^_/BX;LC5
MCVK\.8]KF.151R*BJG0/*CT3IVJ(A(>N<50Z$$1LJ36"GS!D%]PB#F3_ *F4
M(@W(BL(,S7M5$5'<IT$QQ8,."-!0XH(HT]T8 3!,1>./9K$1$]DX]N@ZF*J"
1X1>$5R(O[]!JN@YT'.@__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g257749g42x55.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g257749g42x55.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[1,64&AO=&]S:&]P(#,N,  X0DE-! 0
M      \< 5H  QLE1QP"   "    .$))300E       0S<_Z?:C'O@D%<':N
MKP7#3CA"24T$.@     !'0   !     !       +<')I;G1/=71P=70    %
M     %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT    /
M<')I;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4    '0!<
M %P ,0 Y #( +@ Q #8 .  N #$ -  Q "X ,0 T %P 4 !( $T 00!% $<
M4 !2 $X ,@ S       /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\
M;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $     0FQT;F5N
M=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT
M   0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O
M;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP
M $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B
M;V]L      !);G1R8F]O;       0F-K9T]B:F,    !        4D="0P
M  ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0%@
M   *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',     4&=0
M0P    !,969T56YT1B-2;'0               !4;W @56YT1B-2;'0
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M3009       $    'CA"24T#\P      "0           0 X0DE-)Q
M  H  0         !.$))30/T       2 #4    ! "T    &       !.$))
M30/W       <  #_____________________________ ^@  #A"24T$"
M    $     $   )    "0      X0DE-!!X       0     .$))300:
M  ,U    !@              *    /P          0
M       !              #\    *                      !
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M;&]N9P   "@     4F=H=&QO;F<   #\     W5R;%1%6%0    !
M;G5L;%1%6%0    !        37-G951%6%0    !       &86QT5&%G5$58
M5     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$58
M5     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@
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M       ! 0 X0DE-!!0       0    *.$))300,      E"     0   *
M   9   !X   +N    DF !@  ?_8_^T #$%D;V)E7T--  '_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1"  9 * # 2(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$
M         P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)
M"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$
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M1KV_UF)*<?H?U@R^I]9ZEBVTMKPJ#_D^UNKK&U678&8^YP>]G],Q7_9_YO\
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MS=% D7N?Y,JM>?NKK<M1))3_ /_9.$))300A      !5     0$    / $$
M9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P    $P!! &0 ;P!B &4 ( !0
M &@ ;P!T &\ <P!H &\ <  @ $, 4P V     0 X0DE-!"(      2Y-30 J
M    "  ' 1(  P    $  0   1H !0    $   !B 1L !0    $   !J 2@
M P    $  @   3$  @   !X   !R 3(  @   !0   "0AVD !     $   "D
M    T  .I@   "<0  ZF    )Q!!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD
M;W=S*0 R,#$U.C$P.C$S(# Y.C,T.C4T   #H $  P    '__P  H ( !
M  $   #\H , !     $    H          8! P #     0 &   !&@ %
M 0   1X!&P %     0   28!*  #     0 "   " 0 $     0   2X" @ $
M     0              2     $   !(     3A"24T#_0      "
M    _^$!,$U- "H    (  <!$@ #     0     !&@ %     0   &(!&P %
M     0   &H!*  #     0 "   !,0 "    '@   '(!,@ "    %    )"'
M:0 $     0   *0   #0   #P     $   /      4%D;V)E(%!H;W1O<VAO
M<"!#4S8@*%=I;F1O=W,I #(P,34Z,3 Z,3,@,#DZ,S0Z-30   .@ 0 #
M ?__  "@ @ $     0   /R@ P $     0   "@         !@$#  ,    !
M  8   $:  4    !   !'@$;  4    !   !)@$H  ,    !  (   (!  0
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M.(BI7EX&EC]XRHY$)##V;$@N=DJ(B5/W.K!H)39:X<$-#TOF$3K^+GYQ.Y.
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D(EA# U^XG4CI>AW?]N]4R[R\#-H4Y8CT$VBB4@(+.W#9A__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g257749g44q86.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g257749g44q86.jpg
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M0TE381E(4E1Q<R@I-#8X.4165WBV)S<Z1D=CD6)R=X&W_\0 & $! 0$! 0
M              $" P3_Q  ^$0 ! P," P8% P,"!04! 0 ! !$A C%!4? 2
M87$#(H&1H;$R0L'1X5)B\1-RDF/B(S-3@L)#DZ*RTG/R_]H # ,!  (1 Q$
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MM_-Z^F,EJ@@54DV!6@&-^-;N.T[AP  ZI\^GU3?]>Z?[02E3=07J-"=Q:O\
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M(5Y2(HDZ%S'J[2%5N2!I3L7MK"P@"1$S9ET,AF(>9#OP*V6KQD#K58Y8M>.
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M<:ZZO2#_ .)>O,:ZZKK*>F,<*L=#Y%14)J3K0R]^TKFLJ,:?1YJ4C'+:$PN
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MGY,AVQFGD[R\$G$26<7VZIWU<W7:?0>SJ0,3%F>L@4VR7,DHL3BPSM!&R*=
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M=;@X6!G0K,C.Y9-E7CM$$+>*-71EVV9(.'R[(9HZ=IL6SIYNAALV753+1IJ
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M0P+B1#-%1(<$>!8*(6D#79_J[UE2"F6.\CN<,4.6,0ESEC@V*L0*6[)%WO\
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MF6N(S:6!+ %AAP//5EM%X64X1.$6B6DO_P 0OW9_^0&@/_K4?PM_^F/[S_\
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M- U Z@T[<LSRU)P@*;8#HQ&<C7)-LR4<R^J(P/#5S5;>1L9_(\HU00Q('RF
M)?B$8.FCR2,P/TY'I@^E)$/7D1(:OI%W)L"4XK.*6E830XE/ZNC,CBHM<7,I
M*RCNX-4V'QO*]6TH3B<T(@(K2P;$=L#1^^X069R& N0&+EI%FN\7<PRFQ+!'
M9PKO(&ID>8$ D42V]P=7JCA3HD;["T.S3):&IT7*'9,=W":M<BEY!]/%)O\
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MS*,)2UZ/<K)Q"TK8=K12/O:[K'U&N@&=ZBF@V>*V6!<993\JYA <YF:R#4K
MP:4HC,N9V!/U#95@BLY0DY&U NYZXN)-@\8:&4*[=NE4W[>+'K=*["D38*I\
MNV*C)/>D%/S+)6$B_9#CYC,?15W).21N.1MT9B.?G=EKFRF^=5'!0G7A&HYD
MAICU#DLRYNP[PCLNE'XY<!-!ZD<-5:H[]ZKLM0T7S9+N>N%VC(,[T>I"M [U
MZ<.QUVE#8YF/63N98.L867$-_9.IIP_]T-G.!>R_10_#.]S'%_=,'] R5E*A
M)KK45W:53I-W>29R2=7I5(Y:-J<BC),!(R/F>L#D$.GU.DCD< #0;7> C&/P
M0M[LL)9EY>UI:IW!>[:P^K3+/E>DCA<TX1>=N=57)J]_$%=/9 =O2X+8'V5U
MW[@RL!#K%)Q=>'TXQWV'8^D*L$1B*QGY:!V17:-W;R0K2.4%$0X;4O(7^P]'
M;!= ?^'4& 8TSDN]_+IR6J'M)WTI.^?*AT_OV;W&L $]?N_#JC*\J!V'F:>M
M>4I!19P+.[PE+=,#E@\E%\W!ACH,8#MWI8'6L&KY-\V;O'QG5(MTTD451!I=
MX#Y O8#U=\+."4]1^S/1CLO+NRRMF4R&D]G2[M8%C=UC)3;<GN*]AMXKDK#"
MR+LO7!YBC7(*L?'W4<:EUH-T8B4-('6-8QN'QQ@!(2[=!R6'%4?VQ@-=IO54
M;X>7QMP\<G;/K=;D)%T!1T&O2KL5'4E:S>+1_L) W$*E]G4O8>3;>%=@0+U8
MH8VFP.S#0"1DS$J(N&4G?RA8B^E =@1)XV<%FH%R2Q<F19]/#V6S+A96L>P_
M#1XP[7GLTL^P^GM:2F?6)*C\VFLF?O)EH^D$JE!1T:/FGNC24-FNKHF4>NGK
MC#=N@CA5;?W22>GIK@M<50M54.A(694FZWT?,II1MB2>N@IB:=:OJ'-%R!RH
M2U>5Q]6 &$6D7R35%\DW5^:Q\6P%N/F2#_T;MD\I>[5SLIL67];\U9OL!T2H
M2]F78 NZ@D-'6KV+IM"BYY99P*;E"A& LG;=\)%$HXUEL8:D4 CULB2%I(D!
MF?F39HJ04(,DW ]T5%1#28D<CN^JR)C%40^+U!'J.1:N2D!CM;":H28E7.ZC
MLC#Q,7;Q#1J2>,\,U-W+L*WPB\<M<-=]E5%%4,(;9U]DH\OFZIR+]<:+AE$M
M^L<=J^)LZ ;0XG7VE3N6&2T05A1I-ZB7C;P>84?Y(#"29%]J]1?*N=G&'2V5
M-]L[>O".7?.JMCU;Z&]1NE>)=GK%24<JQU._E.DL*LR4GDAXRS I+(@A"TAF
MAV2'6\?").%]0\<9D6P$9[U3+$<AG;.>%22;J,LCHYU1MZJ%J2LRF([,ZW7L
M:06]D0:(218LC:,JD1^4R"?,YDF;2FS"5%#$ID67!EC(F[S LN\CZ2J<?4P,
MP0$B0>7@HY[U;BP"!"H+1\GF- BX3 TH55H"M3CL/7L&R)9.DHT_Q7J6VL=.
MICGRR#PFR*HK)R)-#9N7W<8<+*;D?67O9_,N51EB=KQ,*Z@G.P$J:-HR<&MT
M(')(VH1)80BMRNILWJ Y%5# M@Y(;#HO9CAXS6DS1GJRW #5)9AVT!9V*H$9
MRVVOK=L/>+KPAQH8>C\6@LB&1*P6*L:K^-6]]8Q?KJ_M^*-B46['2Z+15JXW
MNJ8$9*@W9+D"A&$CR[1I)(0P?3:\0^91K*8Y'QY=C8S8V<"6!AM!=[F]BI<?
M;K1..GP@TB!&*0JG2,'!F +_ *^=69"V(;]A1$V<HX<L%=-@S@_6\DR\1?21
M/<2(KLBF8E@F%7#)V&.+>R.\06,?%4X(X>E_;-*J:QC.&+BTHP2E4S'1(M+;
MVJEQ'9-V'=S2)#!M"GX'<KL7HZK"!OBH9(+&WR J2EHJBK8U+U^^TAS)65KS
M-\^V(!:):DAJ9D$2Y<^@)S"EBZ$=GLCERX<)3-IIE9CW!/27 8+V@<2=T&S7
M,1E\; F8@E(@,><1LD1&#%B\>"E4HF=3>1ZG:W/@I(==@B9(;1N&2W0R79B8
MT(<N)4T>@Y"R0<KOA%A1+Y8 DQX[FU>H%3GP^I;LS0PL*W($Y_.2RSLPW<J"
M8DB0E>T<;E24F)PRJB@%Y&X.]G;5MM4P03/*K-)RSL^!8<+W7T,@Y(E1 ^/8
M(MGCLIU4J 4QJSLA2$#W,8LZF3P*<"AU91-H<?GW.9 *'N"$?!2I;)FR,DTJ
MT)O:WCC,&C/'3I/WPI9X&3DV(ESURS.(=RI8UL..R<E"7\FL./'FTLLOJT=2
M=W#,;BM)61"(:/F]6DMUY%7<4!C38,K,ACT<&E#J(K [FG#1[)+!'Q-.'1M9
MM4P6%@69AS<N(BX!! S,RR#@DAHB$SIK73,@\C4+B5JE)50<,O6QE-"L*OHO
M$X2UU:73+V#9UJ-^)8_1$A7("Y)#GL@,]A#12Q8B4CNCHJ[P^H9QD/@2P#$6
M-BQ)?F<$$J_C\A /VFKD_!:7Q PXB6==>O-$G\DU.R8V9"&H"1$BI#<<**12
M1N" <F^8/P.M=J'9ZWV@UE$HB 1>F_KN5((?F]ZC\I!>9)+/_C9RJAECTE'F
M=H1H"<ER -T>NFMXRZC_ '!A#*+&H[1$IB-NDWCE.-1'4V"!PB%$3"K\YO@9
M+*I@;_*$R#'9--&9X$]-_55IM9KTDD<4#D7/@;!@%)I::B\K*'$"4@IZ;LY3
M8G;V4[B[-2[,[FVK876<,F0D#(@,#2:"QXYVUP-$C([&##IN!B4A#16I9?'S
M=@G &T^Z!PV&X;<.(N9S$'4O(4W^E# ?*,B8PNPP+YW'[&D94^!ZZK7-#GTC
M[,4.+%."<P?VI)A[9V&DYI(",EI7Z;;@GZ#\%UZ/Q)P:BLC.-:IHYD#-0!/"
M39@6S))D/<NM=O:N[-]\J537H]\5>R4#64">$8_3E9UM*G-OUN"JAE+JZ=1R
M#JER2ZF96GLXF;UMEX7)6*'"1ZOY6\K@6X;E"Z4TY+,)8NS%YD]1<AKV &O(
MFJUD*)A!I)@))W)FVMD2\U+ &@N2"I<"&S!V3B0<]A(D^=M9"X+*>FK)1B-D
MAO,8R:;#E@[9PD72S.#$#1H8G>8RHU@H8:R$=)X+'9)'I&^>9LFEQ-?R-20[
M0[2-2,GDF2<M-MCTK3>AM(4\=H.7[D.610#-Y,\3< %1ZRA#H6(M42&>(:PN
M>F!*I]7Y*J.>B1AN-OPD:9BISAU)8S].RN4G3#6%")'!&!$1DT8?M A)V2W'
M-GDB&"'(8(?EK3 8N5P)4*Z1R8& -<#T?"JE#!B-N7IJ,AI0"L)RW3FT#3@,
MJT. X34A2/S,I+D""#3Y_)VSAL-("UFKHE)F+H"":2M>9CG;HFT?M%U+P2X$
M5.&)J#-H+S&;*2(OHTU7QC1>(2Z'5S+\FQ8:41TA"Y7;(4N8#MGXDL2AJJYY
M,=D>&167%O+$:.XLS*F5H@4U)OGJFQ _,.+ N*6TM[+DQ'GHYAQHSQ+V!T:!
MT?S&3PT\/E $)3EC@(^&^%>-8]E31G@BA/, 9 @7F+1CL\DK."&A8>0Y?I*D
M\ V S$U!_MI-W9>RO\)/VJ;:2+L_TP>3$"O&FC85;M*!G<=;Q*7R)-F<-A+(
MDK]L(8$!I<H[%E*XU*X/S,M)@PP4%!!%3L5 [K1PN'; ]VIKACD Z>^%[<^%
MP3A$X16$3ZST\EV><]P](Z\Q?CNC$>N*\K^?&\L-ZE0G>;)2C^(QE_F.:N]9
M=G)#)S49@SE'_(<OLLOZ#A5RS8=_&R)]9Z>2[/..X>D=>8OQU1:/7!>5_/C>
M6&U2(3S-DIQ_$8R_^G-7>LOSDADYJ,P:RC_D&7V67]!PCEFP[^-EU3WK#3%J
MF;3+V;%<3S2XJ<2H*9!I&]=.0?Y3[.Y&_,18$Q0W;;1[64D)*X?2DJ*7;FC;
MD/$U')#TA\:U%D<AFP7'6/LJ7ZM]-*+Z>AYB-IP7+MR-A%A!B<S.QK$G%K6!
M*E8T%0C41'EYM81V0R!8'#8TU;@(H!3>I"08W175FTT<O'[ET0DF_H&'D-<K
M*CA1.$3A$X1.$3A$X1.$3A$X12H\;%QD&9DAQWHP"Q\41-F'RN-]DV0L2S6?
MD':FJ>NZFVC9HW66WQIIMOG73.-==MO3&2+\^.\[DUO6WYI<J3IT.4D\GG_8
M>'[::&CYR!@R#8KM'[Y#;[LB"1HO'P)D"&C]'N4!VFNK1JOJFUWU4,9+LQ 8
MNUC@F?AG'[K!I"M@C'F+5\,V"198+F,?5-SQ=:+Q(\0,5GN8%S?.W96HL.NM
MCYT2[)G';.+9<4LNS%.8N(B0&9"U(&[A4=MKJRWN,JB<F8;EI<=VY)!9SEV,
M"J#:"QKC0;#WL73 B#]A -(7 !HUS7KN4)7<G^;U#$4NOD'4$]U9WHU 9L6
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M4R6A$DD:&"SENXPXPT@>S0@TG4R5# *4-8AT;.@WTZ;8[]BNA<\_AT;('_\
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MY6ZGPHS*GS.64I'T7FI' QH!?Y:LR(:[. ,@U%?,2A\EJB"(VC(&'U AUCK
M9&[$NTW>4$>O[YH0ZV>;M?R@A3J)$0T@DPUP<C3=^02C,N=M#=Z#20261@#\
MX(SM'ZG(I:01J88^.&8LL&>Q-VP"$15+:OL5,&F\\9U_(@=AU@\[0JO( 6HB
MKC4'#,A3ZQRZ#S!B3.Y%\IB[HO[F5@&;0[++9#;+3J.IBH&QR_"W32YSPO-)
M%(^(OC#3%X M&M-MH1)F<FXT&")S:7HN[#B.*ZD2H'-6?2IR3/R[3 E);VA+
MQL*C#@P)9.2FI <"V!&FCMPN_P!$]ZNI:QL&!</Q/ ];Q=2O#YFW%8PS*F1<
M;#-V,LB ^1QUN13EEA;8@P6;"]"#%-)JB)TQH7)MMWR[MMJ%",1+UKJ9-;J;
MN2C<@38L;"2['P4T49N":AG6.#HWO,S#/\Q?FT+/KB6<;B_TW)2,QA; 1APP
M%M5]F9%#)('KHY>L_D.08#=PV*+#URO6UI:2]^FC]2HC0BS :LS^53*4>BLG
MTEE+0*Q(HSDPF9!WLD=-C+@\NNBQCK\2W7B309*$$13\7('Z! (BBRR@]W1(
M)C)'>-.-"/IIS4E1%(:H.FZ3868UBJ3>83>91>5[L"#Z$RG2"@,Q,6T-[M!R
MCX$3D"PQVB*CY(CA\7*Y>I/XO'MG").>M@1F2^N]2N\L<?C6XU0DZ-J?2X_8
M#5L-G\7:&&*-63;,\DBI=-P0PD-27:EI/J=$9:!%VQ Q)G,E$D&.X=LFY)];
MD',"-XRY7-N& #GJK8HT'R.$P*9:!["EM<S%009L&-DSFFC3,42FK=QIEOA
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M$8RWD;MY"2A +N!,%] [;AGO"F+8B^U5!LX;)[>=[L1P36I4!@_<=LC:QQI
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M;M3.4*_NDEN9*=OSLV3=US<\WI9@NUDZPP Q+DV*Q'8FC-7K,AD[*6VLIO%
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M"DDW!5F5H_=*3=FVNY6(N<=EB^T9,[47)$B2"6K%UN;)E6ST_+9ZSKI>'&@
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M)PB<(G")PB<(G")PB\@_FJ9J1?OL$D)_8&RA6:WZ_7"Z<2RD*=*Q8JYKNP+
M@#IBYN*:EQLD2<# TO,/3(MDL--P&,.W$@JIX4L*4M1B)=*?A/CJUABV-),&
M%I='E2\!A[@LF6E\=6@5&/2D@S#^V=3 &<<+O.S"8"22$Q"8A#G?RH85A1]G
M%)$BUP['-8X6 U;+WD6L":%R2;?V6PS^,=TYIB20Y>1>S@E0MB$A+QE9((S)
MX*2*Q]I8-') [1+]@3YAXQ@%M0^P)$MHK7C9FW+&MR3_ %3E48&_)I1$-"D/
MHVMA<RK]*4H-H_/=O=00S"+N!3D<,/H9FX[Q+E5>7@"DD(2UP+KLWLWE4^[<
MDOF%04G+KP#OX$*BD.LX2,P%M.2 PYUN?DHQ0W*VN[Q>#V].GVH061@NM=RE
M-O57;H.&2>;!VG66[MV+J$,/5'Q1X9)N&7S9PY[$V>0(GJZH^CI%%R5RTT((
MPIP5D>-)2=+/F4F%.AS,@6"H2@Y9+,KB<#7]01]<J5>/X4:.7=>Y@%HECJ ]
MLN5%:G3H_P"!CRA:QHZ/^7497>,@NS\$L-JPSV,I4RZ<N@4:A@]NE+'$I(#9
MC(8X'3/.QLAE9$O=4;D;M"*1:,C7@C&0WZOET+-)+8$6##+J01I.%SB6Q$9H
MZH>:$S-A]3$FY(69[-:%7]<QBNYA7I),><4#12*K-C/LMA^EBR5F&=X"G7EH
M70(::.AIG>;YQ[S[^<D:_-,7<$0'Z9E^%3.%B38(56[O2O[*A>HD=6MOJ-RG
M3P!-X.F%K"Q)I6\89,2EMSB1'V<19I.MG(43[1@A5$"6G<\BCR>2";HQY&K1
MR'!,QQ3(N6@LP<.Q8?" RIW1T]B,*]V*>CV", I)=[H;KVZ^N_6J1B9(0[$#
M]M\; @S1RJ/R5@4B$JG&I1+#0%7#D5'"[*"6]+#ZA:;T_CW3 <]!)/PY),@$
M,&ZNP4TM<JW19V'$9)/BCH!AI9U(BAEJV99<_'L'516U!;@DH)8A6$*6?#]P
M,<.L1%@XARCR<U:,(,J5'K3(87D+MQ4#."!H00 (+C)%FR;S"J,;JS6LN62F
MOHM"9 7TMOM41>/:JA]XSU7(FK4H'<D:3=P:4RX8).PY69 Q[R00Y59M!K)+
M#Q555\6"*"9 (>E/E +_ "F],@O2+:CJSO,+-EI<A$D& $+8M#P7U?(I0(0D
M3&L.[/CX?U18*4>)*+?)BS](3@B )BS#9/+AD;CQ9^+<X]\CMLS(M2 UD3A$
ML.T+0>&H'V'79*Y8V@LB^_M_@XY.GO\ [Q.0U(:<^O\ V_Y/JOM_A_1Y]K/Z
M;;>OK.C;NDBW]8#VUT^B^_D3 9#_ ,SG\-Q8OO/MC\IN[)J(^_SG[?Y-_G%'
MW?M>O\GZ9USZ??UQCE5?]_:BUP?H>GYQRTZ+P0[MC=/PE>/6P=\Y]=-ZB\OA
MN'[*Y_Q:;8E*&R.=O]7G&=?9QG'_ !X4XG'_ #*FYT?G6RK$=X^I"T1RX ?A
M_+LC++3./8?TAYPVDD;X],?VVK8C8";K7;'ZZ)[HY^V,8QMMZ;9X3B_U*?'L
MV?RI/W4P_A:GT>_V:/FZKK*?_P )?)4&EWN<8_ZM_7)?WOLXQ_)C'K[7IC'"
M<3_-V?\ @9&A>DMR9,PZ<Q__ $U;_BXH1JE_[/75[QFPV2?I^R;1\6>HN=<?
MMCTQG?'VQMCU]>-[C>J>/8^1Y<N7J5\Q8$\C^/72XOQ84!U3_16T.M("<()X
MQC^TJN@$=(NM=<8_FWTWVUV],YQG/"$<NQ\*F_\ (+[_ !;3Z._[4[S'UWE/
M'Z6SXP LN]QZ?]9_J4OA7V<^OM_?/KZ?K^^2G#^WLSR%9Y?O;.\R8GY"WZ6N
M=)-^(2F(U'3'L_+;O\&&"7LXQ^B;TJ'@**F,Z_;5153VL?KGVM<<*\(_Z?EV
M@_.]5[1(<W=LXC%FA FD:?M8X#;O3" A./HEG: QJDY)H@4=$T@B3];7=TF(
M2TT3&Z*X9Z::ZHXQ@N*J/A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A%H%
M\_@C<E3G7?7?5,TU?VQ+@.U?$&R*,:L5WFJI7-VX24RM<661@H4*U@)"9+RE
MTW1&L]HWJF5(AARSDX,+=%^DN[-/K]EY@2P1QEL8W*"DI=@C-Y;&"Z]E5SF$
MC[?*0?-T-UH5V7^8=6!F]/U73[BI#2-=35T7B#62'J\41=QV)K5[84FZ8%TR
M&> +&1_:14'<$:L)#QQ=;P8R8N]E]L+E/AU%52QNU&@^-/I0['E9NQU)]FAN
M:9@:@**1-:+;(4+)\,453<B2W1?;[.L/HM7Y0VS&F!/PE[ZX; L'Q3>/N'CY
M0YN$Q&&Q9P\-6;,!J2 5H2*)Y92+LFR:32**FV1G8$PSU[)C-'#WX!,"]'L5
MW*@%3D:UXW.JC!QSP--*6#\SCS*ZVTC;Q--HM]7_ $@I6>!Z2[BP+(^H5:=
M27$(1;/NQHH!VO$*SV56)J#C[.B[#",F;VOV:55;"IS&7L%K5*H*M%[-Q/H#
MSBDFF&,F)<O=SP'$!<75CS?YDWAB=4!8= U&TAD!^;GZ4C$J=U<P5K6R=A]K
M'D[*E-G-8ON)C$^#L@JM2LQ[%2-@J[0B5;"Z6(Y>9=Y&6>T!BX,$^/Q/\%LA
M4?4::N![>+H5L&%5LO\  ACUAFZACDV<TVBM2#)BWKJQ-;@C-O,%9=B86/@,
M<<0 ;(249U:/4248KNTB.X@^U+\/%+DQAF.'7 5&413<-IO$=0ZL#4B-,$D8
M)7A"QC=:,9XGUYPKUIIK=WU7L!M?77&T\SLVTN6S-REFR$3^:9L<+&6D#M5L
MT\K<(^XZSRWF+B3RR;L[ M46(X:@&8,'-[=V-##DQI"/(;Q;9% -]%0SY36\
M*!&6@,2?'4$1S .N1'-8-6=J=*S#V7/I;9L\^8RO0J6L4?(=IE/5;D>VYVL#
M?/>R94Z3EW;4!W+"HV ;/+A$*+<)-&D2;X0;.%&>P]HFTA2HE%F58I)4D^>2
MBAR;^R(9H6Z1P=LF:-VTP*$1&"HO*+YV;'-=9G85&56/#\U O!/'@?J8N&@S
MZ(6$U!RJ$RC-Y2*JMV4FAT[CMD52QVL61OG4<1K!BGV6Z\U@WN>?$IIU=@<@
M'O8F<ZY$Z])[R66B#V"\6B:<(M>!='RO)GU![MWBH@ <3!WB,EQQ;&?XX; )
M_;'FE\CLE]K[X^C_ !"!0^5?T^R.?H%/.F=L?;7],8SG&<_\2RP_11_[E_\
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MW<0=U[,N6;)=F1+.3K$<2*5V>SEHFHVCP@37SPCB(N8U=,C;9=EKVJJ:#4<
M'K8/<O)+!3B7GS$3C,^#/9Y9$*8PB(R^DV:Q#MH'GL'=*US?<4E\I6)AZBAZ
MIL=&1 62QMM)"P?8Z7K.*#8[7,D#2]S.R$AT;;>^2RQ@D78CND%^'#DW;5GZ
M,H67!HC.)%.]"P^F)H](3SLJ ?/F(#M>[EHB!5Z/BE@H;F(RZ7 B3R3I1;!-
MU &CI@]43!1JI*2/QUF*D I&;WX]$LQ$#NM\/0SCKS<DXJ!X.)LW2A=]&[%"
M"BG\5=M,-#/5JN+-&_++HI44\9-VIV92DF#E1,_)@R8*22!!H0!32RFS.O)H
M(;L86<,/+O'GOR2>GPB*CKIA@8T>#I"L,%63ARB-:-$"3X/"XVD,B=LTE24N
MQ/\ LI02SES&6(Y9CM+WSYO/XV@Y4'Z;)GB,]%*2(,5DU+15-B_)'F/TU&+#
M+6@M<:%VX(RU-]D,Q-6LY2%2N6].Z_0$6I;<ONZ.#!1NLI3'7*[-Y4T+?1.1
MQ,A(13XE&R#O"T5LN3B9%:ZXP!(H3''APC$/I-@T ODX 9KL64LKT1'':U7V
M.&@P59RK+J7LQQ)^O8+L5+"PP54,BFM>"50^MQ3000RWCX'5TW%&'21"75V,
M%F[7N-&2@Y7%TM"IC(D57-.6+M-R.6@#A?6.AB%1\&[)QE9K(H32[&1G8?*^
ML%'TD+*O=.R9L&$%AY3L\(;" +""2M50<H65:(Q>MM7<UK66#;).#T<O5+@'
MF3<G%CF_(/ (B.XYDU#@<\# I/,TWT3@<TKALYCW;&OQX)M]&W 'FDZ*NQD=
MCLA?BH"$BZQ].2NG"KMW!*^> *[M<8:FLX(.AP<D'0,6XNZ2Y(Y,"2?!WQ"Z
M9V^ADQ(6+%=SU9F]9#9_9P2SCUH[]DGDG4$5F*@=JZ[N6E;,0 -SJVV'-,ZP
M2/\ PAJ-MR8"NZ"+DQI.3ID(X\G]+J 'H TT\(<V;UT9RYEE<>($YM#)]I;4
M&A<MA<D 2OMQ<Z#F)=?,W8'4?VU3D:D43?._S?.$,NAQ,NT26DTCPXVC,V*B
MX/3NP@%*P+@JXNXWLH6;PIR*1!(+C[@-B2LOENT>Z;0 QMKR&^* %81.*1&2
M26K^P_C)^22>%OI9&Q<D^F)00B#0W%ERXE(JFQ*+@3I47EVBO\(^72QA3) !
M)%'::/342#S$ F^GU4+^9]?2+]+I_"DV!MOC'HI:76&2PM57U]/],KHR0RWV
MSZYSMG&/Y<YSG.O[8;WZ(Q'R]MJ&+SX#IS7SZ3KR1_=6M/PCTXV4SG^@KN])
M!6[Q7&<Y],)L'BC91IOG&,8QIZ[8USG&?7[^F".=>V?F'QH_CTT7W^%NMY%_
MLS_"-8F=_MG\IO)66B/Q'KC_ -EQ@\A[GVO7^3/ZX]<?X<)Q?O[0'^V(T JY
M3_*F8[H%&7*GO@'@"I20.=LX]'U*><A_&]]LYS]MFS1U-V[?/^*>F_IC]-?M
M^NLTA_ISG^4XO]2;3V8Y]<WS+R56B?1J<A--54?"9Y X GC&/94J+S#A9AHG
MC_I-,_7ZV5?3&?Y,>F/7&,>N,>N>5'=N_1X]GZ/PKG^1D^COK_X'/XD"N\:?
MM4W>0++O<8Q_U;&)0OE7V?3'L?K[7IC&/OPCC]79D\Z/.>'^5Z!/%34Q6&4[
M*+#,ROR:.WEE'D6:5>^3NU1]@VG 6<%<&1FCJ)!!*BS2) 9:Y)NG:JCU;<Q(
MFHP*_5T3%H"=URYU%S\L9I# O/I9;2N%E.$3A$X1.$3A$X1.$3A$X1.$3A$X
M1.$3A$X1.$3A%XE_*)UJVH7MQ9^R&[QQ&+;(A[2AKD8-C0V2#(W(9C%V!^JF
M(@;7Z[%?K/'Y*_D1>U".Y]N6 ,"JA$RR02>MT;2;]ME= >Z-0\3H3$W.NEC@
M:X-W:&6J6=3;3.Z[7ZN010E ;(]08U0C:CZ0QG1Q+8]J:Z.Q1 P24E@0AKIN
ML-&;^^:N&4<E;R-M[GT6I))# 8+99IR*BW,7=12LB1V>J.4IFX<XV47ML4]5
MLI$HW>M/DA((8OYHYSVM8:2/I\$4/26+.*D+E,+(2+>6,R;3&B-H0+8KBSXL
M3)/PMP!ZWR2[3E0OSAFLT>K,Y#HLX;I[7<#>)G) 6W9+%MIFJ:[-#T'MLR/$
MFJ1\L==+1V@3C,JH#SL7T5&M'LCG3BPBAT/1GT X:?A'GR#E=I1 >-9(O0J2
M@!2+MYM>@$D)&2*2FZ^4.[V(\V[3095V!)XE,W.K' I(51Q XAM&L[M'BY6.
MO0I.:1!N52<7M278<4 M=A ^*&\5R)QAH">F< 8BXANL'4DMPQ;Z AA9T9I;
M:2";=5U[(=?5'W5<&_>]KI:N A;B65%LTA3^M8I6PZ8B<50_IN.6EXWRKY=W
M8%SF.[5WH F>9!N15#%Q#("QDR ^%K15.(_.IT'$U[!!(=2%)RC3L(DA)^N#
ME*DH!@7W!E?RH9BXJY^!BT?@*T-)A(Y":]3IN'5WTY*/9Y+LY+?I^(DD\(EB
MS^9-46;V;LG!-FS#+8RD^)IC0-8-QH'20D%2=]):U_UIV1D 58!VJ342%HWL
MU^7*Z*-A)6,"PKYZ&BL+MHH&S<L2[:4F1(-.A#F;3'(R;T?MCS%@3;2K23RN
M2!!(RO)FWC2%Y'D$;>_^P'K;D5VF/9@?9F'-SH-6[9<*&31K.WQ16*!I9:#:
MZZPCWDQF].GT?VPK[PSOW06DQ-. YM@-W,G*&82F:F9Y(0P#RX6BR7^7!5+3
M\2]O,8?7)TD$E=B(D:_M4>M:MAC1AZN,N4$!;H1(/<S)T?DD^;?4@.2 [4LX
M"^]_E2& [@;%8GT&<^42LDLT]8!+&?3J]^)PDOM?IB8]S0H7WGK^RO\ 633V
M,;?WOMG..51^?9?X'_\ *^YZNS\C_LV?.')?:^_];_),%#^\^_\ K?29:>QZ
M_O\ ;U_?A5V^?LS$]S2UJ9^T@)_ ]/R7Z^%KR.27VO3/];_+V$#^\S^G]+_7
MY/V/7]\_;./VQC'"CB_'1_[>?\% N?'K*%,9V(_A\+I)IY_M*3CSH#A6NW^.
M5M6MA*[Z^OZ[8]/:_7TUQ]N/#\[V5>+_ %!_[8\K?94R[\><;USG8G^'NIP;
MOC/\RDZ\YQLOG7/_ $EM$YKOIG/KG[X]<X_PQC/IZ&;>_P 61QCM#X=GKMO2
MREV>C<!&Y]?^15\<49]G/WVF7ES-&L)X],^GOL?5&^=_V]<Y]<Y^_P!OOZX)
MQ'_J5ZQ1XZ\QR:]T_A:K\9G_ -6OX.(WG3[^DO\ (X:,>[QC_>XR:4]KT]/O
MZX],^F<>G"<6E?:&QBGZ<6OAU3\F( .]?7JO^&1C?L??^M_<8T8]C&/][Z/U
M/;]G^]G/VS]_M]^$<_J[4\Q2P_\ MY)F+P(;_HX?^#X!YU_N2*Y9!)E=/3]M
MTD?;RIG'[XSMKZ__ .^%9U[<[ZFZW'^(NDQ9V=2R]5JV\%96/PEF[B,)LKQ9
MU@4>SJ-6&3:-/J$5);7/Z[(AF6\$,;MG@ 'CYJ5;R1NH_<LA6/A3!8K.'[3I
M6?*%Z ^%S3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$7E?\]O255]*MNV,0
MK.&S%M.:RB](S 8Q!6F0L'2>A;:!6##)>* UY,HT.G3DJ/&N(PC'LMM)P1D(
MV(H@GQ%#W[!L72@XYO<"&8W!9X<Z.\+1C,(X2)&9J,5CL_CXB36-V5"J8FW4
M&G#XF0#(>XBUCB-AECV*>*MWKB16$P076/2%)G7=P6:D5EMB+15@#&L!;\XW
M^5H,&G]/S&3JPTLP>  '+J'3.%'Y9R:9DW(YP_*]H[0'[U'VAIFIF"R$WH%C
M,*T+I1T6P?K:H1[4=(3T;V7;;S\2YW/6<?Q*82*!OM)L^OUT5L&QW14&)(EC
M+^>+4L&+R A)!)!-(;)IT,,_*(Q&M@6]G2^UY-L6*=J>N:AW&11&&186BW&%
M=!#]*&"528^"KBS4IO,(NPM,Z"!.;Z]4;E.@#?"9OS%[_*>Z"5-(?$$#S^-/
M(G6R$G%R*>=3X['']'0^\97A!NSJ4S")@;:M;,.[H@I 4;L6;1ZH9"$IA6=:
M/\!+!CZ<@LL7(DBA+ W^8,33J^ TN[,QN+'BB(NBHU(5J<D"8T<"(R6DIRNU
MN'K3U[ZVNF48I0[)*F3'*&7LI7-QAJE%B8$B?CD6/MU(A$R,8B]+GS<T?_+&
M#>^J$,^LVJJJ=YO:>8DD\0 8J61R6&J^BX.7DYC9D/;PZI];,DN!_;Z 30'H
M6;]GB%;/RTEAM6P%]JU2*1F0"XC+QZK18%)5WH*BCOTL0/%'(N6SS<MK];(/
M#R(^6&)@,7YCO$/"IF2MXW\HG QRXIZ52B&5^3J,B&.;=HBDKP; =FXY)3.P
MO<.Z"CY#-,D20]@>BHO8?(D##\+6T!!RZJ8@9PU>_NWY3F' 9_ET:Y?D7/6"
M25<&2U^3(ZS0<-@]B(-3\XO^&QQQ"NM3*XPYF&0<E$+;08"WUAG6K0RN9EB"
MLJ.K$%B4'NJQR;Z68,U\.KK='>J^(8<+S&, V:PN!^J5P=E47Q]64[D@[HX1
ME7:RY6!$%(NN?5F5LER]*@)? FS(@2WD2ZA$ 5#.$(\^?!6TH7F>)/++""2.
M#HQ1P2FGCIN('NLD!HY8J-JB_EI9F:26ZW<J-*J(@74_FPU\N.B AR(E5\$[
M%C0M_P!L*!>.Q2T.VKL:P3R])BV"IB&!L*/@[T3'S/9<5-6$BV%CV55Z!Y_3
M?A(F8R><BDPZDT4"0R9R.,L 0"HI#L2D_3BO,JUREV/0D+R'/Z4E-=R[0-]9
MMHS'0SU8<CD"3G!IK'5XS&")4]<,70ETQ0)MIKX=?QCU*&'A[D6NX.K98,\V
MYY#T'>ETT\)8QX/;TFZL5Q+PL>E\@D]P>.J%6;6D/A];@Y+5Q)3(Z52F262R
M'"4X+%FK&%C"1?>!0YBBF.=S9^7781^HSDEN*XBN2YY!K.^L>-^?XMX#(O\
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M>>/)K]_G/X> (EM]_:4GGGA>N/WSZ^]1'SE73/[^UC7.OW_O9XW"<7^I8O%
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MCKO?XYF3G^L1XV\E/XH7"2>41R%0V?\ X4-682TZ)C$6CE;=8I'+#9V0G7Z
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M)PP%*8S!ZPEL>4CM;/*MCY>KZ)/7>"*&P/:H-8^=Q&ET34FUD#QNQ*/)1%6
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MP&1?_H-^%3L/._\ =JGM";AVZ_K^S?39RAE'.WK_ "XVQ_+^GW],<;W[*/\
MN[;Q'^Y??X.X#(OT\2_B+L7"G_PF\HIJ)>_]?^J_UA0]U[6,?R_IZ>O_ &\)
MQ%V_J5^-+_\ D_.WJMXGCX\8T-HV&8O6M.M4;\;_ &@.X-1YW&X7>\E[IP@M
M7FCYDZ&#)GO9+O(I()+"(YI(" NGC\&E>@Y@ 1S9K-5P7!-"Q54YOQ")(8_7
MI*V0_GO8%7?Y+V0K%T&"H?R?G;3Z)JQ*G51T_EP_F$>;,-[0J3931-<D66-Q
MV5UC$1VN/FUSNM]=E,EEM/+/V^IT61T8E,8FP 5*X9(P4NBQUIH_"26,%QYX
M 88JYSA-Z*,"G#L<0:*9UVQHX:.%D=LZYQKOGTSPHI]PB_/6']X^V WJ99G8
M]CVL\ONW8:'7',AL5D24)9R_QTBA@:X$XZ-0L.=2B%OA" <?'-UFDB;O)$];
MLSN&K#82LCONTR7HX0X#4,P>>_(> ]](7HS[S^9F;=*WHQ%*E:,L>,@Z(@%R
M2:>2WMY7]+*6\M*VV%GL>ZK5T0C\TFMN;-VR:I1N6U9CV"VF^!B.KAPEHY<E
MRIHXLEW9A22W]QAAYJG.Q_G<Q5EQ1.JZPH:NSNQKKE3_ &2PMV'[00_JZ4GP
M6Y!B)L) *4S+HC((=-YL+%KZ)D?FDTCK!8^B^CH_#IRSRZ5*BAPY.6@.W,S
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M=C%%3.S<D.-@HY=$AKIU'!NTH-*?1LPTJA>IF@PF'$"U6^HBP<JNU'.54UM
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MMN<?E/;@XS]5?P9S#7'[I-95.%=<>O[9S[C13?&/_P"[7.?^EC[\;W_"2_\
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MHZ8=Q^K@ROY1'E^EMV^/^WNXIN5%8D80F3-* &4_8>[9V4P1&-PP5$DF<C^
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M,M5UA!'1)8-)U(B5E,2 R^-"Y?(OCRH+?;>W .%Y0.Q/0WL7TKGP#>:1),W
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:Y&IYV*BH@-X6D/=CSSR6PSA93A$X1.$7_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g257749g48d64.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g257749g48d64.jpg
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M"B(Q,E1RE-4C05$S-#=AN"0E)S5"0X%B<8*259&B_\0 & $! 0$! 0
M          $" P3_Q  W$0 " 0(#!P,# P0!!0$!     1$"42$QD1)!87&A
ML=%2@9(RP? B@N$#0F)R\1-#HK+2@\+_V@ , P$  A$#$0 _ /6SJ!J!J8L:
MF:NJZOJ[KLJJRKKM":DIJ:E"<:GE!14#T:MDR=/GSIELBF3ATX9%%,&C1@40
M<P.)F*+GF)GEE<:;<O%YO>6)Z%^G?5/UI]!,7=EJ$EW>K'0OT[ZI^M/H)B[L
MM02[O5CH7Z=]4_6GT$Q=V6H)=WJQT+].^J?K3Z"8N[+4$N[U8Z%^G?5/UI]!
M,7=EJ"7=ZL="_3OJGZT^@F+NRU!+N]6.A?IWU3]:?03%W9:@EW>K'0OT[ZI^
MM/H)B[LM02[O5CH7Z=]4_6GT$Q=V6H)=WJQT+].^J?K3Z"8N[+4$N[U8Z%^G
M?5/UI]!,7=EJ"7=ZL="_3OJGZT^@F+NRU!+N]6.A?IWU3]:?03%W9:@EW>K'
M0OT[ZI^M/H)B[LM02[O5CH7Z=]4_6GT$Q=V6H)=WJQT+].^J?K3Z"8N[+4$N
M[U8Z%^G?5/UI]!,7=EJ"7=ZL="_3OJGZT^@F+NRU!+N]6.A?IWU3]:?03%W9
M:@EW>K'0OT[ZI^M/H)B[LM02[O5CH7Z=]4_6GT$Q=V6H)=WJQT+].^J?K3Z"
M8N[+4$N[U8Z%^G?5/UI]!,7=EJ"7=ZL="_3OJGZT^@F+NRU!+N]6.A?IWU3]
M:?03%W9:@EW>K'0OT[ZI^M/H)B[LM02[O5CH7Z=]4_6GT$Q=V6H)=WJQT+].
M^J?K3Z"8N[+4$N[U8Z%^G?5/UI]!,7=EJ"7=ZL="_3OJGZT^@F+NRU!+N]6.
MA?IWU3]:?03%W9:@EW>K'0OT[ZI^M/H)B[LM02[O5CH7Z=]4_6GT$Q=V6H)=
MWJQT+].^J?K3Z"8N[+4$N[U8Z%^G?5/UI]!,7=EJ"7=ZL="_3OJGZT^@F+NR
MU!+N]6.A?IWU3]:?03%W9:@EW>K'0OT[ZI^M/H)B[LM02[O5CH7Z=]4_6GT$
MQ=V6H)=WJQT+].^J?K3Z"8N[+4$N[U8Z%^G?5/UI]!,7=EJ"7=ZL="_3OJGZ
MT^@F+NRU!+N]6.A?IWU3]:?03%W9:@EW>K'0OT[ZI^M/H)B[LM02[O5CH7Z=
M]4_6GT$Q=V6H)=WJQT+].^J?K3Z"8N[+4$N[U8Z%^G?5/UI]!,7=EJ"7=ZL=
M"_3OJGZT^@F+NRU!+N]6.A?IWU3]:?03%W9:@EW>K'0OT[ZI^M/H)B[LM02[
MO5CH7Z=]4_6GT$Q=V6H)=WJQT+].^J?K3Z"8N[+4$N[U8Z%^G?5/UI]!,7=E
MJ"7=ZL="_3OJGZT^@F+NRU!+N]6.A?IWU3]:?03%W9:@EW>K'0OT[ZI^M/H)
MB[LM02[O5CH7Z=]4_6GT$Q=V6H)=WJQT+].^J?K3Z"8N[+4$N[U8Z%^G?5/U
MI]!,7=EJ"7=ZL="_3OJGZT^@F+NRU!+N]6.A?IWU3]:?03%W9:@EW>K'0OT[
MZI^M/H)B[LM02[O5CH7Z=]4_6GT$Q=V6H)=WJQT+].^J?K3Z"8N[+4$N[U8Z
M%^G?5/UI]!,7=EJ"7=ZL="_3OJGZT^@F+NRU!+N]6.A?IWU3]:?03%W9:@EW
M>K'0OT[ZI^M/H)B[LM02[O5CH7Z=]4_6GT$Q=V6H)=WJQT+].^J?K3Z"8N[+
M4$N[U8Z%^G?5/UI]!,7=EJ"7=ZL="_3OJGZT^@F+NRU!+N]6.A?IWU3]:?03
M%W9:@EW>K'0OT[ZI^M/H)B[LM02[O5FF/AS-?8%BC4R/'%%L(Q#&K@.[$M)%
M.+K C5F,Y8-HYB-9;/&$DRIMU%3CHZ8.=3D\X,0%'S*BFB!,QF%D*5 SP&Z&
MV\6\O!N<TO\ ([U/^#3!/V7-:AAYOF^YI)X9#;^>'*T)*96H[_7H[C;4B5=:
MB^U,ULQ65$55<TH2=.L4-!MZKL5T(IT@:+'$!KO;.2IU/I1L:Z65NQ(W4N1X
M5NI-#&Z$I4XRJH5HI>.N7)NQ;;;Q7DK9SA$X5X/%N3-+$$1 AZLO/<B?E^"W
MF?C64)&(>R:G0U%\:I<DH=L',SV]BX[N%Q.O%O&2AQQIQ3!+%.$^Y #V$6%+
MJA-RDIQ5WPMJ41DO<W8S@\8]X5C6DG*[TG)VZVH6L+JTJDZ;U?!^2<22-SE\
ME%I!O2 Z5,K<1]^PI)1LPLMU7=8:LIKJ+?$@OF#A,J63@A52JMAY2WM)9?IQ
M;2Y6P3RL3M*<8S#P8#_T5F-%W VFV#0)JVAB74S;%F[$2TM2<R7E>?BRJAI<
MP,1MKUABD1K+'D$DFGBB,Q+IJ:9:YP-O&@C!0@/BI HJVELI0FU&$1NG>HG/
M'(V.<)YL\Z--M"MEMC6,7*F'XP6,4),'GQ8(Z1*OU_.A C9D*1PB/:X"@527
M2[TE4,)X_$ ?!)YDQLL0AL\K#-*FI*[-9\OQ9.?!AY:9;) ;C;1SV:>NR$(:
M_;H,V=I:69'BY_H4^G<VBN2''C&60KID3+<>OPTE*K(3&'BB$[MNUFVL"'R8
M1BR@-)JO:6S2H3:A)1&YO?A<YL3Q;-'"?.;=^=E/<3:77XE%>SLR:OZ@,Z )
M96HTCQCDH N1;5I7?[20L R<MK+^D#-44U]'?EE8B UP<FXG6)E38&"8#:IV
M5LI_I3<XS,/VA88&Q?@MMG'GN'H5KM/LD@E 9+<S<<+9DG(@7 )E#D@1:^71
M%3Q6 ")7$,H0"<"^RSZ\&0)AADR0:GB6*!X%@@L+#-2BII9;N3Q70O\ 4,B@
M.CS<S;"SS"%<"&&('EE@('FK$,,\,\+WQSPSPR,6RQRQRM?'+'*UKXWM>U[6
MO:K#L]"2KK5'\^%38]\:#\L)_K%(=GHQ*NM4/"IL>^-!^6$_UBD.ST8E76J'
MA4V/?&@_+"?ZQ2'9Z,2KK5#PJ;'OC0?EA/\ 6*0[/1B5=:H>%38]\:#\L)_K
M%(=GHQ*NM4/"IL>^-!^6$_UBD.ST8E76J'A4V/?&@_+"?ZQ2'9Z,2KK5#PJ;
M'OC0?EA/]8I#L]&)5UJAX5-CWQH/RPG^L4AV>C$JZU0\*FQ[XT'Y83_6*0[/
M1B5=:H>%38]\:#\L)_K%(=GHQ*NM4/"IL>^-!^6$_P!8I#L]&)5UJAX5-CWQ
MH/RPG^L4AV>C$JZU0\*FQ[XT'Y83_6*0[/1B5=:H>%38]\:#\L)_K%(=GHQ*
MNM4/"IL>^-!^6$_UBD.ST8E76J'A4V/?&@_+"?ZQ2'9Z,2KK5#PJ;'OC0?EA
M/]8I#L]&)5UJAX5-CWQH/RPG^L4AV>C$JZU0\*FQ[XT'Y83_ %BD.ST8E76J
M'A4V/?&@_+"?ZQ2'9Z,2KK5#PJ;'OC0?EA/]8I#L]&)5UJAX5-CWQH/RPG^L
M4AV>C$JZU0\*FQ[XT'Y83_6*0[/1B5=:H>%38]\:#\L)_K%(=GHQ*NM4/"IL
M>^-!^6$_UBD.ST8E76J'A4V/?&@_+"?ZQ2'9Z,2KK5#PJ;'OC0?EA/\ 6*0[
M/1B5=:H>%38]\:#\L)_K%(=GHQ*NM4/"IL>^-!^6$_UBD.ST8E76J'A4V/?&
M@_+"?ZQ2'9Z,2KK5#PJ;'OC0?EA/]8I#L]&)5UJAX5-CWQH/RPG^L4AV>C$J
MZU0\*FQ[XT'Y83_6*0[/1B5=:H>%38]\:#\L)_K%(=GHQ*NM4/"IL>^-!^6$
M_P!8I#L]&)5UJAX5-CWQH/RPG^L4AV>C$JZU0\*FQ[XT'Y83_6*0[/1B5=:H
M>%38]\:#\L)_K%(=GHQ*NM4/"IL>^-!^6$_UBD.ST8E76J'A4V/?&@_+"?ZQ
M2'9Z,2KK5#PJ;'OC0?EA/]8I#L]&)5UJAX5-CWQH/RPG^L4AV>C$JZU0\*FQ
M[XT'Y83_ %BD.ST8E76J'A4V/?&@_+"?ZQ2'9Z,2KK5#PJ;'OC0?EA/]8I#L
M]&)5UJAX5-CWQH/RPG^L4AV>C$JZU0\*FQ[XT'Y83_6*0[/1B5=:H>%38]\:
M#\L)_K%(=GHQ*NM4/"IL>^-!^6$_UBD.ST8E76J'A4V/?&@_+"?ZQ2'9Z,2K
MK5#PJ;'OC0?EA/\ 6*0[/1B5=:H>%38]\:#\L)_K%(=GHQ*NM4/"IL>^-!^6
M$_UBD.ST8E76J'A4V/?&@_+"?ZQ2'9Z,2KK5#PJ;'OC0?EA/]8I#L]&)5UJA
MX5-CWQH/RPG^L4AV>C$JZU0\*FQ[XT'Y83_6*0[/1B5=:H>%38]\:#\L)_K%
M(=GHQ*NM4/"IL>^-!^6$_P!8I#L]&)5UJAX5-CWQH/RPG^L4AV>C$JZU0\*F
MQ[XT'Y83_6*0[/1B5=:H>%38]\:#\L)_K%(=GHQ*NM4:-N'^6T91TXC4!/5D
MP\-CLPS1<@29\J:%Q"QBV9<,A,@P!<\[!VSSPQOG>W)MEGCC>_'E:UY#6:@W
M_3:;<-9?=&U#3&W'ISJA:U[X\>M$%6Y5OVVXXM:UN.W'QVX[?MM[7[:$>;YO
MN:#]R.!MFZ,]$GG$.MNWNX\U%S4MQ6]+P>LIVO"B7>*ZO[+L-\R%(SE7R,,H
MC[<3H;XPRU*0ZTK/(R:.*C=*AJW?5("$1S W36MJ732L&I_5Z6DOJ?!9%N9D
MA^>M+]P=;-WD-N3_ +TM5,U5?&E^S!YIM]F.38[%"-RD7FJ+I:3H[:I)@H;W
M#(NO-6:+I36>EIA]'0#)16+)*L-D:Y BAITX)S*M:)>6<RWN*QR%HULAP@L;
M\*;L0K1@Y->9"VI1=;&SIM%,QV2D*1T=!TV62<E-9;E%-)J2FGL<]-,G%C!+
M%!5CMSK11+8#JULP! 3YH55*G86<3M1_E":4V7*>I-4C/#8GA-)"T<B90TNV
M/UB:4!;+Q9MCM:^)^:R.TV636H&)JJHW(AA]6+.%5$F(%Z2.=*6S=: 5*I:>
MTTPLK&LL!E V03WY^?GW(HIVGM)RFE&^<V\,,-V9:7=R,I6X0W57A ].@H?=
M4/JB>3;R)!LDO942[-";'2VS:'*S1<3<%(V$-HC9*OII(K96S2H$*8)\Y&/!
MEQP@>Y""4M4U4O!K?[RFGAGR]BHTHO/9SA,#&FVNKATIV,UN C38F%M@]SY"
MFYKH38BM**0$:$=!R-H9=!%RJ_LOCR-(95.(M]Q-@KD02VQ@&L*P0'.3>*0-
M84[3VD\&E$RY48K",,YWW.7&3RV2X,MU;LPBDZ5;&[-(<T;*R]M!J$^X):Z,
MZH[4AY\Q(KQV)YD<!IQI L/> ,B!G2IUT.0L*04VH<&5R'=A")0%7!Q5LO:2
MA*EISNPGC@;&.#'U>=.FNBFO6O+\/$E&0V>V5M=D<TFCX&T^TBR6\W+*#Z(D
M3H=L0U BDNEY*J024 L PCQ0@ :"#"#%P#Q&:G-3:RW<E@NB+XT,D0R%KY D
MN*I-=E:$(ADY<3D_!(3UF0HU9CT52*4&9,',$PFHN1%4C99/P-G#9K D -@6
MQ,FC ]@["CBY9!+63@I'P?>O$ +.H,/*"Q!D/*I_,L\R^9U2C)E'C>8!"17>
M0(@9&32(*-D"3(EBQ(H'?.^!<H7 +@XX A!X8Z552P5525DVB0GBTFRY71DU
MMZO<'^B=A?V"FW7ZJOD_(A66B'1DUMZO<'^B=A?V"FW7ZJOD_(A66B'1DUMZ
MO<'^B=A?V"FW7ZJOD_(A66B'1DUMZO<'^B=A?V"FW7ZJOD_(A66B'1DUMZO<
M'^B=A?V"FW7ZJOD_(A66B'1DUMZO<'^B=A?V"FW7ZJOD_(A66B*E6CXFZY'F
MMIQ?I7I0HMJ'I 0H\S7'Z<":RXO*2K#D4RV:/8H#>UP>I!/(E I1+(A>UW";
M,&A$@<\(&5Q-!E@FW7ZJOD_)=E88+%65VOL=S[ ;YZD?!Y_.Q8_*+3;K]57R
M?DD*RT0]@-\]2/@\_G8L?E%IMU^JKY/R(5EHA[ ;YZD?!Y_.Q8_*+3;K]57R
M?D0K+1#V WSU(^#S^=BQ^46FW7ZJOD_(A66B'L!OGJ1\'G\[%C\HM-NOU5?)
M^1"LM$/8#?/4CX//YV+'Y1:;=?JJ^3\B%9:(>P&^>I'P>?SL6/RBTVZ_55\G
MY$*RT0]@-\]2/@\_G8L?E%IMU^JKY/R(5EHA[ ;YZD?!Y_.Q8_*+3;K]57R?
MD0K+1#V WSU(^#S^=BQ^46FW7ZJOD_(A66B'L!OGJ1\'G\[%C\HM-NOU5?)^
M1"LM$/8#?/4CX//YV+'Y1:;=?JJ^3\B%9:(>P&^>I'P>?SL6/RBTVZ_55\GY
M$*RT0]@-\]2/@\_G8L?E%IMU^JKY/R(5EHA[ ;YZD?!Y_.Q8_*+3;K]57R?D
M0K+1#V WSU(^#S^=BQ^46FW7ZJOD_(A66B'L!OGJ1\'G\[%C\HM-NOU5?)^1
M"LM$/8#?/4CX//YV+'Y1:;=?JJ^3\B%9:(>P&^>I'P>?SL6/RBTVZ_55\GY$
M*RT0]@-\]2/@\_G8L?E%IMU^JKY/R(5EHA[ ;YZD?!Y_.Q8_*+3;K]57R?D0
MK+1'\LV.6J'-#=B.6].-/V[@[HOD>1D%>CDNG/C+#*-G7$S94DA73'- \>6*
MXJ%I7(G2)XF?4+XW239<<IA8<$;%MU^JKY/R7943"W;EOGP6>Z,FMO5[@_T3
ML+^P4VZ_55\GY)"LM$.C)K;U>X/]$["_L%-NOU5?)^1"LM$.C)K;U>X/]$["
M_L%-NOU5?)^1"LM$.C)K;U>X/]$["_L%-NOU5?)^1"LM$.C)K;U>X/\ 1.PO
M[!3;K]57R?D0K+1#HR:V]7N#_1.PO[!3;K]57R?D0K+1#HR:V]7N#_1.PO[!
M3;K]57R?D0K+1#HR:V]7N#_1.PO[!3;K]57R?D0K+1#HR:V]7N#_ $3L+^P4
MVZ_55\GY$*RT0Z,FMO5[@_T3L+^P4VZ_55\GY$*RT0Z,FMO5[@_T3L+^P4VZ
M_55\GY$*RT0Z,FMO5[@_T3L+^P4VZ_55\GY$*RT0Z,FMO5[@_P!$["_L%-NO
MU5?)^1"LM$.C)K;U>X/]$["_L%-NOU5?)^1"LM$.C)K;U>X/]$["_L%-NOU5
M?)^1"LM$.C)K;U>X/]$["_L%-NOU5?)^1"LM$.C)K;U>X/\ 1.PO[!3;K]57
MR?D0K+1#HR:V]7N#_1.PO[!3;K]57R?D0K+1#HR:V]7N#_1.PO[!3;K]57R?
MD0K+1#HR:V]7N#_1.PO[!3;K]57R?D0K+1#HR:V]7N#_ $3L+^P4VZ_55\GY
M$*RT0Z,FMO5[@_T3L+^P4VZ_55\GY$*RT0Z,FMO5[@_T3L+^P4VZ_55\GY$*
MRT0Z,FMO5[@_T3L+^P4VZ_55\GY$*RT0Z,FMO5[@_P!$["_L%-NOU5?)^1"L
MM$.C)K;U>X/]$["_L%-NOU5?)^1"LM$.C)K;U>X/]$["_L%-NOU5?)^1"LM$
M.C)K;U>X/]$["_L%-NOU5?)^1"LM$.C)K;U>X/\ 1.PO[!3;K]57R?D0K+1#
MHR:V]7N#_1.PO[!3;K]57R?D0K+1#HR:V]7N#_1.PO[!3;K]57R?D0K+1#HR
M:V]7N#_1.PO[!3;K]57R?D0K+1#HR:V]7N#_ $3L+^P4VZ_55\GY$*RT0Z,F
MMO5[@_T3L+^P4VZ_55\GY$*RT1YW_P!)(B2*8\U$A528$91ZQE$]L>DD3I]G
MLQN-DZ<)>QE)1CF9HTBII(<P5[N$$-S<43,+NH88G(Y>&-['4VG+;Q6;;W,W
M_325>"C]+[TF_K2_R.]3_@TP3]ES6K)'F^;[EEJ$% * 4 H!0"@% * 4!2;@
MZ?(UAO\ D?WVH/:@+LT H!0"@% * K% G_%7=KX3K4_Z,M1J%>2Y?=EG:$-=
M[JX6?@W&0YW&S'7N+#"&Z&DNJS9<B*=7C-CB0O()\PEK"6;L&0$#L9(*!4P4
M'MAGGA84+.V.65N*]Q8=GHS5APA?Z3'J3JSC&J-K'FW]OW>YEY/4GP&V%X\B
M-!DQR54.Y+7='.(E#8G'^NAA&"C612Q0T23,0QEYS"@E<4A)<0W3_2JJQR5W
MX^Y?V.N'#X+B16*U'R#MQ'+1Q=*&06,VJ^!C[?>#;,&P<<C2$Y4?(F8P)+*2
M9[L1/X%39Y/$' S'35!03Q2QT<9=-2;33P([VWX3=#>.L:V]>#-F>)9LF='G
M'7>,.]A4#-TI&)V9GY=NHC;6"8H108B(]+)ZFCIJJ7L*,GB8&#H 8HI2P68M
M-,O]4I0WQPSSMU.;-?"(/57G?@XV]K6.BJ43;%!1Q)4UG5)))J2W>.)]0W"+
M +71!S!LN50%M[&&#+:H94C P5R?L;BIW'R#YD8J)LX.936"YIJ=)6''/#&?
M5?A.X'2H<:,T!L^755(<NK6QVVZRU$Q :.3UCF.M5T=+'EI!D)../DFD(S[(
MO%7*Q8E(Q!<5TM1D()2(Y+I9!25)PE05+;C#ZE3KD[QA8^"5O*HF'J_C)Z&=
MDB^2%KU%,L-O7K",HW4Y'7B$FSG)D5,YWD5=ORRK=YS3T";:6KKC8D;%D(D/
ML<IX92:Y&L,$]DMH!&&:SB<;3;=EAF\I6)^IO"5Q^J-]:*DX<EH_-B7L&BZP
MD->D16A1R/5SRPX(J#G).!;[W;\N*,+YM8K$."J_'$XU:2DFS73&TXDU<($W
M&2*HI\-GBHB9QB)C>ISPRS,STGV9>VP:=M@X9&;*XP H>VG><3(C+=:0A)SM
M9;::41PXYU!#= C46W0WE]4(.IUNL0)QMUP+R&NI(B:=05941Q"!TP#4*GBI
M_P#*I=DB@ FY6P?1WBS>=Y[EZUZ_ID_I-Y7@G5":6NUVM%;AAX80@NHK1=TX
M&E(>32\I*<;*B*LN)_H.6#+9SN702UXQ6T!,SQ4PC%TPVU@VI;GANSUN7;E7
MA)HCBU\/AO\ @))#V84.&6 4GV:VB;BS&/8:&DE$;KK0^^Z:YY+;<CO<-&93
MO:K[? \6L1[@M)G.%-5#F8YNYM-*"1Q6.2<XYY81FHQ>9_0'",LH>2C+/M!4
M^%V"E[0Y:=+T[G4^+BT:),[&UTNVFZBAI?LI"2@L-EQ+R@AHY9YHT>'4%.57
M&D)RP8(FR[D";PNSQ64QC,:1U. U.$LCI[.Y"16S#DR*K0D=QR:PX&DT(]")
M=KSS)$7(3W<!QDLY*49D(O5HB/<E'+S#C%V3 UXV83M&1+BB.E)3UEKGE\2.
M*48M8SC'#CS*\0/PI0[AB2%9DGAIOAIN22].(6F7V$60QF.K!/B1IHF))A^/
MRT2N O,;F61C\JO1PH**P&(]!DG%(05I,7)#<S452S@3$D5TK::3P3>/!8XX
M3@IF%CN5[$.3A%TYF -YN//66?F9-KKE4]$K<A-X*4"-<^OJA".@94S<K?EI
M;FLC +B:IEICX%R>:!*:FYAG<$>:&38"5DE7Q(!L\4U$SCXGIQ+SQJ][22PF
MH^[--[L/)T(Q55&9<DM_-K/QK&1L;XFD%U(61@Z$16$PS@*5,W(*"FDF[AV.
MHRJJI)DDH&1DU]R;O:=@/8#;Y,DA$<SQB:%&/P>6+(:<9-A)5Y$./W<.;9DA
M,UB7#4EM!"72HKA2(\%YADH!FB"<461$@JJ*1L%-,OXZX%2F.;Z),R;'A&&P
M7"76FMZ_3PA;#I<U-J!DC6(QG#2G);O>SRBTU-S</MYU(,NJL+^!UXF2W$]'
M"Z%:4$LFUB;2<R<K!AK)9+3U@79XJ(EO&$IBTYV1;J$98RF9A@O$U'<B1.LE
MUYSM5R1Y*:0FI+P;#C:"\?;RN4,"H"PY&JX$DT9(74FX[&>Y7$UG.@'4U91E
M<R7-\D(9)<H"L;H\LR#O@Q[4_:IIO0NY\UV99RA!0"@% * 4 H!0"@% * 4
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MIFR"J(2<)BTF"T$>1$^/]9T',$^%D!'3!.2H^%)MJP]C"F6[^&B8A,0.^ F
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M9=%'7,L;0A6-T>69!WP8]J?M4TWH7<^:[,LY0@H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@/-A^D\>1O!7PF4G[+).J[G
MS79FJ/K_ &U=Z3=SI?Y'>I_P:8)^RYK5"/-\WW++4(* 4 H!0"@% * 4 H"D
MW!T^1K#?\C^^U![4!=F@% * 4 H!0%8H$_XJ[M?"=:G_ $9:C4*\ER^[+.T(
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!6-T>69!WP8]J?M4TWH7<^:[
M,LY0@H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@/-A^D\>1O!7PF4G[+).J[GS79FJ/K_;5WI-W.E_D=ZG_!I@G[+FM4(\
MWS?<LM0@H!0"@% * 4 H!0"@*3<'3Y&L-_R/[[4'M0%V: 4 H!0"@% 5B@3_
M (J[M?"=:G_1EJ-0KR7+[LL[0@H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0%8W1Y9D'?!CVI^U33>A=SYKLRSE""@% * 4 H!0"@% * 4 H!0"@% * 4
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M!R!@P$ -G@*TUFBPE"'P-&2Y(L8.'!PBI0H *9-&1Q,0@"Y< /(4<<87.^.
M8006&0@@F=[8X88WRRO:UKWH#JFPYFZ]6VWGDT%Q)<[3=J&DN9KN5!/EE5#<
M+=7B!=51%Q&5"0@Q-2259--%CZ<?*#"ECA,P"8 $S"$PRN!Q$9[,]Q+SP:R
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M,551UD7.Z/ 1HL8XXU4J.,E*XUNE)3"PB=[3<>RW//+>4WBB<'VFLZ+604V
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MR!H54F.H.5,>^)8FA-$./>XCJ:LICCJA5-!2FUB 4,*"I<^$3)AA%Q31S#'
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MRL;897QM;BO>U ?;'&V-K8XVMCCC:V...-K6MC:UN*UK6M[5K6M[5K6]JUJ
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M H!0"@*QNCRS(.^#'M3]JFF]"[GS79EG*$% * 4 H!0"@% * 4 H!0"@% *
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M[TF[G2_R.]3_ (-,$_9<UJA'F^;[EEJ$% * 4 H!0"@% * 4!2;@Z?(UAO\
MD?WVH/:@+LT H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0'FP_2>/(W@KX3*3]EDG5=SYKLS5'U_MJ[TF[G2_R.]3_@TP3]ES6J$>
M;YON66H04 H!0"@% * 4 H!0%)N#I\C6&_Y']]J#VH"[- * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!YL/TGCR-X*^$RD_99)U7
M<^:[,U1]?[:N])NYTO\ ([U/^#3!/V7-:H1YOF^Y9:A!0"@% * 4 H!0"@%
M4FX.GR-8;_D?WVH/:@+LT H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0'FP_2>/(W@KX3*3]EDG5=SYKLS5'U_MJ[TF[G2_R.]3_@
MTP3]ES6J$>;YON66H04 H!0"@% * 4 H!0%)N#I\C6&_Y']]J#VH"[- * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!YL/TGCR-X*
M^$RD_99)U7<^:[,U1]?[:N])NYTO\CO4_P"#3!/V7-:H1YOF^YHDVMTZA:'-
M9-BMJ^$RG5;RW:?3HFIQ0'(<8[#S0CJT=+6:FMWUEAK5%E)2JR,#JJW4L)GW
M.H!)@* I]QJ"^:="BK(!>ZW@-IMM*E888-)X[W5A><=R2R@[A#2YEWFV#X/K
M1O> ^^DY!9G!@H&[.V<8)+F<D=FYIFUP/!N0LV6Q+8[*4FZM\T:"J6<[V6VD
MGJ*<CYO000JJ$39,H2*E@P2J=/K:I><4XWOAB_8@Z;)YEC@W67PNFHD"OUX8
MMJ-FUJ [M*S3O="\]5^!0-SWB1A=\ME%=KJ/+"_FWH]=(YAZ1D44CQ_-"&S$
M"%S.CB#&3(J2JV&\WM;6Z=G'<K8%F)YU48?!5/?0&?\ 6-SRL06GOM]"&J6U
M=GC+,C/TCLBQ-@\55I+#_DA%>3G7D@>1VN]0DU[MY8;Y)#YH;.*:?@'=*#3T
M\J(FZMI.,G4MT-8X1NB5'@V.<+3L4^M4N#IVEG*,#ETR1VVQTAML59PP#$&;
M[LE%[M:*4!RE<!L!0,CC;4WL6725C((Y7G:>#SH <OW0',9H2=23RW[LE)K/
MV'U)9W!5DM*=I=>GE+.$E ;2Z_09MNX'=+DE/L':>.IU6/ *15R26^\G0N(1
MI[E74I$GPSU=+3DS!O*=ABY8M<J"EX)HTGM[2<84MK!*(QPB-V'7.#FP#J<Q
M^%56][]CMDW9+!EW(6VT\:TZG'F?+,D,,KK''T F23*:3RC9 9KH044M(BV[
MPE!].E66B2S@J* 1$@*%WO$4RZ@#>SLI1]*;E+':4XSFE,+R;%^"+V$D/:'@
M[=;9=EM1NM2B90GBP9 7L[8]W<;IAV27E$2FZ#F0> 80A]T9L?%PJ(@(0(.9
MY3,9!  87L#@,U**FO?53]S9%0R1+($_03$ZH30Y3FJ)8T6E!/Q52"/($CLY
MFJAY+S,&">"D33W$LIILRGYFRAHKB<!!S+Y&"Q@"PEQ01,<0AO)2:_\ 0/;/
M59M:D1&C.+9C7Y 6"@3US-)*U,T<I2D6P.2,[SQ3,P1/.0 T#B:)&2YPMD(%
MC8<J8!,!7R"%#SR%AV>A<3IH:=];#6GT[1=VIH(=GHQTT-.^MAK3Z=HN[4T$
M.ST8Z:&G?6PUI].T7=J:"'9Z,=-#3OK8:T^G:+NU-!#L]&.FAIWUL-:?3M%W
M:F@AV>C'30T[ZV&M/IVB[M300[/1CIH:=];#6GT[1=VIH(=GHQTT-.^MAK3Z
M=HN[4T$.ST8Z:&G?6PUI].T7=J:"'9Z,=-#3OK8:T^G:+NU-!#L]&.FAIWUL
M-:?3M%W:F@AV>C'30T[ZV&M/IVB[M300[/1CIH:=];#6GT[1=VIH(=GHQTT-
M.^MAK3Z=HN[4T$.ST8Z:&G?6PUI].T7=J:"'9Z,=-#3OK8:T^G:+NU-!#L]&
M.FAIWUL-:?3M%W:F@AV>C'30T[ZV&M/IVB[M300[/1CIH:=];#6GT[1=VIH(
M=GHQTT-.^MAK3Z=HN[4T$.ST8Z:&G?6PUI].T7=J:"'9Z,=-#3OK8:T^G:+N
MU-!#L]&.FAIWUL-:?3M%W:F@AV>C'30T[ZV&M/IVB[M300[/1CIH:=];#6GT
M[1=VIH(=GHQTT-.^MAK3Z=HN[4T$.ST8Z:&G?6PUI].T7=J:"'9Z,=-#3OK8
M:T^G:+NU-!#L]&.FAIWUL-:?3M%W:F@AV>C'30T[ZV&M/IVB[M300[/1CIH:
M=];#6GT[1=VIH(=GHQTT-.^MAK3Z=HN[4T$.ST8Z:&G?6PUI].T7=J:"'9Z,
M=-#3OK8:T^G:+NU-!#L]&.FAIWUL-:?3M%W:F@AV>C'30T[ZV&M/IVB[M300
M[/1CIH:=];#6GT[1=VIH(=GHQTT-.^MAK3Z=HN[4T$.ST8Z:&G?6PUI].T7=
MJ:"'9Z,=-#3OK8:T^G:+NU-!#L]&.FAIWUL-:?3M%W:F@AV>C'30T[ZV&M/I
MVB[M300[/1CIH:=];#6GT[1=VIH(=GHQTT-.^MAK3Z=HN[4T$.ST8Z:&G?6P
MUI].T7=J:"'9Z,=-#3OK8:T^G:+NU-!#L]&.FAIWUL-:?3M%W:F@AV>C'30T
M[ZV&M/IVB[M300[/1CIH:=];#6GT[1=VIH(=GHQTT-.^MAK3Z=HN[4T$.ST8
MZ:&G?6PUI].T7=J:"'9Z,=-#3OK8:T^G:+NU-!#L]&.FAIWUL-:?3M%W:F@A
MV>C'30T[ZV&M/IVB[M300[/1CIH:=];#6GT[1=VIH(=GHQTT-.^MAK3Z=HN[
M4T$.ST8Z:&G?6PUI].T7=J:"'9Z,=-#3OK8:T^G:+NU-!#L]&.FAIWUL-:?3
MM%W:F@AV>C'30T[ZV&M/IVB[M300[/1CIH:=];#6GT[1=VIH(=GHQTT-.^MA
MK3Z=HN[4T$.ST8Z:&G?6PUI].T7=J:"'9Z,\]WZ1Q/4&2SJ1#"/%<T1/)BNF
M;&)*DI)<?R*SWFHIZ=>,Y)*]\#I%N+"D9*$N<C@E^=#A!@=W&"![IW03#&]W
M/FON:H356*?TOO2>A'2_R.]3_@TP3]ES6J&7F^;[FB" 8RX15BS&\]I]A^";
M)[0;:.9Z.M2;<PO'>/7T!'A:.S*V>NPHMU_8:P2<J9$R U6OD3)*BNAF<G:[
MEXROK2^X#>"KB1*C;=,0JH6$_I>+WM_:RXETYMCG<)N[*:R<)?%6L6+SD\/6
MET:Q[6:A$)ACT!\)K!<SO2I3:ZA&\G+QAOQB[%V.)!3U"ZR7-*2/@Y$55YLW
MQ0QQ#(@0B:ATMQC-+QBSE<5&Z<"OSAX-S8O=>*N$QE/8-OHFN$^;PIL&H,"1
M@.[4A_YP(VM3#!1VPMF_GHS;*2"8<#^DTIFXY!+-(5R$&^C#EBR<;4C=C:6"
M*JE2Z8Q5,R[NI0XE90E$HD=P,W?C?Z2=,&9LIJ(!J=%6K<],':2<WPIS-&,D
ME)@E6%TU4RCICPPWH_6UU:Q8BN]E4)VKRQ(!=M&"B$0*I6 !E8*#DU 3"F8J
MVI36343>5:SZ9VEVN@B<M^===]-1)0CENPPT7212VWK+*P3\(N^TAFTH)-?3
M;?;L;2,6NKL,HVI.;R 4/(QBQE4/)(1D\0MW3N6%Q$U2Z7G=/#VW[M_0J,ZF
M1PA6_*OI_"VS&I136:.=?YTBG839J7#\SQA(2#-;F@?NZLUF-";38BNK.C!L
M20^>][E75)]$6H.TVZ5R2<;J"V#S<\+^E2TY;3241$X/:W96;Q.4V67P@&@#
MTW*C76G48MM1&6RD]R3LSKS(Z?,T81TEPU($X%2!Q\L2:FR_EE%7\F4T'P2-
M.E 5&$5=)E;;QX9(SL26# )1/#]-23;AI)-1,PL&HPRA0XYFQC@\]5A])],8
M#UE4%TLZ'#&S3.9/1QD;#63UN07FY%N0)#4DRYH( V(DF7NZE_))%. %S@B9
MS3,T7+CY" AC-3EMZ<MW0N=0A\\P@A+\>88>=[6XK7SPQRO:W^G'>U_:H"DO
M!U  7TVAR]P0KWY#^]NX>%[_ /%![?YWM0%V.;E_< ?BL/NT YN7]P!^*P^[
M0#FY?W 'XK#[M .;E_< ?BL/NT YN7]P!^*P^[0#FY?W 'XK#[M .;E_< ?B
ML/NT YN7]P!^*P^[0#FY?W 'XK#[M .;E_< ?BL/NT YN7]P!^*P^[0#FY?W
M 'XK#[M .;E_< ?BL/NT YN7]P!^*P^[0#FY?W 'XK#[M .;E_< ?BL/NT Y
MN7]P!^*P^[0#FY?W 'XK#[M .;E_< ?BL/NT YN7]P!^*P^[0#FY?W 'XK#[
MM .;E_< ?BL/NT YN7]P!^*P^[0#FY?W 'XK#[M .;E_< ?BL/NT YN7]P!^
M*P^[0#FY?W 'XK#[M .;E_< ?BL/NT YN7]P!^*P^[0#FY?W 'XK#[M .;E_
M< ?BL/NT YN7]P!^*P^[0#FY?W 'XK#[M .;E_< ?BL/NT YN7]P!^*P^[0#
MFY?W 'XK#[M .;E_< ?BL/NT YN7]P!^*P^[0#FY?W 'XK#[M .;E_< ?BL/
MNT YN7]P!^*P^[0#FY?W 'XK#[M .;E_< ?BL/NT YN7]P!^*P^[0#FY?W '
MXK#[M .;E_< ?BL/NT YN7]P!^*P^[0'5Y*C=QSN%DHHN(F.=P\@\C9&V>.=
MK\F^%\+B<JV=LOU;XWMQVO[7%QT)*NM3M.;E_< ?BL/NT*.;E_< ?BL/NT Y
MN7]P!^*P^[0#FY?W 'XK#[M .;E_< ?BL/NT YN7]P!^*P^[0#FY?W 'XK#[
MM .;E_< ?BL/NT YN7]P!^*P^[0#FY?W 'XK#[M .;E_< ?BL/NT YN7]P!^
M*P^[0#FY?W 'XK#[M .;E_< ?BL/NT YN7]P!^*P^[0'FS_2=0@@].(+O@&'
MA>^S"3:]\,,<;WM[%DG>U>]K6J[GS7W-4?7^VKO2;O-+_([U/^#3!/V7-:H1
MYOF^Y9:A!0"@% * 4 H!0"@% 4FX.GR-8;_D?WVH/:@+LT H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * UH<()PLNG
MW!KF(P2MB'4M#.J4UY/)I;*8B86<SM0F8*>N16I3<R-WP(F$YAH N H68X/.
MUYPG0#:<T$)P&TU7P3AJFBJN867Y',V!L-^,N466UY%CIT(CU8CU1$]R--V-
MM0+JJ$X$)5+X&D]42U KF( 9*F0!,<\,\,N/&_*#$QP$PSPQ&3+* 4 H!0"@
M,4<;\8[/PN*[GFU&L%CCR\A'&XDA$PQQXN/E7S4SA7&V/%[?'>_%Q>WQTAO)
M2)2S<$)G=Q=9RIG,F2EQNNDX'?BR*, NM209O?\ RQP 8"6Y!!+W_9C;#'+E
M?Y<?%>M;-6<8<<.YG:5],>QQ.E "I^TSH%V3>6.?^[&@HJ,,A.,<?[@F)Z5%
M5AX6+Y>U>XUL,N+'CO;#*]KXTV>-.O@;7"K2![)>SZU^H@:R(;;Q%_V1R39O
M;Q#N%K_NB&$R/&[(PF?%_P"L$-1PSQ_9RKY>U2*?5/!+RQ-7ICBWX/)^Z(^D
M<1TN*YEC.KGN;@5[F,"K=71@>=9*)CNN)<01/#%%#[K?*P6>808F>/)RRPQR
MO?&W8XGJZ*8[I %2UK9:Q';8EP;6Q%"E=($]H/'VA/\ &6>3G;]F7M9?K<?M
M?Y5Q_1_ET.WZ_P#'J<COGN>![>3,UC4;6_;8*2932L\OY;"16JX8W_F$O;_G
M3]'^70?J_P >H\,MO"O^W@>%E7B_;WLV!<A'E?Z\GOE"&7%Q_P"7*_\ FI^F
M[T_D359:Y\OY'LF;1!?[?5QM#?Z]Z]A4,Q_^O?*/T;C_ .7'R?\ GQ58I]7_
M (_R_L)J]/7^![+NQ 7^\:CN 7B__BYFB0SQ_P O?)81N/\ Y<KD_P#/BI%/
MJZ/^1-7IZH>SG,!?_P QU!F0/B_;WL><#+'_ .M@97 OE_R]JU_^7'[52%ZE
MU\"7Z7T[:_F3I'.<+VCNJVS1;*W[UP4**E,.W\N29+AL3+_X"]O_ "XZNS_E
M3K_'YS&U_C5I_)^=)[N?^]:\[0E/]?\ PF[X<7R,OJ?'_P#CRO\ E39_RIU&
MU_C5H?O2K; 7^^Q)LT0QM^]F-KG*ID/'^85,;Q\/_P#K*_\ RXZ;/&G7\_.
MVN%6A$$][T-MAQ"]G2PD)^A/Q(3R8K>(R-!<T(#9%-CJR>4&LKJ:@V6\FE L
M"1@T(#D:7T[ 0U@ #B*)F)@ ,5,OA=-$=:CC9IW_ #>4ZU X2.>)YV(CZ)WH
MWXO)MMV>%.*@:;J"Y2*P#=%9CA<13(F9/O!5*!\LZD%PA[#$![9EA!L,.Y"Y
M8#!ZJH23>)*:VVE@;Q*YG04 H!0'FP_2>/(W@KX3*3]EDG5=SYKLS5'U_MJ[
MTF[G2_R.]3_@TP3]ES6J$>;YON66H04 H!0"@% * 4 H!0%)N#I\C6&_Y']]
MJ#VH"[- * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H"CLU\(OJ7![K$C)0D<>4)POW7 GKYK\VU^>9S-F@\K86*FHYC @X
MU=KXYYWY-E-[^"Z$%>V5S*J!CC?*PTJ6U,87<)=8GV(=]DSA-]C_ /#BB$8S
MT.C@_P"T%(VTBB5F_8,=-,^V"H(6NL1.8I'#24PP<>7W*0IT6#)487 )09V>
M00P6(?I6>/+!:M3T]]YYF.%^X->-'].R3C($Z; 27LL2,LY1F&?GX8C:Z8_6
M"H)  EF8SHI8['8S9CB[7!M:S--DS2L7+8FU(HXB;AOFGGD[:HE3(7]=T-I4
MJ+8YN,<9?7AAF;7=8]<^#?;D%1Z6AB;-P]/E@DG'4XS'L);D;'.);YXFJQ\B
M*X5^-4XX[([&5G<8 S=AT,A%",E&SRR.9 1\,!K7S.BK<I5\/)G_ *VUC5$\
M:5W2_.I//@UM^WO\+7'>/?Y_I5N.Z83V"TA@:2T87*_[EQ78X6GJ.[3Q2_ZN
M-\AWE82P=KWN-<>^8N4V>-*X2/\ J4O_ +;?&F5I+:Z>Q-T*N[ACL5D0M,$>
M:E.)HE\[6(+(22Y8D>:P5MC:]A5=+1)UG]!13PM^/CP(XG0 _:MD7QO;*D+U
M>R3[X!OTTU+_ &J7V2?0Q63=F>%>:KE'+@Z(<[C@+E]W>D,N.&9A>@.-LN+'
M,@PGYLO!IE0Y6''E:V  PM\K6QR+A\?MOT_Y-^R7W"3?]U*]JGUB-87L1WTX
MR!7VMG)$X2O78G^P814X/QT,EIAC6_?"O(<7Q-L$B AX?^Z-:0;EP0^(3(\'
M;*PV3:6ZE>[;\#8J>.W/)JEZ9],(9)$?[!\%#,!KO:-OJUI07KB6!NUI:W$<
MC8<%A[\7+ RC1P/9B#8YVOE:PQ3)IVP"SRM;,##/*W&VGNA;L$N8_P"F]ZJ?
M%RUJL#8 P=?=502)9?CZ*8852AB_="KF2VXUG.*9O[65Q G** J&C%[WO;++
M/%0SOE>]LLKWO>UZ;53WO4FRENU_DL&2($4TN&33B94@4"MQ!%21<$J7#M_H
M& !@&%A;VK>UCC:LE.50"@% * 4 H!0"@% * 4 H".Y8C!L3/'CGC%Y=\/!I
MVDRY)5NDF\2*CB$5/E%(#,H;S!,8 B8&R0&7'F +AEC;+#+"^.5ZJ<.2-2H*
MJ0SP=>OD%20W939(K]%=#7[[=Z[+;E)GTVUUE%44 YD8* (A(0:]B"H:L#;G
M&.. UPQ+XY\CDWKK;48$5"3G$O?630H!0"@/-A^D\>1O!7PF4G[+).J[GS79
MFJ/K_;5WI-W.E_D=ZG_!I@G[+FM4(\WS?<LM0@H!0"@% * 4 H!0"@*3<'3Y
M&L-_R/[[4'M0%V: 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MEJ$% * 4 H!0"@% * 4!2;@Z?(UAO^1_?:@]J NS0"@% * 4 H!0"@% * 4
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MGGC0;*PFI*<M\8[[3GO-C&N\]1WM#!T6["1,HF%2/)<9R0]&P.= P*J1<FJ
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MXO6#UY^B@_\ \WE!A9ZKP/ W<7K!Z\_10?\ ^;R@PL]5X'@;N+U@]>?HH/\
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M>HBGT]O_ ).0=X(9&/)YA.#>4.H&1C#''!<;D03R,Y4[+ 3$3NB49?>Z3]0
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MW++4(* 4 H!0"@% * 4 H"DW!T^1K#?\C^^U![4!=F@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * \V'Z3QY&\%?"92?LLDZKN?-
M=F:H^O\ ;5WI-W.E_D=ZG_!I@G[+FM4(\WS?<LM0@H!0"@% * 4 H!0"@*3<
M'3Y&L-_R/[[4'M0%V: 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H#S8?I/'D;P5\)E)^RR3JNY\UV9JCZ_VU=Z3=SI?Y'>I_P:8)
M^RYK5"/-\WW++4(* 4 H!0"@% * 4 H"DW!T^1K#?\C^^U![4!=F@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * \V'Z3QY&\%?"9
M2?LLDZKN?-=F:H^O]M7>DW<Z7^1WJ?\ !I@G[+FM4(\WS?<LM0@H!0"@% *
M4 H!0"@*3<'3Y&L-_P C^^U![4!=F@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M'4^YGE\T[ER.>@<GNG+Y5^1R,@6#3L2?0"@% * 4 H!0"@% * C%X1S=UO\
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M;6Q<6&HQ-2W&J><322N[HY&R55HHJ8((JVA".!LJQA#?*&36TX^IM4J2S&,
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M;H,1D(O"1<$6\T=FM5)>#GV V=!<KK3&\D$'*X0BFEDN!E0EQ=*DPE16#+8
M X%\#YHQB#@"%B';&P>%K4M/T_U.5/\ [(W$4,&G#APB+N%U,B=;;3N+1XC,
MW=S3EUR)(ZDDIZ\A1JQR,SH1'.2'(AK& J(KM]@.Q2:CN4B"^ .@C!(]KK0
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M)/QJQ5-FR>JKZY)#35FLBJS;?JNZKA>$A]XH:B3-)KC'7+  !J>2N6-V. @
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M> H>A !SC@&'):*XZ:C&$7Q2MQ;D[K0[=2T\=3P(]W'Q(!'1!@2& PN!/ '
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,%#  ,#5-+3EQD?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g257749g78s94.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g257749g78s94.jpg
M_]C_X  02D9)1@ ! 0(!>@%Z  #_X6EO:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q(#8V+C$T
M-38V,2P@,C Q,B\P,B\P-BTQ-#HU-CHR-R @(" @(" @(CX*(" @/')D9CI2
M1$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D
M9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O(@H@(" @(" @(" @("!X;6QN<SIX;7!'26UG/2)H='1P
M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O9R]I;6<O(CX*(" @(" @(" @/'AM
M<#I#<F5A=&]R5&]O;#Y!9&]B92!);&QU<W1R871O<B!#4S8@*%=I;F1O=W,I
M/"]X;7 Z0W)E871O<E1O;VP^"B @(" @(" @(#QX;7 Z36]D:69Y1&%T93XR
M,#$V+3$P+3 W5#$S.C,Q.C4R*S U.C,P/"]X;7 Z36]D:69Y1&%T93X*(" @
M(" @(" @/'AM<#I#<F5A=&5$871E/C(P,38M,3 M,#=4,3,Z,S$Z-3(K,#4Z
M,S \+WAM<#I#<F5A=&5$871E/@H@(" @(" @(" \>&UP.DUE=&%D871A1&%T
M93XR,#$V+3$P+3 W5#$S.C,Q.C4R*S U.C,P/"]X;7 Z365T861A=&%$871E
M/@H@(" @(" @(" \>&UP.E1H=6UB;F%I;',^"B @(" @(" @(" @(#QR9&8Z
M06QT/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z=VED=&@^,C4V
M/"]X;7!'26UG.G=I9'1H/@H@(" @(" @(" @(" @(" @(" \>&UP1TEM9SIH
M96EG:'0^,C P/"]X;7!'26UG.FAE:6=H=#X*(" @(" @(" @(" @(" @(" @
M/'AM<$=);6<Z9F]R;6%T/DI014<\+WAM<$=);6<Z9F]R;6%T/@H@(" @(" @
M(" @(" @(" @(" \>&UP1TEM9SII;6%G93XO.6HO-$%!45-K6DI29T%"06=%
M05-!0DE!040O-U%!<U5':'9D1SEZ84<Y=TE$375-04$T46ML3D$K,$%!04%!
M04)!05-!04%!045!)B-X03M!44))04%!04%104(O*S1!1&M&:V(R2FQ!1U1!
M04%!04%F+V)!25%!0F=114)!545"9U5&0F=K1T)164I#=V='0F=G3$1!;TM#
M=V]+)B-X03M$0D%-1$%W341!=U%$031014$X3T1"351&0E%417AW8D=X<V-(
M>#AF2'@X9DAX.&9(=T5(0G=C3D1!,%E%0D%91VA54D92;V9(>#AF)B-X03M(
M>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX
M.&9(>#AF2'@X9DAX.&8O.$%!15%G07E!14%!=T52)B-X03M!04E205%-4D%F
M+T5!84E!04%!2$%114)!445!04%!04%!04%!05%&07=)1T%104A#06M+0W=%
M04%G241!445"05%%04%!04%!04%!)B-X03M!44%#07=11D)G8TE#46],14%!
M0T%1341!9U%#0F=C1$)!24=!;DU"06=-4D)!049)4DEX459%1T4R16EC6455
M37!':$)X5WA1:5!")B-X03M5=$AH37A::3A#4GEG=D5L47I25&MQ2WE9,U!#
M3E51;FLV3WI.:&156DA41#!U24E*;TU*0VAG6FA*4D92<5,P5G1.5DM"<GDT
M+U!%)B-X03LQ3U0P6EA71FQA5S%X9%AL.5=:,FAP86UT<V)7-799,U(Q9&YD
M-&58<#=F2#$K9C-/16A984AI26U+:31Y3FIO*T-K-5-6;'!E66U:)B-X03MQ
M8FY*,F5N-4MJ<$M7;7 V:7!Q<75S<F$V=F]204%)0T%1241"455%0E%914-!
M341B445!06A%1$)#15--545&55).:$EG6GAG6D5Y)B-X03MO8DAW1DU(4C13
M3D-&5DII8W9%>DI$4D1G:&%357E7:5DW3$-",U!33F5*16=X9%5K=V=*0VAG
M6DIJ6D9':61K9$95,SAQ3WIW>6=P)B-X03LP*U!Z:$I3:W1-5%4U4%)L9%E7
M5G!B6$8Q95@Q4FQ:;61O85=P<F)',75B,E(Q9&YD-&58<#=F2#$K9C-/16A9
M84AI26U+:31Y3FIO)B-X03LK1&Q*5U=L-6E:;7!U8VY:-F9K<4]K<&%A;G%+
M;7%Q-GET<G$K=B]A04%W1$%104-%44U2040X03E5-'$W1EA9<3=&6%EQ-T98
M67$W)B-X03M&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T98
M67$W1EA9<6=B<EA.2'1:5$1095),8T-N*VI"9SAX<C T>$Q74G9O)B-X03M'
M2W%0-F)N;49B2%1,=6-(<$I):3)Q02\U475$2$PY26I/2W5+95I:,4E,,F1I
M3VA#:5,W2D(W:&HY5D-N-7$R2W!(-4TX;EAM:F%V)B-X03MQ5C=*3SA.;$M4
M0EEA5D4V:3)73E=Q8FAO66MI:5-346I92W9W<G-34V1L5UE9<3=&6%EQ-T98
M67$W1EA9<3=&6%EQ-T9867$W1EA9)B-X03MQ-T9867$W1E5N8E9,+U5*2&@P
M5EEX06A+4V%P3T,X4$I447)$1W!5>D94<W@U2V]08VM%0E952&PV,VLK2R]U
M3&I52$]Z0V%1<D52)B-X03LT1T-,,#134&UH3TMS5UAZ6BM52#%/5SA#,E,R
M,%1O:D]B1C%Q2D5K:U-605E16&A-8T5J*W-O369&1V)L4E-1<7E',#!N>6YE
M*W8Y)B-X03M2=$E9,G1:;6=L;G153G,V>7@P3'%S<U%J63A3,41X86Y+;S9G
M:D965G1/,65Y0F)48G<S35DV5TXK>&1A94-824142V9E5#%-5E)/)B-X03MM
M871"9FE606IW6&1S470Q6GDP17-28F1A,$I"5G8R5U5L5#)06$959&ER:5%!
M4U111&-K-'%L:F5:9$4U1EEB:UAB<G,V5V%09'-V)B-X03LK=71U<VA8-F-6
M82]397)Z549P<$QQ1'8V;#5,2$%H2'-)+W)%;&9::T=+=2MQ*UE*+S<K*VET
M54\O0S!H-5-,-V5R3UI%8B]!2D9$)B-X03M&6&8T9'-:3C<R4V4O2BLR3&U6
M,FEB+U=G57!"+W=!:SA64C%P6E=D;D-)3%-#3S)H1S1I:5)5544O-4MG1$96
M8D9867$W1EA9<3=&)B-X03M867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ
M-T9867%L;79M4U=#,C Y2&%,.4EZ:3-K;%%L5U=-23@P;U5J8T9O-&U116)I
M=&4R)B-X03M+<&I$1$9$16M-2T-/2TY1:V-A:6EQ<6EG04$V041&5S-26%5O
M-$1+=TE:4TMG9SE14FER>6I29GEB=3!S8C5D8VMH,4-D3%,R,"]2)B-X03M,
M6G U2'0W94<P1392,5I)<F%4,'EL,#9'1FDY535).&IH:FER2R]+1V=E8G1(
M,4\V=#<R*VAU4$QQ2S8V9D-T1$YY85%-2DAP0D5Y)B-X03MU45<Y571,3#9J
M;FM05"MZ:7),8U936'I*1$Q!24Y8<WEK9#EB3VM43S1*4C=E9'A(27-G56=L
M535#554S<79U87%Q,S9.,65B+V5R)B-X03M66%1T=W,T631623DO5BMS=B]W
M3&I&5W@U6C!2:41C5S,Q>&AU<EAR=F1L4TXO:#ED<$]0*WAX5DUL5E952V]!
M54-G03)!07A6=D98)B-X03M9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W
M1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ:UAM<E5B1WAI=&)Q5S1J4S1S<&AC
M>%=Z)B-X03M/:7E42GAA1U99,5EG<S-P>71W039T45EQ;DYR9%<Y,6)X,TYT
M27,Q=DUO94M61%9753=G9VI&6&LV*UIR0S$Q3SEV4$U7=5@Y;#5K)B-X03MS
M=%9M+W="=S%V4$E9>'!K57@T3V));%E7=#)T1CE34V-R56)N;%@T8TMP4G!V
M;7(X=TQB4W1E:3%&9%%T8C=7;V]T8C!S>G9$3DI")B-X03MA4&1*2&9X,F%X
M4U1L571R4U=.,%9G1S5C:GAX5F)E95IB>65$53E(,$,K;G9D4$]O-DM,1R]I
M,7$W=4DU:W9.4CE#4T@Y24-&8FE!)B-X03MY27%I5EDU2E)(5VDW,4="5V8X
M03594S9O<659=% Q2U=4,3E.,59O23=34S=M=B]!14EM=$QE6E93-W51='A-
M:D=5<T=K555Q5D=W)B-X03M'2W O<E5W=7)M,C!E2#1P<%AJ=6)O:F-2,C!-
M9V-L+RM-<DHV86IV5FIU1D]+<'9I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D
M:7)S)B-X03M69&ER<U9D:7)S5F1I<G-69&ER<U9D:7%8>BM99$9H;&%$-C)K
M='EH;S%R0E=E8T@O:D9%2&LO-%A&5E Y3#,P,C%L<&,W<69S5#-*)B-X03M3
M,FE0>D1&<#$O-44T<3<P9DUC-"M/-'1R2E1S6319,G5*05!&6G!$171F;D-C
M5F-F3#A%=BLY=#-D,W O=T-,2FUI46IW361V-DUB)B-X03M$-7)I<4QS=$XP
M-GA6;'-R5T<Q5G9T0T=.67=F;GA!>%9"4V%28U=K.&QZ;SAQ=T=6:DI067E!
M+U9P2%DQ6FAX*TM*,E!6;'%$=5=6)B-X03MJ=FEQ-&$U3$0X3B]P.3%B=C U
M47AT9'AS9CA!26$S16HX9F0P6#59<75(;5AY.50T=%-T-#(W<$Q)<V)J-7$U
M5F@Y,DMT3C5L,&9F)B-X03LP2EAV2V0W3TM7-D9F9&]6:U5F4V-653-U9DU&
M.3A&<F)$5$E4<SDQ9$9*2G%5-GA14G,V8CEJ22MX-F]C5E)M;F%883)%8G)$
M>657)B-X03M:=E5U3&E1.'!:6&]">61U*W=O0C!!,D%!>%9&-'$W1EA9<3=&
M6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&5G-S<U558E-3)B-X03MU
M<V-A0W)/>$%51'A*3TMP8B]I6%(S+S-L;&$K.3=+3U,U54AS1V5&6%)39CAP
M:&ER=C!H<FLS*S@R;$-%9#)V6C!J*VQ69T8Q6"]:)B-X03M&8U9D.5(Q,F(O
M96I61F=(54-Y9U)$.&UA-$YY1#E#:D989C1A,&QY1&1P2F9(=4QY5U,T4W9J
M-E5J3D5$.&Q'2W!J0D)"0D5S345A)B-X03MX46]+2D=G0W%"-$%$65EQ=GA6
M,DMU>%8R2W5X5DMB+T%-,V569%!V2C=,54Y8<S=/-G19575B:4LT;FII2U%Y
M35574G5:5VEL='9U)B-X03LX4FEQ02\U5V(K5S,O53)A3B\S14Q8+W%P:7%9
M>65A+TLX9'AC,C!M<U=+6$9N16)I.&AA-6A$=W=G8VI*27!A<4I1,35.=&EQ
M2D]R)B-X03LV4TIB2TDS<T%L,45-,FYX*W%N2S1#2C9J1T56<DI24&E01W4R
M*TMO=D9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W)B-X03M&
M6%EQ9W)Z5'!,;5AK8C8U:&=P4G)A17AO<#DK650Q9V8Y5GAI<6Q&-6,P4DI"
M2S%O='A/<'%S.7E7=5I14C!P2DU:2$@S-'%M5TMU)B-X03MX5C)+=7A6,DMU
M>%8R2W5X5C)+=7A6-4Y*-6$X,E=8-78V>'(K;39):W1N3D1"8VU:,F=E2V53
M2WEU644Y2C5U37-&,%A+4E5J4$0P)B-X03MY>&,O175+<#="-5(Q:CE&95<Y
M1W55.6$S;&Y/<&5B-V]U=C<V-59F5SE.:'DU37-L,'DW0V\T2G@V57A6:$AM
M=CAU4%!E;U1A-4AB)B-X03M7:VMY5'EA,4YB23!T;71K>6%H07E19E9Z>5<V
M1G<W8U!6.6,K:U!I-# R=W%M,FAE45!.,70U,S!#-W9,64A2=DLQ,6,R3VM3
M0U=-)B-X03MK85I,83-F0U9K-59"<DYB=V-A5B]D.'%53W=6-C=I<G-64V9Z
M4#5S,%!Y>%EW,W5S5&U+2S1U27)70D52<%I*2EIM;W%P2$='9'E")B-X03M6
M:49"3D%C5E%#9FU6-5!A-&AH*W,S0TQC4GE4,CDQ2EDS<V1P2D1&1UIN;&IU
M;FA7,V5-4FIL>D0X4T]H,WA6869Z4#AL:49P1&54)B-X03MH,4MG,C,Q2SDK
M<SA74G!&:T9T-E!R;4UX>',S<4)/1D%46$954F$O;40U3G4T=%AM=#E5:FMI
M,$M'3S4Q5G=(-'A1>7<K=DA*6&HX)B-X03MA=$=/44M6.$]U2W!X<&UP5U=Q
M86)A86Y9>65T6E@P361Z87DX5UAN1DUG9$<T<T995E9G8456>%9%-'$T:T%%
M;F].>FER=S-Y-34V)B-X03LX=WI2*UE(,3=Z3&514&$R+W=#;$E7,#9#=VUH
M;&I3,W1M2S)5,&MD=T]$=&1)0DA*1GI02D1Y-65P57%N9&AR=FTO4SED<S=8
M>E!Q)B-X03LK;WDR,$LV8D)D>C)K96MM,RMV6#@P;C=M-TAP0S8T='II:59O
M23$R2$DP<EA!<D8Y82]/1'IW;FU3-4YQ;#%A44ID,D4P5VHS1VYZ)B-X03M1
M=CA!;RM+1%5:<G%*,W5);"]F6$,R<V)+45(O2VQE1&Y&5V5E42]/=7)E6790
M1W9R.5I78GDQ.59T-VI115)&1EEX8UA&<$I.>D%$)B-X03MU2EI,5FU7<'!X
M<%1X2W(P4$9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1E5U
M,3=6:G!D:71Y140X<%5I-"]%5U!-)B-X03LP06I247I33U1S<41Q97!!<5%Q
M>%=,.'DU;FIC=%I24G9%0C8S2V1416I60WE-,'%H;#E'2C9X96]+;5-11DDP
M3D-C3DMR:CAW8F=Z)B-X03M#26%E>%EY;4528V@V,U!J>5-(,#8O-S!3:C1V
M4S5F=6\O:FQD4',T<7EF4G118E5.3FAU,T59951K2%=&+U925U)Y:DM*2TQY
M-&QA)B-X03M%9U4X3G-#;S-&6%EQ=W8X,5!+;7-E63E&,"M$4V\T2F)M>3%+
M,'9E13!J,C<X65I">6%'-FEQ.74V9S$U<7)(:E5!5DEX5E1S=DM0)B-X03MM
M;4=/+W4Y475R5%9T65A2;TY+,'57-D1E:3!G:4Q856QW9U)Q0S1U0W9-3'EQ
M:4PS>%9*;V9);FY5,DXU.6%T8D,T,4Q51E=,57)U)B-X03M45F)S5%A#0D=6
M9E1N=#=+,6$P4T9J.$U52V-85FU"<#%:5DMR3#AK+TUL=%-*=%-T6DEB>5=+
M3%=M0610<DYL0F$R46I54G%N1D@K)B-X03MS,DQJ:E=N<%-.=EA91EAP+VLO
M4TQN4F9+5VEA4&1-:C-7;3)&<EIZ=D5367I*0D-S8D9#=U5L4U8R<4)G5DXX
M5F1I<D1T46HO2V9Y)B-X03MR8UA+86A(<$]K>F%Y,S%U-6IM4T=0-G=90W)C
M>7)$-'5$24@R-DXX6%5K-'%O6%!N8CAM<#E5:#%/-3%44EID5G1U4U%8,&I1
M3F-2)B-X03MC0E8Q5U5J;6Y%2&-!-UEQ=6XX.2]K+U!D0SAU3E<P85<W*T9H
M8T\X1%-(,&\S-&M/9FDK0TLT:W T2S=D;4]+<VXP=E1.1'19;W!T)B-X03M,
M<S=A,VEA0T]'1C=A2DEX.5=1<SA586Q!4#-A;5)I<3E"52M/2V\O1EA9<3=&
M6%EQ-T9867$W1EA9<6<Y6C%A>3!F4V(S5G(U:6QN)B-X03M945-83GEY<5=9
M4GA+6%EH4G5D:&ER17)4.#)D2VTP3%1D56939%-J;#%+37IP66E&5VU&=6M5
M53!L>79X:%I915,T:E!+27-X<G@T)B-X03LX9U9#<5IZ968Y2FDQ4%=D4$YR
M96UB4DQA2S9N+W="1VM8,5).2DI'<3(T8TE:871%44A8-$0O3G-C5E%.;"MA
M,F=82&U$5"]!0R]0)B-X03MA6&QL<70O3&17+V\S0U%L65IR3E5D-#5:27!:
M57$V>7)W2T9G4V%60C)X5D]02V9N2%-03D5E<'DV64IF4S!Q+VTP>6%35E95
M4U-W)B-X03M+:DTX6$9M-5)K4T1I5%-V:&EQ95EQ-T98;G8U-V5:<FYY,RM8
M,"MP,CA3>G-T>$)&2D,W3VEU:VIC5U5T1U9C0FAS94Q#;S(W-'$K)B-X03ME
M1R]/<E@R9%A7=V=347%R+U=9*U%+<VA%8V)*5VEX:4M/4F\T5EAI<V9)=%)8
M<7=+,#50>C(Q=C!R:T13<E5)=DM*;U9A640V=4)6)B-X03MR8TAL>E=/4G9I
M;$MN;DEF-W@V54)6<#E-9FQ$<F0U<F8U9#94<58T;U,T;"MS23A9055)26)Q
M5TI50W%&5E%Q;T%!;V]/9S)W2WI()B-X03M&6%EQ-T98>D1Q4"]!1&Q:-7=T
M6C-J6%(Y4$E76#!Q=#8K=SA4>&-N9G(P+T=O0W1.9CA!43%V;D@Q0VXV1G-+
M04M19C,R.657,SDU)B-X03M49FHR+T4P0E9P;68U32]N=#5G.#DK6E<P<E5.
M4'1,5T57,',O<5<O<3AG,&));T(U<S-8;#1F>&]Q.7-X5C)+=7A6.# O.$%/
M5W%S)B-X03MD4S!V-&U#+U5N3%5#;&1P<6IK0T,R+U)3=F9R44A&43A&;FIC
M6'5N9G9'-4)%0W-1;TI#.41',T=L1#!8;G5V-U9+67!D2D5W:3%4)B-X03LT
M,G!Y0F-C5D9#1%@Y-'9(63%.0G<R0C8W1W5+=G8X03AT9CAO-7!8+TU(8B]W
M1$IP8U5*:FER<U9D:7)S5F1I<G-69&ER<U91;7(R)B-X03M-;6]A5F0R361W
M.7!*9%%V16PQ1T9:-'DV;%$V<31:5%-V46I&6&QD;"]Z:B]'=6AA9F%83W!W
M:2]T:VMJ;&MI=&5535-Z=S(X56I7)B-X03MA3DE$1$]R5V=L4V9F.31Z4'<S
M-&A6;F0O=T-5<G%B5W12,65Z,4XW2S9V3DYT9$]G9%EW-U).851Z5&E5;&TK
M35 V+T9K;TYH,3,R)B-X03M666=F>5!02V4U:#%I3WAV-49M93%A>'-H0F)7
M;#%*4%IZ>%,R='8V>CA&4G)$-&M,2&U866MJ<&ER3"]!0TXU2W1V2U9L93)6
M<D]:)B-X03MR939U23=I3E-N17AI3WIT-U1I5'EB;50Y5S5L='9T9E-65U-9
M<3=&6&MN+T%$;$@O=T-3;75V*UEU,2\T;FEO9DEO:FE,23-O1W9#)B-X03MO
M:D%J3E1Y441Q4V4K,C-Z-4-U2U9&16I-9#!04W)X3%5F-&1T:E%B=#DS2#AE
M>6PY<B\X-"M+<2]L1F]3<4]+<3$V04YG9'(V8V)H)B-X03M3=W(X='-73#!4
M1EA9<3=&6#4S-C9Q3&8S0CE+;$QL<7-E2416,TE016<O,F5"<E931E P;R]7
M8CEW9"M)2U5J<4-1.6$W.61V0692)B-X03MS47$Y82\U>%)#+SAR0V,X2T5A
M9F-$,4YT+S-K5S-7=&9W+VEQ6#$Q:6@R2W5X5CAZ9CA!3U<V2V16,'!Z1GHT
M5U5N>%519V-P<4-T)B-X03M32$<O47(S,DY18U9$=U-:26AD5TDK<C!75E99
M2CA!<4A.0GA)86A!4%%V=C)B;%1&3&-K8V9$568Y2&]95T%*-&]/3E1X*TEC
M=FA0)B-X03M)5B]D-U8R4'<P059F;T8U82\U4GI3=BM93S,O04]44S1O5$A&
M6%EQ>&9Z<"M91VUE5EIR0S-U3%<U=F)R55A54E%7:65O-&HY94=")B-X03LU
M3TYE5#A7=55O:UE:>EAP4W!#<6QR;C5M*UAD2#$R9E):;&UN=3=A,"MT>F5G
M9UI1-S-%1G1&8D)I5DAR4U!D>#!7=7=)3$5!:D96)B-X03M+8C@P=$9H:$A/
M=W9Z9G!.4$)E85A(2$1*9%<O,5)9,W5*2D935FM:23!U23(O9$\U25EC451I
M<6AE+VY&-51S.4$X=V$Q36PQ-DAL)B-X03MZ54I.3'9B8U)O6C5*-'!"1GEH
M6&YX6D=.4T=,1%E'=$M9<7IN1EA9<3=&6'IX*V5(-7<K9B]+;FYA8E,Y179O
M8F5W4T,S8TQ*8DI,)B-X03M2<%!T5F%J3BM(>3,R>%9G0B\U>4\O3C,V,'-8
M-E1T.3!$52MP=S%/.4M$86@K:'%E1RLR2V%4:GE:*V9V-6\V;C5S,%14-S-5
M64I,)B-X03M/.3%3,'1,;$9T155M2U<U4THQ-6-1>6MQ,C%2.4YD<U9P.5A9
M;V1I<G-695-F.$%/55@O04I+838O-6DW6"]I94MH.&MH6GDV:SA7)B-X03LK
M06XQ94I);U=116UR069&6&IV-"]&4W!O<%$V0V(P<G)C1VI0>5=J5D<R-4<Y
M4BM0*U8R>%,K,78K8V9W-"]+5%%W-#1S1W9!54%))B-X03M#,'9P>'AO4V%C
M96Y81FDY1'A6,DMU>%8K94]U0U58.'AQ17!C;FE10T-U-4E.5DI/+S)T:#AT
M*U%X4T9G4V8Q;3)18DM!94=X2'A%)B-X03M!04Y496QF:#(R*TAC0W%R,6HO
M;D9,;B]!37)!8VMG<BMJ-V=$63%(-WE0871F<#95.$XK5TML.6,T;V1I<G-6
M9DY(+T%$;'%S:#%8)B-X03M35U=G0S)-=%@T:VQA>3!.1T)$3'I(=S=!9R]T
M538T<4AG,#1U0F0R5EA8:S9K:C170WE&=&EX<7A$96]0:$IB:50K,D(Q>%,S
M27,O)B-X03MP,R]X0VM:<%1I.5EQ9TQX1E=Q;%8O9#=C:#)0=S!/2W9V-WDQ
M+WEJ;6QF.'=D=B]!36UL>%%M3TMU>%9H4#5N+VPW92MC-T<R=&)F)B-X03M5
M:%E*1S9E<GEH16I"9EAI;$TQ=DE#<G<S0TQ%46IB9VAI<$<O24MO2%A0>5@P
M5R\Q930Q4WEV2C=/835G=6QL:6MM=3=I2G)M-6YH)B-X03MM.6-O8FA!1E@P
M4#=T3T\O1C%+=D=H0W%86$@U0S)-,7)(>3%,;'%5:S$S3&4S,'--;'=38C%9
M1F53,BMS6$5S<TTX4S)S9G!3=DQ))B-X03M687)(:V5I<G16+TEI0R]F540K
M;35),#%%86DP,%!O.&]Z3F5Y,TPR.')R-F<U3F)*9GI*+VPQ0BM(:4U697$T
M<3=&6%EQ*U%0*V-O)B-X03M"1"]Y<W$T3'!8+U)R5W)!14AO86=0>%ED3S,P
M-SE-56@U3U)"*VM&2'!J9$YL.4YQ8W9%>#AA.5!!;GAQ96U+<V@O3%E7+RM0
M9DQ0)B-X03M"2T5A-5E566=K9R]823959FE.=5 W2G T*S)+=G9B1D1S5F1I
M<GE4+VY+4"]W06Q.9&8X>&1R+T%-5'A54&M50S),24%G-#A0<V5M)B-X03M3
M>#5-;$]I:798<EAF;T].4FEL4E0P4%1U:GA(2W)C5S1604)";T(X4'<Y4#EQ
M;39L.7(O05!/4&Y!9FQ&;U%3;D5.96I91E)T9E0Q)B-X03MO<$-K1#(W67-8
M;VU+=7A6,DMV>G8Q,S!29C-"-#<O5U<U:TE6<4]P;WA".&0O=C-R44M1<#!T
M+U=91D)18U%&.4DQ0D%C-VEN86TK)B-X03LU*VUL0W$Y82]W0V-59E0O04]6
M:$]1=$@O4CEW0S-(<E-33&\Q4&9P+VU&4RMU<U5/>%8R2W9M8B]N3&-29G!8
M4VDV0FE,2U%G;$-X)B-X03M&6G%#:F=%2G5D-B]A-F)(1E$X16TK<6DV<V%2
M,%%Q<' V6D925VDX;$LO=E158FMB4#A!-4IR:6QU45=W5%5126=#:D%F,V)F
M0V$X)B-X03M2=TI8.3$X6%IU;S(V:7!69F]&-6$O-5)Z4W8K64\S+T%/5%,T
M;U1(1EA9<6]8,&IX5U9X3$=A3VM4<W V,$E5:V1C5F9'<VXO3U%F)B-X03LU
M>6EA,FI(;49A=4)Z+S!+>3-053=E:U,S<U8R8CEN1DQB9C@U0V9N1T9U;2]W
M05%R4D-"2"]O5FQT,R]!3CEF0G0R9F9T,7A6-T8O)B-X03MZ:FHK679N6'IF
M3'$V*UI.4D8K3&%+0C=C0T-'2&E:2&M"*TM&140W2U!L.#A51C=D:7)S5F1I
M<C5#+S5Y9#E59FU83WE/<78Y5W1!)B-X03MH2DM(8F8W9DI2<V%':#9D9'5U
M2U$X;DEF-BM&1')W161(2$5G8U%A:T=,;%5F1G919%!T53<T<7E,.'5$2V90
M=FQK=DER5C%Y=T$K)B-X03M)<U-0<G-:240X:E@T="M*<B].,W)I<C=Z>%$W
M1EA9<3AK+S5Y:2\X;$YD9CAX9'(O=T%4>%50:VEK=DY!4W)3;$12:6AB9&U4
M9EIJ)B-X03M8:T\Y4&DO>7$T<%5%-2ML9$AK3TA*.7%%-VMD=FDK1W10<#DV
M8DM8,G0O>FHX82]L2&]84VQB>6=&44%0<C Y04%3>$9"=%-U,U1&)B-X03MI
M.41X5C)+=7A6*V5/=65O3"M9:&=O*W-N9U%#:$)"2E!X1G1T>E@O04EB874V
M:TQ!2#E:9T-O64)1,S=S9U5(26M5-6)D2S R.&1U)B-X03M.8U9E<V8X04]+
M6% O;%E$:VM&9C!F8T)25&-5:VIQ2S$Y*VXP.3DQ4RMU8U5/>%8R2W9M:B]N
M3%5.*VQD2DE)0D9L3'A*53%&6E!I)B-X03M!:T)!5&MU,40Y<G Q>%500G!H
M4#ED<VAZ57-W<DI25'5Z065O4W!B.3976#EO8E-D3GII;'HK<C96*V5A8U9.
M27%"=&=6;U%P3"]U)B-X03MQ;T%V1G9T9EHV:6U+=G8O04UT9CAO-7!8+TU(
M8B\X04IP8U5*:FER<U91,G O.$%(3G4O*TU-;B]%5&ER.#<U9E,Y97HO=D]"
M0SAA)B-X03LX-F=D<58S3D0O25)8='AX6DYS130S=3AN245C:BLX*TPU+WDW
M-R](6'=R,WA6.4-F.#1G.&98,3AR>7 V1G0X2C550C5Y,6]4.$IR)B-X03LO
M:VIB=EAR:6=V<%1&1'-69&ER-4$O-7EF2T0X>7)K='IP.59T3U9#-F<P<65O
M1$HP.%(W-SE-56@U465(,3E&*T]O44)F-S)O24Y2)B-X03LX4#)W2V1G,W95
M.4U66D0K5WI2;GHY-6%+;#DY8W-!87,U0E Q>4UJ96=5-V1I064O=&ER-S%X
M43=&6%EQ.&LO-7EI+SAL3F1F.'AD)B-X03MR+WA01E$K4FAW;T1Y:T5803%5
M*W%A+T=L4G112&9C.6HO:VUL1DMI9TA'-D9:3UE,-R](=4\Y840W*U@T9#%,
M-U@O-7@K+SAL2&]D)B-X03M73$AL93%:=5939G(P.50X9GAB*RLK3$8V2&ER
M<U9D:7(X-SEC0R]8-VEP8VXV>65F,GA51W1+13%(>3(Y>'1S1DE755@Q4'13
M8U-%)B-X03LT8E,W5C4X9G4W8FXR<E%G<7979BMC5650+TMW<$MC=5@V4'5/
M6#)U4#DU2%0O2B]Z*S55=G)R1D1S5F1I<C5N+W=#8W1G4#!R<$I0)B-X03M0
M+V5+445,>F]A>3=62R]#3GA8-'AV,F]D.%9$=U-C4D<V<U8O96M-;S0O,W9)
M0G9S9T%I<F)N.6EG8G1X3TM7-41'53%%,6M*-55B)B-X03ME5VI%.4YY4&@K
M259P2E=O,G%#3U)69F]$-6$O-5)Z4W8K64\S+S5.3&EH36-69&EQ1S%0+VIM
M,V8O1T=4+VE*>%8K955O;"MT,FYX)B-X03M+5TE(-THR,D9E3R]):BM8:%%F
M>6(T<&-W:SE+."M*94E)+UHV-V9T9D911VY4;E4Q-F9&6$98,$@O>FE'1RMS
M83A73F$R.7)1045!)B-X03M$;DQ3:')X4'9X2%AR=FEP9E-E2TA9<3=&6'E$
M+W=!-5!E<B]!37)+;31U9R]W0D=T84DT2$9V<&,X3FHQ,G)4<CA/2U$X;TEL
M+U-&)B-X03M055AA33%B:653:7 W5CE4:T0W,7 Q*TA&5U$O;'8V=BM04$LU
M85)+2%A,1V]53%)V.4UJ,T)5.&$Q.$)7;BM45$98,W!I:#)+=7A6)B-X03LU
M2B]Z;$@O-4MA-B\U:3=8+VEE2V@X:CA:9E=J*TIF531B04MA9%4O;&(W<68W
M1#EN1DMG9V8P8G(T:'A$3E4X4E5M:#A$464Q9CA!)B-X03M9+W19<&9A,R]/
M4&Q2*U5/9S%.9#=Z96Q0*U V9G%+;F9X<G8T-S1S6&]M2W5X5C)+=GIX,7=0
M.65M*TIA9E=M-#AL<'98.7)M94\S)B-X03MV,B]Y94]+47 X6E!R1"]'3U9"
M>7%J9C5D97)C<6HS,SAD=5=+=E=F*V-59R]W1'ES0FE33U V4'5E24$S+W9)
M<3%.869H6'@R-#1Q)B-X03M8,7II:#)+=7A6.#!F.#5B0B\P<'!*5F=V*VA3
M8D9347<Y5&-%,4-!.3$U1'(Y;C1S5D1W5UI:=G)T:4,V<U-"54)0<S%!-4)2
M>7%W)B-X03LW<#9:0VLO66]C575C5&5L9FMY;V9I2'AC9G0W8CAZ>3).2T5E
M<%9U5F%F2%A&6#9!95=V*U5C,'(O;41T+SA!:S!U2T5X>%8R2V]B)B-X03M5
M+SA!:FTS9B]'1U0O:4IX5BMD.'9P979::CDU=T%8:51Z<5(R<%AC5E!89T14
M='EX6DYS530S<'!*>4I(269V4&@K9C@R*S-X,#AA)B-X03MD<U9F46XO3TE0
M2#$Y9D,X<65H8F9%959#96-T84$O0TMF-4HS-S V66],-E5X43=&6%EQ*U%0
M*V-O1$=0>DMU07AK54YB5W9*,#5%)B-X03M#9T]X1E98<'5.-C$K+T9)951K
M<"MK1C)L<7%55U X06562DA12S,R-E4S1S-8-SA66D0K5WI2+S0Y.',X5$M3
M,G571E=024-O=DEY)B-X03M!=W%6-F(Q<E=V,S1Q*SES54]X5C)+=DI0*V-O
M=B]*5%A8+TU882\X5'A54&MA<69#=C=Z,&EH1$XK.4<S3D0W.2MV:"]L1VQ6
M2VEH)B-X03M(1S9.2#5K=G0X97=0:E$O9GDO2'-P9F$S+T]0<$QF;$AO4E!+
M<&$Y2C5C<3$K=E0Q<GDK22]--'-8;VU+=7A6,DMV>G8Q>FHY9G5+)B-X03LX
M=V9R2C5F8DY!2S!O1%%B.70O66)B;%-&;%8Y4VQ*3TE#8T176&5N4&HY+V)9
M9E)U47$Y6B\U>%(T+SAR0VMP>35(5#=J;#ER:5 S)B-X03MK9% X;B]0-S%3
M*W5S54]X5C)+=FUF.$$U>3)+:E9.2G%(,W-P05=8;E%F=F%I;U@T0T-2*S!2
M5'%+.4U61'=38C!Z9#)#+W9A0E5#)B-X03MH=E8K24AD4TMN:W9-;F-*5VY6
M4S-41DQN84UX-F<S-S9R34]69E4K16YC0G0V4%9H43@V2&%O2%9C5F9O1C5A
M+W=#56,P<B]!2F<W)B-X03MF+VLP=4M%>'A6,DMO8E4O*T]B9"]W1$='5"]I
M2GA6*V55<&PK<S)H-')Y04A-5DY!4E1M0V%F=2M),V]0<V125$9,;CE4,#=W
M8U8T)B-X03MK,51C+T9T56MF1"LX;W4Y5# K,3-R:7(V1"\U>$1,979R-%E!
M34E,6%E-83!,>3A357!286IF8C=86$93*VLX54]X5C)+=FM,+VY*)B-X03LS
M,6HK6E9W23 U;C9T85519D54-&9!5EE(9F%V,&(Y355H-5%43#EF43!(17AJ
M.35Z<6]5;C=1:S0X:#A8=V<W*T933G-66D8K6$AR)B-X03LO=T-09DQ19$].
M3F-S2VI91VXQ,E!C<49!*S$X4$E5.$]M,DMV=DQ&1'-69&ER>50O;DM,+W=!
M;$YD9CAX9'(O04U4>%50:VER:#%*)B-X03M24DM%3D8U;%)65U-T9FA&2T%(
M879W.69H-#1P544U96QD1&E/2$HV1W!"<4(R*T@T<58K:C)R=7!F83,O3U S
M+VMO.4,R;T-B=W)V)B-X03M88C8Y4%$X<4QY<4\Y3BMU3$8V2&ER<U9D:7(X
M.&1C-6TO;4-Q1"]P2C152F-K:VMF6DLW-VEN+T%!=3E.;$E70FTY6FE!<%EH
M0S,W)B-X03MX:4M(:T-A.&0K=EAF=S,U57A6-G@O>FEL>B\U5T,T24%8.4@S
M0E4Q,TY:22LQ4&)R.4AB6E5V<FY&1'-69&ER-6\O-7DQ3&9P6%-G)B-X03MO
M0DIS6F%+5TE*06QQ,45O42]%8FUV,F9T1$91.$=N33,Q=7A*4F1L;S1Q4W%K
M9C-G63A1675!,TMR.6IQ=$U5='E'9C Y47%O*TDQ)B-X03M5.'%L>%%&:5!G
M<$Y284U74%0W63=N1E@S.35A+W=#56,P<B]!2F<W9B]K,'5+17AX5C)+;V)5
M+RM/8F0O=T1'1U0O:4IX5BME16AG)B-X03LK<S):16YW:%5(4&U34E0W4$DQ
M<D@W9V9:-U9X6D]B,$]&-D$T<5-$>#5M:#<O1#A8-WIF=65N6#)X5CE#9CA!
M3TE*5#$Y9D-T>7!")B-X03MB5DA):V=M4U=O2V1&.7%D975+0RML355/>%8R
M2W9J+T%0-7EG141F;59/<G11:3)T5',R-'%+1VE&;$(R-R]W,WA32&Q"*W)F
M<$%0)B-X03MZ,EI+;CDT4T-X<4-$2EAK2VIX2'-25&9&5U%F;'-T<U!0=FQD
M5F%R3')L9U5"659(*VQX:C=026=G<4]O<CDR*TMV=F9&1'-69&ER)B-X03MY
M5"]N2U X03AL3F1F.'AD<B]X4$91*U)2-DA*0TI2>%9".&9Q:TU/3$IX,C5(
M<#1!8F12>7!I;%)4,&94=6AY1F%T>%AM44111VA()B-X03MX9D8Q+W="=G-P
M9F$O=T1Z:C1&2#52845&24DU6'4T4$E6*W94,6\Q5'E(=C-X6792359D:7)S
M5F9N9G)V;VTK=4)Z<69R3&,Q1&QQ)B-X03MD:5%P24AB9C=T<59+:TMD65!7
M66U155!%.'9687!*1&<Q3F$W,3,V9E)7;U9E=&8X-&\K;B]Y<TIW1W$O=T-J
M-V=L83E+>5)B:&$P)B-X03LS<#$O>DMP9EA72TA9<3=&6'I.+WIL=5EV,'!P
M2W5W0DYM-55C>7!Q2F1Q2E5"*W4Y96Y55C-'2V@T2DMB55AL:7EY-TMQ5F8Q
M0V9S)B-X03MF6C5(;'EJ-F9%<2]:-G)81DQN1F])=%%!9G%W2W(V;&1X,#0O
M1E-8-&E253EV:4AD8U9F;T@U82]W0U5C,'(O04IG-V8O:S!U2T5X)B-X03MX
M5C)+;V)5+RM/8F0O=T1'1U0O:4IX5BME57!L*W,R;%58-$%!0GE.130P2E5M
M;$8Y4')V5VXW5F-5=6-Z96YE5D,O1V%K.&TO94%#)B-X03MT4G16<40T.7%$
M9F9A9WA6.4(O.#1H;'98,3E444%15W1)=V%K5F55,4EP56-U=350=%%9<5@P
M;FEH,DMU>%8X:&8X04]4=VU0-6Q4)B-X03MQ:UEL6#9T845X2&M383=!:%9O
M9'HX4%@X8U5H-5%44"MK1F5I12MN5EIU4C1G5F]'3%4T.69H*WI4-F0X5EI$
M*U<T;DAN>GEY<&E6)B-X03M"*VY,075V>%8O,W1J2$E!-SEF9W)7;G189D98
M,VYI:#)+=7A6-4HO>FQ&+S5+838O=T-9=3$O-&YI;V9*0F%93V=)5551:C!U
M4DA2)B-X03ML3$1D86)5<G8P<#A69#9Q5D)$3#96,7-"5FXU4%9T.71W3G%N
M.% X<G1I;#ER9C@T*VQJ*U57:$9U<$XT86=K9S%V<"]I<6%D978V)B-X03MS
M5TPP4$9867$W1E@U-#8T6E1F>D-G971Y94E"2DQB:T%554$W9EHR4'DS<6-5
M:%E(;3E:=#%/>45$;6%!9D5!86AA8E9P='1V='52)B-X03M25C9X+W=!-'!C
M+RM69W5+04PK:C=G.515+W9).395*UDV,#A.-C1Q6#%Z:6@R2W5X5C@P9C@U
M871,*VQ.2E9/2D1756AA36MG<T9K)B-X03MQ4W%G5E!$-U=Z0VYE;WA54$)P
M:E Y8W-3>7%/04%5:&TO9&-!3U-S95!W;4AR.%%9:CER:TM9<&,U=693,4%&
M54)C9W12;7!+0713)B-X03MY0VYX8U%E9%4T:6@V1F1G<2LO+T%#,2]Y:FUL
M9CAW9'8O>6%81D-9-'$W1E5.<68O2$YU+W=$:D1*+WA%-'$O4$-2:TYZ6C!N
M<C9A)B-X03MO3V16,C0W:6A!;U!B;G8O0415>%I/6C0K1C<K*S)L25!'<6)K
M8B]&.$\U<6%F0C,Y=#A69E%N+T%$:4-W.698,$5N4&I"8D=L5F]/)B-X03M5
M:W!O05!I2'9Y*VIB1D)F4VU+2%EQ-T98>"\O04TU44=-+VU63VI3:%=.=&%K
M0F=#;S)O5%%";DAJ-$5F9&EK4$M#.%@V440K='-%)B-X03LK2G9G-44W9VET
M3T1(=C=J,S)X5FM(-6)'265F9DLV:5I72C%Y=TM+04MF-S%X:EEC47EK:F9S
M2V)D9'-69F4K2TA9<3=&6&MN+T]5)B-X03MF+VMP<G(O;4QT9BM*-'%(>4M*
M541);VXS-$%E;T1(=%)K2S!*04DV8F(Q.&5)<FEL4E(P160P9E9O1TQ55#1D
M.6I1-W(Y,T@X3S9L)B-X03LY<B\X-"M-2"]+3%%N1&-G>EAR5D9/.3E/9C)1
M1BLW8D9I.45X5C)+=7A6*V0K=7-J6#%W1$Q51S5A<6MQ471.:5-&0E Y;FEA
M,%5H)B-X03M4.5905V(Y*V%J:5,Y639S44AR=E-L9"]%+U1S0W$Y82]W0V-5
M4W8O04-S2GAZ<51P.7=F5#(R+V528C!P6'<Y=C1+;#ED66]D:7)S)B-X03M6
M9DTS+T]7-V].53!L1VLT8S=.-DPX3D-6;')U0T,O>4LY3SE!831Q2&=K<GA'
M.'-33&EP:59&3#%116-.>'A93%%!+W,X.3$O86]")B-X03MI;'IY46U,54M8
M04EM6492.$%Q4CA8>$QX-CEG63EG9CAK,7A6*V=F;'(O;$A.2R\U9S=F+VLP
M=4M%>'A63#1.5VUN:&IN:3 V-6%+)B-X03M643AB5G1X5E=&46%'87941E9L
M-618<S%N4$-M;3-(3U-.,%=R5S%+<W!!+S-D:7(U5&LO-7AP+TY.<'):>&%7
M=D=%04U$8W X3D]Y)B-X03MD<4PQ6&PY3F-5,C5V*V-A9GI42S-1*W)7,5II
M0W K<W X6"MV=G0T+T0S.71S5G0V<"M1,S5B*V-F26(V;61A<U$T=31O56E7
M,6UH)B-X03MK04UB3U=0>'9'9FDU:G@K9UEO979F<$,W+S9T;'HO=U9T+S%7
M>%941W)41V0T0G Q>C9Q2W)S=&)F6EA,0E18,79&1&EQ<"MK3'8O)B-X03M!
M2W1L>B]W5G0O,5=X5C1,*V,S-5!E9E!/9FTV6%9T2W-9;',S:&=J160Q3D=P
M3%)F84I#3V%E2#)V=4\K1E%W9R\X04].6#5Q1SA7)B-X03MF-G1A-TIX-2]7
M22M94&HO04-N8F)O3G5W3RM"3G!R-5(O-7@Y+TUR4U!-,FHV;&,R9'0Y5W-.
M5'1B,F19<#!,1T]'-%=6=4E:=G0X)B-X03M&;T)7;C8X5G0Y3V9P0S<O04]R
M6F,O.$%"5S,O0497>%%P>F%T3D-G9514<FM+5U)!83(U*TM29VEJ86)U>D1&
M5E0Y25AF.$$Q8DQN)B-X03LO9W)B+W%T:7)"4'IP.'-E62]/;FM79E%T27-(
M:G9*2C1:5F$T:V=34&I',5=Q5FMC+VAI<G=V+T%+1G(O3D=Q:S(Q<T%Q:V5M
M3&U/)B-X03ML95-M;3ED=FAR,#8P<GDS>%1A:VXO3TTO=T-A9U,T6#9T83%L
M3$971GEM+TQS,B\K9F5U,49B9E)0-5<V3G)N;&)Y3'!U:&%J<#AS)B-X03ML
M-6%'-$US:U1W36IE<F-Y>DMA=$MU+T=15C(V.4YS54UR+U-&,R\Q8DQN+T%)
M2S(O=T-Q,DMQ8T]R5%1)6&HP-C5+:&Y1;71U4&EJ)B-X03M9;W<S;3=-<'A6
M52]31C,O04Y7>34O-$LR+S9R67$K5714+S5X=2].1S9U6DI)-U<R2W1.-F=$
M,TM#<2M"-&YT,#8Y4&5P2VTR=CA!)B-X03MO5S,X,'953&96-V5H0V=$-GI(
M=%1L=C1B8W1T:#,V1VA#=',S+TDO.&]04&9K9GI1,G%A>%I2=F)',6QG<&%Z
M>$]X85(P6E-1-THP)B-X03LT;G8Y2%=Q9W9D+S!H9"\Y5WDU+S1+,B\V<EEQ
M<&Y6<&A/:T(P-C4Y5C%:,5=T=G5Q1E%X<C8S:31X5E4O4T8S+W="5WDU+S1+
M,B\V)B-X03MR67$X9B]05#AT9D]F;FTW<S5D1W-H2$A"8DY$271Z3D-G6FDO
M269:9'HX4%5%2#))27=Q.'AL+S5X="].2G)M,&Q&<F)C8F111"]P)B-X03M+
M0FQP,$-'=314<79,9CA!;35$06TS4"]!330R+VUK57961G)A,75#0W8X07!#
M05!4;UA&9FA)*S!/1S%D=#$R0W1V<4Q2-611<SE*)B-X03MS<E-85&)G>3(Y
M=D9&259A,TDU26=5,"]F1&%O>%%I6CE7;6=H:VYL,#8U5TM*4SAJ5G1Z4E9&
M4V%#87941E5E:4I':7AX<4520492)B-X03M&1D%!3F=!0FEQ2#%057),4SE.
M=3E4=G!04G-R1T=3-75P94Q.=VEH474W8U9$36%+<$Y!2S1Q;$YJ-38X=3-K
M,79%<EAD=3$S27-&)B-X03MQ,3=96#%K:W-J;SAI;VML,41#:D5R1S%+2#A3
M3597>&9M1#50;79B0WAI,4M.-W95-35B87AG06-02S!(35-/:6M!;4E.0WDK
M<5!G)B-X03M*-DA&5F929D]F;'97-W0W5%1B<'!:,6I->4(T6F]L;&A69VI3
M=U!+:4I.1T=)0F5-<W1E*TMP,6ER45)!-6M#9T]W0W,Y3GE&<5%#)B-X03MF
M8FMC5F)X5DE:9E!(;"M05V)J4F@Y9&YV-U-33T<V1G1P.2]C4E)35%)P2VEV
M4$1"2D-T56Q6:E8Y9V0X5E=N>B\U3U<Q=$QT.55I)B-X03MJ=&(R,F4Y:&UK
M1&]I,CA:5EAE57-O14Y(8TI35&EE6'<O83)X5E-K+TUB>69(66%F9GE8>D,Q
M,4]"8G4Q:U=#9'=,9&EQ*W1.=U)V)B-X03M2:C5/05AL-')8=FER2F-6861%
M8V-854U!47="1E)65'E5-RM"1E)I<F5+<%IR+VU84TY":'1P9%-E5E)E5&DQ
M=%DW93-U3'574UEO)B-X03LX;U)9<EI*6D0X151(-U!B1E5'=FYV>7@V1C%.
M3F-Y,F=S-U@V.6-2,VQR9%=K<3(O3C0O5456>$9&23-X>&M55E-F<S=F1716
M5F93)B-X03MV3B]L>E9D574Y3# K.5,T=G)#3T]7.6A51W-);$Q"5FMQ0G=K
M2$$X:V%J3#-'2W$S;#=Z2&\S;4Q49C!L;SEW3'%X37-S2WIQ0T9:)B-X03MO
M2D1'+T=O1E)Y6%EJ66I&57EX5G!%4D)X4E%O2DQ%055&5U!*:G0T:S%/2W0T
M<7AA>2]-,WEH95=A6#A-,31U;E-#2F\W*V)4=%%G)B-X03MT5U=A4DEO,D9X
M3&)P1GA,4TQV>7!49F]#8U921V]F;40U4# V-&4R=3E4:FEU174T=% Y26AQ
M=&148TM24C=F=D=54W%8-%8T5BM+)B-X03MM2V]U,3@Q85!D83%0;SEU8FU3
M.'18361W-',W=C9S:V=26D-H=2]3*W)C=41G,#E3=2]J:7%B67$P55%U2D-O
M3'%#<7948T)Q16=()B-X03LS-&I&5SA64TQ6=D]U9S98<78V2W5F<FMU;T-"
M3'!O3$]W=G(P<D1)-WAO-T<Q:&U6951234)5.7-68E!N9GES26\U6'8Q4EIB
M<6%X)B-X03M!9$I%6EHW64U:,6M2;$12<D=S6EIN8T)1=$=R46=L5E-J+TU$
M>6I,;T@V9FAV>$YP2FYE,FIU24DU6FI*3$<W4FQ9;S1L9#5D,$I()B-X03M"
M5%5B.4U65'EZ=3=A.71)3'DP;%=A,759,6UG;5$Q5C0U1D1+>6YW24YC5E9(
M4DI%84]2439/0W)O=W%#1'-146-68GA62U!/1VM8)B-X03M/=&55=&(P93%:
M175T4W-,<7IG955K4FE3949O,4QL47A#9W1V44A&56DQ>CAV16XX:&%L-68P
M-F59,SDQ078Q5S1V-S(X=6QI=31G)B-X03M':&Q34V0U-4EG:VEH:#99,CA-
M5E(R<BM5=6$K5F].26IG=&),>3EF<&-I,DI:1D5%9&QC5WEX>#A69F9L3W98
M=%AV<U95<SAI*U8O)B-X03M-*VXV<2MO95DW87EE.4YS,71$9#)D-4Q*2$1&
M-FEU3&$R<WI:,FM515!W9VLX,F-L5C5&=6]66GII<G-69&ER13E,.&II1'IH
M<G9M)B-X03M'-FYM-5@Y,V(S1FI$8C-L,T9%16AS;V)C+U=,6DAJ9VM9=D5X
M*TI7*T=M+UE+<79L8GEB1&]F;4AZ2G%A4G=O;7-856-T;TEY>&%/)B-X03M%
M47$P:4U'04-C<G0U-6%,=%8V.51S<7A3-R],6'I9+VM44U!+,%5T:3,Q9E19
M8DLW=697=5E41&-29$IO+U1J+W="2VE&9CDU-75+)B-X03M-44-C5F5O<4-&
M04HU141D=DA&5SA69&ER1W9/=FQ/5'I',FA2:59O8F94=%17*W5Z2%!08E1'
M2F)7-&AP1$QB;$I&9FY/=E)L*T=U)B-X03LO67%O8GI&-4)T3E-U9DQ$>$M*
M63E$=E).3SDU3E!03$IA:4XR.4EY4T=2-50Y85-#4VMJ52M!1W5W1TMU,79Y
M4%!R3W9A>F-46'(R)B-X03ME;F%T<$9P<%IK=$=56%-M0S5U2G!F-S)/4U!G
M-E1Q;31.9FDR1WAX5E@O3#=Y;F9E5TY)=DQ'.'949710<4XW95%V4TI1<U9Z
M8TY*)B-X03M'2U)25S9H:7)C;D%79UEK3#A.0FER2CA69&ER<U996C5(+TQI
M>3!4>61B84AQ:E-8,'-L9VQJ<6M-;#5D,TYM-#1C6D)$1&-/630P)B-X03M/
M-"M#3F1S5E%T="M8,F]W+VQL<&YL8U-7+S959VTP*S4Q0S4U4TY(3%!B,S!.
M-613.#)8,4AA47AU45=89&IV5'-Q<6%8-4XX>#)8)B-X03MN:5A6;S=P24Y+
M;75B:35U-#0W=3=K*W1,3D9W:FEE>&Q"=#17:6-+,W%X=GEA;$M!1VU+<S5X
M5C)+=7A6:60W-4A&+S4W;3AW,U4X)B-X03MY5VXV3W1,3S-J=$QY-W1*1$YB
M,T9X335L5S-E1EI%-'IP>$1L=2MW-W%Q=&XU3FAT+WI#=B].0WAW:4\W<TEB
M9$%#,W%I-45J+U=*)B-X03ME2DA!97!#;'5H64=P-%505&16:G5Q+VQP<F1X
M;VMC14YX1V(R,3AW86AR8TU3,U9X6G!*1F5Y6%!"1W5914TP5')(9$%K;W S
M0EAO)B-X03MA-'%Z<GDO65AE;F%&<#%H95A0,7DW=$QA2T,T=7=O:D5S:V%"
M5V-)3FPU159P:7%0>%8R2W5X5C)+=7A6,DMU>%8R2V]!*UE.0D5H)B-X03MJ
M3W!7;VM"24M'94]T4C%&3U=+<75P-G)P96Q78C-U<5AK1FA:4FM#4S5U6D5H
M:55S94LQ9'EQ:7!.0G9I<E=L-GAP3W)79W9.2W9B)B-X03MF54Q.:597-71:
M56UJ3$QS44AJ3$Q567%I.%9D:7)S5F1I<6LQ-6%)-TDP.&%U<DMJ2U=514Y*
M.6A32SE7-V5/2W)P2F]9;UAN;&M6)B-X03M)555U.')%0E950W!9<V1G04\K
M2V]84W1C,%A724=U3DHQ0S(Q1S-2:6I45VLP8S9":#%5=$=71F9B1E520F57
M;'<X-E%4>'I08E-E)B-X03MJ8W)'>7-9-4]+=G=C02]#,T(Q86@S;U%E*TMU
M=&)Y,'4T9E=T2C0W:4AK.&9Q4DUR<GII8WAY3%934E9(57%W-T55>%9B0G%&
M:%!0)B-X03M.8G=8355S.75X:FYH4C%:-#-#;S56,4)Q<$-Y;V%(<W<X4FEQ
M>E4Y5C!V4W).-S-63'E#=W-O>4)*8S--:5%X2U=01F%U-59256UG)B-X03LS
M>%9R4SE9,&Y6<E%8;6Q8='9Q1FUX2W)C,G-Q5%)L;#))1'AL;'%-5F,R<C93
M=&QC6'I8<T,R5F]:5G5R;WEO26]J07A765-06&EP)B-X03MJ6E-(<61I3CA6
M5F)E*W-R;4$S1G1C4GI7-G1):E12=7)O1VEC<$EP645I<4]J2S-G45%C5F1:
M,S%L9E<V6$YL8U)85G9)<79(3D,V)B-X03MY27EU;V131U5K14UR0F@W1W5+
M='1E5VDS85=B5'AI-VMJ86%/,DQ,-FI2>'-Q=313=DEQ<E-+0V5G2DAJ:7%R
M:7)S5E=V2D=H44]W)B-X03M5>4AI9TI!-4Y1;6<X5%%%-'%U>%8R2W5X5C)+
M=7A6,DMU>%8R2W5X5C)+=FDK*R],1'HP,VY'-'5K.',V9SES.31:4%5.<CA&
M0F--)B-X03MX6E=#.'5L0W K:'%J0W(V<"]-4%$Y53%R4F)/,# Q;E,T:C%4
M5&)L<#1J14I);W)E.&EL;&U4,7<P6F%.1DQG37)6<%1I96U"6&YM)B-X03MS
M95-F>E1T8GI55C!M-75:;TQJ56)M-6$Y4U-+3S5U5VMS-U-/,75*4F)85VQ*
M>&AE2U9'5VQ.9U1&3%=O5E1#,CAS9FTK;FQN5F)7)B-X03MB57!(,4]Y:70Y
M4#!I8C9W>G1D,C!D>#8Q>&1-4DQ%5G5*24=%05IP16%Q13AK-3AG<6AT33AR
M9FTP:WAU-VTW=E,Q=BMJ5'!K0G9#)B-X03MI2V\Q4U$S:5A%5%AD-'-R3%EV
M=5I*6DMJ:4%Z36]O<7%A:&]N-7=Y3&,R;&TY,45B94A5;$8V.3)J<&,O5TY9
M:'590D-Q,TUC<75T)B-X03MH-FM58E V9D1D47E!:'-66C$K6'1L-6QS+TQI
M=RM96DAK=E!7;&%&6E-7;&IG6G%X>'E-8FDK3$UV:5HU1%0Y;S1Q>#-Z4G!/
M=%A/)B-X03MU,TIT8E=F,$A,8W)O2S9R1VY!0U)O:$8X9GA$-%AD9C,P;CDR
M;D--1G=52G@U;#AT-FQQ;C5E,BMK,F$X8G5&3$=1,FMW:6A%>3)K)B-X03MK
M57-L=$E)9S!397%S6E%H9F=&9C5C0U=)96$Y2"]-=E9B=V%J;V5J;GDO0DMN
M;S-.=D1,1BMK2G!9,5!O5%1083,Q;D0V55)D9W$K)B-X03MU>"]M4FA247%G
M=%,X;F9M-4<Q,CEL2S9M-W8U8FTU83!K16)Y>G1P,6I"1F,O0F4V9CA!=6QM
M9VUQ:D]E,5EP05)25EIP6&MN.#!B)B-X03M85#5R1T@V-UI/,7I),F]44C-Y
M<$1C979R:U8P2G)'2DHS3G%%<R]8.55(:5@U8V%/96EQ13@S84@U>3AS*V)B
M;GIH13EW,%9T8W9$)B-X03MP2WDS.5)D27EA87-6<3AB>F-N*W-E:&-)049:
M:DE&6FQO07=+<R\Q-WEL-6AU9DDR:6%/;#5.9&%V8E@R;#-&.7%03TYP9S!.
M-49.)B-X03MC,T-'-$1O9E1O>F]J2W=O079%.4U#<% U;3AL*V)T2%,U:SAQ
M>F%H<6PQ<3%P<7DV:F-M-G0W854V:&51,C!6;F1/1BMP=V=13&)K)B-X03M+
M63 U3#)'-TA&5T]8;FM$.'=:9$,Q>E1R5WEV67)I+VLQ>5,W33$O1DI:6&-6
M-C W5VMC14AR<W-5<&MD2%HR:E1A=%<S;T-Q9656)B-X03LO3&XU:C)M;S-1
M,5),.7DY+V94869D4C9K:5=K5FQ,3$]Y>'IW8S505FQD;E8P4' Q5E-O.5)/
M2E5Q<U<X;RM7=E!E9S8U62M86C=U)B-X03LU=&)N>D%,5UA652MV97)*2$1B
M5VQK,7AC4CA*<$A2>DIB5#)R=GA!*TY/3$5,44MV45!Z1#AS*V$Y4SAW,E8W
M;UEL:E9,15=K=#%B)B-X03LS0S(X<4-45G1/;6Q53GI2+VET64II86113U!5
M9T5+>$QZ1F]V-6<V3$9A>G!C87A.85A'<'I7;'A$2'%4>5-0879R3G%M;7AO
M.&LY)B-X03M9,FMS;6Q5>4)G9"\S<E9X5D=896AF;D%S=6AV8F981$A:=4II
M:'9695)95'%,4V96<G1J9%)2>GER66-)>3=*34=A=39K96\V<7!B)B-X03LK
M5'9/,7IQ;FQU-S%3,3%+8693=%1T-VI6<&XQ45!B>D])<FU/4S9T8EE3+W4T
M43!K9%4U2U-L5D52*TQK<3EF>%8R2W5X5B\O.6L]/"]X;7!'26UG.FEM86=E
M/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z
M06QT/@H@(" @(" @(" \+WAM<#I4:'5M8FYA:6QS/@H@(" @(" \+W)D9CI$
M97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70]
M(B(*(" @(" @(" @(" @>&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M
M+W!D9B\Q+C,O(CX*(" @(" @(" @/'!D9CI0<F]D=6-E<CY!9&]B92!01$8@
M;&EB<F%R>2 Q,"XP,3PO<&1F.E!R;V1U8V5R/@H@(" @(" \+W)D9CI$97-C
M<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*
M(" @(" @(" @(" @>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E;&5M
M96YT<R\Q+C$O(CX*(" @(" @(" @/&1C.F9O<FUA=#YA<'!L:6-A=&EO;B]P
M;W-T<V-R:7!T/"]D8SIF;W)M870^"B @(" @(" @(#QD8SIT:71L93X*(" @
M(" @(" @(" @/')D9CI!;'0^"B @(" @(" @(" @(" @(#QR9&8Z;&D@>&UL
M.FQA;F<](G@M9&5F875L="(^9S<X<SDT/"]R9&8Z;&D^"B @(" @(" @(" @
M(#PO<F1F.D%L=#X*(" @(" @(" @/"]D8SIT:71L93X*(" @(" @(" @/&1C
M.F-R96%T;W(^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @
M(" \<F1F.FQI/G)R,C,P-S(X/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F
M.E-E<3X*(" @(" @(" @/"]D8SIC<F5A=&]R/@H@(" @(" \+W)D9CI$97-C
M<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*
M(" @(" @(" @(" @>&UL;G,Z>&UP5%!G/2)H='1P.B\O;G,N861O8F4N8V]M
M+WAA<"\Q+C O="]P9R\B"B @(" @(" @(" @('AM;&YS.G-T1&EM/2)H='1P
M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O1&EM96YS:6]N<R,B"B @
M(" @(" @(" @('AM;&YS.G-T1FYT/2)H='1P.B\O;G,N861O8F4N8V]M+WAA
M<"\Q+C O<U1Y<&4O1F]N=",B"B @(" @(" @(" @('AM;&YS.GAM<$<](FAT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]G+R(^"B @(" @(" @(#QX;7!4
M4&<Z3E!A9V5S/C$\+WAM<%109SI.4&%G97,^"B @(" @(" @(#QX;7!44&<Z
M2&%S5FES:6)L951R86YS<&%R96YC>3Y&86QS93PO>&UP5%!G.DAA<U9I<VEB
M;&54<F%N<W!A<F5N8WD^"B @(" @(" @(#QX;7!44&<Z2&%S5FES:6)L94]V
M97)P<FEN=#Y4<G5E/"]X;7!44&<Z2&%S5FES:6)L94]V97)P<FEN=#X*(" @
M(" @(" @/'AM<%109SI-87A086=E4VEZ92!R9&8Z<&%R<V54>7!E/2)297-O
M=7)C92(^"B @(" @(" @(" @(#QS=$1I;3IW/C8Q,BXP,# P,# \+W-T1&EM
M.G<^"B @(" @(" @(" @(#QS=$1I;3IH/C<Y,BXP,# P,# \+W-T1&EM.F@^
M"B @(" @(" @(" @(#QS=$1I;3IU;FET/E!O:6YT<SPO<W1$:6TZ=6YI=#X*
M(" @(" @(" @/"]X;7!44&<Z36%X4&%G95-I>F4^"B @(" @(" @(#QX;7!4
M4&<Z1F]N=',^"B @(" @(" @(" @(#QR9&8Z0F%G/@H@(" @(" @(" @(" @
M(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @
M(" @(" @(" @/'-T1FYT.F9O;G1.86UE/DAE;'9E=&EC83PO<W1&;G0Z9F]N
M=$YA;64^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT1F%M:6QY/DAE
M;'9E=&EC83PO<W1&;G0Z9F]N=$9A;6EL>3X*(" @(" @(" @(" @(" @(" @
M/'-T1FYT.F9O;G1&86-E/DUE9&EU;3PO<W1&;G0Z9F]N=$9A8V4^"B @(" @
M(" @(" @(" @(" @(#QS=$9N=#IF;VYT5'EP93Y4>7!E(#$\+W-T1FYT.F9O
M;G14>7!E/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z=F5R<VEO;E-T<FEN
M9SXP,#$N,# P/"]S=$9N=#IV97)S:6]N4W1R:6YG/@H@(" @(" @(" @(" @
M(" @(" \<W1&;G0Z8V]M<&]S:71E/D9A;'-E/"]S=$9N=#IC;VUP;W-I=&4^
M"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT1FEL94YA;64^2%9?7U]?
M7U\N4$9".R!(5E]?7U]?7RY01DT\+W-T1FYT.F9O;G1&:6QE3F%M93X*(" @
M(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D)A9SX*
M(" @(" @(" @/"]X;7!44&<Z1F]N=',^"B @(" @(" @(#QX;7!44&<Z4&QA
M=&5.86UE<SX*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @
M(#QR9&8Z;&D^0FQA8VL\+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q
M/@H@(" @(" @(" \+WAM<%109SI0;&%T94YA;65S/@H@(" @(" @(" \>&UP
M5%!G.E-W871C:$=R;W5P<SX*(" @(" @(" @(" @/')D9CI397$^"B @(" @
M(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@
M(" @(" @(" @(" @(" @(" \>&UP1SIG<F]U<$YA;64^1&5F875L="!3=V%T
M8V@@1W)O=7 \+WAM<$<Z9W)O=7!.86UE/@H@(" @(" @(" @(" @(" @(" \
M>&UP1SIG<F]U<%1Y<&4^,#PO>&UP1SIG<F]U<%1Y<&4^"B @(" @(" @(" @
M(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @
M(#PO>&UP5%!G.E-W871C:$=R;W5P<SX*(" @(" @/"]R9&8Z1&5S8W)I<'1I
M;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @
M(" @(" @('AM;&YS.GAM<$U-/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q
M+C O;6TO(@H@(" @(" @(" @("!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(*(" @(" @(" @
M(" @>&UL;G,Z<W1%=G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S
M5'EP92]297-O=7)C945V96YT(R(^"B @(" @(" @(#QX;7!-33I$;V-U;65N
M=$E$/GAM<"YD:60Z,$-"0SDT,38V,3A#138Q,4)%-#5!0T$U-#,P13(V,S<\
M+WAM<$U-.D1O8W5M96YT240^"B @(" @(" @(#QX;7!-33I);G-T86YC94E$
M/GAM<"YI:60Z,$-"0SDT,38V,3A#138Q,4)%-#5!0T$U-#,P13(V,S<\+WAM
M<$U-.DEN<W1A;F-E240^"B @(" @(" @(#QX;7!-33I/<FEG:6YA;$1O8W5M
M96YT240^>&UP+F1I9#I!,3@W,40R0C0P.$-%-C$Q.# T-$(V0SDX,4(R1C)&
M0CPO>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/@H@(" @(" @(" \>&UP34TZ
M4F5N9&ET:6]N0VQA<W,^9&5F875L=#PO>&UP34TZ4F5N9&ET:6]N0VQA<W,^
M"B @(" @(" @(#QX;7!-33I$97)I=F5D1G)O;2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(#QS=%)E9CII;G-T86YC94E$/GAM<"YI
M:60Z,$)"0SDT,38V,3A#138Q,4)%-#5!0T$U-#,P13(V,S<\+W-T4F5F.FEN
M<W1A;F-E240^"B @(" @(" @(" @(#QS=%)E9CID;V-U;65N=$E$/GAM<"YD
M:60Z,$)"0SDT,38V,3A#138Q,4)%-#5!0T$U-#,P13(V,S<\+W-T4F5F.F1O
M8W5M96YT240^"B @(" @(" @(" @(#QS=%)E9CIO<FEG:6YA;$1O8W5M96YT
M240^>&UP+F1I9#I!,3@W,40R0C0P.$-%-C$Q.# T-$(V0SDX,4(R1C)&0CPO
M<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/@H@(" @(" @(" @(" \<W12968Z
M<F5N9&ET:6]N0VQA<W,^9&5F875L=#PO<W12968Z<F5N9&ET:6]N0VQA<W,^
M"B @(" @(" @(#PO>&UP34TZ1&5R:79E9$9R;VT^"B @(" @(" @(#QX;7!-
M33I(:7-T;W)Y/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#I!
M,3@W,40R0C0P.$-%-C$Q.# T-$(V0SDX,4(R1C)&0CPO<W1%=G0Z:6YS=&%N
M8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C Q-BTQ,"TP
M-U0Q,#HP,SHU-"LP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @
M(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@26QL=7-T<F%T;W(@0U,V
M("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @
M(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @
M(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F
M.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z,$-"0SDT,38V,3A#138Q
M,4)%-#5!0T$U-#,P13(V,S<\+W-T179T.FEN<W1A;F-E240^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,38M,3 M,#=4,3,Z,S$Z-3(K,#4Z
M,S \+W-T179T.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T
M=V%R94%G96YT/D%D;V)E($EL;'5S=')A=&]R($-3-B H5VEN9&]W<RD\+W-T
M179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC
M:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F
M.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP34TZ
M2&ES=&]R>3X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(#PO<F1F.E)$
M1CX*/"]X.GAM<&UE=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" */#]X<&%C
M:V5T(&5N9#TB=R(_/O_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! ?_  !$( 7,!V@,!$0 "$0$#$0'_Q  ?  $   8#
M 0$              P0'" D+ @8*!0'_Q !%$  !! ("  8  P0(!0(% P4#
M 0($!08'  @)$1(3%!4*%B$7&"(C)"4F,3)8E]89.4%XMAHS)S1"0U(I-5%$
M865WL__$ !@! 0 # 0                 ! @0#_\0 -Q$  @$!!04' P0#
M 0$  P    $1(0(Q05'P87&!H;$#$B(R4I'!<M'A$S.B\4)3@K)B(Y+"_]H
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MV5!EU.HM8Z+[!$9GUS&M6UE368=1Y=EV)"WAO:;PE>&NR^<VVISO1Z/^"@X
MX X X X X X X X X X X X X X X X X X X X X X X X X X X X X X
MX X!U_)<MQ7"ZLMWF.38_B=*#]#6^2W-=1585\E7R+/M),6(/]$5?XRI^B*O
M]R< MGE]_.C4.26"_N)UCD6 'J,]96[SUK;V@2)_>PU959),GB=_T\GQVJJ_
MHGZHO!,/)^S)?_B"='&?Q3.VG7^I%^G])O\ :.)8]#1%1%]3IEY9U\1K?2J.
M];C(WT_Q>?E^O [KR?LRKFO.Q?7S;I&!U/O;3>SS$\U&+7FS\)S4CT1/-58S
M&[RS<[R3]5]*+Y)^O]W!#35ZC>5DX X X X X X X X X X X X X X!^*J(
MBJJHB(GFJK^B(B?WJJ_]$3@%L&7=T^K&&7DK$YN[<-R/.H2^F5K761Y^XMJ"
M<JJUJ+JS4T'-=AO5[VN&/T8R[W"M<(?J(BMX)AY>]#K/[S6T\P_@TWT^WID<
M8_\ \CF&XC8=URP=57_#]G4Y]=R]_P!8UR*U_FG7^8K&>MI&LD-2.\(S:Z]*
M<Q^7>]F<_P 5WL?KIU\K#_PR:;6^$YKV"S*.U?\ ZZC:6P[33V(QCC_N\[7K
MU>A*JHOM"1BM*%,)>^G)3U'[F6.9)_,W1O+LYO<SO_=B99N2UUGB<D:_XHEG
MK?K7!T7K3(J]4\F?"RK$;\;VM:\[CR$=(<$Y0M83+7N5IU?H#1>D@R0Z=TWJ
M_5K9WJ=8DP# \8Q*3:%(Y'ED6TRCK(4NUER")[LF98FDRI1E4T@Q"N<]1$MW
MN2KO *6ZRTOK;3[\[D8!CC:FQV=GV0[-V#>3+&UOLBR_-,D.CY=K>Y#?SK.Z
MGBK8 8..XQ5FG.JL1Q&HH\1QF%58Y2UE9%#X*I< < < < < < < < < < <
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MK?3%J::+"@1T]+6M\@QV)Y-:G]R)P0=FX X X X X X X X X X X X X X
MX X X X X X X X X X X X X X X X X X X X X X!+3)D.NAR["PEQH$"
M!&/,G3IAQ18<.'%$X\F7+DG<P,>-'"QYCG,]@@B8XA'-8U50"P*KJK_OC_:?
M*376*]*#N5<(U_%-.H<C[9UGFJ#SW9\L+HMO3==[QB>]A&K(A(,O;^/D#DNS
MI!L!OP:ZL!-V_I^5_5TE^M/3U&/55;0T%774='308E73TU/!C5E54UD #(T&
MNK:Z$($.#!AQA#CQ(D4(H\< V""-@V-:@@^CP"S/OSV>O^HW6C)]LX7B=5G.
MQY^5ZSU7JW%LAGRJG%[+9>Y-B8UK'##9;:0F.F0L4J+C* 7F1.B*&;*JJV57
MP),6=,C2!";*EQA5O<DV^A9VG;#N+U/[ ZZT5W!GZ1["L[#Z3[$[+TE<=<]<
M9GJ?+(VSNM.&U6QLVTY9XAENP]H!R>ER;$+1[\"S.OL*JX;<54FNO\=*EE"D
M1A,)J;,J&DY:=\UE)1NA[SJ'6'Q+,_NLDQ"P[ [,ZH[#UGLSIQG7<NPL^L</
M+DN.KU+@4W6[96O-NK<; S]<V;DD/8<BKQ'*XE1K6_N,YP',L?%KI[7A2H!V
M:4F^*X[J*,)3S1EBT3:[2R#5>+9-N:I@8UL'*A6&4V>&P >S^0:O(K6=<8MK
MZT,DN:.TR?!L5F4V+YC>QI'UU]EM7=W%3&@5,V# BBNXJ[P!P"UG<76_\RY,
M_=6D\ACZ<[)U\"+#!GT6N?-Q39E15H]T#7V_</B2( =DX*J/-&K)Q)$+/M>K
M,F6.MLLQJ1,MHUN)3P=5TVK+YQ.UZ#W@/<5-D-=D&-R-=;?UK<CQ'<FJ;">.
MSFX3E3X0K"%+JK@<:$++-?YC4F!DNN<ZB0847*,<EC^97463UN2XO0B&5[X
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MSHLO,[V2K7*U95Q>3I+FJJ.*J?IP1+_&'L5\X X X X X X X X X X X X
MX X X X X X X X X X X X X X X X X X X X X X X X X X X X X X
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M]M\RRRX@UXK*Y=:QBK*:*9.;+%VX5E)M4E[6V_B$LO<O3U#I+K3X<\#N1G>
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MQNAK2HY?-?-R/\U\U\U_5> VW>V]^PK?P0. . . . . . . . . . . . .
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M##5V)9!ALA27""'?%,RI' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
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MEW8O+=[6*$BL]F3$K:DJ&.C&OXVZQ^Y%UAK<WO;<<NL10]5/!S' ' ' ' '
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M'B*Z=[_3^Q(-/8WG516==]JOU=97^80Z2)69Y[P)DZES7"/J;NVE2,0R.HC
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M157C+R16,IK$D<'9:<;)HTU&<IP5!U=XC?678V)[XR>]M,ZT98=8,?#E_8#
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M.>Z\TW_.V9QN"@X X X X X X X X X X X X X X X X X X X X X X X
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M >M*'&K6?-C6<A]Z%[ 2!B>!H"))&-SQ^H4M]F["F9K%SRDSW\',< < < <
M< < < < < < < < < < < < < _'.1J*YRHUK45SG.5$1J(GFJJJ_HB(GZJJ
M_HB< XC(,HV%$]A!$8T@R#<CQD&]$<Q['M56O8]JHYKFJJ.145%5%X!SX X
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MW[S"D#D'IE+(A$]AKR@4K3QF_P!9(E7$<%U@X(Y=MY5]5_!TUE4V0G!E' '
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M2'3N5N?3F0E@^N"VN&84IWQ1OFQ_MT6P?* >M9$'/M?):X2J4K?Q9M6>#(.
M. . . . 8\?%M_Y87?G_ +3]W?\ @ESP6L>>S]5GJC4<FBD:4K?I",G-CSGR
M:%85TP55"95PC!O1D)9/G.(1CY%@5LOU0([8X3E;(@2618XV\>-*WTX$*3'
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MT?\ F2$JE^<X-C]5";8FN&TT QJTH6VSE6K!:.C1137RE<.#)D6XJY\QY:5
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MRO\ ..M@1H:=_+(W"_AX>_\ N =&?E?!^5^YYUF^3]9];];[_P"Q7"?>^O\
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M7H2 JW)6V0V0/KK9ME,'%HX(QST/7'"E:^:DA"DB/CE@26Q88VR1^Q.=-::
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M.AN"O#M3T^'YT6;\):SRZ<]9$^N=\A5K_+2F$)\)5EN?*58O_L+\E[I'F/\
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M66D9T1L"UL*S[)*VH0:L=N]W3KH1W(9##>U]:MJM9(8>.L3&FU Z=N,1_C2
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M%!40HYHH@")!E2UERQ0A3M?VWPSS6IQ-JKP8QP!P!P!P!P#'CXMO_+"[\_\
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M0P@K,1&Q&>S*B'F2F'.2;)BOBQQ3!Q[;RKZL=SNV:6S9$\&8< < < < < <
M\P/XLY8S?#7U<LQAR1$[EZN60.*48)#Q?LGWQZVA,4,@8R*G^%[P%:U?U5CO
M[N#KV7GIDS73^9O>(U[*M;1:N.H2,+C"4[:=,8.DAA0(%8+\B?!6(X16R!Y
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MAW^"(6#*BLB*5\Q2/B/$3Y@?AC#($:/+=+"6$./;>58>+X=;S9$<&8< < <
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M]F43PU-_S^2Y[H\8+NZ'3\:.D+#3MCH\D"B=.FD)1G+MG72/M)'KKQUYVV
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M#%9!B%9+DE)",-L@CR^D'R7Q0./& X(4>.7;^5?5\/7]FR)X,HX X X X X
MX!YB/Q8J'7PWM4)%^#\C]\[5GL_9+6I7^Y^R??'I^8MQY5:1_/\ ]SY_]%]/
M_N_P^?!T[+S\'=/Q4US3$B?%D^EW]5_T'W5(VF^Y^Z6EGJ%L9A"?9K1_:))9
M-)$7XJ1/KR63$M%JQ<&OKQB)ZQJ".YI?>'Z5J_M?K)"G1WY7^F2G_+$=T90O
M1_P%R)8/S$,QS4OVWZ1D$KLP<1K0Z<9F>FKB7,D7X;_)W]6_,M?IU1M-]PZ4
MB5'K^Y:$BV@Z]8:A6&IU)7?-2P;3^HWW;D#6.W6DB;DM=[]QZW5WRT=+_,2
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M]R19F'6,ERX#A-CLC,?'@QCF',^O*$PK'W!S[7R6O^?;O47#$VKG!D' ' '
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M3>=]"<E2?4>[5UX>5**Z7]]8_;61!YNU^003M2&AJ@4I5,5@KU[LB54.^O\
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ME6'BNC8ZZS-D1P9AP!P!P!P!P!P#S"_BR41?#;U4BPELD7N;JU/@-4Z++_\
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MF'^E^G?]H<B;/IYLF+7JY(?LHW?_ )I\P_TOT[_M#B;/IYL1:]7)#]E&[_\
M-/F'^E^G?]H<39]/-B+7JY(QV=PO!-Z_]]L_Q39_:K/LYV;F>%8J'"L=LQA@
MX8"'C(+JTR!E8:KP0V,U<Y/M;FQD.E38DB:]DCX[I"QQ!$--GT_R9:S:[2SY
M;<3_ /-E]2T)/PL'AO()XO8V$J/(,GK7+LL4K5&TK4:PGYJ]31O]U5(Q/T>Y
M@G._4;>)L^GFRWZG:_[/X6?L1/\ TLGAO^Y[GQ<^\_8^/Z/S5E7M^7QOB^[Z
M/S3Z??\ 3_.][_'\G^D>?N?KQ-GT\V/U.U_V?QL_8X+^%@\-Y1,%[&P41A"$
M]:9;EB%<I&B:K7D_-7J<-GM(HV*ODQSRN;^I'>:;/IYL?J=K_L_C9^QS=^%D
M\-]SY+_BY\GRO5ZFMRK*FL#ZCL/_ $9J93Y1_)6(-OM^7I YXD_@>J<39]/-
MC]3M?]G\;/V,RNL^LFP-/ZWU_J77W9+,J/ M781BFNL(I7Z^U=:OI\0PFA@8
MUC56^TM\;G6UDZOIJR%$=/M)TRQF*%9$V5(DD*9Z;/IYLYOO-MNU5U?A6)W?
M]E&[_P#-/F'^E^G?]H<39]/-B+7JY(?LHW?_ )I\P_TOT[_M#B;/IYL1:]7)
M%+]D4N_,)LM508G9C)IK-@[0K\"FODZRU$QU?"F8GF.1/GQ4%B*(24P^-1X[
M6&\Q**29RIZVLXFS7PW;7FE\D/O*/%>TKEB50_91N_\ S3YA_I?IW_:'$V?3
MS9,6O5R0_91N_P#S3YA_I?IW_:'$V?3S8BUZN2'[*-W_ .:?,/\ 2_3O^T.)
ML^GFQ%KU<D8C=Z?AUNEG9/<&9[YW+;YUENT=A77YAS+(664^@!>6_H"%91Z/
M&[BIH8R.CQP1W @5L6.H0L9[7]ZJFSZ>;+JUVEE0NTA?39*1)^%@\-Y!/%[&
MP51Y!D]:Y;EBE:HVE:C6$_-7J:-_NJI&(OD]S!.=^HV^2;/IYLG]3M?]G\;/
MV.?_ *63PW_<]SXN?>?L?']'YJRKV_+XWQ?=]'YI]/O^G^=[W^/Y/](\_<_7
MB;/IYL?J=K_L_C9^QP7\+!X;RB:+V-@HC2/)ZTRW+$*JD:-JM<3\U>IPV^VB
ML8J^3'/(Y/U>[B;/IYL?J=K_ +/XV?L=OP3\,WT$UIGF);+PLV>5&8X+E6/9
MMBEFM_>SPU&2XK=0<@HK$=;99#,K)*0;6NB'^)-B284@;'QY4<T<I!.39]/-
MAV^U::?:4='X+./ S0?LHW?_ )I\P_TOT[_M#B;/IYLYQ:]7)#]E&[_\T^8?
MZ7Z=_P!H<39]/-B+7JY(?LHW?_FGS#_2_3O^T.)L^GFQ%KU<D4OD4N_ [HJ=
M8)V8R9:ZQU?D.>OLUUEJ+YHYM+E>,8\* P:8C["Q3 OC2"/5/=:4 FM7T.>G
M)\,3W<8O>1'BF.]A-RS*H?LHW?\ YI\P_P!+]._[0Y$V?3S9,6O5R0_91N__
M #3YA_I?IW_:'$V?3S8BUZN2)&STON.XK;"IL.T68G@6D&773@)K/4(E-#F@
M)&DB0H<3&4:D"5[/<$]A&>?J8]KD1439]/-B+7JY(P@M_"R>&^U\9_Q<^7XO
MI]+795E3F&])WG_I+5RGRD>:O4;O<\_4!K!+_ Q$XFSZ>;.GZG:_[/XV?L<$
M_"P>&\@GB]C8*H\@R>M<MRQ2M4;2M1K"?FKU-&_W54C$7R>Y@G._4;?)-GT\
MV/U.U_V?QL_8Y_\ I9/#>]Q"?%S[S0/L>C\UY7[:I\?X_N*S\U>E3>7\WW?\
M7R/Y_GZ_UXFSZ?Y,?J=K_L_C9^QP7\+!X;RB07L;!\FD<3UIEN6>ZJN:QOI4
MGYJ]2C;Z/-K//R:YSW)^KEXFSZ?Y,?J=K_L_C9^Q6CK[^'CZ:]7-SX9V!T?=
MYSAVUM>SI]EA^1%GS,CCTTVSI["AEG90Y1;7./RW/JK2?&8R?62AB4_OB8PX
MQ%8FSZ?Y,AVNTM*'VDKZ;)EG_91N_P#S3YA_I?IW_:'$V?3S92+7JY(?LHW?
M_FGS#_2_3O\ M#B;/IYL1:]7)#]E&[_\T^8?Z7Z=_P!H<39]/-B+7JY(I?AM
M+OS)L_W!B$CLQDT:+K:]Q*H@2PZRU$Z18CR+!:++#FF-?B*C&^/)MR1 M"B-
M< +'O\R.=Q-GT\V0N]+7>NC!8E4/V4;O_P T^8?Z7Z=_VAQ-GT\V3%KU<D/V
M4;O_ ,T^8?Z7Z=_VAQ-GT\V(M>KDBG&W^I^9;XU9L'2^TNQF9Y'KC:6(WN"Y
MQ0#P+6=*2XQ?)*\U7<US+>BQZMN:UTJ%(,%)M780YT=7>Y&DB*UKT39]/-A=
MY--6JJJ\*P,.Z_A8/#>43!>QL%$80A/6F6Y8A7*1HFJUY/S5ZG#9[2*-BKY,
M<\KF_J1WFFSZ>;.GZG:_[/XV?L<W?A9/#?<^2_XN?)\KU>IK<JRIK ^H[#_T
M9J93Y1_)6(-OM^7I YXD_@>J<39]/-C]3M?]G\;/V#?PLGAO-=&=\7/E^-Z?
M)KLKRM6F])GG_I+5RKR/YJ11N]SS\PM8)?X&(G$V?3_)C]3M?]G\;/V."?A8
M?#>1A&?'V"J$<QRN7+<L5[/0KE\AO7*O-C7>K^-&^7J1&HO]W$V?3S8_4[7_
M &?QL_8N=ZF^!/UEZ.[6=NSK'F>=:ZV2_$K;"'WY7#R\9,;O)-;+M(3Z?-IF
M14JEE2*BO>L[Z])PO8]() V%*UZ;/IYLK:M=I:46K<J_RV5T,F7[*-W_ .:?
M,/\ 2_3O^T.)L^GFRL6O5R0_91N__-/F'^E^G?\ :'$V?3S8BUZN2'[*-W_Y
MI\P_TOT[_M#B;/IYL1:]7)&(7)O$'[-XMD>08PW(\7LVXY=VM"VRFX=5"F6#
M:B>>O2=+'"6-#')EI'^0=D2.",PI'M $0D8QO3N6<N;^YS[]K/DOL9^H%? J
MH4:MJX,.MKH061X<"!&##A1 ,3R8&-%CL&  6)^C!B&QC4_1&ISB=B<X X X
M X X X X X X X!*3Z^!:PY%?:0HEE E,]J5!GQ@S(<D?FCO;D1I#"!,SU-1
M?01CF^:(OEYHG )O@#@#@#@#@#@#@#@#@#@#@$I*KX$Y\,DV%$F/KI;;"O?*
MC!D/@SV!/&9-AN,QZQ9;(\J2!LD"L,T,@XD>C#$:X";X X X X X X X X X
M X X!*+7P%GLM5A1%LQQ"UX[%8P5GC@&,*2:$R8K/D-B%D  <L9I$"0P1%<Q
M7C8Y )O@#@#@#@#@#@#@#@#@#@#@$H"O@19,Z9&A1(\RS($UE+!&"&38%C1Q
MQ(Y9QQL:662/$"**%YW$<*.(86*T;&M0";X X X X X X X X X X X!T,^J
M]823&DR=<8'(D2"D.<Y\0QXICF*]2%,8I*YSR%(]SGD(]SGO>Y7.5555Y,O-
M^Y$+)>QWSD$C@#@&-GOOVG[$Z*V#T\TYUFP_2^4;'[7;4SS742;O6VSFFPG'
M183K&\V22?)F:_A6MZTDJ+C\R"Q!5%BU9!8S7""-Q9 A9*5:<QW8PF]QFCYL
M3(/&"J,6VA<Y9K[P];NZI-9Y+<ZOQK6F;]A[&SRW9U62NFT&)73LUQ/#JFLH
M<EK@W=1]T.Z9(J;V7133Q9-4*R9P12E7MIA[G1<R\57%YG1+5/9G2N"FS;?7
M8C):#1FE.L]Q*-7Y0_M5;VLC&,FU+FXT'%GT<745[5919[(MI8:L$7%<6E6@
MI4,=O3G,)5ES#N56\(S6<X9T/N=^_$J'X?\ J#%Y68ZRS':>][NKU<V7!P#6
M>U!Z"K+/,\UIL#O;G(]TEQRTPS!Z*+<GM5Q['+_)Y&=V928S )3^W?Q[3@6;
M/>=Z2K>U-*W3/LH*W]N.U^>Z8SW0/7[0^IZ3<?8_LO+V*; :'-<ZD:TUEB6%
MZCI*>ZV-L38V9UN*YS>Q*>C=DV+5571T&)6MQDEO>AB0W1&QCF0$IENB43G6
MY+;RVDITZ[<9]O/.^QG7_>^I*73G8_JO<ZYB[)H<)SLVS=99-BNW\:L<HUIG
MVO\ ,YV,87=&K,BA4601IU!D&+5EUCTZI='FND.D-]H0U$-.4\U#]I?4ORX(
M' ' ' ' ' ,3?8?M7W:3OL/I7U%P;JQ9NK>H>,=HLBROL?DFVJ!OIO=S9SJ<
M^/4JZRHLE4R@7'*BR%\ZMCHJ2K+USE]N+'<+1X>\WBU=DD\UF2FV^QWB2=6-
M Y;V&[ ZAZH9_C^KLWP6^V5BG6?(MU9#D\7K:A;$.ZL]HV[!QW%F2,VUQ"?4
MY=74"19M5=8M79:LN?63H5<V8"2;B7+F+E6**_%T*J[J[R2TVWT\T)U0KL,W
M/L/M.*'N"QO9L^PE8/K3IW4PXT_*M^VYJ$\>9);D![2CQ74];(DUU?F.5V1H
M;K$#:V0,@11S2.LJGM,Y0=?W#XE6+8!W;ZT])<6U?LV^RG<NSLGPK.=B9-K?
M8N#ZMP^NQ[4>4;)$/#-@9'B]=B>TLILY-941D@X3:W5/65GWY;6UB6L %<8%
M9FR[4JD4E2ZI77KCLS.Q[Q[3]GW]BKOK-T^ZZ8#M+)]=ZPQ7:VVMD;TVKDNG
M]78_'SNXR2LPG7.*2\6UCLR\R_8&01L2O;J81(%7C6+U@ZU;2SD2[1(L,$E$
MMT;B$I=(G%1?^"M'2CM+$[B]?,;W6S![/65Z?(]@8#G>N[6W@Y&;"]BZKSG(
M-=9U01<GJP1JS*:B+DF-SWTF1P8T05O4&A2S0*V8^371!#33A[.:DNOX(' '
M ' ' ' ,+N.=K?$KW]OCM]@76+7O1J+KOJYOP^C$L]\9EORES3(9X<%P_-UM
MEB:^Q+*J/XBQLN!%1WR(1O?C&;\/VT8<PLTDDY=5-VUJ^5EE[E3\P[<]K>K>
M5]3OWS\%Z_1-5;VS:\TIM/:6B+S8UEC.E-PY+:F_=_F6LW8%;2S"ZZV4 8\*
MO;BRHZL6(Y])@$E71::TA">"2:<.JK=>L=T7[5SJ[2]MLPV9WUR;JIIW$\=O
M=6=?=<QLD[7;>M3V9'8QLW/X[96I-(8&."<%?*S0M".1GN>2;%MC!I,7DU5:
MK85]/$-X0E9EWNY;%>_@IWH'Q*L5[(]Y\\ZDX#K#9M#B^ONNK=SS=C;8UOL7
M3MMDMZ_9T/ ?J<0P;9>+XOD5IAL<!SE7-30(L.PNHLVLJPRH\ LXH.S"F55Q
M":>$X-^Q,^(SXC%)T7I==5=!@Y=M[7V)F6 PUPN'8$@0L$U9D>U,&U9D&X,]
ML8T6:6FQ>#E.?XQAN-#>!LC*,YR.LK(".@5V1S:D+-GO.^/O%%K"3)CP5' '
M ' ' ' ' ,#_ %%[8^+YW/ZZZU[-:SUGX;F.8+M2'?6&/4N=9_V=A99!C4.6
M7V(G;=1L?P+(*<1RSL?E2 I!N)HUB&CN>\9G$ (6M659M-2Z;%]R\O!>VVV\
M2[EU'3_M+AVO,3G;;TI1[-ZW[*US.R0^';,S3"Z6*WLGJ)[\J04UF6:_M9(L
MPP]HHT4N0ZJE,NK.%67$*;7M$125G$8K)ZN>]$CUV[U6N^)';;=@L/'&Z5:)
MRBVP#4&S,5QS.=@;(WY>:S#*B[LS?#\.PV!>3L@UY1Y;&DX9KY,+H,DN<^L:
MNYF07"^&RN,)=F(K5WK*;I;YY8GUN@_?6#WLG=I9U%K3,-:XIH7? ].XN'8M
M#?X=L#)J\.N\+RR5DV5X)DU;676%&GVN13TIJ2RCLLORXRGG6D>#8RY4",%J
MSW8JG*FE5>U$XW>Y1KK)W;[X=GX6LMHXET7T[5=:=EY>UL#9MEW&,N<QM3AS
MF9C4S8@M8-Z^#'-M'X_72LIJ,23,H[+5KX=?^8(K97SA U95)<Q=W5$Q,3WN
M$P9<N"HX X X X X!:3WQ[$9!U+Z==B>R>*T%/E.1:9UG>9S3X[D!9H*6WFU
M7L^U"LC5Q03AQ2^ZON.BF&5/)/2Y."UE=ZTE=.);3K3*_&(R@N 9#D^'>&G#
MP+(B8K=9#]#L'M$?+XN(6SH$ZV^EBV&M14QLD!32)'UT>=/'6$LVA')F,B*\
MR"*9OV7W.Q:1[]#%/[EZ^[@P\/T?M'I/87.:YY)K)5HW"<TZQV==/R;6783#
M/N#3+.12WM#76='E-+&EW,O&,[HYV/R3MF3J^"HEV;FI:=U,<MOSDKB#IWO?
MF/[FM3W'[/:6SS ZO9^26EWI_3NF]5[3W3M\.I,@^;/T_P#GW%\&I\HF0\[R
M[&*[\QWL[XU!A&.-O*2HM[&ILE,-P-5A-/;*2F*PW&-V9\_3'B88AE_AB0/$
MLVKA5E@N*DPW.\QFZ[H3NR#(B$H-F9-KC#\-IW21U[)V7YK;5E!2P8AOB0FY
M+?BANE#A#^6@.S%KNJNW@=CT?V6[OV.W=98+V@Z45&KL+W?C657^)9YIK:]_
MN^+IFZQBE!D;-=]FW2-58)28/=W]4^7"Q[+,;O<CQ&URZ!^48AB3K"%)>#5F
M)3NO343]-7/)X[LCO!4< < < < < < P=^+'J?&]X]I?"1U;E\W,JW&LL[+[
MPC6T_7^;Y9KC+XHH'6C/+<#J;-\'M:/*: KY=?'%(/4VL,LJ$^37G>2'+D!(
M.EAQ9MO8KU-]I*YF0WK9TMU'U6M<IN-:Y+O>]E9?7UU;:#W!V(W1NZ#'CUDF
M1*COI*_:F:Y7#H93R22-ES*@,.3-"T0912B")C11MO+@DNB1C*TCUQU31^/!
MVFR>!C\@;<7ZT:_[ XCCY+&<7#,2WCV-N[C6^[MJ8OBSR+2TF=;'P[4&(U.5
M9# C"L;8;[HDTQB6\AR"[;_37U-<$I2X-N-Y7WQT6N=X8&_T:BN5<TZL_HU%
M5?T[>:&5?T3]?T1%5?\ ^$3SY#NXKJBMCS+CT9(>*'XB\#I_D.A]&8]LG3ND
M]E=B4SB<[?F^8=K<ZUT5KG!H]2S(<O)B-(:%:; SV]L[RNH];81]I3T5A;@L
M;7++:+14IXME)-FR[4NKB**]S/LJ5?(^]X7%ETKN8.^+_K5VK=W/WAE^183F
M/;+?U[:BL,XRW)["GN:/7H;*NKJ:AQO#<)I:?&\AIM;8#BM;'HL4I8$R&'Y,
MDDJ?-$6E:4*THI1:_LRP<%1P!P!P!P!P#S^[_P"L&O.TGCC3\4V1=;;HJG'O
M"CUYD,"5J+<NS]*7!K%.WFVJU8]G?ZMR?%;:VK4C3BD^GL9DFN^4V/-^-\F.
M K!T3CLZ1YW>D\%FF9@=!=:-;]<M=W&K\)G['RG%+Z]M<@M$W+M38.[[J1(N
MJFJI;"N_,6U,ARN[9CQ8-1':S'&3FTH3GL9(H33V<XAQ1N<N"2Y*$8G/!+Z^
M:TU1D?B26F+5%BD_ ^_6Y.K& 2[VWLK^1A'733$'$\GUEJ/$3VYY)J3"<6N=
MFY?*AU4$@PR72HBSEE$K(1 BUMSW:WV9=U[;EN,6DJNI77Q!&N7NOX.:HBJC
M>VFY5<J(JHU%ZI;<1%5?^GFOZ?K_ ->"+-UOZ5_[LCM]VYZQKM#:_3#NCLC*
M^FN&+@FO-GZEWW$[#93U\C[UJK%<ABY[C^&;'Q8^'$J;W6]Y6U]7D^OB9?<3
M\OJ\BJ;%:$M40D=P).^RIOI$QO33Z<R'X)8KZ!TA'CHQ6<C2V);TWQC74O*\
M@P^%@^5;(ZJ0-@6)=2;*RNEA4>,_+OLS#)N+:1E4['ZJWSB,2)F=P*597TFQ
MFA;\VUI-UF&U53LXQ=)ESX*C@#@#@#@#@'F_ZM=&=.]H^V7BO9ALG)NP=#:4
M'>V;CE?'U'V3WEI2D/7-T=J&S218T&KLYQ6GMK19,\XUN+"')L5B,C0ED_&B
M $,=&VK-A4\K=;*=]JUFF9A=N]7]1WW2S8G5G*:R^S;4IM-Y)AQXV=Y;D><9
M9*@P:J5/JK:=G&5V-OE5CE-+;1H5W3Y/86DJZK[JNKK./+;*A (P4ES*H[Z4
M+3O YPVHQ_PSNN&;L2QL<[WO16F]]R9KD%C-N\NV-MC8=Q-F9/F>77UD4]E<
MW$H46NJQ29IBE!45-9!1[F16N43;\UK8VDE<DJ(X1FN_X[]V[R7T_P#"0Q=O
MJ\E]/J_?&R]?+S_N\_+]?+^_R_7@?X?]?!BH\0S0OB&ZMT)V^VUM/&NFV?%W
MQVCZK6,_:5=N/=SMDT6M<0[?:AC]:=,8W@<WKY#Q7&\!PR9)K$RZ-%SBQEGM
M\JV3L3Y.3Y%8Q*LXM9[KM68[RA.D36*N]=,$>I77IM@2,(Q<^UJW#J?9!::&
M_-*O7MW=Y)A$'(7#1;"-B]]D=!BM];4PR^:0YMMCE+-./R<>OCN_@X.9W'@#
M@#@#@#@#@'F#\'/PU.O^Y_#>ZO;4S#,NU55E&54N=3K2NP7M_P!E-<XA&/ V
MWGU6!E/@V%[*I,5HH[XU> DF-55,0$J6^3-D#)*ER"D'2W:?>M>6)]-E\XDO
M7\?_  NIM_#%WELH2VE1LG0LW!-HZ>SO&K*;1Y=@6;+G./85,ML>NZT@9T1;
M7#\NR;&[:.PB@G55O)&5GNCC& *V/,LG>L'C7BC*]I_4N :&U;@&F-5X]$Q3
M76L<4I<,P^@A)_*KZ.BA"A1&E,[^;,G2$&LNSLI3B3;2Q/*L9QCS)1S/%6VW
M+JV8L>B,R15;G\:>SCTV09!(@=T;"?%H<5^&S*+TT3JOIHXJC&764N!7I?61
M!I"IW3IT.$EB:/\ *EQ@H0S!>U_A]"_]6C#[)J?#)QO1?4VU\*JUO<<\1INW
MNOF/:OUX+8>77':ZCC@V/C$/>>M>WF!LR2V/2ZWPW5[,_K,_@YI61=84?TD0
M.+3$H/A.EBR[TOO^6LN/#,4[L0I;2JN)[%^#D. . . . . 8Q?&@17>%7WL:
MU%<J]?<O1$1%557^B?HB)^J\%^S\]G>0.L?AK=?M8)I?;V/9GVHFY5CN/XKD
M<&NRWN!V3S+"BV$G'(Z$#9X#D^R[3$+6K;\LOM5%C3R*T*M#[<9OL"] AVFY
MF-OALI^\26K^,#USU9M?L9X7MGE]%+E$V9VQINN>U05MG/JH.T=#2J*_WJ?4
M^QXM>4(LOP1VS=08;D(J"Z23!C2&6RQ1@+;2C.%K#A6MEF5L<I2O<SSL8P;&
M#&QHQC:UC&,:C6,8U$:UC&M1&M:UJ(C6HB(B(B(GEP<SR?8OJ?8>X/PO&-8I
MK*)E4W,:6$39<>MPJ,25F4NGU%WHL=HY3^5H+&$-/R6!B^)6]OCM<$$B187=
M?7PX\<QCC8K";SJVEVK;AJ7NJH*OZ'E=)0=\^C1O";V*3-G996;<M^\ L"V?
ML/9&,66B?V6V9<3RGLRS+,@OOI-QIN5^(@P^3E#*G9DVZL+Z'> +4C.*.(A]
MU]Y1=W9I6;EFHETI1;#TR<',< < < < < < < < < < < < < < < < < <
M< < < < ^5;T5)?QQ1+ZFJKN*"0*6&-;U\2RCAEA\_9E"#,"88Y O4OM&8U"
M#\U]#D\UX!]5$\OT3]$3]$1/^G ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
M ' ' ' ' ' /E1Z*CB6<V[B4U5&N;(8PV%O'KH@;.>(/I]H4V>,+9<H8O2WV
MV'*]K/2WTHGDG /J\ < < < < < < < < < < ^774E-4$G%J:BKJRVDITZS
M)70(D(EC-?Y^N9.?&$)TN4_S7U2)"D,[S7S>O /J< < < < < < < < < <
M< < < < < < < < < < < < < < < < < < < < < < < < < < < < < <
M< < < < < < < < < < < < < < < < < < < < < < < < < < < < < <
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M!PR 2_DU^+UR7+JV.^XD0Z6-YS3!C."5':5OB-OB5Q8CC>H-@9-X7W:77\#
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M+NNP+XOT.EU=M7+79QVE\'.SP*SK\"RNT+LJEUB_J@+8F3XF^%5R4RFNP_\
M+M](S:SI'V$/&75-PZ[D0TKIBA"RU-BJI8M)_P _NO<K7B&WY?0W-?$UUANG
MK/OG=>:]D.SNS>PG7F!K[0FR-N8)VFPO;>L<$QO&=-R,[Q/#,NPS#[+"[+&9
M^ YI4;4F8Y4TN-R8UY$!:T\YSI(B.]W7*4*'+4J,E>\U"OH4]VWH'==X+Q9*
M>CZVVN 2MA^#/USU9KS6>M\;F6.O(FQZ/679F!;:(TY=U./TF.9>7 )ES38I
M54V*U\4S84G'6AHJT=K70U$IKP5N[1M[O!5^S(?=#:&;Z5T'T(\3?KSKS/Y^
MQ<%U5D_3?*-=93@63:VS_(H&_<'3!]65F3X=L&JQ[(X<3"NX&":JF5\:PJ6C
MMZ/)[.\H4LZVTK)DD+*J[#:B^;U2KJO_ )GC"9FWZ8]=:WJ7U6T5UVKY+;$^
MK]>TU-DEVCR$=D^>36DO-BY>8A40I).89[:Y'D\IY?YCI%L57JKE5>"C<MO,
MP)[@T!M[(NO?B[8P32NRKHFT/%YZW9OB-!^SK*9Y=A:RK]H]*9&1YAC58E.4
MF58- JL<RB1=9%5!G4,2!0WQILP<>KL' %TX[M;K%OW\<=5[F5"9@&5%\9:@
MV@["LA)@L+PS,JP=FPUQRR?B47,9O:3$;Q,/;EJPUIP9-+HHI;A*!+!MH>IC
MEL$B.AB>5L8K<_@K_C_U\&$_';2ZZN9IX8F6[8TEMNP%C7B/>,!ELO"*;5V6
M7NQ(F%98_>DRIV;CNMXM07*\IHZ+&;H&R8ZXS36ME9XA D7>)0K>6E:&3.6I
MU>6O=JJK8L7N]KN4G"JQQH5TWID&_-L7/B)=[.L>BMAOUUEVI^F'7C /VC=;
M+RVS79]5KC<M_EN\.QF'=7=M8S69/G9]-X5GR"UC#S3"F_F7(,6ES*VHM(5!
M\"<"CPV6U?:<IJDI)*;JM5AW.L,ZQCE/E&R.^.B<JP?9'B([LP7/^J'<;05)
MVC[0Z&S/!<+H-S[*I=<3<>J<2Q7'NONEY.M:&$&BL+2USK*->T>'7UA B45#
MF]_:XI:PZP$UW;2\*<V6E,S$YM^TR7"=0MYIC?63HCX?MYT.VEF_8W3MUHO6
M&Y-?;6T1F=%IG2*:8G0_S3VP9O'(==WFE,D!!E8X396HYN!Y9:Y-EV875!$J
M95+92B6,4+57:M*U1R[U+G")G8]E2[OPP4O<3R/Q"]69A@VR,,RFO\0[L[MR
M%(R_769XWB>5ZYW7G<W(==93@><V]+$P[.X5O4UDF5-#B=Y;3L?82!^8(M8E
MM5+-%6KG2J5S6"2JL.)E<X*C@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@'
M5B8-A)B/*7#\6*4KW$(0F/U+R$(]RN>][W1%<][W*KG.<JN<Y55555X!,0<1
MQ2LE"G5N,8]7S0>OV)D&EK8DH/N#>$GM2(\891^X(A!/]#T]0WO8[S:Y44#L
M/ ' ' ' ' ' ' ' ' ' ' (1P E -&DA%(C2!$!(CG&PH#@*Q1E"81$<,HBC
M<YA!O:YCV.5KD5%5. 0R0XA4BH6+&(D(K#PD( 3TB'&(@!FBHYJ_'*P!2A80
M7H>T12#148]R*!,\ < < < < < < < PN>.CD^44O5/4^+4&4Y/C5)N#M1K'
M3&RX^+9%<XO)R_5FP<0V96YI@]I:8_.K;5*/(X(Q1[$$6;'(1HA.85A!L>T6
MLWMY)M;T9B<:QRBP['*#$<6JH=%C.+4M5CF.TE<%(]?345'!!65%5  W^$$.
MOKXL>)%"W]!@"QB?HW@J?:X X X X X X X!A![8$E[ \8OH+I7,+.ZNM1UF
ML\JW_&UN6\N(V&DW)J^1L&5K[8-A0P9T6OMKW$I;0S:9]J&9%C3HD"=\9TNN
M@FCBR\MIXS97!JU/0S?<%1P!P#'CV?H:FR[Q>&-<S8GO66.9]VH-32??DC^&
M6SZO9G73G>R(PX\CWX12!],H1VC]7N!094:]!*N>[Y1D.X(' ' ' ' ' ' '
& ' ' /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g257749g91v69.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g257749g91v69.jpg
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M?!_!(W(4< < < < < < < < < < < < < < < < < < < < < < < < < <
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M< < < < < < < < < < < < < < < < < < < < < < CFG_ -4]9?X!B/\
MH+#E=WQ?R9P?:N?RR1N0T. . . . . . . . 6W[W\2ZNZGL"1U-6'7[MMV_
MLB$NTAM@!.JE($9[':Y++M&S] )-[*D96&5L+D&[%TBY5C8^5%Y&QT4TP2$L
MMM]?2-+#.:2U;C^^QWKK+WZK#LE+'=8/:R[#=<+L9@GDIQ2O:.GCU2S@Q%AS
MIBP)2:'OU534%G@0<^),6Q)Q"YB=<BMG;50LS8).F^Z@CPM:-:IROZYQ9Z,K
MFX(. . 1S<'ZIK._R_F'^WR'*KKBODCL^#^"1N0HX X X X X X X X X X
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M175TV&4VK..!W<8+&!&#44&',! MBCJW8C1C-NP8,T-/_L1:LVJ:3=NCK_\
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M7ZAZ&%^Y:0I:J*>$Y2U1W'5A7L2@C15/7T>C"Z,8$C-'&<YUQMMNOA3???\
MZ]]MM\YVX#;=VWQ)>X(. . . . . . 6QK\[JV5U6[PTI7-XQF)#NE'9\*,K
M*K;T&H%FYBNNV&A FY:5];K]T27!M8O:H+9FTKTLU'C]T)$-=M'VZS!(L2'C
M24X6U=76JU7#/=6D%SG@R. . . . . . . . . . . . . . . . . . . .
M . 1S3_ZIZR_P#$?]!8<KN^+^3.#[5S^62-R&AP!P!P!P#&@\3OK=1,R[XU+
M J]Z_>';";VNBC;9MBPNQ?=:O/B.%2T3!YC6X'2)1J##RT9C\[NUXZ*-2I.9
M295])8W6HPP@,<X:/WB6XZ8<36%R\<*$EA<73SK"W9[X+E_A&S^-6'TBA3Z+
MU-2=.M(M85W5L3C_ %K':CNO4CD=;6[,87(K'I?3&FN[B 6*7#.I:*<+[NG'
MMB;MNN_(J-\OW(SC48G5NS^J]4G#WJQ<M4432TV454T23U_OVW4VUTTUQZ?1
MZ=MMLXUQ_?G&/[\_^<^C@R?? ,<'Q<*&I8;:5&1@-UE1MNR.SL_N^Q",VM3O
M9>G5&F(A((A7]2BSC!Y(8K+=6"LHF\;CD=S#( )9,V6K:%3B2#A>5U9.^W'3
M \YB$E3"L3B>&3N[U2+B_A5UEFINKRT5S7E<5EG-F2TI\-5;V>G?;>,9\XPC
MR?O':U[$=O9 F2=>7]1W%L+>0#IMV[AMIKN27SD9QN<5V^*6'LBXXX?L6:K1
M!V]:-5WZV6[%%PY105>N,:94R@T35WUW<+8TQG?*2.-]\:8SMG7T8SG@R;K.
M<:XSMMG&NNN,YVVSG&,8QC'ISG.<_P!V,8Q_?G.?[L8X!H-'C1^V2>,'3=ZT
M<:^N@Z:+I.6RVGISKZZ2Z.VZ2FOK8SCUM-ML>G&<>GTXSP#H-P?JFL[_ "_F
M'^WR'*KKBODCL^#^"1N0HX X X X X X X X!$MP7W2'7R-[3&];?K2G8MCV
MF-#UF3:.0H:X42QKG9NR<R$B/T?O,^MIJFR9>W=K**)I(H[J*::["I-T2;>Z
MIU^Z;AD\(HHO;]'5,=[2GMQ,:+0&N*TE4.#.[$:2DD(:CR0B7RHJPBK4 @++
M8DSTSL[=ZY ,W+H<T(K90;K DFX;A:E/O4:;>)#8<QE,I[A4EUKZ[5&\C>FM
M?U5 K(E-OWP)EV2C/=1:PIZR:BJD=Q_0)E\AJVB8U8BH7\NMEVDR3W3<BO9R
M;;SI"Y5DXB\?"QZ<=G;R>7SV1ADRO4UE$"F KRR;2L$S1\+5 B6H?5U%:;0D
M#&!M5BZ+7SAY(F(*LR99R_*J-='KYTLJ"Q-*$XWJCZW[P5[QF,1N%QL##H='
MPL4B45##8[&8O'!;()'H['PS-$<(!@PPU!L.%"!8]N@Q'#F+=!FR:()-VZ*:
M*>FF!DY31HT2VQNDU;I[Z^GT;Z(IZ;8]./1GT;:ZXSCTXSG&?1G_ ,9]' -Q
MP!P!P!P!P!P!P!P!P!P#J$XKZ!V:"^%K(A,2L",^] IOX=FL<#RD'[YC95H=
MCQ;W2<9OF'O($;8,3 =]Y?S0TFS:OV:J+INDKJ$Q:A!<9[?4_).V%F=+ME9+
M'+SK:OH?:R0F5!=0P:R*[ENN459;51;9ZMM,!$1->I&)HOHT8[!9'OD>GH]U
M;O%VPL.%BR;:YHJCX(. . . . . . . . . . . . . . . . . . . . 1S
M3_ZIZR_P#$?]!8<KN^+^3.#[5S^62-G/H_OS_=C']^<Y_P#UR&C:LG[$DWT>
M#GC5^T4SOJFZ9.$73=39+?9-3&BZ&ZB6V4U--D]\:[9SIOKMIMZ-L9Q@!EZS
MU>:#]G;75^HWW=)L<KI8>*-4]]4E'.C;._MMF^BF^B>ZVNF4]=]M=-ML;;8Q
MD#7U43WW43U4TVW2SKA737;7.Z>=]<;ZX4UQG.=,[:9QMKC;&/3KG&V/3C/I
MX!^(K(N$4G#=5-=!=/19%='?55%9)37&Z:J2FF=M%$U-,XWTWTVSKMKG&VN<
MXSC/ *+>^$#Z32.DG4T[U5;7UEU77!42\%IS.NG-D&Q\IEIH1#@ F @P8<U,
MGTLFTA+ HH, 1!HN4DY%^.$Y:.\;Z)ZBX7B3^EM/=^23>J4[Z_V#1,**=818
MN-4X$P:@\>A(N!D:KVKTE!#I*)R>ORU9&0<:,P$_#Y*)*A#<7+ !3Y@1:KY4
M;;)K)N%@<IUO>\WK,YS>3'0\6RA95-^[I(79<IH:54C:-?PRV6]567W$&4A,
M9Y#^I-67I-7G6 ?6IPL*09U_;MTJ12QIE>*:B$?@[2+.GTC)MT@&6RPWAHI2
M<J5,3#;23FN5E2MKUR&ND\!G-5=/>KM:V;+FL\L*"4%4\4F4P8%]I$/D$A"0
M@*P)D!\B4VV5D3!1RAOJRD*VV5SK71(JMZ%7>^.##JVU9MQU*!/%5Z+W%VUL
M7J78-54UU-OYE1:-\,Y?67<>33\?6)%*T1=<,P14;&X/$)1H9DP=W$7KAL5+
MJLT C?95L@P*+&=7H$7"XFN+#,5PJM.:I7K&A5OX?5'S?K]0:L"L"B.K'78]
MM.I&=Q7W3]63+5)NQ(M R+<]OO+(]&2OQ62W9+(F<8&Y:X;LAGL7*NV5-4Q&
MY=V][O\ +^2@WQ,J K"XHOW8G==Q&EKU[,5Y0H..S/7L/)'0Q?J'7K*!6%8$
M<L3K1NG7)/>.6@;>.W<U:/D9Y AL@E47"JFK,C:<-18(BX;JZ4Y9NE&].NY5
MDEWN5. EG]'^K"?OF0N:DOFZ?#[C-UJRUUH+E!&B;HLRMTS 2TMF+C&0[:RM
M2(B$6$CNY18D!TGD 99QNP>N/6!7>Y-KEIKKW.[],(=$*B[E>(+25-QP#!:(
MB;3J?-0U=0D8Q 5_!KAL6"V)FU1T7BX=)L"BJQR)Q>G)B>#!F(]LX)R3:2.&
MFS^0NGCP'93>O%K?W7!;BM2]R<F:5Q8;83%VY<:K7DJR[)J'VXU1GON&*:+:
M:L%&+A1S[%#5-?&VJZ>%<J91QC7.F=\W#=<5[<YXFX=)4.LG9/B.R/IJQ^^V
M'Y+Q35]%Y$XOX]T/B.R/IJQ^^V'Y+Q35]%Y$XOX]T/B.R/IJQ^^V'Y+Q35]%
MY$XOX]T/B.R/IJQ^^V'Y+Q35]%Y$XOX]T/B.R/IJQ^^V'Y+Q35]%Y$XOX]T/
MB.R/IJQ^^V'Y+Q35]%Y$XOX]T4B=B_$<Z[=2L92[%V=2=6%O0ELG%#MT 74[
M<IK>KE-9E7P004F[]OZ-T]MW+*/KH)ZJ)[**::[Z9RIJ^B\E2QNV!O@R2KVM
M?M9&:M=2/KIU@C%VV,]<A6T>BAZ]8]78## NX33=R<M("L><>N, ,U?>CD0P
M0R7+I)Y9#\IN5-=]8XRE\DOR7#5_4ME:W[$,]47'BDHG)_)>ZP_JN]$&VP1*
MN*QZZ+RYDW@^[58@H5=R&>SY9V3DSXBV78-7#- ,B/1=L=W@URT;K;LUBW]E
M_>D#$U;#AQ/5MI=O[.%/^'1U5F5_2SL_872"M+2NV9.ACPK++:G;RU&+-4,,
M9"1F(U#;!TD<'B.C)LP05;ZQ>-B?9O<JOM,X<J94Y::OHO(V_P!2(AI+)8DN
ML7YE=;<U8#-N@T:5<+:M6J*3=LV;S8:@W;MT--4D4$$4@FJ:***>NJ:22>NN
MB>FNNFFN-<8QQ35]%Y,SB_CW1K?$=D?35C]]L/R7BFKZ+R)Q?Q[H?$=D?35C
M]]L/R7BFKZ+R)Q?Q[H?$=D?35C]]L/R7BFKZ+R)Q?Q[H?$=D?35C]]L/R7BF
MKZ+R)Q?Q[H?$=D?35C]]L/R7BFKZ+R)Q?Q[H?$=D?35C]]L/R7BFKZ+R)Q?Q
M[H?$=D?35C]]L/R7BFKZ+R)Q?Q[H?$=D?35C]]L/R7BFKZ+R)Q?Q[H?$=D?3
M5C]]L/R7BFKZ+R)Q?Q[H?$=D?35C]]L/R7BFKZ+R)Q?Q[H?$=D?35C]]L/R7
MBFKZ+R)Q?Q[HP';5FMF8N&RFN?C)GK\SY"CG720*N7;!3!VC/^QI_3X>>:.>
MHK[&B+>[7^4"":14A(O213Q(GK*>0[IVHI2K2(5:O_:(BT3I*48BIW8[? C;
M=T4:;()P1GJK""KE\#;;+AZESB-5HZS'".2?2LSIZV\\DFY$[ET]+&%53D@5
MD[]Q9T]]W>K(.[HZVKE6&_\ :;)[K0:0R9V1EFV63<&E,H;JC_9Y*N' Q+90
M; ME8Q"U58D_]?I<[TQE63R=5PXT1=O7V^#S?WZ]>36EM,+6LMT_.+2:4Y*4
M:1F%C?."DM5D)DU44M"J 7LX*LL;<;Y5*@=_E\#;;5;(-2/3]^FCLY3E:Z$K
MT+EU7"F[^5J.'CU\)BHFJ)UO$O6;_5THT[F9+V*ZIX[$VGUIO)_$#U>7)U9L
MMM.:^L>OK$CPZ1$HN_UPSL"GI4J1BA) O6-FAO2*E0C**+U-/&%Q! >HL_U>
MVFKZ+R<5CQI-;-,2AU7%/BBJH?8$L+.S+ 5#HX3?1U^F*D#(?985Z[!$UF#,
MJB.,MFPM188_5%D&!)-F]T0<;L'S-YJGENY14W4U?1>23B_CW1ROQ'9'TU8_
M?;#\EXIJ^B\B<7\>Z'Q'9'TU8_?;#\EXIJ^B\B<7\>Z'Q'9'TU8_?;#\EXIJ
M^B\B<7\>Z'Q'9'TU8_?;#\EXIJ^B\B<7\>Z'Q'9'TU8_?;#\EXIJ^B\B<7\>
MZ'Q'9'TU8_?;#\EXIJ^B\B<7\>Z'Q'9'TU8_?;#\EXIJ^B\B<7\>Z'Q'9'TU
M8_?;#\EXIJ^B\B<7\>Z'Q'9'TU8_?;#\EXIJ^B\B<7\>Z'Q'9'TU8_?;#\EX
MIJ^B\B<7\>Z'Q'9'TU8_?;#\EXIJ^B\B<7\>Z'Q'9'TU8_?;#\EXIJ^B\B<7
M\>Z'Q'9'TU8_?;#\EXIJ^B\B<7\>Z'Q'9'TU8_?;#\EXIJ^B\B<7\>Z'Q'9'
MTU8_?;#\EXIJ^B\B<7\>Z'Q'9'TU8_?;#\EXIJ^B\B<7\>Z'Q'9'TU8_?;#\
MEXIJ^B\B<7\>Z'Q'9'TU8_?;#\EXIJ^B\B<7\>Z'Q'9'TU8_?;#\EXIJ^B\B
M<7\>Z'Q'9'TU8_?;#\EXIJ^B\B<7\>Z.LT23E#NNJ];%HLW$#$J^C&6I1.0-
MR2CO=,0,30TV'I,6ZC?#A#91QG?9=3".4\([8VVWQMABN^+]N,%K4U.I]OP-
M-2^A9)!^P$U,P*II_**L@<H,!"2P94OO,;6A4?!5^4*)"R^&D6M61/Q-83'"
M[=JW>167F!RI<'AY[X8PVKT]I^"@7H9%DZ$[J=YZ@,U=3/7EH6K[JU:T0JCK
M>237Z]"H<4?W173*;+ZK1*M-8W>-A'HNX%SL*E78 80CD/KIP)+R]VF5*X%=
ME6;U=\J9VNN+611M/8C#WE5=J.VSL&&6[PP/Q=PM=UI:*C9LM;@$>![@5/3M
M0TI'3N^N9 TKR<=;S8MH3K5FOK%Y!'+#D4B?!W"YAV3V&JT4_2\,Q1?MJ])E
M4;K;@3'8G7UYTOE5FVB7L**,&<KK/M:;L*<5+7QP!?LNH(C.X_?%RW5?DOS*
MW_Q]9M(0P2UH7KN;&,$U0L]NT6;;H1V*."45'B3-(TUA4B%N=WG355NO=9[G
M!V.+EM>MJ@EU!22B7D4@QRHI=O7SI6+!2L*!R:![A255S&>09R!=1(DQ;-F8
MV0Y>!G8Y\,>#VR+=BZ?C,<_=Y8SN"7J=I>^MR=$HO$F58A);-)8UFL47L2SI
M X,R&HHC!;SB_9VS:+$#83FEH#-IHN+#4_V&ZZWM7=HD[;#QTY+%)JGHK&10
MVI2VO'#93KE+>%IJ)31?+Z@U&WHRC@=9HU<TJAT$.RY\;$L[1D-UZ2F3261D
M9/)['<6M-4&=@3@C/CY@C(RANP1PR8*$GCIN29:(MVBRPPZO^H[*B,>WOW04
MULWQ0['(499G2<%8HB!4#/9X#[XA9;',M8KFJNQ='H#J/E01H79V94TC$6D9
M)7%7*J<>;H6)'H?[U+*,26Z.SY]R-IK9A[2JZJ/]7RB+UGE3(DZA5 .Z_=5N
MN='")MK9(RI*5K:O&$_3W1W;3%M$HD*"I2(?JW>$$$!175GAV):(D'Z3(:HT
M9IOG>B&'"@PW+;M+;ZEM+Q=.X]D]9[ Z?5Y'.XM5]$J^O%:^%YYV!L&GQ][$
MF9:L@5?OX9#PT *%!C%N(DJLJ.8/2MQO[$2_91MAL^9+F&K(T]]J:PJ4_I>)
MJ*+2LO5Y1Q*PO#CM9Q<?7A67N>ZT,[[*:S^2B?GK!*?#4@#2U9,@:F(1F%@R
MAACL]CWFLNW!GS?MG^AA%)1+3#33.PRU#L\.Y_V3#<'3CJQ?\K%SFZ:$K*RY
M8)&- :1R5QAB2>/X^/(K%Q\:D/KZ81E488%7+HDRC<F2+@FCYX]=-QZ:[UUN
ML)+U.ZR#K[1LL2L]O)ZDKT^WNN.QV)6VW,10.00L:,Q%F0'Q4'+T7+11(V-C
M;,L20!-GNJN@K5XMECA#?;UL!+5G!N*<HNG^OD5<0FE:[C%<1AZ9?2,D-C0_
M5IDS(B2;9!_(#KY398B=..FS)BS6+F';TALQ8,&/F/)L6B"(-MW.2N#]4UG?
MY?S#_;Y#E5UQ7R1V?!_!(W(4< < < Q?/']\5SLCTLL?K'4/3L$8,6*-.-[V
MM]U\'R.30\I!F>3$:B532?4%LTW?"9R^S(CDK',3 8^,:1V)/!Y%GDPFXT'7
M]/!AQ3M.EE6'-Y+P?A]B.V9"M5KC[1]JX=V,3O..U[8-8QFNJ,&4W!JBC)<$
M[,J#0;MPY=6!,MI,U-A7+UQ8.[<H#4#Z,F[)NHX(;*C&*)A*(U<OQT)8B71[
MI_!K9F5\QGK93K&ZY_*"$SE5K.8,$+V _DQ5;S)(HUE1IJ0,A=GKK_NG+4&[
M&LE7.<N-FV5LYWX)+B)<:2X*J."#@#@#@#@&/-XS_9WL10=DT^$I:PI7#TIG
M!I<DTA<=D30.;O.6H0ZW]V58UJ[65T5B-CXW;"38N9[BI<U]_MX($1CY0Z\!
MP2S!O DYG=RK5ZTT34EF@SXD'=I?UDAG:0[(MBIJQ@$<9PZ4CF!&ZY %;]HD
ME>NM3./CJ5)0ZY*Z<-H6HO9#EK*1TQ=MJ,3CL=FV#4,"=N9[OX>-:<7K957%
MHO-/MAO5.L+)3+TW3_Q&NZKYT_U&]F3DK1/F)I'HX]A$U#"&-U/AJW8G=6H>
MOZ:MP'D8G:M.ZX@V\JG3HG9@>7M@],IL4)-F1Q[7NS1LX<]W)/9KBI6;12LU
MOL[33Q&NZ9AKKHQ[1GK,5DFTP&@\U-,!$>?W0L%/6OZL$H1%W=1W>*V!3;+>
M*YL.2/A$Q;3$"$KQ88UEK8VVG/:A[\DA7B(B9JE3.D5:>:BUX2RE_"MN287Q
MU CEBSNU8G<\B?3RSABT\A2[=8$\8!ID38"!*.$+4M[*;B."TF@%QNO)4EG^
MX_!;&LA;D$)],1G%>T2DX?\ Q%QK@R. . . . >>S<;#?YUV_A,(7QOO;DH6
MTR\/HY=9;(&:&U>OZ]QI)%/=W4MWE%9"U1V-V_KF#+W3 QWM&MAL'>^]CJFM
MU$H[N'"^Z:)RIGI& M!1%@#VW'H-L)Z0G5-S#WFB0+"&X.KU'*4.T\^W4&]*
MRV4'"\D:>T9[Z/2[EML$VRT4:Y%BKG?&ZN>:Q/X<R[FV;,]UVKM=0'[7'KNT
MD=G)#1N)09(!HMNNW"([;.LL>ESKR;G9ZEC1/.KI_IC46KEOC7 7UJ^G&?WU
MHZ)S?(E6CQ:J=U4GG6/F&^N]M56/TVANR:CW1K@JJNI'&_I%NM4NI#WW0Y<@
MG7J+85+I:^L&7]ELJB]]]S)EBC^+O,4</CB55G2LGH4\'(M9R+J)<%.>(E&^
MX/5C<#FM.R35K7_?JH39O8&,+[18&[UK'LE!D\H.$-[(BN4-(=)Q*2>N)4!(
MI;ZHH$79J1-!J4\,/*N'K5/.MUO+IG!D< < < < < < < < < < < < < <
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MXUR<134%;#\"L^RD&-M9%MNUZ0O5D-$$PN-5FVCW;11$H]__ (7'O0GLY_\
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M?(*+&9*F.*9<+-4AS4 --RDG=43W:<LJTMI%Q7@R. . . . . . . . . .
M. . . . . . 1S3_ .J>LO\  ,1_T%ARN[XOY,X/M7/Y9H7)<$ H.M93;=GF
M%@<)B#=BJ4=LQ14\3=/"Y5A'P ,%'P3,B<D,DDLB+"8Y&X^&8/2QP\5'"AS5
M=X[12VAI*:(CBA>T]>=@35@0\&"LJO['JW2+/)W6%P0(S7D[!@YT@77A$IU%
ME-561>+2OX=D;80<!DB;/WG'3H=]NR+B7K%$5J.?K7+P[-,CXUW[Z_ K@=5
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M1#U?;P/@:4?66R?PNH/Z4\2M%W\B'J^W@? TH^LMD_A=0?TIXE:+OY$/5]O
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M2!9H[8[/AC8\?V"KEW@UB46<IU3]S5F7#>#(X X X X X X X X X X X X
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MA6=GQEA*HD?9^G7#D>^UVU5:O6V__KC3(EZDZ$'@[S5)^%-,7XD@B@]9N$=
M::;3NB5^"#@#@#@#@#@#@#@#@#@#@#@#@#@$<T_^J>LO\ Q'_06'*[OB_DS@
M^U<_EDC<AH< < < < QXO$\[0]=3MK1R' BW@<7#*:T;RB*6,'\16T(RE8U:
M29(JUPK%XT*3A\V=B&BOL5E)$Q([BG.A)NVQLT5]7.^@Z8<+O'ZBM#PK_G(K
MA\'Z!CJ[Z+P,((LOKM: LE/[ME[$CU.(IF^O<21FMO3*4[5G6![*#9^:CE<K
M%58FV=F$$RC7(W80M[1$:W5W&<?W.C5ONO1*KWN_,M$>)?7\&@_B%VE:MP=<
M?#H['Q^UJ8I ="1W>7N]4]&2V%;P',W'GG=;PBP!;]R.A<D=%D$B641SG4A)
M@3\JB<QAZX$,DI7<&L.)K#">).77#AF9B]559:+B9&G5%X"(=8NO;Z+Q6NX-
M&W=,ULX PNHI4-G-5Q,0K$1.X^.UQ- S5D(ED'#-<I#XO(Q;-L/-!4&9%F@D
MW<)Z8&'=S,R[T?-9,HO["^%C$K:NZ9=AZ>[3]MNF=EVFQC["Z5^LEFCHI%K<
MVBXM,"!D4NBI^.R(9K-P\>;MP8V5B?=[A!@CZR[5T\6<.UA5BA0TL25I5JSD
MT_P59]1>KE.]0:6%5'2BIXM'%C4@F\AF\QDZTWGEG3R9/]BLMLB?3-?71242
MZ4/\X<$BNJ39M[-%JR'M&0YFT:(C+<E3G ' ' (YN#]4UG?Y?S#_ &^0Y5=<
M5\D=GP?P2-R%' *+?$06\KTRO)_ZYIM[I"1TU@E'S6\=* ,A)O&"V)0D;3F5
M<J#6T5RR^)"3E.QJ[4U&BW>J<_A6^VLG%"JZ]G=SM^&8*(:1:(X":ZS4BLBI
M'8Q/=-8X>^'%) C'-J.RAV0K_=._HCM!>H$0V@K!4[U^:J0C;?2 QM1&KX'O
M7 UYU#GOOM,SNU>GM4L._$YGK5MN3:298M%5_C Z,SOHYLA)P[E>VHI_A(/"
MF3?M %%H]BA>!O3A+:-BA3RFT ;S8CN !L$QYG:.#(=5M,S3C%8LU78^U_5_
MLVE%=9*R379HQWQ-B#K(S FR4W X_LV%A-6@9^Q;=FGK)#L(YV0Z7;[-A@<7
M42(P)N-<J,F:.(QAX,ATU"]9XTCBDX3VLMI5A1>]Y/P0)0BOW9-A,6&!<*/J
M(F1W2&$WF"4^D6I>PDR>ME1DKI>TQU;4#,66["2U=!]1DJ3C[0GDQA@/2-M+
MAMP9Q_:J4F_%-M.EYO7+/++MX.8X X X X!B_P#C^ZZ;V/0S;+EAME_7DH04
M%3(7OO41%+26B$LXLLW@2MA@HCJ]56@C?4RRV<2Q-NEALX4<((N1O!G6D//Z
MK?M4[E)8-_Z'Y,<CN2<E-CCA;7=M.XAEH/DB+=:&I^GLMJWKS.0\J ^\UMJ*
M$88;;%4$@NB8Y[L78-I:O[^#:BULXGBOIJWE55OQ 9MH8(L4]E!YO$D=5\\6
MS/X9Z"$V;L5J4VW/=D6J-/R/:-W3%-CJFU%0Y,-MFQ\I F.D9MG6P!@F_P"/
M/Q[/M&*I7I:5$4G[6L5J0Y=F[0?<-%?%&L.:J(:S_P"-\5X?W;73#-FF]DH-
M)!U533L+L4[^2DRR*[-PO25N$*%K5-[+M[9T(#0B4:NY*\Q=?]_EM_N=(R]I
M*RBU[/\ ^5JJG\GN=5'TY@O@I*Y>=%(:6V?G#F3TB?'LRF9"-8[8\R][QJ)/
M?BVT(YK&XCL)GQW"OFS;E4,^5EB>S*=[V%=F95\\[+ISQ7?JY;NG!6+M7!D<
M < < < \\N_QV8]:W8+;#"*U]B*6A?\ :"C@&AF0*UPDZ>]@4,]E0/M84PUD
M$_*9;+HJ4^FJ#]Q*CX^Y5^&$0"ZU=CLIIG9<;/943.&E6JN'36/SZ2PAF>7W
MR"CZL%3E-K>]1S7*ZE,XD@;MCICM0(8[  FTOE4S53\NG3Z>62T->M80\2]D
MN'V2@0*D=*I5C9G#?)NZJ[.<OB2;IQE"9+Y8PFL-H8O8MG)KM$MS^:1UD^W;
M;3': :U;*M,S1.U=]DQXZHV+=/:'X=5CAKCUQ <=P6&W=OJFVH^F8A0LZ3>*
MUE2LT]6%YP'7W-#06D,MDM-M-&1!)\VI;:=R_LCA.]7/L3GJ3@'>.KY%K#:\
M1244A?Q)7FR"A[;0./G GA++ZFDJ)TAX=4LM3T(^#B. . . . . ?F<8SC.,
MXQG&<9QG&<>G&<9_NSC.,_W9QG'_ )QP#$YN7O/0'@C>(A7O4:L)(45ZZ]F;
M8>WKV.K1ZBS)1/J:C:X=:+ &E-H"VWO./AY-/--[?G4,<8>M@<28B&D+$LDY
M.HHN]_X=5AQ?J)O^*A;XR=\N[61=YISQF.@]Q6A%:+Q8D[J:])L;9QN,4_?5
M*VW4$R+GB+G5F/$LU)9#VL97(OG>^C5JR1D2CE5RHFAA+VJJ>NPP\&)5BEZ-
M.G)LNE[*::[::;;Z:[J9SJGKMMC&RF==<[[8TUSGT[YUTUVVSC7&<XUQG;/]
MV,YX,GWP!P!P!P!P!P!P!P!P!P!P!P".:?\ U3UE_@&(_P"@L.5W?%_)G!]J
MY_+)&Y#0X X X X!B,]][7C48[)6U 8CV+'26<1"R9G*KG>5+X)=9]NV501R
M=)@I! X):]G+G1WFY% P>A-R=E&BQ>0R+!OTR(:**!]F697+NO[1TPIPM]IQ
M[,UAPJ9E_P#\-Q<&1Z:U ?C%ZUSV2C,I:R.2@+@JFC8WUPALE&EY4:7T:-J<
MBKAP-AI>-KX7C4F8N/+FMI&)**'V+ SL^9HTQBNY4;G7N8V'B!3_ *#6UW5[
M'VA'NWW09_:$%<TCZ\#[E5;(99"UYY5L2N6FY]4B<NCVSPL5K Y"; .$YM%!
M(?0D!NR*0$X@JKNB@_&CIAVX2C'#SPS9PT^44;NG>ADR^'$DR0Z =*T!DK=3
MD6CU<HU(7,7D>6BCB2B]*XCVHTSM'76=G8E-\QP@L@V>[J/?8;)J/5%'2BRF
MPYXON>572^>I:P\?R S@U%NODS!772M11G09V!HHB0NJ[']0,HQ).RL4A]>I
MW'#A+'13:U997]4(7/%482BBX,-A]GO9 #0RN-=*)C6!W4.Z=%,K#6'54F&W
ME!6AX0U(IT-UJL.(A=H6*KU]V?O@G5%=P&S$K; U% 1<B:09&OEY>V679_$N
MLFATGF$R M=]?AF6RXT">(-";!\T0$Q.7+O"JU#=+QPSSN74.#(X X!'-P?J
MFL[_ "_F'^WR'*KKBODCL^#^"1N0HX!17XBF^R/2V^G>FB^5!T:#EDEV[A=M
ML.5$R^.$TC*VS4[%G:S,&HTU,$&+.41EZ18L7 ]G(@;ERD4:BX;KWWOP=C!6
M9FW.ZC+&3BSM-T!"V4MJU3*B]CJP;:N54.R@S.EN!\ :,%;@6BICK\BJ*)$=
M6.-F<: ;- B]4-WOM3M9I<MV<J-5PI%[S^:F7+1J44V($!OK>]K26>$21)VQ
MV=K!6S;'995@G>3?&O6U;1L@R7H'W8=+.ULH).$Y4DBRBK<2$DFL.FF44MOG
M:RA-IGR\-+J-=5%2A!3W;LVM'+O0V3R/CBZX2<-=.RTH'X[$$<$.IY;#S5@)
MHA 1@D-6?8:Y:M$SFD/O4:B%9)QHEQPV^Y?RX7+RW@D23;?NX=!J2E@DL5I.
M;2I2#%R[LW81')ZSSIOYK,SV_82P4\T58&'^ANIZWW;3/>#(OG4A6%@5ILCV
M![/*^^Y]CGCMO3BT)4M:]>:B]%ARZN#F. . . . 8O\ ^D N&3>Q* V<J"TO
M5@DC]IM.W:>M.9PK/HFD@G8S53=?3WHKC+O6N%-ASC&\FPLK[1/1@KND-X,^
M5K\NM=S+ B;AAY\=YG;VVB9!IH_:6*JGH,>;>UK##9'M&MN+(Y'V8AJH0VH5
MHX0-[+MET-4,M=6"Z),;R=U&BM>-G./Y1:N<-_0;5ALZ0\VQ$&/,.JY7(-[%
MRW:OS:NJO7_*I#M+E6&2'47V0;9=F,49'W#4\L0<%]$-=)%HDL.M &Z7I#><
MJK^UYJ:O)<(/F),VA-Q%4GHEK*U2RU:NRFMUZY'/)D_2?]7,JR_LMHI6T]W#
M]PA.A21MJ0ARB=@NCZ$Q=I:MIZD]<1OM8]]YFK-[Z*$]&OI_UMM.GC,-\$W?
M"_1*(//:%WBA&4%B3DU+FV@ZRY0^? 8LY(2NVPVC =D+9LD?J.2\H8*IEUME
M73=^M.K54>[6Q.!RQ_=7^J.*;O85E=NX,#@#@#@#@'GE]@AFL9LWL:YV!8@&
M8G95]63LO$PNLG;U1KL0[+ZI=EHZM\M$?BB[R>T;W3F=))E02<$8 )B44C-2
M_+QT<ZQ#LK*LTK+O;Z4ILWGG1RIK'4H8[!T9BOLT)17>%IRNRL%-1&K[%,Y)
MB.WJ6.R\>8YKR/;6%9UB9CF&=@4?[#&:^; + 5WB<)WK[3^RN*N,RHBD-+96
MS.Z^6]J7.C)T-(RWEZN&[ZLM80VL.QD]TVNDO:4DK(B';UFEV)2:YCJ>+#DE
ME^12:2VF$DU=*Y7:SO3$1AN8ZD(JX,]>TPDMFZB$J8H>>\E6N&F!MWUYKD,M
M&]8C:[^68T=N,/\ >FU9=+.P6N+:7TRBGM8KFX<O<:GJUT0,HULJ1E>J<=C^
MS#1@.$HU>?I76,/TIW41KUR]"K@XC@#@#@#@#@#@%-,_Z7].[7EI:?6EU/ZT
MV5.CV663DUG]$U=,9::R-'M!([):1R*+$3!'+ 4P8C&67CQ;RH]FT9(>HV;H
MIZ"R]7U*@M@@;9,6EL(%[) ]D=PB6S!IE,/NW0RU;[B],I>J/V0:[;-D=FF$
M<I(9RCIG5/.=>"%+?;3HMU<[Q!(@"[,5JI/$J])$S4"*#IE.X'(H<9,-V;4B
M3 R*OI-%S#9PY1'L=54U7B[13RJ/M6V^,9QD58GALX]T=#D^J/4R%=/X7(*_
M@%AWM/(R;DV\D8-KSMZ4V^\AR>PL>+UC,+)RQ9P0!Q-/ _S^@?#ASZ2;U^\4
M<*;.,:I@W+FG)1SH4C2Z+>-'"+/D1BL+6Z"7Q3I>;DR8B%6]7]Q4O8<1@I V
MLX&Q@3,*Y+3P :)QX(LB.V.R($KN859[$%FS99QEI@7Z(JL2>J:<\G;J5M]F
MKZ?];ZO<6</HF^>Q.S,X(%.Z]ZX0T7/K-U8$MU\.I SBI.1QG)08(T0QE^B.
M>N2>=W#;5NP63V75;B)2XE+>[=DR)^I/?FF>XY&:QR!1&^ZZG-<L@Q";0"_*
M*L2G9.!:GEW[4;E3>4ATX\175<C'R2K0,?(O&_L,JK(:(;:*["O"U$Q68AIV
MX%5+*QJ^(RTM 1\[AK^=@-6VQV%,I.$=2T+J\9($F>Q:.(/MS W5T.=-G[;+
MQFCA=DY0=)>L@LFIL,G<N . . . . . . 1S3_ZIZR_P#$?]!8<KN^+^3.#[
M5S^62-R&AP!P!P!P"Q%%^L_C#=<K5[8O.JYOPSR52=A^U-G]DA>;^T[0O;,'
MKV"SC0A,085KEF#C*:; 3$Q6J;9O@KN@Y4=ZZF';;+9-N-SA:6TL4I11J.Z9
M7+X:G6BV>IG5814=X%:S+V:M9]YV5)5Z=4DJE;-7%OW!,[.3%Q367"0L@;C1
M24JU8)M'[+;=MLALCJ\?ZZ8>+B8G+E44)=$E^"R;XD%OW!5O=BVJIJ<)%.O#
M&>1BF9V=O8-THCEP/1_7JKJ^NNW.SW9 O.3L/D4=E$D@F\5!T['JR(I+/'6)
M0[(!V"TE)CG.XUA2:EUB4E,5<0MR<RW:D4SR$>ETWL^R^HG6.PKJCB<2MN;4
M15DHL:-IB,Q[03,#<+#D#C7X=SHGM'-O/+JJ;QW=--0#NIL(4TTW9[:X&'$N
M*J7!9Q\=BG1ESSCIW"AEM5#45JSJ*]NZJK\SV6C*[OKRY$SJ"UX]G:A&PF1-
M$A5ERC!L5&.:?+LPYC,AW5E@1=+V'KMW(U@<)RFU1N&IHYSK&NE)R+COALTP
M[J"E[%)R"W:>N:P;Q[!VE?\ :<@Z_(),Z4 V%8NX/WQ#JW9>^C[]N!"L0XI9
M98Z14/ES#\H?+Z:.RV_I&<3FR:40IJX]Z6.:[9]I;<H.T^JT'AE([2:"7I?]
M8U+.+G.R6+H1>%M9NYD^CD"(B365L[$+SA9M'T'3 GM&MH,-:$=5GA,D_06"
MZ@E?<OS'O3>I([A7Y(^OE3B#<"CP656E9-KU'1%3 Y0\?#XEO8=SST+!0IF8
M/!FBA32)Q%L4(3*1MQ6NI4F(CSL2,7:OW[9T@"J_<E)U3J_>EN2ZS^P_77L
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MB[?Y]C^VM/WE'^/@R//L?VUI^\H_Q\ >?8_MK3]Y1_CX \^Q_;6G[RC_ !\
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MIH[-/G0%LUA3 F7:C-Q 15B*<+Z/U<D7#11_OJENXRGJ,.)HH6DSWH3IP0<
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M&K)$;K#W>+#R=A(I4XBA6+-24(W&&*K>8%5!AX76]RQJ6-6$BQ83!_N\>&'
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MCFPXPU62<,DM]8=,,37)-]$VES:@COK$'7HSN[V2ZKP^56')J4'=<NM'8*+
M[&LJ?6V3K*=6%.NP];34$*F=FR.73/0!-!U11>7H1XE(G3(<?UDY02V:)G7:
M>0=D][66262X^P4(SB23Q2NNR??+2U+=:7E3'B7:TC!(HUM6?LJJ0I."]NJ^
MZP8I)[23.1(5>8%VM!"!B4OS)*(N9HXG,V%2MA(4G(2/:,A=%ELS,*[4WW<<
MHU)/-B>SO5J:6'.;.MM6,B)K'>Q(H[912^K+MD.=&$ITPM03V28T7+0>T&ZY
MANGO6N-6 /5C$&3W!3Z>R."UJYV-:.XS('8DIY:422I6FK;<9NE=RNF]<KDJ
MZTXB[!5MI8 G:I]@,$/Q"VH=8<$LN-^I& Y:,JR8':0L5,GFA^+/Q1AA)7R;
MW0Y[=WAP15-L335D,OV(_!4+P!P!P!P!P!P"CR^.BO7SL9+GTTL0;.VQ.2PL
M?6=EL8):5A5U'[GK$23*F!==7( A<B"B[$B+![()'HV'G6ZR^HN326/[.]H_
M(3 IZ*FU;C:J>J=U[F=UL+JC2=IAK3CDX!2 O'[>%UP,D8/2>3@:) [U&[W)
MUR;K,>,D#-I4\HBIK#*0CY16Z48/;2$, -.7ZY$$*<-1)CW7VQRE#]<*VZ[C
MY>E!]I@;D-BR1*76+85DSB3V59$\/M PV-BG<GFDP)%##MJ!C8<5'X\&;K-
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M#6XF$!$<DW#L0%):BLPI<*^;E9;R:_#@O"<]A.J47L.QI/I,96G/KJA:LA>
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M7<1.5#Q2Y!%YP794WF&DZ1G%*_,'6:V\02T(D%BI6SX*2GW8&=].O#8)QR$
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( X X X!__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
